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Dear reader, 
Before you lies the result of three years of research. But not only of three years, the findings 
are inseparably connected to earlier experiences and acquired knowledge of others. 
Similarly, all within a person is connected: the outer world is reflected upon internally. It is 
observed, interpreted, and remembered. Experiences are linked to emotions, earlier 
experiences, and to experiences of others. All this, originally, so that in case of threat, our 
fight-flight system can operate more efficiently.  
In our Western society, however, threats nowadays are more often social or financial than 
physical. Mankind has become the dominant species, but at the same time has become so 
complex that there seems little grip on the exchanges between the outer- and inner world. 
To what extent can we be conscious of all the steps leading to our reactions?  And why 
worry about those internal processes?  
Sometimes, reaction patterns can be conflicting desires. Someone reacting externalizing to 
stressors can push away those around him or her, where he or she might actually want to be 
heard and helped. When struggling long enough, such internal conflict can find its way to 
psychological healthcare. People can be struggling with work, family, their past, chronic 
illness, feelings of powerlessness, all of which can be expressed as anger, anxiety, or sadness. 
Often enough, thoughts and behaviour do not occur to the person suffering: these are logical 
consequences of the situation. In psychology, one looks how childhood, acquired patterns, 
current coping styles and current problems are interconnected. In the development of 
psychology, different schools have emerged that offer different causes and solutions of 
problems, also known as the three generations behavioural therapy. The behavioural school, 
the cognitive school, and recently, the meta-cognitive or mindfulness school. As often in 
history, they build on each other in their development and their search. Behavioural training 
and exposure can help with certain emotional problems, but not all. Thoughts are involved: 
questioning and challenging those brings us closer to the subconscious steps leading to the 
issue. After all, making the subconscious conscious gives us the possibility to choose. Where 
cognitive therapy concerns a verbal treatment and focusses on the content of thoughts, 
mindfulness returns to the experiential approach, aimed at the attitude towards thoughts.  
 
History of mindfulness 
Mindfulness has a millennia old history in which people studied the capacities of 
concentration and awareness 1, 2. These techniques of meditation, contemplation, and 
inquiry have been passed on from teacher to teacher, in life-long journeys in search of 
enlightenment. This was a religious path, chosen by monks spending their lives in 
monasteries. But slowly these techniques of training awareness, encompassing pains and 
discomfort in observation without judgment, and being able to see the coming and going of 
experiences in the here and now, raised interest in the West. Western society, where 
everything is future-oriented, aims at prosperity and making everything better, faster, 
higher, stronger. There is no time for standing still, stagnation is even considered decline. 
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Our focus on the positive and rejection of the negative can create marvelous inventions and 
scientific advances that can help a great many people in their daily lives. For some 
individuals, however, improvement is no longer an option and even stagnation would mean 
relief. Mindfulness teaches that thoughts are not facts, and that what comes, also passes. 
Especially the de-identification ‘I am not my thoughts’, offers an extra platform to cope with 
not-helping thoughts: do you follow their first impulse, or do you choose a different 
direction? Based on this theory, Jon Kabat-Zinn started integrating the old techniques of 
observing, non-judging and acceptance in the care of chronic pain patients who had not 
improved with traditional medical care 3. He adapted the Buddhist teachings on mindfulness 
by removing the religious framework, and developed the structured eight-week course 
Mindfulness-Based Stress Reduction (MBSR) 4. With an intensive schedule, participants are 
trained in noticing what happens internally: from awareness of bodily sensations, to changes 
in emotional state, to eventually being able to observe one’s own thought processes. Five 
main skills are taught: observing (noticing, or attending to thoughts, feelings, perceptions, 
or sensations); describing or labelling observations with words (for instance ‘an itch’, 
‘anger’, or ‘memory’); non-reactivity to inner experiences (‘I see the anger but I do not 
have to go with it’); non-judging of experiences (‘it is okay that there is anger’), and acting 
with awareness 5. Especially describing, non-reacting, and non-judgment were found to 
contribute significantly to and independently mediate the relationship between mindfulness 
and well-being 6. Offering this program to his patients resulted in significantly less pain, 
mood disturbance and other somatic symptoms in patients that were otherwise considered 
beyond help 4, 7, 8. Mindfulness did not take the pain away, it provided no cure. But it did 
seem to give patients a way to self-regulate their reaction to the pain and be more aware of 
moments in between the suffering. Could it be that by accepting pain as a coming and going 
experience, their quality of life improved? How would that link between attitude and 
physical sensation work? The results of Kabat-Zinn’s studies evoked a chain of applications of 
secular mindfulness in healthcare. In recurrent depression, Mindfulness-Based Cognitive 
Therapy (MBCT) seemed to enable patients to break the negative spiral of thoughts often 
leading to relapse 9, 10. Subsequently, mindfulness was incorporated in the supportive care of 
burn-out, cancer, and addiction patients, and it was introduced in schools 11-14. MBSR and 
MBCT were registered as evidence based by the US government in 2012 15. 
But what do we know of all these applications’ effectiveness, is it just a hype or could it be 
that this third generation of therapy really offers a new step in treating and preventing 
psychological problems? And what about physical problems? 
 
Aim and outline of the thesis 
The aim of this thesis is to gain knowledge of the effects of offering the mindfulness based 
protocol in chronic patients, the neuronal working mechanisms underlying these effects, and 
future fields of application.  
 
 
By performing systematic reviews and meta-analyses we summarized the evidence of 
mindfulness-based interventions in health care. Within a large population based study we 
evaluated the correlation between meditating, psychological functioning, and brain 
structure. Additionally, we aimed to assess the long term effectiveness of an online 
mindfulness training on exercise capacity in cardiovascular patients in a large randomized 
trial. Combining these explorations, our aim was to provide insight in the connection 
between psychological functioning and physiological parameters, by linking psychological 
effects to changes in the brain and in cardiovascular health. Finally, two pilot studies were 
performed. One on walking in nature as a pragmatic method to sustain the effects of an 
eight-week mindfulness training, using detailed Experience Sampling Method to examine the 
relationship between mindfulness and mood from moment to moment. The second pilot 
study assessed the safety and applicability of an adapted mindfulness protocol in Borderline 
Personality Disorder patients. The possibility of double blinding in psychotherapeutic 
intervention studies is discussed to further improve this field of research. 
 
Part I of this thesis will give an extensive overview of current scientific literature on MBCT 
and MBSR RCTs in health care (Chapter 2). In which chronic patient categories are these 
techniques being applied and in which is the benefit such that these interventions can be 
indicated as supportive treatment? 
 
Part II of this thesis aims to evaluate the effect of MBCT and MBSR on neuroimaging 
results, to discover the neuronal pathway behind the changes found in Chapter 2. Chapter 
3 summarizes current scientific literature on the effect of MBSR, MBCT, and aspects of the 
trainings on brain activity and structure, focusing on structures known from traditional 
meditation. Chapter 4 reports the use of meditation and yoga in a well-defined suburb of 
the city of Rotterdam, The Netherlands. Although less specific than the standardized MBSR 
protocol, we aimed to assess the association between these practices, experienced stress, and 
amygdala and hippocampal volume, both cross-sectional and longitudinal. 
 
Part III aims to evaluate the effectiveness of mindfulness in cardiovascular patients, to 
further add knowledge on the link between psychological training and physiological outcome 
measures. In Chapter 5 we systematically review the literature and pool results on the 
effectiveness of different meditation styles in patients with cardiac disease and their effect on 
several clinically relevant physiological and psychological outcome parameters. Chapter 6 
summarizes the literature on yoga on these outcomes in cardiovascular disease. Chapter 7 
and Chapter 8 aim to evaluate the execution and assessment of a 12-week online 
mindfulness training in a randomized controlled trial in patients with structural heart disease 
conducted at the cardiology outpatient clinic of the Erasmus Medical Center, Rotterdam, 
The Netherlands. Although longer than the standard 8-week MBSR protocol, this online 
training was less intensive and had no teacher contact hours. The goal was to test a pragmatic 
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self-help training that was easy accessible and low cost, and that could be beneficial when 
added to standard care. Main outcome was exercise capacity assessed with a six-minute 
walking test, to see whether learning to cope differently with stress improved physical 
functioning in a population at higher risk of physical consequences in case of stress. Chapter 
7 describes the effects directly post-intervention, and in Chapter 8 we discuss the long-
term effects one year after inclusion.  
 
Part IV aims to explore future directions of mindfulness research. Chapter 9 is a pilot 
study focused on how to sustain the beneficial effects of MBSR and MBCT, and it takes a 
closer look at the relationship between mindfulness and mood. Chapter 10 is another pilot 
study, exploring the feasibility and effectiveness of an adjusted MBCT protocol for 
Borderline Personality Disorder. Chapter 11 discusses the possibility of conducting double 
blind trials in psychotherapeutic interventions, in order to improve research on this type of 
interventions. 
 
Finally, in Part V we will reflect on, and discuss, the most important findings of this thesis. 
In which chronic patients is MBCT or MBSR recommended to add to current standard 
treatment? How does training in mindfulness affect physiological parameters related to the 
brain and the heart? Which forms can this training take to be more applicable for other 
patient groups? Concluding remarks and future perspectives are provided for clinical 
practice and research.   
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Abstract 
 
Background: Mindfulness-based therapies are being used in a wide range of common 
chronic conditions in both treatment and prevention despite lack of consensus about their 
effectiveness in different patient categories. 
Objective: To systematically review the evidence of effectiveness MBSR and MBCT in 
different patient categories. 
Methods: A systematic review and meta-analysis of systematic reviews of RCTs, using the 
standardized MBSR or MBCT programs. We used PRISMA guidelines to assess the quality of 
the included reviews and performed a random effects meta-analysis with main outcome 
measure Cohen’s d. All types of participants were considered.  
Results: The search produced 187 reviews: 23 were included, covering 115 unique RCTs 
and 8,683 unique individuals with various conditions. Compared to wait list control and 
compared to treatment as usual, MBSR and MBCT significantly improved depressive 
symptoms (d=0.37; 95%CI 0.28 to 0.45, based on 5 reviews, N=2814), anxiety (d=0.49; 
95%CI 0.37 to 0.61, based on 4 reviews, N=2525), stress (d=0.51; 95%CI 0.36 to 0.67, 
based on 2 reviews, N=1570), quality of life (d=0.39; 95%CI 0.08 to 0.70, based on 2 
reviews, N=511) and physical functioning (d=0.27; 95%CI 0.12 to 0.42, based on 3 
reviews, N=1015). Limitations include heterogeneity within patient categories, risk of 
publication bias and limited long-term follow-up in several studies. 
Conclusion: The evidence supports the use of MBSR and MBCT to alleviate symptoms, 
both mental and physical, in the adjunct treatment of cancer, cardiovascular disease, chronic 
pain, depression, anxiety disorders and in prevention in healthy adults and children.  
 
  
 
 
Introduction 
Chronic illness is the largest cause of morbidity and mortality worldwide, causing 63% of all 
deaths1. Often there is no cure for these illnesses and patients face a high burden due to 
symptoms or side-effects of treatment. Consequently, stress, depression and anxiety are 
very common among these patients. Equally important as finding cures are efforts to provide 
chronic care and teach patients coping mechanisms to improve their quality of life. One 
adjunct therapy in chronic care that has gained popularity in the last 40 years is a secular 
variant of mindfulness.  
Traditionally, mindfulness has been described as “a state of presence of mind which concerns 
a clear awareness of one's inner and outer experiences, including thoughts, sensations, 
emotions, actions or surroundings as they exist at any given moment” 2,3. Unfortunately, 
such classical descriptions of mindfulness do not easily lend themselves to scientific 
investigation. Core components are usually described as follows: ‘full attention to internal 
and external experiences as they occur in the present moment’ and ‘an attitude characterized 
by non-judgment of, and openness to, this current experience’ 4-6. Recently, Goyal et al. 
published a review of mindfulness interventions compared to active control and found 
significant improvements in depression and anxiety7. However, they included quite a 
heterogeneous group of meditation styles. Although the history of mindfulness as a way of 
life goes back 2500 years 1, a standardised version of mindfulness interventions for Western 
health care was only recently developed. In 1979, Jon Kabat-Zinn integrated mindfulness in 
his treatment of chronic pain patients and showed how changing the way patients relate to 
their pain can change their experience of pain 4. His program, known as Mindfulness Based 
Stress Reduction (MBSR), spread quickly to other hospitals and other health problems. 
Teasdale, Williams and Segal converted MBSR to Mindfulness Based Cognitive Therapy 
(MBCT) for the treatment of depression. Since their initial promising results (50% relapse 
prevention in patients with 3 or more episodes of depression), studies repeatedly confirmed 
the benefit of MBCT in depression 8. Subsequently, both MBSR and MBCT were well-
defined and introduced in the care of various chronic conditions; MBSR, focusing more on 
the physical level of stress, found its way into supportive care for cancer, chronic pain, heart 
disease and fibromyalgia, whereas MBCT pays more attention to cognitive aspects and is 
used in the treatment of depression, anxiety, burn-out and eating disorders. Since 
mindfulness as a life style intervention is unlikely to have dangerous side-effects and can 
reduce stress, a risk factor for both mental and physical disorders, it is also being used in 
prevention (e.g. in education, parenting, the work place, pregnancy, and in prisons) 9, 10.  
Despite the expanding application of MBSR and MBCT, the evidence for their use and the 
appropriate indications are debated. The aim of this study is to provide a systematic 
overview of the effectiveness of MBSR and MBCT in different patient populations in order 
to identify the patient categories in which these interventions are indicated.  
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Conclusion: The evidence supports the use of MBSR and MBCT to alleviate symptoms, 
both mental and physical, in the adjunct treatment of cancer, cardiovascular disease, chronic 
pain, depression, anxiety disorders and in prevention in healthy adults and children.  
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their pain can change their experience of pain 4. His program, known as Mindfulness Based 
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used in the treatment of depression, anxiety, burn-out and eating disorders. Since 
mindfulness as a life style intervention is unlikely to have dangerous side-effects and can 
reduce stress, a risk factor for both mental and physical disorders, it is also being used in 
prevention (e.g. in education, parenting, the work place, pregnancy, and in prisons) 9, 10.  
Despite the expanding application of MBSR and MBCT, the evidence for their use and the 
appropriate indications are debated. The aim of this study is to provide a systematic 
overview of the effectiveness of MBSR and MBCT in different patient populations in order 
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Methods 
Inclusion and exclusion criteria 
We performed a systematic overview (based on Cochrane guidelines11) of systematic reviews 
of randomized controlled trials (RCTs) of the secular mindfulness techniques as Kabat-Zinn 
and Teasdale, Williams and Segal designed them (MBSR and MBCT, respectively). Although 
MBCT focuses more on cognitive skills, both MBSR and MBCT are delivered in an 8-week 
group course designed to cultivate the same non-judgmental, moment-to-moment 
awareness and involve the same meditative exercises and expectations for home practice, 
and were therefore judged to be equivalent in approach. 
 
To be included the studies had to have the following characteristics: 1) be a systematic 
review of 2) randomized controlled trials with 3) MBCT and/or MBSR as the intervention 
4) performed for treatment or prevention and 5) reporting any health outcome measure. 
Other types of mindfulness or meditation based techniques, such as Transcendental 
Meditation and Attention Control Training, were excluded. Also, articles that combined 
other types of interventions with MBSR or MBCT without calculating the effects separately 
for mindfulness were excluded. When reviews reported RCTs as well as other designs, they 
were only included if they reported the RCT results separately from the non-RCT studies. 
We also performed a separate search to check for RCTs published after the most recent 
systematic review. Unpublished dissertations and conference papers were excluded. As the 
aim of this study was to define indication areas, we did not restrict the search by patient 
population, publication date or number of RCTs reviewed.  
 
Search strategy 
Six electronic databases were searched: PubMed, Embase, PsycInfo, Cochrane Reviews, 
Medline OvidSP and Web-of-Science. The databases were searched for English language 
publications using the following terms: “mindfulness” or “meditation” or “mindfulness-based 
stress reduction” or “MBSR” or “mindfulness-based cognitive therapy” or “MBCT”, in 
combination with “RCT” or “randomized” or “clinical trial’’ and “review” or “systematic” or 
“meta-analysis” (see for exact search strategy S1 Table). 
 
Study selection process  
Reviews were independently selected by title and abstract by the first two authors. Any 
citation considered potentially relevant by at least one reviewer was retrieved in full text 
form in order to determine whether it met the selection criteria stated previously. 
Disagreements about the relevance of particular reviews were resolved by discussion with a 
third reviewer with methodological expertise. A log of rejected reviews along with reasons 
for their rejections is available in the supplementary material (S2 Table). 
 
 
 
Data extraction and quality assessment 
The systematic reviews were evaluated independently by the first two authors for both 
content and quality. They extracted data based on the PRISMA guidelines for systematic 
reviews12. If information was missing or data were incomplete, the authors of the review 
were contacted or the RCTs concerned were retrieved in order to give an overview as 
thorough as possible. To assess the quality of the systematic reviews, a checklist was created 
using the validated PRISMA guidelines12 (for items see Table 1). 
 
Table 1. Quality assessment items based on the PRISMA criteria for systematic reviews.  
Ite
m 
Question Item on original 
checklist 
1 
Was the objective of the review explicitly described with 
reference to the participants, interventions, comparisons, and 
outcomes (PICO)? 
PRISMA item 4 
2 
Were study eligibility criteria (inclusion/ exclusion criteria) 
and study selection process reported? 
PRISMA item 6 + 
9 
3 Was a comprehensive literature search performed? PRISMA item 7 
4 Was the search strategy reported for at least one database?  PRISMA item 8 
5 Was a list of studies (included and excluded) provided?  
6 
Was study selection and data extraction done by at least two 
independent authors? PRISMA item 10 
7 
Was the risk of bias of individual studies assessed and 
presented? 
PRISMA item 12 
+ 19 
8 
Were also unpublished studies included (risk of publication 
bias)? 
PRISMA items 15 
+ 22 
9 If applicable, was the method for combining results 
appropriate? 
PRISMA item 14 
+ 16 
10 Were the strengths and limitations of the review addressed? PRISMA item 25 
11 
Is the conclusion supported by the data, taking into account 
the quality of the studies?  PRISMA item 26 
12 Were the findings interpreted independently of the funding 
source? 
PRISMA item 27 
 
Main outcome measures and measures of effect size 
Since we evaluated the effects of MBCT and MBSR in health care in general, we extracted 
both mental and physical outcome measures. We report the summarised RCT results of the 
reviews in different patient categories in order to address which indications are appropriate. 
No primary or secondary outcome measures in specific fields were pre-defined and all 
reported effect measures were considered.  
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form in order to determine whether it met the selection criteria stated previously. 
Disagreements about the relevance of particular reviews were resolved by discussion with a 
third reviewer with methodological expertise. A log of rejected reviews along with reasons 
for their rejections is available in the supplementary material (S2 Table). 
 
 
 
Data extraction and quality assessment 
The systematic reviews were evaluated independently by the first two authors for both 
content and quality. They extracted data based on the PRISMA guidelines for systematic 
reviews12. If information was missing or data were incomplete, the authors of the review 
were contacted or the RCTs concerned were retrieved in order to give an overview as 
thorough as possible. To assess the quality of the systematic reviews, a checklist was created 
using the validated PRISMA guidelines12 (for items see Table 1). 
 
Table 1. Quality assessment items based on the PRISMA criteria for systematic reviews.  
Ite
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Question Item on original 
checklist 
1 
Was the objective of the review explicitly described with 
reference to the participants, interventions, comparisons, and 
outcomes (PICO)? 
PRISMA item 4 
2 
Were study eligibility criteria (inclusion/ exclusion criteria) 
and study selection process reported? 
PRISMA item 6 + 
9 
3 Was a comprehensive literature search performed? PRISMA item 7 
4 Was the search strategy reported for at least one database?  PRISMA item 8 
5 Was a list of studies (included and excluded) provided?  
6 
Was study selection and data extraction done by at least two 
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Data synthesis 
Intergroup comparison effects (improvement intervention vs control group) are reported 
unless mentioned otherwise. If the intergroup results were insignificant, we also looked at 
intragroup differences in order to see if the intervention had at least a pre-post effect (which 
is already incorporated in significant intergroup effects). The control group includes: wait 
list control (WL), treatment as usual (TAU) or active treatment (AT). Results reported as a 
standardized mean difference (smd, including Cohen’s d and Hedges’ g) were combined 
using software specially designed for meta-analysis (RevMan version 5.3, 2014) 13. The 
results are pooled by outcome (anxiety, depression, stress, quality of life and physical 
functioning), to indicate in which populations these symptoms are amenable to mindfulness. 
Data synthesis was performed with random effects analysis. Reviews that reported effect 
measures other than smd were excluded from the data synthesis due to incomparability 
(heterogeneity in effect measure). Since we included reviews instead of individual trials, 
there is a risk of multiple included RCTs. We therefore a priori set the maximum of double 
counting in the meta-analyses at 10% per patient category and excluded reviews that 
reported more duplicate data. Furthermore, in order to be totally transparent, in the 
supplementary material a table is provided to show exactly which RCTs were included more 
than once per meta-analysis (S3 Table). 
 
Results 
Study Selection 
A total of 299 potentially eligible articles were identified, retrieved, and screened for 
potential inclusion (see for the flowchart the online supplementary material S1 Figure). 112 
reviews were duplicate records. From the remaining 187 articles, 146 were excluded based 
on the abstract:  34 were not systematic reviews, 33 were not reviews of RCTs and 79 did 
not have MBCT or MBSR as intervention. Five results were conference abstracts and not yet 
published. The full text of the remaining 36 articles was reviewed. Eight articles were 
excluded because the RCT results were not reported separately and five were excluded due 
to too much overlap in RCTs with other reviews. All excluded articles and the reason for 
their rejection are listed in supplementary S2 Table. 23 reviews met our inclusion criteria 
and were reviewed by the first and second author. The search for RCTs published after the 
most recent included review gave 9 results, which are reported on at the end of the result 
section, together with 7 RCTs included in systematic reviews that were excluded from our 
review. 
 
Data extraction and quality assessment 
Characteristics of the study, patient population, intervention, control condition, and 
outcome measures of the 23 included reviews are shown in Table 2.
 
 
Table 2. Study characteristics. 
Author 
(year) 
Desig
n 
Population  
(# 
participants
) 
Interventi
on (# 
RCT’s) 
Control 
interventi
on 
Outcome measure 
Ledesma 
(2009) 
Syst 
&Met
a 
Cancer 
(381) 
MBSR (4) 2 TAU,  Mental health, physical 
health 
Piet 
(2012) 
Syst 
& 
Meta 
Cancer 
(955) 
Both (9) 6 WL, 3 
TAU  
Depression, anxiety 
Cramer 
(2012) 
Syst 
& 
Meta 
Cancer 
(327) 
MBSR (3) TAU, 2 
AT 
Quality of life, mental 
health 
Ott 
(2006) 
Syst Cancer 
(326) 
MBSR (3) WL, 2 AT Mental health, sleep, 
nutrition 
Smith 
(2005) 
Syst Cancer 
(268) 
MBSR (3) WL, 
TAU, AT 
Mental health, sleep 
Shennan 
(2011) 
Syst Cancer 
(215) 
Both (3) WL, 2 
TAU 
Anxiety, mood, mental 
health 
Veehof 
(2011) 
Syst 
& 
Meta 
Chronic 
Pain (409) 
MBSR (7) 3 WL, 
TAU, 3 
AT 
Mood, mental health 
Cramer 
(2012) 
Syst Chronic 
Pain (117) 
MBSR (3) 2 WL, AT Pain intensity, disability, 
safety 
Kozasa 
(2012) 
Syst Chronic 
Pain (208) 
MBSR (2) WL, TAU Depression, quality of 
life 
Abbott 
(2014) 
Syst 
& 
Meta 
Cardiovasc
ular (557) 
Both (9) 6 WL, 
TAU, 2 
AT 
Depression, anxiety, 
stress, hypertension 
Bohlmeij
er (2009) 
Syst 
& 
Meta 
Chronic 
somatic 
dis. (667) 
MBSR (7) WL Mood, anxiety, mental 
health 
Lakhan 
(2013) 
Syst 
& 
Meta 
Chronic 
somatic 
dis. (883) 
Both (10) 6 WL, 4 
AT 
Symptom severity 
Chiesa 
(2011) 
Syst 
& 
Meta 
Depression 
(781) 
MBCT 
(14) 
12 TAU, 2 
AT 
Depression (relapse), 
quality of life 
Coelho Syst Depression MBCT TAU Mood 
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functioning), to indicate in which populations these symptoms are amenable to mindfulness. 
Data synthesis was performed with random effects analysis. Reviews that reported effect 
measures other than smd were excluded from the data synthesis due to incomparability 
(heterogeneity in effect measure). Since we included reviews instead of individual trials, 
there is a risk of multiple included RCTs. We therefore a priori set the maximum of double 
counting in the meta-analyses at 10% per patient category and excluded reviews that 
reported more duplicate data. Furthermore, in order to be totally transparent, in the 
supplementary material a table is provided to show exactly which RCTs were included more 
than once per meta-analysis (S3 Table). 
 
Results 
Study Selection 
A total of 299 potentially eligible articles were identified, retrieved, and screened for 
potential inclusion (see for the flowchart the online supplementary material S1 Figure). 112 
reviews were duplicate records. From the remaining 187 articles, 146 were excluded based 
on the abstract:  34 were not systematic reviews, 33 were not reviews of RCTs and 79 did 
not have MBCT or MBSR as intervention. Five results were conference abstracts and not yet 
published. The full text of the remaining 36 articles was reviewed. Eight articles were 
excluded because the RCT results were not reported separately and five were excluded due 
to too much overlap in RCTs with other reviews. All excluded articles and the reason for 
their rejection are listed in supplementary S2 Table. 23 reviews met our inclusion criteria 
and were reviewed by the first and second author. The search for RCTs published after the 
most recent included review gave 9 results, which are reported on at the end of the result 
section, together with 7 RCTs included in systematic reviews that were excluded from our 
review. 
 
Data extraction and quality assessment 
Characteristics of the study, patient population, intervention, control condition, and 
outcome measures of the 23 included reviews are shown in Table 2.
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health 
Lakhan 
(2013) 
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AT 
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(2007) (265) (3) 
Piet 
(2011) 
Syst 
& 
Meta 
Depression 
(593) 
MBCT 
(6) 
4 TAU, 2 
AT 
Depression relapse 
Chen 
(2012) 
Syst 
& 
Meta 
Anxiety 
(1244) 
Both (13) 8 WL, 5 
AT 
Anxiety 
Klainin 
(2012) 
Syst 
& 
Meta 
Mental 
disorders 
(964) 
Both (13) 10 TAU, 3 
AT 
Mood, anxiety, mental 
health 
Galante 
(2012) 
Syst 
& 
Meta 
Mental 
disorders 
(859) 
MBCT 
(11) 
10 TAU, 
AT 
Depression (relapse), 
anxiety 
Davis 
(2012) 
Syst Mental 
disorders 
(90) 
Both (2) WL, AT Clinical functioning, 
mindfulness 
Strauss 
(2014) 
Syst 
& 
Meta 
Mental 
disorders 
(550) 
Both (11) WL, 4 
TAU, 6 
AT 
Anxiety, symptom 
severity 
De Vibe 
(2012) 
Syst 
& 
Meta 
Mixed 
population 
(1942) 
MBSR 
(31) 
21 WL, 3 
TAU, 7 
AT 
Mental health, physical 
health, quality of life, 
social functioning 
Regehr 
(2012) 
Syst 
& 
Meta 
Healthy 
adults 
(247) 
MBSR (5) Unknown Mood, anxiety, stress 
Burke 
(2009) 
Syst Children 
(330) 
Both (2) TAU, 
activities 
Social skills, attention, 
temperament, stress 
Syst=Systematic Review; Meta=Meta-analysis; MBSR=Mindfulness Based Stress Reduction; 
MBCT=Mindfulness Based Cognitive Therapy;  
TAU=treatment as usual; WL=waiting list; AT=Active Treatment  
 
Synthesis of results 
The results of the reviewed RCT’s are summarized below, categorized by patient population 
(see also Table 4).  115 unique RCTs were included, with a combined total of 8683 
participants. 3830 individuals had various somatic conditions; 4276 patients had various 
psychological problems and the remaining 577 subjects were recruited from the general 
population. Effect sizes used were Cohen’s d, Hedges g, Standard Mean Difference, 
Weighted Mean Difference (wmd), T-value, Odds Ratio, Hazard Ratio and Risk Ratio. Of 
note, most systematic reviews demonstrated a significant effect size.
 
 
The results of the quality assessment are shown in Table 3. The inter-rater correlation was 
moderate (k=0.48), and was influenced by structurally lower scoring of item 4 (search 
strategy reported) and item 9 (appropriate methods for combining results) by one reviewer 
due to different interpretation. The quality scores shown are those agreed upon after 
discussion. Nearly all reviews performed well on items related to the description of the 
objective, the literature search, and the study selection process (items 1-4). The list of 
included and excluded RCTs was not always complete (item 5). Although some reviews 
employed independent data extractors, many did not, and several were unclear about this 
item (item 6). Approximately half of the reviews assessed and presented the risk of bias of 
individual RCTs and the risk of publication bias (items 7 and 8). A meta-analysis of the 
individual RCTs was often not performed (item 9). In general, strengths and limitations 
were discussed, conclusions were supported by the data, and findings were interpreted 
independently of the funding source (items 10-12). 
 
Table 3. Quality assessment of included reviews. 
 Items 1 2 3 4 5 6 7 8 9 10 11 12 
Ledesma  + + + + ? + - - + + ? ? 
Piet (2012)  + + + + ? + + + + + + ? 
Cramer  + + + + ? + + ? N/A + + + 
Ott  ? ? ? + ? ? - + N/A ? ? ? 
Smith  + + + + ? + - + N/A ? + ? 
Shennan  + + + + ? ? - + N/A + + + 
Veehof  + + + + ? ? + + + + + ? 
Cramer  + + + + ? + + - + + + + 
Kozasa  - + - ? ? ? ? - N/A - + + 
Abbott  + + + + - + + ? + + + + 
Bohlmeijer  + + + - ? ? ? - + + ? ? 
Lakhan  ? + + ? + ? - ? + + + + 
Chiesa  + + + + + + + - + + + ? 
Coehlo  ? + + + ? + + + ? + + - 
Piet (2011)  + + + + ? - + - + + + + 
Chen  + + + + ? + ? - + + + + 
Klainin-
Yobas 
 + + + + ? ? + + + ? + + 
Galante  + + + + ? + + - + + ? + 
Davis  ? + + + ? ? - - ? + ? ? 
Strauss  + + + + - ? + + + + + + 
De Vibe  + + + - + + + + + + + + 
Regehr  + + + - ? ? - - + + + + 
Burke  + + + + ? - - - N/A + + ? 
+ = yes; ? = unclear; - = no; N/A = not applicable
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psychological problems and the remaining 577 subjects were recruited from the general 
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note, most systematic reviews demonstrated a significant effect size.
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Also, 8 reviews were included in the meta-analysis based on reported intergroup smd’s of 
MBCT/MBSR and the pooled effect per outcome. Reviews that did not conduct a meta-
analysis reporting in smd were excluded from our meta-analysis due to heterogeneity of 
effect size, but were only reviewed. The forest plots (Figure 1) demonstrate significant 
differences in favour of MBCT/MBSR. Three reviews that reported smd’s on our outcome 
measures were omitted from the meta-analyses which ensured that the number of double 
counted RCTs remained under 10%  14-16. The meta-analysis on reviews with outcome 
depression had 3% double counting (1 out of 34 RCTs), anxiety 8.6% (3 out of 35 RCTs), 
both stress and quality of life had 0% double counting and physical functioning had 6% (1 
out of 17 RCTs). An overview of the RCTs in each meta-analysis outcome and a more 
elaborate description of the results can be found in the online supplementary material. 
 
Mindfulness and Cancer 
The search identified six systematic reviews covering 16 unique RCTs performed in 1668 
unique cancer patients. 12 RCTs spread over two reviews were included in the meta-
analysis, with one RCT duplication (8%). Most reviews found significant intergroup 
improvements in mental health but no significant results in physical health16. Significant 
improvements were demonstrated repeatedly in depressive symptoms, anxiety, stress, and 
quality of life 14,17-20. Sleep quality did not change significantly; neither did body mass or fat 
consumption. A dose-response relationship was found between the number of minutes spent 
on meditating and improvement in total mood disturbance, and between the number of 
sessions attended and stress reduction 18,20. An association between the KIMS-subscale 
Observing 21 (a measure of mindfulness) and a decrease in anxiety, isolation and over-
identification was also found. 
 
Mindfulness and Chronic Pain 
For chronic pain patients we found three systematic reviews including 13 unique RCTs in 
722 unique patients. One review containing 9 RCTs was included in the meta-analysis. 
Significant intergroup improvements were found in depressive symptoms, pain burden, and 
physical health, but neither in anxiety nor overall quality of life 22. Pain intensity and pain 
disability decreased significantly and pain acceptance increased compared to wait list control 
but not when compared to a health education program. Self-efficacy showed no significant 
improvements. Quality of life favoured MBSR compared to the health education program 
but did not reach statistical significance when compared to wait list control 23. MBSR also 
improved quality of life and depressive symptoms significantly in fibromyalgia patients 24.  
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Also, 8 reviews were included in the meta-analysis based on reported intergroup smd’s of 
MBCT/MBSR and the pooled effect per outcome. Reviews that did not conduct a meta-
analysis reporting in smd were excluded from our meta-analysis due to heterogeneity of 
effect size, but were only reviewed. The forest plots (Figure 1) demonstrate significant 
differences in favour of MBCT/MBSR. Three reviews that reported smd’s on our outcome 
measures were omitted from the meta-analyses which ensured that the number of double 
counted RCTs remained under 10%  14-16. The meta-analysis on reviews with outcome 
depression had 3% double counting (1 out of 34 RCTs), anxiety 8.6% (3 out of 35 RCTs), 
both stress and quality of life had 0% double counting and physical functioning had 6% (1 
out of 17 RCTs). An overview of the RCTs in each meta-analysis outcome and a more 
elaborate description of the results can be found in the online supplementary material. 
 
Mindfulness and Cancer 
The search identified six systematic reviews covering 16 unique RCTs performed in 1668 
unique cancer patients. 12 RCTs spread over two reviews were included in the meta-
analysis, with one RCT duplication (8%). Most reviews found significant intergroup 
improvements in mental health but no significant results in physical health16. Significant 
improvements were demonstrated repeatedly in depressive symptoms, anxiety, stress, and 
quality of life 14,17-20. Sleep quality did not change significantly; neither did body mass or fat 
consumption. A dose-response relationship was found between the number of minutes spent 
on meditating and improvement in total mood disturbance, and between the number of 
sessions attended and stress reduction 18,20. An association between the KIMS-subscale 
Observing 21 (a measure of mindfulness) and a decrease in anxiety, isolation and over-
identification was also found. 
 
Mindfulness and Chronic Pain 
For chronic pain patients we found three systematic reviews including 13 unique RCTs in 
722 unique patients. One review containing 9 RCTs was included in the meta-analysis. 
Significant intergroup improvements were found in depressive symptoms, pain burden, and 
physical health, but neither in anxiety nor overall quality of life 22. Pain intensity and pain 
disability decreased significantly and pain acceptance increased compared to wait list control 
but not when compared to a health education program. Self-efficacy showed no significant 
improvements. Quality of life favoured MBSR compared to the health education program 
but did not reach statistical significance when compared to wait list control 23. MBSR also 
improved quality of life and depressive symptoms significantly in fibromyalgia patients 24.  
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Figure 1. Forest plots showing the effectiveness of mindfulness interventions compared with wait 
list control or treatment as usual on the outcomes a) Depression, b) Anxiety, c) Stress, d) Quality of 
life and e) Physical functioning in different populations. The size of the marker per review indicates the 
size of the study population. The breadth of the line indicates the 95%CI. All values lower than 0 
indicate a significant difference in favour of MBSR/MBCT. Values between 0 and -0.2 indicate 
negligible effect; between -0.2 and -0.5 small effect; between -0.5 and -0.8 medium effect and lower 
than -0.8 a large effect.  
 
Mindfulness and cardiovascular disease 
One review looked at the effects of MBSR and MBCT on psychological and physical 
outcomes in 577 cardiovascular patients in 9 RCTs 25. Depression, anxiety and stress showed 
significant medium effects (smd 0.35 to 0.50), and hypertension improved with a significant 
smd of 0.78. 
 
Mindfulness and various chronic somatic diseases 
Two reviews included 16 unique RCTs on MBSR and MBCT for various chronic somatic 
diseases (cancer, chronic pain, CVD, and fibromyalgia). In total 1331 unique patients were 
assessed. These reviews were excluded from the meta-analysis outcomes due to too much 
RCT overlap with other reviews in the meta-analysis. MBSR had a significant positive effect 
on depression symptoms, anxiety and psychological distress 26. One of the reviews compared 
MBSR to MBCT for reducing symptom severity and found that MBCT was more effective, 
however no explanation was given27.  
 
Mindfulness and Depression 
Three systematic reviews of 17 unique RCTs with 1058 currently or recovered depressed 
patients were retrieved, none of which were included in the meta-analysis. The overall effect 
on depressive symptoms comparing MBCT with TAU was positive but not significant. 
However, in participants with 3 relapses or more, MBCT reduced depressive symptoms 
significantly between groups. Anxiety in bipolar patients was also reduced significantly28. 
The relapse rate decreased significantly in patients who had 3 depression episodes or more 
with a risk reduction of 43% compared to TAU29. Treatment in patients with 2 previous 
episodes, however, favoured TAU with a risk reduction of 49%. MBCT compared with 
antidepressants demonstrated a non-significant risk reduction of 20%30. 
 
Mindfulness and anxiety 
A review of 13 RCTs with a total of 1244 patients with different anxiety disorders found a 
significant beneficial effect on anxiety 31. Interestingly, RCTs conducted in Western 
countries showed bigger effects than those conducted in Eastern countries.  
 
 
 
 
 
 
Mindfulness and various mental disorders 
Four reviews assessed the effect of MBCT and MBSR among people with various mental 
disorders. 30 unique RCTs among 1974 unique participants were included. Two were 
included in the meta-analysis without overlap as one reported on depression 32, the other on 
anxiety15. Significant benefits were found in depressive symptoms, depression relapses and 
anxiety, and a significant increase in metacognitive awareness of negative thoughts and 
feelings was found. Relapse prevention was still significant at 1 year follow-up 15. Not all 
RCTs, however, showed significant changes in relapse occurrence, and cognitive behavioural 
therapy was found to be superior to MBSR in reducing social anxiety 32. In bipolar disorder, 
significant lower depression and anxiety scores were found. In schizophrenia there was 
significant intragroup improvement in clinical functioning and mindfulness of distressing 
thoughts and images; intergroup differences, however, did not reach significance 33. In 
patients with a current anxiety or depression disorder, MBCT showed more effect than 
MBSR. Compared with WL and TAU there was a very large effect on symptom severity, 
however compared with active treatment this effect almost disappeared34.  
 
Mindfulness in Mixed populations 
We included one review with heterogeneous populations, as excluding it would result in 
missing 18 unique RCTs 35.  Compared to meditation alone, MBSR had a positive effect on 
perceived stress, rumination and forgiveness. Compared to muscle relaxation in a study 
population of 31 inmates, however, MBSR caused no substantial differences in anger, 
egocentricity, stress reactivity or salivary cortisol. Mindfulness combined with light therapy 
diminished skin clearing rates of psoriasis patients significantly. There was no significant 
effect in treatment outcomes in a study with drug addicts. In a neuroimaging study of healthy 
employees a MBSR intervention produced increases in left-sided anterior cortical activation, 
which is associated with positive affect, and significant increase in influenza antibody titres.  
 
Mindfulness in Healthy populations 
Among healthy subjects, 5 RCT’s were performed in 247 students36. Anxiety decreased 
significantly compared to students that did not receive MBSR, and although depressive 
symptoms and stress also seemed to improve, this effect was analysed together with the 
effect of cognitive behavioural therapy, so the results could not be reported here.  
 
Mindfulness in Children 
One review assessed the effects of mindfulness in 330 children studied in two RCTs. 
Significant intergroup improvements were reported in anxiety, teacher-rated attention, 
social skills and objective measures of selective (visual) attention, but not in sustained 
attention. A study with adolescents under current or recent psychiatric outpatient care 
showed significant intergroup improvements in stress, anxiety, and several 
psychopathological symptoms. The study also found that more time spent in sitting 
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Significant intergroup improvements were reported in anxiety, teacher-rated attention, 
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attention. A study with adolescents under current or recent psychiatric outpatient care 
showed significant intergroup improvements in stress, anxiety, and several 
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meditation predicted improved functioning and a decline in depression and anxiety 
symptoms. A study including non-clinical 4-5 year olds indicated significant improvements in 
executive functioning on teacher ratings, but not on parent ratings 37. 
 
Individual RCTs  
Our search for individual RCTs not included in assessed systematic reviews resulted in 16 
studies. Although some conclusions were not congruent with those in the reviews, overall 
the results supported use of the program. One RCT reports that currently non-depressed 
patients with one or two relapses benefit more from MBCT than patients with 3 or more 
relapses 38, whereas an included review 30 claimed the opposite. Note that both groups 
improved significantly in both studies, but results disagreed on which group improved more. 
Furthermore, the improvements in 39 Chinese chronic pain patients were not significant 
compared to active pain management 39 and no physical improvements were found in 86 
elderly COPD patients 40. 
Apart from these results, the other 13 RCTs demonstrated similar results as reported in the 
reviews: significant improvements in perceived stress, quality of life, symptom severity, 
anxiety and depression in patients with cancer 41, HIV 42, depression 43, mental disorders 44, 
ulcerative colitis 45, fibromyalgia 46, nonspecific chronic pain 47 48, insomnia 49 and Parkinson 
50, and in healthy participants 51-53. 
 
Discussion 
Summary of main results 
This review provides an overview of more trials than ever before and the intervention effect 
has thus been evaluated across a broad spectrum of target conditions, most of which are 
common chronic conditions. Study settings in many countries across the globe contributed 
to the analysis, further serving to increase the generalizability of the evidence. Beneficial 
effects were mostly seen in mental health outcomes: depression, anxiety, stress and quality 
of life improved significantly after training in MBSR or MBCT. These effects were seen both 
in patients with medical conditions and those with psychological disorders, compared with 
many types of control interventions (WL, TAU or AT). Further evidence for effectiveness 
was provided by the observed dose-response relationship: an increase in total minutes of 
practice and class attendance led to a larger reduction of stress and mood complaints in four 
reviews 18,20,37,54.  
 
Strengths and limitations of the systematic review 
As one of the aims was to identify how different patient populations respond to mindfulness, 
we included a heterogeneous group of populations. However, even when we categorized 
them by diagnosis, some reviews included very heterogeneous populations themselves. 
Excluding these would cause us to miss 18 unique RCTs, so we defined a category ‘mixed 
 
 
population’ representing heterogeneous patient populations. Although we tried to report 
their results as clearly as possible, interpretation of this group’s effects is difficult.  
Also, though MBSR and MBCT were considered equal in approach, the small heterogeneity 
of interventions could have resulted in some bias towards the null, thereby strengthening the 
validity of our findings of consistent effects of these interventions. Due to the nature of the 
intervention, double blinding cannot be implemented in RCTs of mindfulness, leading to a 
risk of bias. As with all RCTs involving an unblinded treatment, patients’ attitudes towards 
mindfulness alone may lead to an effect: a placebo effect in the active intervention group and 
disappointment in the control group for not receiving mindfulness (“frustrebo response”) 55. 
Whereas a placebo effect would overestimate the effect size, the frustrebo response can lead 
to control patients starting mindfulness on their own, underestimating the effect size. 
However, it might also be that frustration of not receiving the intervention leads to worse 
depression or anxiety scores in the control group, resulting in an overestimation of the 
effect. Because of the need for active participation, it is desirable that mindfulness is actively 
chosen: as bias is inherent in self-selected samples, the results might be extrapolated only to 
patients or participants who are interested in and able to participate in the intervention 16. 
This, however, applies to most types of psychotherapy: motivation for and trust in the 
technique are essential. Furthermore, some RCTs were included in multiple reviews, so 
overlap in the described results exists. However, this was not believed to cause an 
overestimation of effect as the description of effect itself does not change by the number of 
RCTs. In the meta-analysis the overlap was 8% at most, reducing the overestimation 
inevitable in reviewing reviews to a minimum. There is risk of publication bias since we 
included only published reviews, although several of the included reviews contained both 
published and non-published RCTs. Also, despite our separate RCT search we may have 
missed RCTs by excluding reviews that analysed them together with other study designs or 
interventions (such as yoga). Although most individual RCTs included are in line with the 
results reported in the reviews, some did report disputing conclusions regarding Chinese 
patients treated for pain and elderly COPD patients. Another limitation may be that the 
heterogeneity of studies within the systematic reviews may be masked within the overview, 
as each systematic review has a single confidence interval that may or may not contain all the 
point estimates of the studies in that review. This could give a false impression of 
homogeneity at the meta-meta level. 
Several reviews reported that the quality of included RCTs corresponded with the effect 
sizes 31,32, with lower quality RCTs tending to report a larger effect than high-quality RCTs. 
Some were pilot studies presenting preliminary results without confirmatory evidence. 
Despite these limitations, the quality of the reviews was generally quite high and suggests 
that the conclusions drawn from these pragmatic RCTs provide relevant estimates of 
effectiveness in clinical practice. The interventions were compared repeatedly to both wait 
list and treatment as usual subjects. A recent review compared meditation to only active 
control groups, and although lower, also found a beneficial effect on depression, anxiety, 
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of interventions could have resulted in some bias towards the null, thereby strengthening the 
validity of our findings of consistent effects of these interventions. Due to the nature of the 
intervention, double blinding cannot be implemented in RCTs of mindfulness, leading to a 
risk of bias. As with all RCTs involving an unblinded treatment, patients’ attitudes towards 
mindfulness alone may lead to an effect: a placebo effect in the active intervention group and 
disappointment in the control group for not receiving mindfulness (“frustrebo response”) 55. 
Whereas a placebo effect would overestimate the effect size, the frustrebo response can lead 
to control patients starting mindfulness on their own, underestimating the effect size. 
However, it might also be that frustration of not receiving the intervention leads to worse 
depression or anxiety scores in the control group, resulting in an overestimation of the 
effect. Because of the need for active participation, it is desirable that mindfulness is actively 
chosen: as bias is inherent in self-selected samples, the results might be extrapolated only to 
patients or participants who are interested in and able to participate in the intervention 16. 
This, however, applies to most types of psychotherapy: motivation for and trust in the 
technique are essential. Furthermore, some RCTs were included in multiple reviews, so 
overlap in the described results exists. However, this was not believed to cause an 
overestimation of effect as the description of effect itself does not change by the number of 
RCTs. In the meta-analysis the overlap was 8% at most, reducing the overestimation 
inevitable in reviewing reviews to a minimum. There is risk of publication bias since we 
included only published reviews, although several of the included reviews contained both 
published and non-published RCTs. Also, despite our separate RCT search we may have 
missed RCTs by excluding reviews that analysed them together with other study designs or 
interventions (such as yoga). Although most individual RCTs included are in line with the 
results reported in the reviews, some did report disputing conclusions regarding Chinese 
patients treated for pain and elderly COPD patients. Another limitation may be that the 
heterogeneity of studies within the systematic reviews may be masked within the overview, 
as each systematic review has a single confidence interval that may or may not contain all the 
point estimates of the studies in that review. This could give a false impression of 
homogeneity at the meta-meta level. 
Several reviews reported that the quality of included RCTs corresponded with the effect 
sizes 31,32, with lower quality RCTs tending to report a larger effect than high-quality RCTs. 
Some were pilot studies presenting preliminary results without confirmatory evidence. 
Despite these limitations, the quality of the reviews was generally quite high and suggests 
that the conclusions drawn from these pragmatic RCTs provide relevant estimates of 
effectiveness in clinical practice. The interventions were compared repeatedly to both wait 
list and treatment as usual subjects. A recent review compared meditation to only active 
control groups, and although lower, also found a beneficial effect on depression, anxiety, 
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stress and quality of life. This review was excluded in our study for its heterogeneity of 
interventions 7.  
 
Clinical implications 
In chronic care, both MBCT and MBSR help patients cope with pain, depressive symptoms, 
anxiety, and stress, which improves their quality of life. In mental health, there are more 
ambiguous results: some disorders improve, others such as social anxiety and schizophrenia 
respond better to traditional treatment. In prevention, mindfulness is valuable in reducing 
stress and other psychopathological symptoms that might otherwise develop into clinical 
conditions. In education and parenting, teaching children how to cope with stress and 
upsetting situations in a mindful way can help them deal with those aspects of life in the 
future. We also have to take into account the meaning of effect sizes in different populations: 
an effect size of 0.5 in anxiety might mean something different in anxiety patients than in 
cancer patients. In the first case, depending on the exact anxiety disorder, other treatments 
might have a larger effect. In cancer patients however, reducing this much anxiety may have 
a huge impact on quality of life. This discrepancy helps make a distinction as to where to 
apply mindfulness as adjunct treatment. 
There are several benefits of adding mindfulness to usual treatment. First, MBSR and MBCT 
are easy to implement and they allow patients to take a more active role in their treatment. 
Second, there is little emotional and physical risk involved. Third, the costs are relatively 
low as one trainer can lead a rather large group and most exercises can be done at home, 
without the help of external means 17. However, they do require commitment in both 
adherence and time of both the patient and the therapist. 
 
Gaps in evidence 
Aim of this review was to assess in which populations MBSR and MBCT are effective, and in 
which not. Most insignificant effects found were based on pilot studies using outcome 
measures that are only indirectly affected by mindfulness (e.g. nutrition, HIV, psoriasis, 
drug addiction), therefore no definitive conclusions can be drawn for these outcome 
measures. 
Since MBSR and MBCT consist of not just meditation, but also psycho-education and yoga-
like exercises, it is difficult to pinpoint which aspect contributes most to the observed 
improvements. According to psychological theory 56, stress is usually caused by an external 
factor which evokes fear, anger, or other states of discontentment. Stress is also experienced 
proportionately; the larger the discrepancy between the actual and desired situation, the 
higher the level of stress. Apart from the initiating event, individuals themselves tend to 
magnify stress by worrying about the cause and consequences of the event, which often 
evokes more stress than the event alone. Mindfulness intervenes in this psychological process 
by creating a different relationship with both the event and the internal response to the 
event. Chronic as opposed to acute conditions respond particularly well to mindfulness 
 
 
techniques since acceptance and reflection may be more applicable to chronic symptoms 
than to acute symptoms. In acute settings the undesired situation may still be altered, 
making acceptance untimely. 
Support for this theory of stress reduction by coping with psychological stress factors is 
found in the demonstrated physiological effects of mindfulness. Blood pressure, heart rate, 
respiration rate and oxygen consumption have been shown to respond favourably to 
mindfulness 57,58. Similar physiological effects are seen in the relaxation response 59, 60. It 
activates the autonomic nervous system to release endorphins and serotonin, and the 
parasympathetic response influencing endocrine and immune responses 61.  
 
Future research 
Future research will benefit from creative strategies that measure placebo effects and non-
specific effects, and distinguish these from actual effects. Nevertheless, the reviews included 
in our overview are methodologically strong and demonstrate that MBSR and MBCT are 
effective for certain conditions. Since the available evidence demonstrates that mindfulness 
exceeds WL control, future research should probably focus on comparison with active 
treatment. Further research should also look more into the mechanisms whereby these 
therapies are efficacious. Alongside investigating working mechanisms, studies should also 
explore the cost-effectiveness of these interventions: as there are few if any side effects and 
there seem to be benefits for chronic patients, insight in financial consequences is useful for 
further practical implementation in health care. 
 
Conclusions 
Although there is continued skepticism in the medical world towards MBSR and MBCT, the 
evidence indicates that MBSR and MBCT are associated with improvements in depressive 
symptoms, anxiety, stress, quality of life, and selected physical outcomes in the adjunct 
treatment of cancer, cardiovascular disease, chronic pain, chronic somatic diseases, 
depression, anxiety disorders, other mental disorders and in prevention in healthy adults and 
children. 
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treatment. Further research should also look more into the mechanisms whereby these 
therapies are efficacious. Alongside investigating working mechanisms, studies should also 
explore the cost-effectiveness of these interventions: as there are few if any side effects and 
there seem to be benefits for chronic patients, insight in financial consequences is useful for 
further practical implementation in health care. 
 
Conclusions 
Although there is continued skepticism in the medical world towards MBSR and MBCT, the 
evidence indicates that MBSR and MBCT are associated with improvements in depressive 
symptoms, anxiety, stress, quality of life, and selected physical outcomes in the adjunct 
treatment of cancer, cardiovascular disease, chronic pain, chronic somatic diseases, 
depression, anxiety disorders, other mental disorders and in prevention in healthy adults and 
children. 
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Abstract  
 
Background: The objective of the current study was to systematically review the evidence 
of the effect of secular mindfulness techniques on function and structure of the brain. Based 
on areas known from traditional meditation neuroimaging results, we aimed to explore a 
neuronal explanation of the stress-reducing effects of the 8-week Mindfulness Based Stress 
Reduction (MBSR) and Mindfulness Based Cognitive Therapy (MBCT) program.  
Methods: We assessed the effect of MBSR and MBCT (N = 11, all MBSR), components of 
the programs (N = 15), and dispositional mindfulness (N = 4) on brain function and/or 
structure as assessed by (functional) magnetic resonance imaging. 21 fMRI studies and seven 
MRI studies were included (two studies performed both). 
Results: The prefrontal cortex, the cingulate cortex and hippocampus showed increased 
activity, connectivity and volume in stressed, anxious and healthy participants. Additionally, 
the amygdala showed decreased functional activity, improved functional connectivity with 
the prefrontal cortex, and earlier deactivation after exposure to emotional stimuli.  
Conclusion: Demonstrable functional and structural changes in the prefrontal cortex, 
cingulate cortex, insula and hippocampus are similar to changes described in studies on 
traditional meditation practice. In addition, MBSR led to changes in the amygdala consistent 
with improved emotion regulation. These findings indicate that MBSR-induced emotional 
and behavioral changes are related to functional and structural changes in the brain. 
 
 
 
 
 
 
  
 
 
Introduction 
Mindfulness has a millennia old history and is usually referred to as a mental state 
characterized by ‘full attention to internal and external experiences as they occur in the 
present moment’, and ‘an attitude characterized by non-judgment of, and openness to, this 
current experience’1-3. Stripped of all religious aspects, application of Mindfulness Based 
Stress Reduction (MBSR) 1 as a stress reduction method, and Mindfulness Based Cognitive 
Therapy to prevent relapse in depression 4, has increased over the past 35 years. In 8 weeks, 
MBSR and MBCT participants learn to cope with stress by means of cognitive exercises, 
concentration training and mental exposure, using a standardized evidence based protocol 5. 
The MBSR- and MBCT protocol comprises both focused attention, open monitoring, and 
breathing meditation but without the transcending atmosphere of traditional meditative 
practice. The goal is not to reach Nirvana or Enlightenment. Instead, by learning to 
recognize automatic reactions, and letting go of dysfunctional ones in a non-judgmental 
manner, participants gain a new coping mechanism that studies have shown to improve 
perceived stress, anxiety, depression, and quality of life in all types of patients 6,7.  
Previous research on traditional meditation styles (i.e. Zen, Vipassana, Tibetan etc.) found 
that individuals who have regularly practiced meditation for several years exhibit significant 
altered brain structure, when compared to demographically matched controls8-13. Recent 
meta-analyses report eight regions to consistently show structural and functional differences 
in long-term meditators: the prefrontal cortex (related to enhanced meta-awareness and 
reappraisal), the sensory cortices and insula (related to body awareness), the hippocampus 
(related to memory processes), and the cingulate cortex (related to self and emotion 
regulation)14-18.  
Former neuroimaging literature focused on traditional meditation styles, or a combination of 
traditional and secular mindfulness. MBSR and MBCT are in some core aspects different 
from traditional meditation (i.e. duration and goal), and may therefore have different 
neuronal effects. In this article, we want to explore how the distilled mindfulness techniques 
in MBSR and MBCT, rather than spirituality of the traditional styles, are related to changes 
in brain structures and activity. We focus on regions described in studies on long-term 
meditators, but have not restricted ourselves to these areas. The current systematic review 
focusses on functional and structural magnetic resonance imaging (MRI) in order to 
understand the neuronal base of the psychological effects of MBSR and MBCT. 
 
  
Processed on: 27-10-2016
504961-L-bw-Gotink
3
Neuroimaging of MBSR: a systematic review 45
 
 
Abstract  
 
Background: The objective of the current study was to systematically review the evidence 
of the effect of secular mindfulness techniques on function and structure of the brain. Based 
on areas known from traditional meditation neuroimaging results, we aimed to explore a 
neuronal explanation of the stress-reducing effects of the 8-week Mindfulness Based Stress 
Reduction (MBSR) and Mindfulness Based Cognitive Therapy (MBCT) program.  
Methods: We assessed the effect of MBSR and MBCT (N = 11, all MBSR), components of 
the programs (N = 15), and dispositional mindfulness (N = 4) on brain function and/or 
structure as assessed by (functional) magnetic resonance imaging. 21 fMRI studies and seven 
MRI studies were included (two studies performed both). 
Results: The prefrontal cortex, the cingulate cortex and hippocampus showed increased 
activity, connectivity and volume in stressed, anxious and healthy participants. Additionally, 
the amygdala showed decreased functional activity, improved functional connectivity with 
the prefrontal cortex, and earlier deactivation after exposure to emotional stimuli.  
Conclusion: Demonstrable functional and structural changes in the prefrontal cortex, 
cingulate cortex, insula and hippocampus are similar to changes described in studies on 
traditional meditation practice. In addition, MBSR led to changes in the amygdala consistent 
with improved emotion regulation. These findings indicate that MBSR-induced emotional 
and behavioral changes are related to functional and structural changes in the brain. 
 
 
 
 
 
 
  
 
 
Introduction 
Mindfulness has a millennia old history and is usually referred to as a mental state 
characterized by ‘full attention to internal and external experiences as they occur in the 
present moment’, and ‘an attitude characterized by non-judgment of, and openness to, this 
current experience’1-3. Stripped of all religious aspects, application of Mindfulness Based 
Stress Reduction (MBSR) 1 as a stress reduction method, and Mindfulness Based Cognitive 
Therapy to prevent relapse in depression 4, has increased over the past 35 years. In 8 weeks, 
MBSR and MBCT participants learn to cope with stress by means of cognitive exercises, 
concentration training and mental exposure, using a standardized evidence based protocol 5. 
The MBSR- and MBCT protocol comprises both focused attention, open monitoring, and 
breathing meditation but without the transcending atmosphere of traditional meditative 
practice. The goal is not to reach Nirvana or Enlightenment. Instead, by learning to 
recognize automatic reactions, and letting go of dysfunctional ones in a non-judgmental 
manner, participants gain a new coping mechanism that studies have shown to improve 
perceived stress, anxiety, depression, and quality of life in all types of patients 6,7.  
Previous research on traditional meditation styles (i.e. Zen, Vipassana, Tibetan etc.) found 
that individuals who have regularly practiced meditation for several years exhibit significant 
altered brain structure, when compared to demographically matched controls8-13. Recent 
meta-analyses report eight regions to consistently show structural and functional differences 
in long-term meditators: the prefrontal cortex (related to enhanced meta-awareness and 
reappraisal), the sensory cortices and insula (related to body awareness), the hippocampus 
(related to memory processes), and the cingulate cortex (related to self and emotion 
regulation)14-18.  
Former neuroimaging literature focused on traditional meditation styles, or a combination of 
traditional and secular mindfulness. MBSR and MBCT are in some core aspects different 
from traditional meditation (i.e. duration and goal), and may therefore have different 
neuronal effects. In this article, we want to explore how the distilled mindfulness techniques 
in MBSR and MBCT, rather than spirituality of the traditional styles, are related to changes 
in brain structures and activity. We focus on regions described in studies on long-term 
meditators, but have not restricted ourselves to these areas. The current systematic review 
focusses on functional and structural magnetic resonance imaging (MRI) in order to 
understand the neuronal base of the psychological effects of MBSR and MBCT. 
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Methods 
Inclusion and exclusion criteria 
In this systematic review we give an overview of the published effects of the secular 
mindfulness program MBSR and MBCT, as designed by Kabat-Zinn 1 and Teasdale4, on the 
function and structure of the brain. Studies reporting specific aspects of the program such as 
nonjudgmental awareness or focus on the breath, were also included to see whether these 
components have an impact on the brain and thus could explain more about the working 
mechanism of the 8-week program. To be included, the studies had to have the following 
characteristics: MBSR/MBCT or aspects of the program as intervention, and functional 
and/or structural MRI as imaging technique. When the intervention concerned a specific 
aspect of the 8-week protocols or it was a very similar secular derivative, like Mindfulness 
Based Exposure Therapy, studies were captioned under ‘supportive studies’. Dispositional 
mindfulness was also included in order to take its effect into account in discussing found 
neuronal differences. There were no inclusion restrictions regarding age range, health status 
or ethnicity. Our primary outcome was activation, deactivation or functional connectivity, 
or structural changes (density, concentration or volume). As spatial resolution of 
Electroencephalography (EEG) is less, we restricted imaging method to (f)MRI. Other types 
of meditation such as Transcendental Meditation, Vipassana or Zen meditation were 
excluded, as heterogeneity of method and focus would make comparison to the standardized 
8-week program difficult. Unpublished dissertations and conference papers were not taken 
into consideration. 
 
Search strategy 
Five electronic databases were used: PubMed, Embase, PsycInfo, Medline OvidSP and Web-
of-Science. The databases were searched for English language studies using the following 
terms: “mindfulness” or “meditation” or “mindfulness-based stress reduction” or “MBSR”, in 
combination with “MRI” or “magnetic resonance imaging” or “neuroimaging” and “brain”.  
 
Study selection process  
Two reviewers (RG and RM) independently read the abstracts of the studies to exclude 
those that were irrelevant. Any citation considered potentially relevant by at least one 
reviewer was retrieved in full text form. Inclusion was based on inclusion criteria mentioned 
earlier, studies of all date and design were considered. Discrepancies were evaluated 
together with a third reviewer (MH) and decisions were made by consensus.  
 
Data extraction and quality assessment 
Studies were analyzed independently on both content and on quality by the two reviewers. 
The data extracted were study design, population characteristics, type of intervention, type 
of measurement and neuronal changes. If information was missing or data were incomplete, 
the authors of the study were contacted to provide missing data. To assess the quality of the 
 
 
included RCTs we used the Cochrane Collaboration tool for assessing Risk of Bias 19 and for 
non-RCTs we used the Newcastle-Ottowa criteria 20. We searched for explicit mentioning 
of each criterium, for example ‘blinding’; when mentioned as present or not present 
explicitly, that article would receive a + or a – respectively, when nothing regarding this 
criterium was mentioned, the article would get a ‘?’. To assess the degree of consensus we 
calculated the proportional agreement between the quality scores. 
 
Outcome measures 
The outcome measures were changes in (de)activation, functional connectivity and gray 
matter density/volume. As meta-analyses on the traditional styles identified the prefrontal 
cortex, the insula, cingulate cortex, and the hippocampus as main areas of change, we 
reported these as main areas of interest.  
 
Meta-analysis 
Due to the heterogeneity in population (healthy participants, anxiety disorder and patients 
with neurodegenerative disease), task-based versus resting state, and outcome measures 
(structural voxels, connectivity and activity), the number of comparable studies within the 
included sample was too small to conduct formal quantitative meta-analysis of the results. 
An activation Likelihood Estimation meta-analysis was therefore not performed, and 
conclusions were drawn using a qualitative approach. 
 
Results 
Literature Search 
A total number of 1156 potentially relevant articles were identified, retrieved, and screened 
for potential inclusion (Figure 1). 597 studies were excluded as being duplicates and 425 
studies were discarded based on their titles. From the remaining 134 articles, 74 were 
excluded based on the abstract: 67 did not have MBSR, MBCT, or components as 
intervention, 26 did not use MRI or fMRI as imaging technique, and five were conference 
abstracts. Overall, 36 articles met our inclusion criteria and were reviewed by the two 
reviewers independently. In six cases, authors published multiple articles of one actually 
performed study; these were therefore presented together as one study (see Table 1), 
resulting in 30 actual studies. 11 neuroimaging studies reported on MBSR effects, 15 studies 
on aspects of the MBSR program and four on dispositional mindfulness. There were 13 
RCTs, nine cohort studies and eight cross-sectional studies. An overview of rejected studies 
along with reasons for their rejections is available upon request. 
 
Study characteristics 
Study characteristics are summarized in Table 1. Seven RCTs and four intervention cohort 
studies performed functional or structural MRI brain scans of MBSR participants 21-32. Six 
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RCTs, four cohort studies, and five cross-sectional studies investigated what effect aspects of 
the MBSR program have on the brain assessing certain fMRI tasks. Tasks that were 
performed were Feeling vs. Thinking, Affect Labeling vs. Gender labeling, Affect matching 
vs Face matching, and Reappraising emotions vs Reacting to emotional stimuli 33-46. 
Observing vs suppressing (for instance participants learned to label affects, reappraise 
emotions or focus on their breath). And finally, one cohort and three cross-sectional studies 
47-50 measured the correlation between pre-disposition to mindfulness and brain activity or 
structure. Predisposition was measured using the Mindful Attention Awareness Scale 
(MAAS)2 and the Five Facet Mindfulness Questionnaire (FFMQ)51. These are validated 
questionnaires that assess the following aspects: living in the present moment, observing, 
non-judgment, awareness, non-reactivity to inner experiences, and acceptance. These 
qualities can be present in a person without following the MBSR program, for instance due 
to education, personality or culture. We first report the results of full MBSR training, after 
which supportive studies investigating aspects of the training are discussed. To keep 
interpretation of the results of the studies comprehensively, we have placed the comparison 
condition in Table 1, instead of in the text. 
Figure 1. Flowchart of the literature search (Search performed 14-06-2016). 
Web of Science 
169 Results
PsychINFO 
322 Results 
Embase 
316 Results 
Pubmed 
349 Results 
597 duplicates
 
1156 studies 
425 excluded based on title 
(animal studies, genetics, 
etc) 
Excluded based on abstract: 
- 67 other mind-body intervention 
- 26 no (f)MRI
- 5 no full text
134 studies 
36 articles included,
reported as 30 studies 
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Table 2. Quality analysis of RCTs and non-RCTs. 
Author 
(year) 
 
Selection bias Perfor
manc
e bias 
Dete
ction 
bias 
Attr
ition 
bias 
Repor
ting 
bias 
Sequence 
generat 
Allocation 
concealm 
Farb (2007) + ? + + NA + 
Holzel (2013) + + + + + + 
Kirk (2016) ? ? + + ? - 
Kilpatrick 
(2011) 
+ - - + + ? 
Wells (2013) + ? + + + + 
Smart (2016) - + + + + + 
Pickut (2013) + + + + + + 
King (2016) ? ? + + + + 
Allen (2012) + ? + + + + 
Braden 
(2016) 
- ? + ? ? + 
Desbordes 
(2012) + + + + ? + 
Zeidan (2015) + ? ? + ? + 
Haase (2016) - ? + + + + 
Non-RCTs Selectio
n bias 
Compa
rability 
Outcome 
Assessment 
Follow-
up 
Other 
Ives-Deliperi (2011) + NA + NA NC 
Goldin (2009, 2010) + + + +  
Roland (2015) + NA + + NC 
Holzel (2010) + NA + NA NC 
Yang (2016) + NA ? + NC 
Doll (2015, 2016) ? NA + NA NC 
Strawn (2016) ? NA + + NC 
Smoski (2015) ? + + NA  
Herwig (2010) ? NA + NA NC 
Creswell (2007), 
Way (2010) 
? NA + NA NC 
Modinos (2010) ? NA + NA NC 
Murakami (2015) ? NA + NA NC 
Murakami (2012) ? NA + NA NC 
Taren (2013) ? NA + NA NC 
Kong (2016) + NA + NA NC 
Haase (2015) - NA + NA NC 
Friedel (2015) + + + +  
+ low risk; ? unknown risk/not mentioned; - high risk; N/A not applicable; NC no control group 
  
 
 
Quality assessment 
The results of the quality assessment are shown in Table 2. The proportion of inter-rater 
agreement was moderate (75%), the scores shown in the table are consensus scores. Of all 
studies, 11 studies were unclear about participant selection, although the groups compared 
were demographically not significantly different. Furthermore, in four of the RCTs 
randomization and allocation concealment were not obtained, which increases risk of 
selection bias. The method of measuring baseline characteristics and outcomes was reliable 
and with the exception of one study there was no risk of reporting bias. There was no 
indication of attrition bias in the longitudinal studies, as group demographics were still alike 
after drop-out occurred.  
 
 
The results are reported per structure that has been described in earlier meta-analyses on 
traditional meditation. In addition to these regions of interest, the amygdala was reported so 
many times that we added this region to our outcomes. The areas are also shown in Figure 2.  
 
 
Figure 2. Based on Hammers ROIs49. Coronal (A), Sagittal (B), Axial (C), and 3D (D) view of gray 
matter areas involved in MBSR. Prefrontal cortex (blue),  Cingulate cortex and insula (red), 
hippocampus (yellow) and amygdala (green).  
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Quality assessment
The results of the quality assessment are shown in Table 2. The proportion of inter-rater 
agreement was moderate (75%), the scores shown in the table are consensus scores. Of all 
studies, 11 studies were unclear about participant selection, although the groups compared 
were demographically not significantly different. Furthermore, in four of the RCTs 
randomization and allocation concealment were not obtained, which increases risk of 
selection bias. The method of measuring baseline characteristics and outcomes was reliable 
and with the exception of one study there was no risk of reporting bias. There was no 
indication of attrition bias in the longitudinal studies, as group demographics were still alike 
after drop-out occurred. 
The results are reported per structure that has been described in earlier meta-analyses on 
traditional meditation. In addition to these regions of interest, the amygdala was reported so 
many times that we added this region to our outcomes. The areas are also shown in Figure 2.
Figure 2. Based on Hammers ROIs49. Coronal (A), Sagittal (B), Axial (C), and 3D (D) view of gray 
matter areas involved in MBSR. Prefrontal cortex (blue), Cingulate cortex and insula (red), 
hippocampus (yellow) and amygdala (green).
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Prefrontal cortex 
Overall, prefrontal cortex (PFC) shows increased activity after MBSR 21, particularly 
dorsolateral and dorsomedial 28,52. The PFC also shows increased functional connectivity 
with the salience network 53, the superior temporal gyrus, the visual cortex, the amygdala, 
the hippocampus and the posterior cingulate cortex 24,25,54. Specifically, there was negative 
functional connectivity with the amygdala, where the PFC seemed to down-regulate the 
amygdala responses 29. Mindfulness-based tasks were positively associated with activation in 
areas of ventrolateral, medial, dorsolateral and orbitofrontal PFC 33,40,45,46,55-57. Also, amount 
of practice predicted increased medial and dorsolateral PFC activation during mindful 
emotional processing 44. One study found that acceptance rather than reappraising sad 
images, was associated with less PFC activation 34. No structural changes were reported. 
  
Insula 
The insular regions are reported in two MBSR studies, one showing less activity 26, and one 
showing more activity 29. Seven studies, however, reported increased activity in relation to 
mindfulness-based tasks 33,39,46,55-58. Dispositional mindfulness was positively associated with 
activation in the left insula and right anterior volume 47,49, and less cortical thinning in the 
left anterior insula 48. Amount of practice during MBSR predicted right anterior insula and 
frontoinsular activation during negative emotional processing 44. One study showed that 
compared to muscle relaxation, the MBSR group had greater ability to effectively regulate 
the anterior insula and thereby promote a more cooperative decision making style 22. In 
healthy adults, greater activation in left insula while accepting than while reappraising sad 
images was associated with greater intensity of negative affect post-acceptance, suggesting 
that this activation either reflected less effective emotion regulation, or reflected heightened 
emotional awareness rather than regulation 34. 
 
Cingulate cortex 
The cingulate cortex also shows disparate results. In two MBSR studies less activity was 
reported 26,28, while in four MBSR studies increased functional connectivity with the 
prefrontal cortex, the left temporal cortex, the parietal cortex and visual cortex were found 
24,25,54, as well as increased cingulate volume 59. Eight supportive studies report increased 
activation 35,39,40,44,55,56,58, of which one during mindfulness-based tasks 46. Compared to 
baseline, traumatized veterans showed increased connectivity between the posterior 
cingulate and the dorsal anterior cingulate and left dorsolateral PFC, which was correlated to 
decreased trauma-symptoms 41. No structural changes were reported. 
 
Hippocampus 
The hippocampus shows more activity and more volume in four MBSR studies 32,60,61, 
including less Parkinson-related atrophy 54. Three supportive studies underline the increase 
in activity and volume 33,47,49, but one does not 50. 
 
 
 
Amygdala 
In two MBSR studies the right amygdala showed less activity compared to controls 28,29, the 
left amygdala in one study 21. Only in Parkinson patients more right amygdala volume was 
found 32, though it was not clear whether volume in Parkinson patients increased or whether 
volume in controls decreased more. MBSR-induced stress reduction was associated with 
right amygdala volume decrease 30. Three supportive studies report less amygdala activity in 
association with mindfulness tasks: mindfulness training was associated with less right 
amygdala activity, where compassion training was associated with more right amygdala 
activity 62. When comparing ruminating to observing ones feelings, the left amygdala is more 
active during the ‘think’-condition and, notably, deactivated during the ‘feel’-condition 55. 
Affect labeling showed less bilateral amygdala activity compared to the control task gender 
labeling 33,45. Two studies report negative functional connectivity with the prefrontal cortex 
29,46. While suppression showed a positive association with the dorsolateral PFC, observing 
showed a negative correlation with the medial PFC 57. When reappraising emotions, the left 
amygdala was negatively correlated with dorsolateral PFC activation in more mindful 
individuals 33. Dispositional mindfulness was positively associated with bilateral amygdala 
deactivation. The structural supportive studies report a positive association between right 
amygdala volume and the describing facet of the FFMQ 47, and a negative association with 
overall mindfulness 50. 
 
Other results 
This section reports regions not indicated by traditional meditation neuroimaging studies as 
affected consistently. More activity or volume in relation to MBSR or mindfulness-based 
tasks was found in the parietal cortex (somatosensory, precuneus), temporal cortex (middle 
and superior gyrus), occipital cortex (cuneus, middle gyrus), cerebellum, and basal ganglia 
(caudate nucleus, thalamus and putamen), though most structures were only reported once. 
One study reported less activity in temporal lobe and the precuneus compared to population 
norms 26, and another study reported no changes in the default mode network 24. Another 
study reported less volume in the cerebellum 32. 
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Discussion 
In this study we systematically reviewed the evidence of effect of secular mindfulness on 
function and structure of the brain, hence aiming to understand the neurobiological 
explanation of this increasingly popular stress reduction training. Long-term meditation has 
been associated with structural and functional differences in the prefrontal cortex, the 
sensory cortices and insula, the hippocampus, and the cingulate cortex 14,16-18, associated 
with emotion regulation and response control 12,13,16,63. Only one MBCT study was found, 
therefore the interpretation of results was mainly focused on the neuronal working 
mechanisms of MBSR. After 8 weeks of MBSR training, participants demonstrated similar 
changes in the PFC, the hippocampus, insula and the cingulate cortex, associated with 
attention regulation, self-referential processing, and perspective taking, all stimulated in 
both long-term meditation and MBSR exercises. Based on the task-based studies, the insula 
shows increased activation, but the MBSR studies showed no consensus. The insula is 
associated with perception, motor control, self-awareness, interoception, and interpersonal 
experience 64, and with linking behavioral outcomes to motivation (which results in learning) 
65. It could be that this area needs longer practice to be affected, or that these functions are 
too diverse to refer to the insula as a whole, or that the insula is activated regardless of 
valence of stimuli (positive or negative) when connecting sensory information to emotions 
66,67.  
 
In addition to these four prior appointed regions, the amygdala seems to play a larger role in 
the neuronal working mechanism of MBSR, than it does in traditional meditation. The 
amygdala is related to the fight-or-flight reaction: it adds emotional value to sensory input 64 
and functions as a pre-conscious warning system 68. If a threat is significant, the amygdala 
responds within milliseconds and activates the sympathetic nervous system 69, prior to 
conscious awareness of the stimuli 70. When the situation allows for cortical processing, the 
PFC can regulate the amygdala, either increasing or decreasing its activity 71. MBSR seems to 
be associated with more efficient PFC inhibition of amygdala responses, improving emotion 
regulation. Different aspects of the training (reappraising emotions, affect labeling and 
breath focus exercises) are associated with increased prefrontal activity, hippocampal activity 
and less amygdala activity, suggesting a neuronal explanation that provides support for the 
stress-reducing effects of the training found in traditional meditation research. While in line 
with these results a negative association was found between amygdala volume and overall 
mindfulness as measured with the MAAS (N=145), a positive association was found between 
right amygdala volume and the describing facet of the FFMQ (N=19). It is possible that as in 
this group the other factors (observing, acting with awareness, nonjudging of, and 
nonreactivity to inner experiences) were not associated with amygdala differences, 
describing in itself may not be a very stress-reducing activity. 
It may be logical that MBSR participants show more effect in the amygdala than long-term 
meditators, as the room for improvement may be larger. Monks or nuns are not expected to 
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Discussion 
In this study we systematically reviewed the evidence of effect of secular mindfulness on 
function and structure of the brain, hence aiming to understand the neurobiological 
explanation of this increasingly popular stress reduction training. Long-term meditation has 
been associated with structural and functional differences in the prefrontal cortex, the 
sensory cortices and insula, the hippocampus, and the cingulate cortex 14,16-18, associated 
with emotion regulation and response control 12,13,16,63. Only one MBCT study was found, 
therefore the interpretation of results was mainly focused on the neuronal working 
mechanisms of MBSR. After 8 weeks of MBSR training, participants demonstrated similar 
changes in the PFC, the hippocampus, insula and the cingulate cortex, associated with 
attention regulation, self-referential processing, and perspective taking, all stimulated in 
both long-term meditation and MBSR exercises. Based on the task-based studies, the insula 
shows increased activation, but the MBSR studies showed no consensus. The insula is 
associated with perception, motor control, self-awareness, interoception, and interpersonal 
experience 64, and with linking behavioral outcomes to motivation (which results in learning) 
65. It could be that this area needs longer practice to be affected, or that these functions are 
too diverse to refer to the insula as a whole, or that the insula is activated regardless of 
valence of stimuli (positive or negative) when connecting sensory information to emotions 
66,67.  
 
In addition to these four prior appointed regions, the amygdala seems to play a larger role in 
the neuronal working mechanism of MBSR, than it does in traditional meditation. The 
amygdala is related to the fight-or-flight reaction: it adds emotional value to sensory input 64 
and functions as a pre-conscious warning system 68. If a threat is significant, the amygdala 
responds within milliseconds and activates the sympathetic nervous system 69, prior to 
conscious awareness of the stimuli 70. When the situation allows for cortical processing, the 
PFC can regulate the amygdala, either increasing or decreasing its activity 71. MBSR seems to 
be associated with more efficient PFC inhibition of amygdala responses, improving emotion 
regulation. Different aspects of the training (reappraising emotions, affect labeling and 
breath focus exercises) are associated with increased prefrontal activity, hippocampal activity 
and less amygdala activity, suggesting a neuronal explanation that provides support for the 
stress-reducing effects of the training found in traditional meditation research. While in line 
with these results a negative association was found between amygdala volume and overall 
mindfulness as measured with the MAAS (N=145), a positive association was found between 
right amygdala volume and the describing facet of the FFMQ (N=19). It is possible that as in 
this group the other factors (observing, acting with awareness, nonjudging of, and 
nonreactivity to inner experiences) were not associated with amygdala differences, 
describing in itself may not be a very stress-reducing activity. 
It may be logical that MBSR participants show more effect in the amygdala than long-term 
meditators, as the room for improvement may be larger. Monks or nuns are not expected to 
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experience a lot of stressful events in their monastery, and if they do, their long experience 
will enable them to cope mindfully. Western participants, however, are more likely to 
experience stress in daily life, and their amygdala might therefore have a higher baseline 
activity. The down-regulation of the amygdala underlines the stress-reducing effect of MBSR 
with a neuronal map. 
 
There are several limitations that should be taken into account. First, unfortunately no 
quantitative meta-analysis was possible in this sample of studies, due to the wide variety of 
outcome measures and participants. The inclusion of studies examining populations that have 
brain pathology (e.g., Alzheimer's and Parkinson's disease) make interpretation of findings 
hard enough. Second, the functions of each of the mentioned brain structures are still 
assumptions, and too much deducting should be discouraged as the significance of found 
changes is controversial. Also, correlational fMRI studies using self-reported measures 
should be interpreted with caution as they often overestimate the correlation, and they 
report means of just the subset of voxels exceeding chosen thresholds 72. The three 
correlational fMRI studies in this review did not explain their calculation method sufficiently 
to assess whether this is a risk, although one study reported r=-0.88, which might indicate 
overestimation 33. Third, to ascribe these neuronal effects solely to the training is precarious: 
MBSR is a multifaceted group program and some positive effects may result from 
components not specific to meditation or mindfulness, such as social interaction within the 
group, or gentle stretching exercises. A fourth limitation is the design of many of the 
included studies: small study populations with a large inter-study heterogeneity make 
comparison difficult, and increase the risk of small study bias. Only three non-RCTs had a 
control group 34,48,73. Longer prospective studies will be necessary to determine if MBSR and 
MBCT training also results in long-term changes in brain activity and structure. Finally, in 
this field there is a high risk of publication bias.  
 
In summary, the findings suggest that the 8-week MBSR training evokes similar brain 
responses to traditional long-term meditation styles. The connectivity between prefrontal 
cortex, hippocampus and amygdala indicates a neuronal working mechanism of how this 
secular training induces emotional and behavioral changes. 
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Abstract 
 
Objective: To determine the association between meditation and yoga practice, 
experienced stress, and amygdala and hippocampal volume in a large population-based 
study.  
Methods: This study was embedded within the population-based Rotterdam Study (visit 
2009-2013) and included 3742 participants for cross-sectional association. Participants filled 
out a questionnaire assessing meditation and yoga practice, experienced stress and 
underwent an MRI scan of the brain. Both cross-sectional and longitudinal data were 
obtained. Amygdala and hippocampal volumes were regions of interest, as these are known 
structures from studies on meditation. Multivariable linear regression analysis and mixed 
linear models were performed adjusted for age, sex, educational level, intracranial volume, 
cardiovascular risk, anxiety, depression and stress.  
Results: 15.7% of individuals participated in at least one form of practice. Those who 
performed meditation and yoga practices reported significantly more stress (mean difference 
0.2 on a 1-5 scale, p<.001) and more depressive symptoms (mean difference 1.03 on CESD, 
p=.015), while 90.7% reported that doing their practice helped them in coping with stress. 
This indicates possible confounding by indication. Partaking in meditation and yoga practices 
was associated with a significantly lower right amygdala volume (β = -31.8 mm3, p=.005), 
and lower left hippocampus volume (β = -75.3 mm3, p=.025). Repeated measurements 
showed a significant effect over time on the right amygdala of practicing meditation and yoga 
(β = -24.4 mm3, SE 11.3, p=.031). 
Conclusions: Partaking in meditation and yoga practice is associated with more 
experienced stress while it also helps cope with stress, and is associated with smaller right 
amygdala volume.  
 
  
 
Introduction 
Mind-Body practices are becoming increasingly popular in both supporting medical 
treatment of chronic patients and prevention of disease in the healthy population 1,2. 
Approximately 20% of the US population use mind-body practices, such as meditation and 
yoga, to gain a more active role in their health. Mindfulness for instance teaches awareness 
of bodily sensations of stress and of reaction patterns in a non-judgmental manner. 
Meditation and yoga have been shown to reduce anxiety, depression and stress, and to 
improve quality of life 3,4. Unfortunately, there is no clear understanding of how these 
practices exert their positive effect. A recent meta-analysis showed that cognitive and 
emotional reactivity are the largest mediators underlying the improvements, together with 
mindfulness, rumination, self-compassion and psychological flexibility 5. Previous 
neuroimaging meta-analyses on traditional meditation styles (i.e. Zen, Vipassana, Tibetan 
etc.) show that long term meditators consistently exhibit a different gray matter 
morphometry in several regions: the prefrontal cortex (PFC) (which is related to attentional 
processes), the sensory cortices and insula (related to body awareness), the hippocampus 
(related to memory processes), the cingulate cortex (related to self and emotion regulation), 
and the amygdala (related to the fight-flight response) 6-12. A review on neuroimaging in yoga 
practitioners also showed decreased blood flow in the amygdala and increased activity in the 
prefrontal cortex, suggesting that practitioners do notice the negative stimuli, but are less 
affected by it 13.  
The amygdala seems to be typically involved in stress and anxiety: related to instinct and the 
fight-flight reaction, it adds emotional value to sensory input 14 and functions as a pre-
consciousness warning system 15. Stress reduction has been associated with less amygdala 
volume 16, and research has found significant differences in amygdala activity and structure in 
connection with both training and pre-dispositional mindfulness 17-20. So it seems that this 
neural structure could be affected by the stress reducing effects of meditation and yoga. The 
amygdala is of course part of an extended neural network 21; earlier studies on the effect of 
meditation also showed a stronger connectivity between the ventromedial PFC and the 
amygdala, where the former down-regulated the activity of the latter 18,22 and an increase in 
activity in the hippocampus 17,23. However, all these previous studies have been performed 
either in specific patient populations or in small samples of healthy, young volunteers. No 
study has yet been conducted in a large population-based setting. Doing so would give 
greater insight in practitioner characteristics in real-life, and whether these methods are 
effective in an uncontrolled population setting rather than a controlled clinical setting. Also 
it could give insight in practice associated mental health, and in underlying neuronal 
differences between practitioners and non-practitioners.   
The current study investigates the effects of meditation and yoga on experienced stress 
levels, and whether these effects are associated with differences in amygdala volume in a 
large Dutch population-based sample of middle aged and elderly subjects.  
Processed on: 27-10-2016
504961-L-bw-Gotink
4
Neuroimaging of meditation: The Rotterdam Study 69
 
Abstract 
 
Objective: To determine the association between meditation and yoga practice, 
experienced stress, and amygdala and hippocampal volume in a large population-based 
study.  
Methods: This study was embedded within the population-based Rotterdam Study (visit 
2009-2013) and included 3742 participants for cross-sectional association. Participants filled 
out a questionnaire assessing meditation and yoga practice, experienced stress and 
underwent an MRI scan of the brain. Both cross-sectional and longitudinal data were 
obtained. Amygdala and hippocampal volumes were regions of interest, as these are known 
structures from studies on meditation. Multivariable linear regression analysis and mixed 
linear models were performed adjusted for age, sex, educational level, intracranial volume, 
cardiovascular risk, anxiety, depression and stress.  
Results: 15.7% of individuals participated in at least one form of practice. Those who 
performed meditation and yoga practices reported significantly more stress (mean difference 
0.2 on a 1-5 scale, p<.001) and more depressive symptoms (mean difference 1.03 on CESD, 
p=.015), while 90.7% reported that doing their practice helped them in coping with stress. 
This indicates possible confounding by indication. Partaking in meditation and yoga practices 
was associated with a significantly lower right amygdala volume (β = -31.8 mm3, p=.005), 
and lower left hippocampus volume (β = -75.3 mm3, p=.025). Repeated measurements 
showed a significant effect over time on the right amygdala of practicing meditation and yoga 
(β = -24.4 mm3, SE 11.3, p=.031). 
Conclusions: Partaking in meditation and yoga practice is associated with more 
experienced stress while it also helps cope with stress, and is associated with smaller right 
amygdala volume.  
 
  
 
Introduction 
Mind-Body practices are becoming increasingly popular in both supporting medical 
treatment of chronic patients and prevention of disease in the healthy population 1,2. 
Approximately 20% of the US population use mind-body practices, such as meditation and 
yoga, to gain a more active role in their health. Mindfulness for instance teaches awareness 
of bodily sensations of stress and of reaction patterns in a non-judgmental manner. 
Meditation and yoga have been shown to reduce anxiety, depression and stress, and to 
improve quality of life 3,4. Unfortunately, there is no clear understanding of how these 
practices exert their positive effect. A recent meta-analysis showed that cognitive and 
emotional reactivity are the largest mediators underlying the improvements, together with 
mindfulness, rumination, self-compassion and psychological flexibility 5. Previous 
neuroimaging meta-analyses on traditional meditation styles (i.e. Zen, Vipassana, Tibetan 
etc.) show that long term meditators consistently exhibit a different gray matter 
morphometry in several regions: the prefrontal cortex (PFC) (which is related to attentional 
processes), the sensory cortices and insula (related to body awareness), the hippocampus 
(related to memory processes), the cingulate cortex (related to self and emotion regulation), 
and the amygdala (related to the fight-flight response) 6-12. A review on neuroimaging in yoga 
practitioners also showed decreased blood flow in the amygdala and increased activity in the 
prefrontal cortex, suggesting that practitioners do notice the negative stimuli, but are less 
affected by it 13.  
The amygdala seems to be typically involved in stress and anxiety: related to instinct and the 
fight-flight reaction, it adds emotional value to sensory input 14 and functions as a pre-
consciousness warning system 15. Stress reduction has been associated with less amygdala 
volume 16, and research has found significant differences in amygdala activity and structure in 
connection with both training and pre-dispositional mindfulness 17-20. So it seems that this 
neural structure could be affected by the stress reducing effects of meditation and yoga. The 
amygdala is of course part of an extended neural network 21; earlier studies on the effect of 
meditation also showed a stronger connectivity between the ventromedial PFC and the 
amygdala, where the former down-regulated the activity of the latter 18,22 and an increase in 
activity in the hippocampus 17,23. However, all these previous studies have been performed 
either in specific patient populations or in small samples of healthy, young volunteers. No 
study has yet been conducted in a large population-based setting. Doing so would give 
greater insight in practitioner characteristics in real-life, and whether these methods are 
effective in an uncontrolled population setting rather than a controlled clinical setting. Also 
it could give insight in practice associated mental health, and in underlying neuronal 
differences between practitioners and non-practitioners.   
The current study investigates the effects of meditation and yoga on experienced stress 
levels, and whether these effects are associated with differences in amygdala volume in a 
large Dutch population-based sample of middle aged and elderly subjects.  
Processed on: 27-10-2016
504961-L-bw-Gotink
Chapter 470
 
Methods 
Study population 
The Rotterdam Study is an ongoing population-based cohort in the Netherlands that aims to 
investigate causes and determinants of diseases in elderly adults 24.  Recruitment began in 
1990, and the current study population consisted of 14,926 subjects 45 years and older at 
baseline. The whole cohort undergoes physical and psychological re-examinations every two 
to three years. Since 2005, all participants of the Rotterdam Study without contraindications 
to Magnetic Resonance Imaging (MRI) are invited to undergo a brain MRI examination as 
part of the Rotterdam Scan Study, which aims to investigate causes and consequences of age-
related brain changes 25.  
For our study, we included individuals examined at the research center between 2008 and 
2013. We included all participants that responded to a meditation and yoga practice 
questionnaire and had undergone an MRI of the brain (n = 3827). Diagnosis of clinical 
stroke, dementia and Parkinson were reason for exclusion (n = 34). After removing 
uninterpretable MRI scans, 3742 participants were included for the cross-sectional analyses. 
We also analyzed a subgroup that underwent multiple brain scans in the study period to see 
whether there was a difference in brain structure changes between the groups over time. For 
this we chose a time span of 5 years in between two scans to maintain comparability, and 
allocated participants to the practitioner group if they practiced for 5 years or longer (see 
Figure 1).  
The Rotterdam Study has been approved by the medical ethics committee according to the 
Population Study Act Rotterdam Study, executed by the Ministry of Health, Welfare and 
Sports of the Netherlands. Written informed consent was obtained from all participants.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flow chart of participant selection.  
Rotterdam Study 
N=14926 
Undergone MRI between 
2009-2013: N=5035 
Responded to questionnaire 
N=3827 
Included cross-
sectional analyses 
N=3742 
Excluded MRI scans 
- due to diagnosis: N=34 
- due to artefacts: N=51 
 
Did not respond to 
questionnaire: N=1208 
 
Subsample 
longitudinal analyses 
N=2397 
 
Measurement of meditation and yoga practices 
During a one-time home interview, trained interviewers questioned individuals if they 
performed meditation and yoga practices, which were defined as ‘looking for stillness inside 
oneself’, ‘meditation’ or ‘mindfulness’ (captured in this article under ‘meditation’), ‘yoga’, 
‘Tai Chi’, ‘Qi Gong’ or ‘similar movement therapy’ (captured under ‘yoga’), and relaxation 
or breathing exercises (referred to as ‘breathing exercises’). As breathing exercises are such 
a core aspect of both meditation and yoga, this category is included without being named 
separately in this article. Additionally, the interview contained a question whether practicing 
this particular technique helped participants in coping with stress. The questionnaire also 
included the amount of time per week spent on the practice (0 hours, <1 hour, 1-2 hours, 
>2 hours), and the amount of years practicing. For the intervention group, a cut-off of at 
least one hour per week was chosen in order to assess the effect of practice, and at least one 
year of practice. Participants practicing less than one hour (N=239) were allocated to the 
control group.  
 
Brain MRI acquisition and post-processing for amygdala volume 
Brain MRI data were acquired with a 1.5-Tesla scanner (GE Healthcare, Milwaukee, 
Wisconsin) using an eight-channel head coil during a 30-minute brain imaging protocol that 
was previously described in detail 25,26. Two trained technicians performed all examinations 
in a standardized way. This protocol included high-resolution axial fluid-attenuated inversion 
recovery (FLAIR), T1-weighted, and T2-weighted sequences. The T1-weighted image was 
used for amygdala segmentation and consisted of a 3D spoiled gradient-recalled echo (SPGR) 
scan, with voxel volume of 0.49 x 0.49 x 0.80 mm3. Automatic segmentation of subcortical 
brain structures, including the amygdala left and right, was performed on T1-weighted 
images using Freesurfer software (version 4.5.0) 27. This rendered volumetric measures of 
the amygdala gray matter (in mm3). Exact processing details are described elsewhere 28-30.  
 
Co-variables 
In order to assess the effect of meditation and yoga practice on amygdala volume we took 
demographic variables, total intracranial volume (ICV in mm3, derived from automated 
brain segmentation), cardiovascular risk factors and psychological functioning into account as 
variables that can otherwise affect brain structure measurements. Highest education achieved 
was categorized as “primary education”, “lower and intermediate general education or lower 
vocational education”, “intermediate vocational education or higher general education”, or 
“higher vocational education or university”, according to the UNESCO guidelines 31. 
Cardiovascular risk factors that were taken into account were body-mass index (BMI), 
systolic and diastolic blood pressure, antihypertensive medication, total serum cholesterol, 
high density lipoprotein cholesterol, triglycerides, low-density lipoprotein-cholesterol 
calculated with the Friedewald Formula 32, diabetes mellitus, smoking and use of alcohol in 
the assessment of the amygdala volume, see for exact measurement methods elsewhere 33. 
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Smoking status was categorized as never, former, and current smoker. Alcohol use was 
categorized as never, regular use (>2-3 times per week at least 1 beverage), and occasional 
use (< 2-4 times per month at least 1 beverage). 
Psychological functioning was assessed during home interviews with validated questionnaires 
and comprises measurements of stress, depression and anxiety. The level of experienced 
stress was assessed with a 1 item 5-point Likert scale (“how much stress do you experience 
on a scale from 1 (not at all) to 5 (very much)?”). Stress unfortunately was measured only 
once, so no longitudinal data was available. To identify current depressive symptoms, we 
used the Center for Epidemiological Studies Depression (CES-D) scale, a 20-item 
questionnaire which has been validated in a variety of populations 34. Anxiety was measured 
with the seven anxiety items of the Hospital Anxiety and Depression Scale (HADS-A)35. 
These items are scored on a 4-point scale ranging from 0 (absence of the symptom) to 3 
(extreme presence), the sum score indicates the anxiety level.  
 
Statistical analysis   
ANCOVA analyses were performed to compare characteristics of individuals in the 
intervention group compared to the control group. Apart from demographics, all other 
variables were adjusted for age, sex and education level. All imaging outcomes were also 
adjusted for ICV. 
Subsequently, we conducted multivariable linear regression analyses to evaluate the effect of 
meditation and yoga practice on left and right amygdala volume. As literature indicates that 
cortical thickness increases with meditation practice 6,36,37, we also performed an analysis on 
the ratio between amygdala volume and total brain volume. On an exploratory basis we also 
looked at the prefrontal lobe and the hippocampus, structures that have been reported to be 
affected by meditation practice. To account for repeated measurements in the longitudinal 
analyses, linear mixed models were used adjusted for all covariables. 2% of values were 
missing, none of which concerned outcome variables. Multiple imputation was performed 
using 10 iterations with all variables as predictors. In the variables assessing how many years 
participants practiced their activity, missing values due to remembrance issues (“I don’t 
remember how many years I have been practicing”) were imputed by the median value of 
the group to account for right censoring. A p-value less than 0.05 was considered to indicate 
statistical significance. All data were analyzed with IBM SPSS Statistics version 21.0 38. 
 
  
 
Results 
Participant characteristics 
Mean age at the time of the MRI scan was 64.1 years (SD 7.7) and 55% were women. A 
total of 588 individuals (15.7%) reported engaging in any form of practice. Using a cut -off of 
1 hour per week, meditation was the most often performed practice (N=159). 98 
participants practiced yoga or similar movement therapy, and breathing exercises were done 
by 75 participants (Table 1). 43 individuals took part in more than one practice, so 289 
unique participants were categorized to the intervention group of more than 1 hour per 
week. Compared to those who did not report partaking in meditation and yoga, individuals 
who did a form of practice were higher educated, significantly more often female (73%) and 
younger (61.9 years, SD 6.8) (Table 2). The median duration of practice in the intervention 
group was 10 years. 
 
Table 1. Types of practice, mean duration and hours spent per week a.   
 Meditation Yoga Breathing exercises 
N  0-1 hours per week 96 37 106 
N  1-2 hours per week 83 69 36 
N  >2 hours per week 76 29 39 
Mean duration, years (SD) 14.9 (15.5) 11.2 (10.6) 13.7 (13.2) 
N (%)* 159  98  75  
a Some participants performed more than one practice (e.g. both meditation and yoga. Unique N=289, 
unique total N=588). *Cut-off: practice 1 hour or more per week. 
 
Meditation and yoga practices and mental health 
Stress and depression were rated significantly higher among practitioners, while 90.7% of 
practitioners reported that doing their activities helped them cope with stress (5.5% 
reported it did not and 3.8% didn’t know). Anxiety did not differ significantly between 
practitioners and non-practitioners. Looking at sub-groups, current depressive symptoms 
were rated significantly higher amongst meditators but not in yoga or breathing exercise 
practitioners, whereas stress was significantly higher in these groups and not in meditators.  
 
Cross-sectional analyses: Meditation and yoga practices and amygdala volume 
Total brain volume was larger in those practicing compared to controls, but not statistically 
significant (943.1 ml versus 940.4 ml, p-value = 0.32) (see Table 1). The left and right 
amygdala were smaller in the intervention group: left amygdala 1321.4 mm3 versus 1334.8 
mm3 (age-, sex-, education- and ICV-adjusted, p-value = 0.21); and the right amygdala 
significantly so: 1386.8 mm3 versus 1415.8 mm3 (p = 0.01). The ratio between right 
amygdala and total brain volume was significantly smaller in practitioners than in non-
practitioners (0.147% versus 0.151%, p-value = 0.001). Looking at subgroups, the right 
amygdala was smallest in the meditation group, whereas the left was smallest amongst the 
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Smoking status was categorized as never, former, and current smoker. Alcohol use was 
categorized as never, regular use (>2-3 times per week at least 1 beverage), and occasional 
use (< 2-4 times per month at least 1 beverage). 
Psychological functioning was assessed during home interviews with validated questionnaires 
and comprises measurements of stress, depression and anxiety. The level of experienced 
stress was assessed with a 1 item 5-point Likert scale (“how much stress do you experience 
on a scale from 1 (not at all) to 5 (very much)?”). Stress unfortunately was measured only 
once, so no longitudinal data was available. To identify current depressive symptoms, we 
used the Center for Epidemiological Studies Depression (CES-D) scale, a 20-item 
questionnaire which has been validated in a variety of populations 34. Anxiety was measured 
with the seven anxiety items of the Hospital Anxiety and Depression Scale (HADS-A)35. 
These items are scored on a 4-point scale ranging from 0 (absence of the symptom) to 3 
(extreme presence), the sum score indicates the anxiety level.  
 
Statistical analysis   
ANCOVA analyses were performed to compare characteristics of individuals in the 
intervention group compared to the control group. Apart from demographics, all other 
variables were adjusted for age, sex and education level. All imaging outcomes were also 
adjusted for ICV. 
Subsequently, we conducted multivariable linear regression analyses to evaluate the effect of 
meditation and yoga practice on left and right amygdala volume. As literature indicates that 
cortical thickness increases with meditation practice 6,36,37, we also performed an analysis on 
the ratio between amygdala volume and total brain volume. On an exploratory basis we also 
looked at the prefrontal lobe and the hippocampus, structures that have been reported to be 
affected by meditation practice. To account for repeated measurements in the longitudinal 
analyses, linear mixed models were used adjusted for all covariables. 2% of values were 
missing, none of which concerned outcome variables. Multiple imputation was performed 
using 10 iterations with all variables as predictors. In the variables assessing how many years 
participants practiced their activity, missing values due to remembrance issues (“I don’t 
remember how many years I have been practicing”) were imputed by the median value of 
the group to account for right censoring. A p-value less than 0.05 was considered to indicate 
statistical significance. All data were analyzed with IBM SPSS Statistics version 21.0 38. 
 
  
 
Results 
Participant characteristics 
Mean age at the time of the MRI scan was 64.1 years (SD 7.7) and 55% were women. A 
total of 588 individuals (15.7%) reported engaging in any form of practice. Using a cut -off of 
1 hour per week, meditation was the most often performed practice (N=159). 98 
participants practiced yoga or similar movement therapy, and breathing exercises were done 
by 75 participants (Table 1). 43 individuals took part in more than one practice, so 289 
unique participants were categorized to the intervention group of more than 1 hour per 
week. Compared to those who did not report partaking in meditation and yoga, individuals 
who did a form of practice were higher educated, significantly more often female (73%) and 
younger (61.9 years, SD 6.8) (Table 2). The median duration of practice in the intervention 
group was 10 years. 
 
Table 1. Types of practice, mean duration and hours spent per week a.   
 Meditation Yoga Breathing exercises 
N  0-1 hours per week 96 37 106 
N  1-2 hours per week 83 69 36 
N  >2 hours per week 76 29 39 
Mean duration, years (SD) 14.9 (15.5) 11.2 (10.6) 13.7 (13.2) 
N (%)* 159  98  75  
a Some participants performed more than one practice (e.g. both meditation and yoga. Unique N=289, 
unique total N=588). *Cut-off: practice 1 hour or more per week. 
 
Meditation and yoga practices and mental health 
Stress and depression were rated significantly higher among practitioners, while 90.7% of 
practitioners reported that doing their activities helped them cope with stress (5.5% 
reported it did not and 3.8% didn’t know). Anxiety did not differ significantly between 
practitioners and non-practitioners. Looking at sub-groups, current depressive symptoms 
were rated significantly higher amongst meditators but not in yoga or breathing exercise 
practitioners, whereas stress was significantly higher in these groups and not in meditators.  
 
Cross-sectional analyses: Meditation and yoga practices and amygdala volume 
Total brain volume was larger in those practicing compared to controls, but not statistically 
significant (943.1 ml versus 940.4 ml, p-value = 0.32) (see Table 1). The left and right 
amygdala were smaller in the intervention group: left amygdala 1321.4 mm3 versus 1334.8 
mm3 (age-, sex-, education- and ICV-adjusted, p-value = 0.21); and the right amygdala 
significantly so: 1386.8 mm3 versus 1415.8 mm3 (p = 0.01). The ratio between right 
amygdala and total brain volume was significantly smaller in practitioners than in non-
practitioners (0.147% versus 0.151%, p-value = 0.001). Looking at subgroups, the right 
amygdala was smallest in the meditation group, whereas the left was smallest amongst the 
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breathing participants. The yoga group had the largest amygdalae, though this difference was 
not statistically significant. The ratio between right amygdala and total volume was 
significantly smaller in the meditation and breathing group. The prefrontal lobe was not 
significantly different between groups and neither was the right hippocampus. The left 
hippocampus, however, showed to be significantly smaller in the practitioner group (3891.2 
mm3) compared to the control group (3958.1 mm3), p=0.036.  
 
Table 2. Characteristics of the study population.   
 No Meditation and  yoga 
practices (N=3453) 
Meditation and yoga 
practices  
(N=289) 
Mean age, years (SD) 64.3 (7.7) 61.9 (6.8)* 
Women  53% 73%* 
Highest education, score (SD) 1.7 (0.9) 2.0 (0.9)* 
   
BMI (SD) 27.5 (4.3) 26.6 (4.4)* 
SBP mmHg (SD) 139.7 (19.9) 138.3 (20.3) 
DBP mmHg (SD) 83.2 (11.3) 82.9 (11.6) 
Diabetes mellitus 8.3% 6.4% 
HDL Cholesterol, mmol/L (SD) 1.5 (0.4) 1.5 (0.4) 
LDL Cholesterol, mmol/L (SD) 3.7 (1.1) 3.8 (1.0) 
Smoking score (SD) 0.43 (0.6) 0.45 (0.7) 
Alcohol score (SD) 1.45 (0.6) 1.48 (0.8) 
   
Stress (1-5), mean (SD) 2.0 (1.0) 2.2 (1.0)* 
Depression, mean (SD) 5.2 (6.8) 6.2 (6.9)* 
Anxiety, mean (SD) 15.8 (3.4) 15.4 (3.5) 
   
Total brain, ml (SD) 940.4 (44.3) 943.1 (45.0) 
Left frontal lobe, ml (SD) 163.4 (0.2) 163.8(0.6) 
Right frontal lobe, ml (SD) 164.0 (0.2) 164.8 (0.6) 
Left Amygdala, mm3 (SD) 1334.8 (170.9) 1321.4 (173.5) 
Right Amygdala, mm3 (SD) 1415.8 (169.4) 1386.8 (172.0)* 
Left hippocampus, mm3 (SD) 3958.1 (511.3) 3891.2 (519.0)* 
Right hippocampus, mm3 (SD) 3959.6 (496.1) 3920.9 (503.5) 
Analyses of lifestyle, cardiovascular risk factors and psychological measures were performed adjusted 
for age, sex and education level. Analyses of brain volumes were also adjusted for ICV.*: Significantly 
different (p<0.05). Groups are based on a cut-off of at least 1 hour per week practice. 1 ml = 1000 
mm3 
 
 
Linear regression analyses of the left and right amygdala volume with adjustment for 
demographics, intracranial volume, cardiovascular risk and psychological functioning 
resulted in the models shown in Table 3. Practicing meditation or yoga compared to not was 
associated with lower right amygdala volume (β = -31.8 mm3, SE 11.2, p = .005). The left 
amygdala showed no significant effects (β = -14.5 mm3, SE 11.2, p = .192). The ratio 
between right amygdala and total brain volume was affected significantly (β = -.38%, SE 
.116, p = .001). Linear regression also showed that practice was associated with a smaller 
left hippocampus: β = -75.3 mm3, SE 33.6, p = .025. The right hippocampus and 
prefrontal lobe were not statistically significant. 
Depression score was significantly correlated with right amygdala volume in the control 
group (r= -0.09, p<0.001), but not in the practitioner group (r= -0.10, p=0.078). Stress 
was not significantly correlated with right amygdala volume (r= -0.02, p=0.227), but it was 
with practice (r= 0.09, p<0.001). However, the amount of practice was not correlated 
with amygdala volume, depression or stress. 
 
Table 3. Cross-sectional analyses. Association between meditation and yoga practice and 
different brain volumes (N=3742). 
 
β (mm3) SE p-value 
95% Confidence 
Interval 
 Lower Upper 
Total brain (mm3) 1352.6 2922.0 .643 -4374.4 7079.6 
Left frontal lobe (mm3) 204.8 708.3 .772 -1183.4 1893.0 
Right frontal lobe (mm3)  686.0 712.0 .335 -709.5 2081.5 
Left Amygdala (mm3) -14.5  11.1 .192 -36.3 7.3 
Right Amygdala (mm3)* -31.8  11.2 .005 -53.8 -9.8 
Left hippocampus (mm3)* -75.3  33.6 .025 -141.1 -9.5 
Right hippocampus (mm3) -36.8  32.8 .262 -101.0 27.4 
Regression analyses adjusted for age, sex, ICV, education, cardiovascular risk factors, depression, 
anxiety, and stress. 
* Significantly different (p<0.05) 
 
Longitudinal analyses 
For analyzing structural change over time, 2397 participants were included who had MRI 
scans taken five years apart. In this sample, only 9% (N=218) practiced meditation or yoga 
for 5 years or longer. Linear mixed models adjusted for all covariates showed a significant 
interaction effect over time of practicing meditation and yoga on right amygdala volume (β 
= -24.4 mm3, SE 11.3, p = .031) (Table 4). The left amygdala did not show a significant 
effect (β = -11.6 mm3, SE 11.7, p = .32), nor did right and left hippocampus (β = -36.5 
mm3, SE 37.4, p = .33 and β = -5.7 mm3, SE 40.5, p = .89 respectively). Depression 
scores showed an increase over 5 years with similar effects in practitioners and controls (0.6 
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breathing participants. The yoga group had the largest amygdalae, though this difference was 
not statistically significant. The ratio between right amygdala and total volume was 
significantly smaller in the meditation and breathing group. The prefrontal lobe was not 
significantly different between groups and neither was the right hippocampus. The left 
hippocampus, however, showed to be significantly smaller in the practitioner group (3891.2 
mm3) compared to the control group (3958.1 mm3), p=0.036.  
 
Table 2. Characteristics of the study population.   
 No Meditation and  yoga 
practices (N=3453) 
Meditation and yoga 
practices  
(N=289) 
Mean age, years (SD) 64.3 (7.7) 61.9 (6.8)* 
Women  53% 73%* 
Highest education, score (SD) 1.7 (0.9) 2.0 (0.9)* 
   
BMI (SD) 27.5 (4.3) 26.6 (4.4)* 
SBP mmHg (SD) 139.7 (19.9) 138.3 (20.3) 
DBP mmHg (SD) 83.2 (11.3) 82.9 (11.6) 
Diabetes mellitus 8.3% 6.4% 
HDL Cholesterol, mmol/L (SD) 1.5 (0.4) 1.5 (0.4) 
LDL Cholesterol, mmol/L (SD) 3.7 (1.1) 3.8 (1.0) 
Smoking score (SD) 0.43 (0.6) 0.45 (0.7) 
Alcohol score (SD) 1.45 (0.6) 1.48 (0.8) 
   
Stress (1-5), mean (SD) 2.0 (1.0) 2.2 (1.0)* 
Depression, mean (SD) 5.2 (6.8) 6.2 (6.9)* 
Anxiety, mean (SD) 15.8 (3.4) 15.4 (3.5) 
   
Total brain, ml (SD) 940.4 (44.3) 943.1 (45.0) 
Left frontal lobe, ml (SD) 163.4 (0.2) 163.8(0.6) 
Right frontal lobe, ml (SD) 164.0 (0.2) 164.8 (0.6) 
Left Amygdala, mm3 (SD) 1334.8 (170.9) 1321.4 (173.5) 
Right Amygdala, mm3 (SD) 1415.8 (169.4) 1386.8 (172.0)* 
Left hippocampus, mm3 (SD) 3958.1 (511.3) 3891.2 (519.0)* 
Right hippocampus, mm3 (SD) 3959.6 (496.1) 3920.9 (503.5) 
Analyses of lifestyle, cardiovascular risk factors and psychological measures were performed adjusted 
for age, sex and education level. Analyses of brain volumes were also adjusted for ICV.*: Significantly 
different (p<0.05). Groups are based on a cut-off of at least 1 hour per week practice. 1 ml = 1000 
mm3 
 
 
Linear regression analyses of the left and right amygdala volume with adjustment for 
demographics, intracranial volume, cardiovascular risk and psychological functioning 
resulted in the models shown in Table 3. Practicing meditation or yoga compared to not was 
associated with lower right amygdala volume (β = -31.8 mm3, SE 11.2, p = .005). The left 
amygdala showed no significant effects (β = -14.5 mm3, SE 11.2, p = .192). The ratio 
between right amygdala and total brain volume was affected significantly (β = -.38%, SE 
.116, p = .001). Linear regression also showed that practice was associated with a smaller 
left hippocampus: β = -75.3 mm3, SE 33.6, p = .025. The right hippocampus and 
prefrontal lobe were not statistically significant. 
Depression score was significantly correlated with right amygdala volume in the control 
group (r= -0.09, p<0.001), but not in the practitioner group (r= -0.10, p=0.078). Stress 
was not significantly correlated with right amygdala volume (r= -0.02, p=0.227), but it was 
with practice (r= 0.09, p<0.001). However, the amount of practice was not correlated 
with amygdala volume, depression or stress. 
 
Table 3. Cross-sectional analyses. Association between meditation and yoga practice and 
different brain volumes (N=3742). 
 
β (mm3) SE p-value 
95% Confidence 
Interval 
 Lower Upper 
Total brain (mm3) 1352.6 2922.0 .643 -4374.4 7079.6 
Left frontal lobe (mm3) 204.8 708.3 .772 -1183.4 1893.0 
Right frontal lobe (mm3)  686.0 712.0 .335 -709.5 2081.5 
Left Amygdala (mm3) -14.5  11.1 .192 -36.3 7.3 
Right Amygdala (mm3)* -31.8  11.2 .005 -53.8 -9.8 
Left hippocampus (mm3)* -75.3  33.6 .025 -141.1 -9.5 
Right hippocampus (mm3) -36.8  32.8 .262 -101.0 27.4 
Regression analyses adjusted for age, sex, ICV, education, cardiovascular risk factors, depression, 
anxiety, and stress. 
* Significantly different (p<0.05) 
 
Longitudinal analyses 
For analyzing structural change over time, 2397 participants were included who had MRI 
scans taken five years apart. In this sample, only 9% (N=218) practiced meditation or yoga 
for 5 years or longer. Linear mixed models adjusted for all covariates showed a significant 
interaction effect over time of practicing meditation and yoga on right amygdala volume (β 
= -24.4 mm3, SE 11.3, p = .031) (Table 4). The left amygdala did not show a significant 
effect (β = -11.6 mm3, SE 11.7, p = .32), nor did right and left hippocampus (β = -36.5 
mm3, SE 37.4, p = .33 and β = -5.7 mm3, SE 40.5, p = .89 respectively). Depression 
scores showed an increase over 5 years with similar effects in practitioners and controls (0.6 
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and 1.0 on the CESD respectively, p=.73). Furthermore, elucidating the causal relationship 
between higher depression scores and smaller amygdala volume, there was no effect of right 
amygdala volume on CESD score (β = -0.001, SE 0.001, p = .21). 
 
Table 4. Longitudinal analyses of the effect of meditation and yoga practice on volume over 
5 years follow-up (N=2397). 
Parameter β (mm3) SE p-value 
95% Confidence Interval 
Lower  Upper  
Left amygdala -11.8 11.7 .312 -34.7 11.1 
Right amygdala*  -24.4 11.3 .031 -46.5 -2.3 
Left hippocampus -59.4 87.1 .495 -230.6 111.7 
Right hippocampus 116.5 84.6 .169 -49.7 282.7 
Linear Mixed models adjusted for age, gender, education, ICV, cardiovascular risk factors, depression, 
anxiety, and stress. 
* Significantly different (p<0.05) 
 
Discussion 
In this large population-based study we demonstrated that individuals involved in meditation 
and yoga practice experienced higher stress levels, whereas brain imaging shows smaller 
right amygdala and left hippocampal volume compared to those not practicing. These results 
are in line with previous correlational research amongst healthy participants 19. Practicing 
meditation and yoga had a significant effect over time on right amygdala volume, but not on 
left hippocampal volume.  
Elucidating the causal pathways of meditation and yoga practice, stress and amygdala volume 
in this context is complex. Smaller amygdala volumes could indicate a vulnerability to 
stress/depression, though the results of our longitudinal analyses imply otherwise. Early life 
stressors seem to have an increasing effect in later life on amygdala volume, and a decreasing 
effect on hippocampal volume 39. Also, depression has been associated with a larger right 
amygdala volume 16,40, where in the present study we observed that the meditation and yoga 
group had a smaller right amygdala. Stress reduction has been associated with less amygdala 
volume 16, and research has found significant differences in amygdala activity and structure in 
connection with mindfulness training 17,22,23,41,42.  
 The higher levels of stress and depressive symptoms in practitioners could also indicate the 
possibility of confounding by indication which can obscure the effect of meditation and yoga 
practice on psychological functioning 43. Meditation and yoga practices are known for their 
stress-reducing intent, making it plausible that people experiencing stress make use of these 
strategies. Also there was a significant positive correlation between both stress and 
depression, and practice. This could mean that meditation and yoga lead to more stress and 
depression, or that more stress and depression lead to more practice. It could also mean that 
meditation and yoga practitioners may become more aware of their stress whereas at the 
 
same time they learn to cope better with stressful events, as 90% of practitioners reported 
that their practice helps them cope with stress. In cross-sectional research, this complex 
relationship between stress and meditation and yoga practice completely obscures the exact 
pathway meditation and yoga practice follows to a smaller amygdala. The longitudinal data 
showed an increase in depression over time but no difference between the groups, so the 
difference in the cross-sectional data seem to refer to confounding by indication. 
Volumetric effects were only found in the right amygdala, not in the left. This is in line with 
previous smaller studies and is explained by the fact that the right amygdala, as opposed to 
the left amygdala, is associated with negative emotions and immediate action tak ing, whereas 
the left is associated with positive emotions and memory 44-46.  
A number of limitations of this study deserve attention. Although performed in a very large 
population-based sample, this is still a selection of participants that are generally healthy and 
motivated to join research. The prevalence of meditation and yoga practice is slightly lower 
in this study population (15.7%) than in other studies (18.9%), where the latter population 
was notably younger 1. It could be that people with a smaller right amygdala are naturally 
drawn to meditation and yoga practices. There is also risk of information bias since the 
questionnaire assessed amount of practice retrospectively. Also, stress was measured with a 
one-item Likert-scale instead of a validated questionnaire, which can increase the risk of 
information bias due to inaccuracy.  Furthermore, this study contains mainly elderly 
individuals, who may not be as actively involved in meditation and yoga practices as younger 
people might, and who also might show a different structural response than younger 
participants due to decreased brain plasticity. Finally, this study took a broad approach to the 
intervention of interest: Practice involved meditation, yoga and breathing exercises, which 
in turn can comprise different styles.  
Despite these limitations, the results do give direction for future research on the stress 
reducing effects of lifestyle interventions. Meditation and yoga practice are associated with 
structural differences in right amygdala volume and the vast majority of practitioners report 
that it helps them cope with stress. This suggests that meditation and yoga practices might be 
a feasible and accessible lifestyle intervention for people suffering from stress and stress-
related diseases. Such practices could be helpful in prevention of stress-related diseases, by 
recognizing early stages of stress and changing the neural response to stressful stimuli.  
 
Conclusion 
Partaking in meditation and yoga practice is associated with more experienced stress while it 
also helps cope with stress, and is associated with smaller right amygdala volume.  
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and 1.0 on the CESD respectively, p=.73). Furthermore, elucidating the causal relationship 
between higher depression scores and smaller amygdala volume, there was no effect of right 
amygdala volume on CESD score (β = -0.001, SE 0.001, p = .21). 
 
Table 4. Longitudinal analyses of the effect of meditation and yoga practice on volume over 
5 years follow-up (N=2397). 
Parameter β (mm3) SE p-value 
95% Confidence Interval 
Lower  Upper  
Left amygdala -11.8 11.7 .312 -34.7 11.1 
Right amygdala*  -24.4 11.3 .031 -46.5 -2.3 
Left hippocampus -59.4 87.1 .495 -230.6 111.7 
Right hippocampus 116.5 84.6 .169 -49.7 282.7 
Linear Mixed models adjusted for age, gender, education, ICV, cardiovascular risk factors, depression, 
anxiety, and stress. 
* Significantly different (p<0.05) 
 
Discussion 
In this large population-based study we demonstrated that individuals involved in meditation 
and yoga practice experienced higher stress levels, whereas brain imaging shows smaller 
right amygdala and left hippocampal volume compared to those not practicing. These results 
are in line with previous correlational research amongst healthy participants 19. Practicing 
meditation and yoga had a significant effect over time on right amygdala volume, but not on 
left hippocampal volume.  
Elucidating the causal pathways of meditation and yoga practice, stress and amygdala volume 
in this context is complex. Smaller amygdala volumes could indicate a vulnerability to 
stress/depression, though the results of our longitudinal analyses imply otherwise. Early life 
stressors seem to have an increasing effect in later life on amygdala volume, and a decreasing 
effect on hippocampal volume 39. Also, depression has been associated with a larger right 
amygdala volume 16,40, where in the present study we observed that the meditation and yoga 
group had a smaller right amygdala. Stress reduction has been associated with less amygdala 
volume 16, and research has found significant differences in amygdala activity and structure in 
connection with mindfulness training 17,22,23,41,42.  
 The higher levels of stress and depressive symptoms in practitioners could also indicate the 
possibility of confounding by indication which can obscure the effect of meditation and yoga 
practice on psychological functioning 43. Meditation and yoga practices are known for their 
stress-reducing intent, making it plausible that people experiencing stress make use of these 
strategies. Also there was a significant positive correlation between both stress and 
depression, and practice. This could mean that meditation and yoga lead to more stress and 
depression, or that more stress and depression lead to more practice. It could also mean that 
meditation and yoga practitioners may become more aware of their stress whereas at the 
 
same time they learn to cope better with stressful events, as 90% of practitioners reported 
that their practice helps them cope with stress. In cross-sectional research, this complex 
relationship between stress and meditation and yoga practice completely obscures the exact 
pathway meditation and yoga practice follows to a smaller amygdala. The longitudinal data 
showed an increase in depression over time but no difference between the groups, so the 
difference in the cross-sectional data seem to refer to confounding by indication. 
Volumetric effects were only found in the right amygdala, not in the left. This is in line with 
previous smaller studies and is explained by the fact that the right amygdala, as opposed to 
the left amygdala, is associated with negative emotions and immediate action tak ing, whereas 
the left is associated with positive emotions and memory 44-46.  
A number of limitations of this study deserve attention. Although performed in a very large 
population-based sample, this is still a selection of participants that are generally healthy and 
motivated to join research. The prevalence of meditation and yoga practice is slightly lower 
in this study population (15.7%) than in other studies (18.9%), where the latter population 
was notably younger 1. It could be that people with a smaller right amygdala are naturally 
drawn to meditation and yoga practices. There is also risk of information bias since the 
questionnaire assessed amount of practice retrospectively. Also, stress was measured with a 
one-item Likert-scale instead of a validated questionnaire, which can increase the risk of 
information bias due to inaccuracy.  Furthermore, this study contains mainly elderly 
individuals, who may not be as actively involved in meditation and yoga practices as younger 
people might, and who also might show a different structural response than younger 
participants due to decreased brain plasticity. Finally, this study took a broad approach to the 
intervention of interest: Practice involved meditation, yoga and breathing exercises, which 
in turn can comprise different styles.  
Despite these limitations, the results do give direction for future research on the stress 
reducing effects of lifestyle interventions. Meditation and yoga practice are associated with 
structural differences in right amygdala volume and the vast majority of practitioners report 
that it helps them cope with stress. This suggests that meditation and yoga practices might be 
a feasible and accessible lifestyle intervention for people suffering from stress and stress-
related diseases. Such practices could be helpful in prevention of stress-related diseases, by 
recognizing early stages of stress and changing the neural response to stressful stimuli.  
 
Conclusion 
Partaking in meditation and yoga practice is associated with more experienced stress while it 
also helps cope with stress, and is associated with smaller right amygdala volume.  
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Abstract 
 
Background: Due to new treatment modalities in the last decades, a decline in 
cardiovascular deaths has been observed. There is an emerging field of secondary prevention 
and behavioural programmes with increased interest in the use of mind–body practices. 
Until now, these have not been established in cardiovascular disease treatment programmes.  
Design: We performed a systematic review and meta-analysis of the available evidence on 
the effectiveness of mind–body practices for patients with diagnosed cardiac disease. 
Methods: We included randomized controlled trials (RCTs), published in English, 
reporting mind–body practices for patients with diagnosed cardiac disease. EMBASE, 
MEDLINE, Pubmed, Web of Science, The Cochrane Central Register of Controlled Trials 
and PsycINFO were searched up to July 2013. Two reviewers independently identified 
studies for inclusion and extracted data on study characteristics, outcomes (Quality of Life, 
anxiety, depression, physical parameters and exercise tolerance) and quality assessment. 
Standardized effect sizes (Cohen’s d) were calculated comparing the outcomes between the 
intervention and control group and random effects meta-analysis was conducted. 
Results: We identified 11 unique RCTs with an overall low quality. The studies evaluated 
mindfulness-based stress reduction, transcendental meditation, progressive muscle 
relaxation and stress management. Pooled analyses revealed effect sizes of 0.45 (95%CI 
0.20–0.72) for physical quality of life, 0.68 (95%CI 0.10–1.26) for mental quality of life, 
0.61 (95%CI 0.23–0.99) for depression, 0.52 (95%CI 0.26–0.78) for anxiety, 0.48 (95%CI 
0.27–0.69) for systolic blood pressure and 0.36 (95%CI 0.15–0.57) for diastolic blood 
pressure. 
Conclusions: Mind–body practices have encouraging results for patients with cardiac 
disease. Our review demonstrates the need for high-quality studies in this field. 
 
  
 
Introduction 
Advances in medical treatment have resulted in a decline in mortality from cardiovascular 
disease (CVD).1 CVD is, however, still the leading cause of death globally.2 Furthermore, 
the decline in CVD mortality has led to an increase in prevalent CVD, requiring treatment 
and secondary prevention of more and more patients with documented disease. 
Traditionally, secondary prevention has focused on well-established and modifiable risk 
factors, such as smoking, hypertension, diabetes, dyslipidaemia and physical inactivity. An 
emerging field is that of psychosocial risk factors (anxiety, depression and stress) in the 
aetiology and prevention of CVD.3–5 Clinical trials studying modification of psychosocial risk 
factors in CVD have focused on the use of behavioural and psychological interventions in the 
setting of cardiac rehabilitation. Multiple studies show promising results of stress 
management on psychological outcomes and mind–body practices have become popular for 
stress reduction.6 Commonly used in Eastern cultures for centuries, mind–body practices 
have more recently been making their way into Western lifestyle and clinical practice with 
currently almost 20% of the population routinely doing some form of mind–body 
practice.7,8 Furthermore, evidence is accumulating that mind–body practices can be used as 
safe adjuncts to existing medical treatment and are effective in several conditions, such as 
insomnia, chronic pain, depression, post-traumatic stress, irritable bowel syndrome (IBS), 
hypertension and cardiovascular disease (CVD).9–13 
Mind–body practices predate modern biomedicine but there is accumulating evidence on the 
connection between the mind and body.14 The encouraging results on improved 
psychological well-being and measurable changes in physical parameters suggest that mind–
body practices can be of added value in patients with CVD. The aim of this review was to 
evaluate the effectiveness of meditation-based mind–body practices on quality of life, 
anxiety, depression, physical parameters and exercise tolerance in patients with diagnosed 
cardiac disease. 
 
Methods 
Search strategy 
Together with a professional librarian we conducted electronic searches through Embase, 
Medline, Pubmed, Web of Science (WoS), The Cochrane Central Register of Controlled 
Trials (CENTRAL) and PsycINFO of the literature published up to 31 July 2013. We 
reviewed mind–body practices with the focus on meditation and relaxation in patients with 
diagnosed cardiac disease15 that could be taught without external biofeedback techniques. 
Practices considered included: (transcendental) meditation, mindfulness meditation, 
autogenic training and relaxation methods. The diagnosed cardiac diseases included were: 
heart failure, ischaemic heart disease, hypertensive heart disease, inflammatory heart disease, 
valvular heart disease, congenital heart disease and cardiomyopathy. The search included 
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Background: Due to new treatment modalities in the last decades, a decline in 
cardiovascular deaths has been observed. There is an emerging field of secondary prevention 
and behavioural programmes with increased interest in the use of mind–body practices. 
Until now, these have not been established in cardiovascular disease treatment programmes.  
Design: We performed a systematic review and meta-analysis of the available evidence on 
the effectiveness of mind–body practices for patients with diagnosed cardiac disease. 
Methods: We included randomized controlled trials (RCTs), published in English, 
reporting mind–body practices for patients with diagnosed cardiac disease. EMBASE, 
MEDLINE, Pubmed, Web of Science, The Cochrane Central Register of Controlled Trials 
and PsycINFO were searched up to July 2013. Two reviewers independently identified 
studies for inclusion and extracted data on study characteristics, outcomes (Quality of Life, 
anxiety, depression, physical parameters and exercise tolerance) and quality assessment. 
Standardized effect sizes (Cohen’s d) were calculated comparing the outcomes between the 
intervention and control group and random effects meta-analysis was conducted. 
Results: We identified 11 unique RCTs with an overall low quality. The studies evaluated 
mindfulness-based stress reduction, transcendental meditation, progressive muscle 
relaxation and stress management. Pooled analyses revealed effect sizes of 0.45 (95%CI 
0.20–0.72) for physical quality of life, 0.68 (95%CI 0.10–1.26) for mental quality of life, 
0.61 (95%CI 0.23–0.99) for depression, 0.52 (95%CI 0.26–0.78) for anxiety, 0.48 (95%CI 
0.27–0.69) for systolic blood pressure and 0.36 (95%CI 0.15–0.57) for diastolic blood 
pressure. 
Conclusions: Mind–body practices have encouraging results for patients with cardiac 
disease. Our review demonstrates the need for high-quality studies in this field. 
 
  
 
Introduction 
Advances in medical treatment have resulted in a decline in mortality from cardiovascular 
disease (CVD).1 CVD is, however, still the leading cause of death globally.2 Furthermore, 
the decline in CVD mortality has led to an increase in prevalent CVD, requiring treatment 
and secondary prevention of more and more patients with documented disease. 
Traditionally, secondary prevention has focused on well-established and modifiable risk 
factors, such as smoking, hypertension, diabetes, dyslipidaemia and physical inactivity. An 
emerging field is that of psychosocial risk factors (anxiety, depression and stress) in the 
aetiology and prevention of CVD.3–5 Clinical trials studying modification of psychosocial risk 
factors in CVD have focused on the use of behavioural and psychological interventions in the 
setting of cardiac rehabilitation. Multiple studies show promising results of stress 
management on psychological outcomes and mind–body practices have become popular for 
stress reduction.6 Commonly used in Eastern cultures for centuries, mind–body practices 
have more recently been making their way into Western lifestyle and clinical practice with 
currently almost 20% of the population routinely doing some form of mind–body 
practice.7,8 Furthermore, evidence is accumulating that mind–body practices can be used as 
safe adjuncts to existing medical treatment and are effective in several conditions, such as 
insomnia, chronic pain, depression, post-traumatic stress, irritable bowel syndrome (IBS), 
hypertension and cardiovascular disease (CVD).9–13 
Mind–body practices predate modern biomedicine but there is accumulating evidence on the 
connection between the mind and body.14 The encouraging results on improved 
psychological well-being and measurable changes in physical parameters suggest that mind–
body practices can be of added value in patients with CVD. The aim of this review was to 
evaluate the effectiveness of meditation-based mind–body practices on quality of life, 
anxiety, depression, physical parameters and exercise tolerance in patients with diagnosed 
cardiac disease. 
 
Methods 
Search strategy 
Together with a professional librarian we conducted electronic searches through Embase, 
Medline, Pubmed, Web of Science (WoS), The Cochrane Central Register of Controlled 
Trials (CENTRAL) and PsycINFO of the literature published up to 31 July 2013. We 
reviewed mind–body practices with the focus on meditation and relaxation in patients with 
diagnosed cardiac disease15 that could be taught without external biofeedback techniques. 
Practices considered included: (transcendental) meditation, mindfulness meditation, 
autogenic training and relaxation methods. The diagnosed cardiac diseases included were: 
heart failure, ischaemic heart disease, hypertensive heart disease, inflammatory heart disease, 
valvular heart disease, congenital heart disease and cardiomyopathy. The search included 
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keywords corresponding to the mind–body techniques and cardiac diseases. To optimize the 
search strategy, we used synonyms including ‘text words’ and MeSH (Medical Subject 
Headings) (Appendix A, see online Supplementary Material). We screened for other 
potentially relevant randomized controlled trials by searching through the references and 
citation lists from identified papers meeting our inclusion criteria. 
 
Study selection 
Two reviewers (JY and CB) independently selected all potential studies, which were 
identified through the results of our search strategy. Disagreements were resolved by 
consensus. We included relevant studies if they met the following criteria: (1) written in 
English; (2) study design was a randomized controlled trial (RCT); (3) study population with 
diagnosed cardiac disease; (4) the mind–body practice was compared to standard care, 
pharmacological intervention, psychological intervention or no treatment at all; (5) at least 
one of the following clinically relevant outcomes was assessed – any form of Quality of life 
(QoL) measurement as described by Ski et al.16 and Wenger et al.17 including subjective 
health status and health-related QoL, mental health scales on anxiety or depression, physical 
parameters (blood pressure and heart rate) or exercise tolerance (measured by 6-minute 
walk test or cardiopulmonary exercise testing). We selected studies reporting both objective 
and physiological outcomes because in cardiac disease especially, physiological parameters 
are good indicators of overall physical well-being. Several studies show the hypothesis and 
rational of mind–body interaction. We know that hypertension is one of the major risk 
factors of cardiovascular morbidity and mortality.18 The prevalence of hypertension is 
projected to increase to about 60% in 2025.19 Conventional medical treatment may be 
associated with various adverse effects,20 especially in cases of multiple drug use and 
treatment-resistant hypertension, which has led to investigations of the supporting role of 
non-pharmacological interventions. We chose to limit our search to English written studies 
based on two reports, which showed no systematic bias with the use of a language 
restriction.21,22 We excluded studies if they met one of the following criteria: (1) the article 
was a review or meta-analysis; (2) data were from abstracts or letters; (3) studies that 
evaluated psychological or psychosocial interventions focusing on interactions between 
people; (4) studies in which the mind–body practice was not the main area of interest; (5) 
studies that evaluated stress management with a major cognitive component; (6) studies 
evaluating practices using an external biofeedback technique; and (7) studies that evaluated 
practices performed during the peri-operative phase. 
 
Data extraction 
Data from studies were extracted independently by two authors (JY and RG) using a data 
extraction form in accordance with the Cochrane handbook of systematic reviews.23 The 
following information was obtained using this form: author, journal, year of publication, 
country, setting, funding, number of patients, cardiac diagnosis, mean age, gender, co-
 
morbidity, use of medication, type of mind–body practices, details of the practices, 
comparators, follow-up duration, outcome definition, unit of measurement, pre- and post-
outcome measurements on exercise tolerance, QoL, anxiety, depression, blood pressure 
and heart rate. If more than one practice or control arm was present, we included only the 
mind–body practices versus the control group. Disagreements were resolved by consensus. 
If data were unclear or unavailable, the authors were contacted by email. In case of multiple 
publications from one source, we only included data from different papers if different 
outcomes were reported. Resting heart rate and blood pressure results were used and not 
values measured during the relaxation practice. 
Quality assessment 
Two reviewers (JY and RG) independently scored the methodological quality of each study 
by using the Cochrane Collaboration ‘risk of bias’ tool23 in which the following domains are 
considered: (1) random sequence generation; (2) allocation concealment; (3) blinding of 
participants and personnel; (4) blinding of outcome assessment; (5) incomplete outcome 
data; (6) selective reporting; (7) other sources of bias. The judgment is categorized as 
follows: A. ‘Low risk’ of bias. B. ‘High risk’ of bias. C. ‘Unclear risk’ of bias. Additionally, 
the heterogeneity between studies was reported and the PRISMA statement for reporting 
systematic reviews and meta-analysis was used for reporting of results.24 Disagreements 
were resolved by consensus. Small sample size can lead to bias but no formal agreement 
exists on how large the sample size of a study should be to limit the risk of bias. Consensus 
between JY and RG led to the cut-off point of 30 participants per study to score the study at 
high risk of ‘other bias’ due to their small sample size. 
 
Data synthesis and analysis 
To analyse the maximum treatment effect we used data of post-treatment values on the pre-
defined outcome measurements. If multiple follow-up data were available, we used the 
outcome assessment at the end of the intervention period in order to determine the 
maximum treatment effect. If multiple follow-up data were unavailable we used the data as 
reported. We calculated the Cohen’s d effect size, comparing the intervention and control 
groups, of the means and confidence intervals according to the equations as shown in 
Appendix B (see online Supplementary Material). Data for each outcome were summarized 
in forest plots, and random effects models were used to calculate summary estimates with 
95%CI. Funnel plots were constructed to check for the presence of publication bias. Of the 
eight domains of the Short-Form Health Survey-36, we present the summary measures of 
the Physical and Mental Component Score (PCS and MCS respectively). QoL measures 
were grouped according to their subscale (i.e. physical, mental/emotional or other). If more 
than one QoL measure was reported (i.e. The Short-Form Health Survey 36 (SF-36) and the 
Minnesota Living With Heart Failure Questionnaire (MLWHFQ)), the SF-36 was used over 
the other measures in the random effects meta-analysis. 
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Results 
Study selection 
Our literature search resulted in 1487 studies, 1485 from the original search and two from 
reference lists (Figure 1). Of these, 551 studies were excluded because they were duplicates 
and 902 studies were excluded when title and abstract were reviewed. Of the 34 studies 
selected for full text review, 21 were excluded for not meeting the predefined inclusion 
criteria (Figure 1). 
Finally, 13 RCTs, consisting of 11 unique studies, met our inclusion criteria and were 
included in this review. They were published between 1996 and 2012 and were carried out 
in six different countries (UK, USA, China, Brazil, India and Portugal).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flow diagram of identified studies. 
 
 
 
501 EMBASE 
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48 Cochrane Central 
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8 Pubmed 
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 551 Duplicate articles 
902 Excluded based on title 
and abstract selection 
936 Unique articles 
21 Articles excluded: 
  11 no RCT 
  8 No cardiac disease 
  2 perioperative 
34 Full text screening 
13 Included in review 
11 Unique RCTs: 
  4 Meditation 
  2 Mindfulness meditation 
  5 Relaxation 
 
1487 Total 
2 additional records 
from reference lists 
 
General characteristics  
The characteristics of interventions and patients are presented in Table 1. The studies 
included 793 unique patients (46% female) with a mean age of 66 (11 years). The studies 
ranged in sample size from 18 to 201 patients. There were two cases of duplicate reports on 
the same patient population.25,26 One study did not fully report its baseline characteristics.27 
 
Table 1. Study characteristics of included randomized controlled trials. 
Author (year) 
Study 
location 
Cardiac 
diagnosis 
Age 
(SD) 
% 
Female N 
Trzcieniecka-Green 
(1996) 
UK AMI/CABG 60 (10) 13 100 
Wilk (2002) USA CABG/MI/ 
Angioplasty 
63 (NR) 14 14 
Tacon (2003) USA Cardiaca 61 (9) 100 18 
Robert-McComb 
(2004) 
USA Cardiaca 61 (8) 100 18b 
Curiati (2005) Brazil HF 75 (7) 74 19 
Chang (2005) USA HF 70 (14) 0 63 
Paul-Labrador 
(2006) 
USA CAD 67 (14) 18 103 
Jayadevappa (2007) USA HF 64 (11) 61 23 
Yu (2007) China HF 76 (8) 51 121 
Yu (2009) China  HF 76 (8) 51 121b 
Neves (2009) Portugal CAD 60 (15) 85 81 
Schneider (2012) USA CAD 59 (15) 43 201 
Nehra (2012) India CHD NA NA 50 
All   66 (11) 51 743b 
AMI acute myocardial infarction; CABG coronary bypass artery grafting; CVD cardiovascular 
disease; CAD coronary artery disease; HF heart failure; CHD coronary heart disease; NA not available.  
a Patients diagnosed with angina pectoris, valvular disease, hypertension or CAD. b 743 unique 
patients. 
 
Patients 
Most studies included patients with heart failure (N=5),26,28–31 or coronary artery disease 
(N= 4).27,32–34 One study only recruited heart failure patients after optimal medical 
treatment and at least two months of carvedilol therapy.29 Two studies included patients 
following AMI, angioplasty or CABG, when considered in a stable condition (2–3 months 
post-surgery or percutaneous intervention).35,36 Two studies included various diagnoses 
including angina, hypertension, valve disorders and coronary artery disease.25,37  
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Most studies included patients with heart failure (N=5),26,28–31 or coronary artery disease 
(N= 4).27,32–34 One study only recruited heart failure patients after optimal medical 
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Interventions 
The included studies compared the effects of different mind–body practices with various 
control interventions. The mind–body practices studied were: mindfulness based stress 
reduction,25,27,37 transcendental meditation,30,33,34 meditation (which consisted of three 
components: breathing, mental repetition of a word and a guided image),29 progressive 
muscle relaxation training,26,31,36 relaxation response (which consisted of eight different 
components: breathing awareness; mental repetition of a word, sound, phrase or prayer; 
mindfulness meditation; guided body scan; progressive muscle relaxation; guided 
countdown; autogenic and guided imagery),28 relaxation,32 and stress management (based on 
autogenic training).35 Further details and the content of the interventions are shown in Table 
2. Two studies evaluated a mind–body practice in addition to regular cardiac rehabilitation 
compared to cardiac rehabilitation alone.32,36 The duration of the interventions ranged from 
4 to 26 weeks. One study did not provide the duration of the intervention.34 All but one 
study32 gave daily home exercises by audiotape or instructions. In one study the trial was 
conducted in two parts due to a hiatus in funding.34  
 
Control intervention 
The control interventions used were: waiting list,25,35,37 usual care (in which the patients 
were expected to solely attend the two moments of study outcome assessment and were not 
invited to group sessions),27,28 attention control (extra attention by phone calls to balance the 
effect of the extra attention that patients received in the PMRT training).13,26,31 Some studies 
made comparisons with an active intervention, such as health education30,33,34 or cardiac 
rehabilitation.32,36 One study had weekly talks on stress management.29 The study by Chang 
et al.28 used two control groups (education and usual care) of which we present only the 
usual care. 
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Risk of bias 
The risk of bias of included studies is shown in Table 3. Due to the nature of the 
intervention, none of the studies was able to blind the participants and personnel teaching 
the intervention. Blinding of the outcome assessor is possible and was included in Table 3. 
Furthermore, the presence of small groups often made the risk of other bias inevitable. 
 
Random sequence generation Five studies reported the randomization procedure used.26–28,30,31,33 
The other studies did not provide enough information to judge which randomization 
procedure was used and were classified as ‘Unclear risk’. 
Allocation concealment Only three studies reported allocation concealment.30,33,34 Most studies 
failed to state clearly how randomization had been achieved and were judged as ‘Unclear 
risk’. 
Blinding of participants, personnel and outcome assessment The outcome assessor was blinded in 
five studies.26,30,31,33,34 In one study the outcome assessor was also the instructor of the 
intervention making blinding to the outcome impossible.36 In the other studies the 
assessment procedure of the outcome was unclear. 
Addressing incomplete outcome data Almost all studies reported missing data whereas three 
studies did not.26,31,35 Eight studies reported adequate information about how many 
participants had withdrawn after having consented to participate. 
Selective reporting Most studies reported outcomes that were predefined in the methods 
section and were thus judged as low risk of selective reporting bias. In three studies the risk 
of selective reporting was considered high since some of the outcomes mentioned in the 
methods section were not reported.25,27,37 Furthermore, one study failed to provide enough 
statistical data (i.e. standard deviations were missing).36 
Other bias We considered other sources of bias to be present if the study included a small 
sample size (n < 30), was reported to be underpowered, or minimal or no group 
comparison at baseline was reported. Almost all studies had a small sample size. Only four 
studies included 100 or more patients.26,31,33,35  
 
Heterogeneity across studies Overall, based on the clinical diversity of the included patients in 
the studies (Table 1), the methodological diversity in study design and risk of bias (Table 3) 
and the statistical heterogeneity of outcomes reported, we conclude there is significant 
heterogeneity across studies. 
 
Publication bias. Funnel plots of the subjective and physiological outcomes were constructed 
and are shown in Appendix C (see online Supplementary Material). Overall, the funnel plots 
show no clear evidence of publication bias.  
  
 
Table 3. Risk of bias in included studies. 
Author 
(year) 
Random 
sequence 
generatio
n 
Alloca
tion 
concea
lment 
Blinding 
of patient 
and 
personnel 
Incompl 
outcome 
data 
adressed 
Selec
tive 
repo
rting 
Oth
er 
bias 
Trzcieniecka-
Green (1996) ? ? - ? - ? 
Wilk (2002) ? ? - - ? - 
Tacon (2003) ? ? - ? + - 
Robert-
McComb 
(2004) 
? ? - ? + - 
Curiati (2005) ? ? - ? + - 
Chang (2005) + ? - ? + - 
Paul-Labrador 
(2006) + + - + + ? 
Jayadevappa 
(2007) + + - + + - 
Yu (2007) + ? - + - + 
Yu (2009) + ? - + - + 
Neves (2009) ? ? - ? + ? 
Schneider 
(2012) ? + - + ? - 
Nehra (2012) + ? - ? + - 
 
Subjective outcomes  
Quality of Life. Six RCTs reported quality of life outcomes assessed with five different 
questionnaires. Results measurements used are presented in Table 4. Pooled effect sizes of 
the physical QoL measures revealed an overall medium statistically significant effect size of 
d=0.45 (95% CI 0.18–0.72) and an overall medium statistically significant effect size of 
d=0.68 (95%CI 0.10–1.26) for mental scores (Figure 2). The other subscales showed a 
small non-significant effect of d=0.25 (95%CI -0.10–0.61). The results were mainly 
influenced by the large study of Yu et al.26  
Depression. Depression was assessed with only two instruments: the Center for Epidemiologic 
Studies Depression Scale (CESD) and the Hospital Anxiety and Depression scale (HADS). 
Depression was reported in six studies. The study by Schneider et al.34 consisted of repeated 
measurements over a period of 5.4 years. The depression outcomes revealed an overall 
medium statistically significant effect size of d=0.61 (95% CI 0.23–0.99) (Figure 3). Results 
were heterogeneous with small effects of d=0.14 in the study by Schneider et al.34 and large 
effects of d=1.25 in the study of Yu et al.31 (Figure 3). 
Anxiety. Anxiety was reported in five studies. An overall medium statistically significant 
effect of 0.52 (95% CI 0.26–0.78) was found (Figure 3). Again, results were heterogeneous 
with small effect sizes ranging from d=0.31 in the study of Paul-Labrador et al.33 to large 
effects of d=1.34 in the study of Tacon et al.37 (Figure 3). 
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effects of d=1.25 in the study of Yu et al.31 (Figure 3). 
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Table 4. Type of outcome in included studies (methods). 
Author (year) Outcome Type of scale 
Moment of 
assessment 
(weeks) 
Trzcieniecka-
Green (1996) 
QoL, anxiety, depression GWB, HADS 0, 10, 26 
Wilk (2002) Anxiety, DPB, SBP, HR STAI 0, 4 
Tacon (2003) Anxiety STAI 0, 8 
Robert-McComb 
(2004) 
QoL SF-36 0, 8 
Curiati (2005) QoL, exercise tolerance, DPB, SBP, HR 
MLWHFQ, VO2max 0, 14 
Chang (2005) QoL, exercise tolerance MLWHFQ, VO2max 0, 14-19 
Paul-Labrador 
(2006) 
Anxiety, depression, DBP, 
SBP 
STAI, CESD 0, 16 
Jayadevappa 
(2007) 
QoL, depression, exercise 
tolerance 
SF-36, MLWHFQ, 
QWB, CESD, 6MWT 
0, 12, 26 
Yu (2007) Anxiety, depression HADS 0, 8, 14 
Yu (2009) QoL WHOQOL-BREF 0, 8, 14 
Neves (2009) DBP, SBP, HR  0, 12 
Schneider (2012) Depression, DBP, SBP, HR CESD 0, 12, 26 
Nehra (2012) Anxiety, depression HADS 0, 10-17 
QoL quality of life; GWB general well-being; HADS Hospital Anxiety and Depression Scale; DBP 
diastolic blood pressute; SBP systolic blood pressure; HR heart rate; STAI State-Trait Anxiety 
Inventory; SF-36 36-item Short Form Health Survey; MLWHFQ Minnesota Living with heart failure 
questionnaire; HRV heart rate variability; CESD center for epid emiologic studies depression scale; 
QWB quality of well-being; 6MWT six-minute walk test; WHOQOL-BREF world health organization 
quality of life-BREF. 
 
Physiological outcomes 
Resting blood pressure. Blood pressure was reported in five RCTs. Due to missing SDs no 
effect size with 95% CI could be calculated for Wilk et al.36 Effect sizes for SBP ranged from 
small effects of d=0.42 in the study of Schneider et al.34 to a large effect of d=1.10 in the 
study of Curiati et al.29 (Figure 4). The meta-analysis resulted in an overall medium 
statistically significant effect of d=0.48 (95% CI 0.27–0.69). Effect sizes for DBP showed a 
similar heterogeneous pattern with results of d ranging from 0.25 in the study by Schneider 
et al.34 to 0.80 in the study by Curiati et al.29 Results showed an overall lower, but 
statistically significant, effect than the SBP results (0.36, 95% CI 0.15–0.57) (Figure 4). 
Resting heart rate. Four RCTs reported on resting heart rates (Figure 4). Wilk et al.36 
reported that a significant difference was found but no effect size with 95% CI could be 
calculated due to missing SDs. An overall small effect of d=0.15 (95%CI -0.08– 0.39) was 
found. All studies showed small effects of d ranging from 0.13 to 0.20 (Figure 4).  
Exercise tolerance. Only three studies reported exercise tolerance as outcome (Table 5).28–30 
No effect size could be calculated for Wilk et al.36 due to missing SDs. A medium effect of 
d=0.51 was seen for VO2 max testing and a large effect of d=1.04 was seen on the six 
minute walk test in the study of Jayadevappa et al.30 (Table 5). 
 
 
Figure 2. Forest plot of QoL results. 
CI, confidence interval; n(I), number of patients in intervention group; n(C), number of patients in 
control group. aWHOQOL-BREF-HK, World health Organization Quality of Life Hong Kong 
version. bSF-36, Short-Form Health Survey 36. cMLWHQ, Minnesota Living With Heart Failure 
Questionnaire. dQWB, Quality of Well-Being. eGWB, General Well-Being. 
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Figure 3. Forest plots of depression and anxiety. 
n(I), number of patients in intervention group; n(C), number of patients in control group; CI, 
confidence interval. 
 
Table 5. Results of studies that reported exercise tolerance. 
Author (year) 
Intervention 
(N) 
Control 
(N) 
Effect size 
(95%CI)b 
Exercise tolerance 
 
Exercise test 
Curiati (2005) 8 (5)a 7 (5)a 0.51 (-0.75-1.77) VO2max 
Chang (2005) 31 28 N/A VO2max 
Jayadevappa 
(2007) 
13 10 1.04 (0.15-1.91) 6MWT 
CI confidence interval; N/A not applicable; 6MWT six minute walk test  
aFive patients did VO2max testing. b effect size is Cohen’s d 
 
 
 
Figure 4. Forest plots of physiological parameters. 
SBP, systolic blood pressure; n(I), number of patients in intervention group; n(C), number of patients 
in control group; CI, confidence interval; DBP, diastolic blood pressure; HR, heart rate.  
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Discussion 
The eleven unique studies in this review had an overall low quality and used a variety of 
outcome measurements. There was some evidence for the effectiveness of mind–body 
practices for patients with diagnosed cardiac disease. Promising but heterogeneous results 
were seen on overall effect sizes of mental and physical QoL, anxiety, depression and blood 
pressure. 
There are several reasons why patients engage in mind–body practices. Firstly, these 
therapies are easy to learn and they allow patients to take a more active role in their 
treatment. Secondly, most exercises can be done at home without the help of external 
means. Thirdly, low emotional and physical risk is involved. Finally, the costs are relatively 
low 38–40. Although mind–body practices require commitment in both adherence and time, 
they are becoming more and more popular.7, 8 Studies on the effectiveness of mind–body 
practices in CVD have shown some promising results. They improved psychosocial risk 
factors, reduced blood pressure and even showed survival benefits.41–44 It is hypothesized that 
patients with CVD are more likely to seek additional treatment since psychological stress, 
whether cause or consequence, often  accompanies their clinical condition.45,46 Stress can 
cause an imbalance between the mind and body, and several studies suggest stress is related 
to CVD at several stages of the disease from the development of arteriosclerosis to acute 
cardiac events to chronic disease.5,47 Furthermore, other studies have shown associations 
between psychosocial variables and vascular function, inflammation and increased blood 
clotting.48–50 Thus, although the precise pathophysiological mechanism still needs to be 
unraveled, it is clear that a relationship exists between stress and CVD. Many biological 
pathways have been studied that could explain the working mechanism of mind–body 
practices. Several studies show positive physiological effects in blood pressure, heart rate, 
respiration rate and oxygen consumption with mind–body practices.10,51 Three studies 
showed that the autonomic nervous system releases endorphin and serotonin, which leads to 
counteraction of norephinephrine and activates the parasympathetic response.10,12,51 In a 
small study on the effect of yoga and meditation on endothelial function, favourable changes 
were observed in endothelial-dependent vasodilatation in CAD patients.44 A mechanism 
illustrating how mind–body practice can have influence on health is provided by research on 
the interaction between the central nervous system (CNS) and the endocrine, immune and 
peripheral autonomic nervous systems.52 There is also evidence for a positive effect on the 
immune system and endothelial functioning.51,53,54 All together, these studies show the 
profound effects of stress reduction and meditation techniques on the body, suggesting that 
the mind may be able to influence the working of the heart.  
Until now, a core component in the treatment of CAD patients is cardiac rehabilitation with 
the components exercise training, healthy nutrition and smoking cessation.55 Lifestyle 
modification programmes have been shown to be of added value in treating patients with 
CAD.56 These interventions have proven to be favourable for physical and psychosocial risk 
 
factors and also showed a survival advantage.57–59 Additional stress management has been 
shown to have additional value in cardiac rehabilitation programmes.60,61 Even though the 
American Heart Association (AHA) has recognized the importance of psychosocial 
interventions as a core component in cardiac rehabilitation programmes,62 these 
interventions have only been integrated in a limited number of settings. Furthermore, only 
25–31% of eligible patients participate in these comprehensive programmes.63 
Some limitations of this systematic review must be addressed. Firstly, we limited our search 
strategy to English studies exclusively, with no consideration of studies conducted in the East 
– for example written in Chinese – from which mind–body practices originate. Secondly, 
we focused primarily on meditation-based mind–body practices that could be undertaken by 
patients at home without external tools. Therefore, no conclusions can be drawn on the 
effect of other mind–body practices in CVD. The connection between the mind and heart is 
a complex phenomenon and the use of meditation-based mind–body practices is still limited 
in clinical practice. Clearly, the role of mind–body practices in the advanced treatment of 
cardiac patients still needs to be defined. Behavioural cardiology is an emerging field that is 
bringing about awareness of the mind–heart connection and the management of psychosocial 
risk factors.57 
However, current evidence on the efficacy and effectiveness of most mind–body practices 
has not been established due to a lack of well-performed randomized clinical trials. Mind–
body research has several drawbacks that can hamper the internal validity and generalizability 
of published studies. A paper by Caspi et al.64 showed several important features to consider 
in meditation research such as monitoring, assessment procedures, integration of qualitative 
methods and a pragmatic design. Most of the studies included in this review failed to provide 
detailed information on the randomization procedure and a study protocol was often not 
available. Furthermore, most studies lacked power and were too small to draw firm 
conclusions from. Until now, there is no clear understanding of the study design in mind–
body research and future methodological studies should provide guidance. 
 
Conclusions 
In our review we showed that mind–body practices have encouraging results for patients 
with cardiac disease on selected QoL outcomes, anxiety, depression and blood pressure. 
Due to an overall low quality of studies, no firm conclusions can be drawn. Future clinical 
trials should focus on using a rigorous study design in order to minimize methodological 
flaws and enhance their validity and generalizability.  
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Abstract 
 
Background: Yoga, a popular mind-body practice, may produce changes in cardiovascular 
disease (CVD) and metabolic syndrome risk factors. 
Design: This was a systematic review and random-effects meta-analysis of randomized 
controlled trials (RCTs). 
Methods: Electronic searches of MEDLINE, EMBASE, CINAHL, PsycINFO, and The 
Cochrane Central Register of Controlled Trials were performed for systematic reviews and 
RCTs through December 2013. Studies were included if they were English, peer-reviewed, 
focused on asana-based yoga in adults, and reported relevant outcomes. Two reviewers 
independently selected articles and assessed quality using Cochrane’s Risk of Bias tool.  
Results: Out of 1404 records, 37 RCTs were included in the systematic review and 32 in 
the meta-analysis. Compared to non-exercise controls, yoga showed significant 
improvement for body mass index (0.77 kg/m2 (95% confidence interval 1.09 to 0.44)), 
systolic blood pressure (5.21 mmHg (8.01 to 2.42)), low-density lipoprotein cholesterol 
(12.14 mg/dl (21.80 to 2.48)), and high-density lipoprotein cholesterol (3.20 mg/dl (1.86 
to 4.54)). Significant changes were seen in body weight (2.32 kg (4.33 to 0.37)), diastolic 
blood pressure (4.98 mmHg (7.17 to 2.80)), total cholesterol (18.48 mg/dl (29.16 to 
7.80)), triglycerides (25.89 mg/dl (36.19 to 15.60), and heart rate (5.27 beats/min (9.55 
to 1.00)), but not fasting blood glucose (5.91 mg/dl (16.32 to 4.50)) nor glycosylated 
hemoglobin (0.06% Hb (0.24 to 0.11)). No significant difference was found between yoga 
and exercise. One study found an impact on smoking abstinence. 
Conclusions: There is promising evidence of yoga on improving cardio-metabolic health. 
Findings are limited by small trial sample sizes, heterogeneity, and moderate quality of 
RCTs. 
 
  
 
Introduction 
Background 
Cardiovascular disease (CVD) and metabolic syndrome are major public health problems in 
the USA and worldwide.1,2 Metabolic syndrome is defined as having at least three metabolic 
risk factors – increased blood pressure, high blood sugar level, excess body fat, and 
abnormal cholesterol levels – and greatly increases the chance of future cardiovascular 
problems.3 Lifetime risk of CVD is substantial as estimated through risk functions like those 
from the Framingham Heart Study,4 underlining the need for prevention and control of risk 
factors. 
CVD and metabolic syndrome share many of the same modifiable risk factors. Several 
guidelines name physical inactivity, the fourth leading risk factor of global mortality, 5 as an 
important modifiable risk factor for CVD and metabolic syndrome.6–8 They state that regular 
and adequate levels of physical activity in adults can reduce the risk of hypertension, 
coronary heart disease, stroke, diabetes, and can help maintain a healthy weight. Yoga, an 
ancient practice from India that incorporates physical, mental, and spiritual elements, may 
be an effective form of physical activity. 
 
Yoga therapy 
In recent years, clinical literature has reported cardiovascular health benefits from mind-
body therapies.9–11 Yoga, one type of mind-body therapy, has been increasing in popularity in 
the USA and in many parts of the world. Yoga, meaning ‘‘union’’  in Sanskrit, incorporates 
physical, mental, and spiritual elements. In the West, Hatha yoga, one style of yoga, has 
been most commonly practiced. Hatha yoga consists of a series of physical exercises that 
focus on stretching and stimulating the spine and muscles in coordination with breath 
control, thought to stabilize the hypothalamic-pituitary-adrenal axis and sympathoadrenal 
activity.12–14 According to the 2007 National Health Interview Survey, about 20% of the US 
population used some form of mind-body practice.15 Another study estimates that about 15 
million adults in America report having practiced yoga at least once in their life,16 seeking 
wellness or treatment for specific health conditions.  
 
Rationale 
A 2005 Cochrane study reviewed the evidence of yoga for secondary prevention of coronary 
heart disease on mortality, cardiovascular events, hospital admissions, and quality of life and 
found no randomized controlled trials (RCTs) meeting its inclusion criteria.17 Another 
review done in 2005 examined CVD clinical endpoints and insulin resistance with 
observational studies, uncontrolled trials, and nonrandomized controlled trials and found 
improvements in insulin resistance syndrome with yoga.13 Other reviews have shown yoga 
to be beneficial in treatment of coronary heart disease, post-myocardial infarction 
rehabilitation, and  hypertension.11,13,18–22 Since this time, several new RCTs have been 
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coronary heart disease, stroke, diabetes, and can help maintain a healthy weight. Yoga, an 
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body therapies.9–11 Yoga, one type of mind-body therapy, has been increasing in popularity in 
the USA and in many parts of the world. Yoga, meaning ‘‘union’’  in Sanskrit, incorporates 
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A 2005 Cochrane study reviewed the evidence of yoga for secondary prevention of coronary 
heart disease on mortality, cardiovascular events, hospital admissions, and quality of life and 
found no randomized controlled trials (RCTs) meeting its inclusion criteria.17 Another 
review done in 2005 examined CVD clinical endpoints and insulin resistance with 
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published. We sought to comprehensively review recent RCT evidence of the effectiveness 
of yoga on these risk factors and provide a pooled quantitative measure. 
 
Objectives 
Our objectives were (a) to identify and systematically evaluate the evidence on the 
effectiveness of yoga for modifying risk factors for CVD and metabolic syndrome in adult 
populations using published systematic reviews, (b) to update the evidence by conducting a 
systematic review of recent RCTs and (c) to estimate a summary measure of effectiveness by 
conducting a meta-analysis of the evidence of yoga’s effectiveness versus no-exercise and 
exercise controls. 
 
Methods 
Data sources and search terms 
The protocol for this review has been published on the PROSPERO website 
(http://www.crd.york.ac.uk/PROSPERO) with the registration number 
CRD42013006375. An amendment was added to the protocol including an exercise control 
group and published in an online revision note. Articles in this review were identified by 
accessing the following biomedical electronic databases with the assistance of a medical 
librarian: MEDLINE, CINAHL, Cochrane Central Register of Controlled Trials 
(CENTRAL), Cochrane Database of Systematic Reviews, EMBASE, and PsycINFO. Using 
existing published systematic reviews (SRs) as a starting point for gathering evidence, SRs 
and/or meta-analyses were searched through December 2013. To collect any recent data 
that may have been missed, we supplemented the search by searching for RCTs published in 
the last three years through December 2013. Citations were also retrieved by manually 
searching reference lists of relevant articles. The databases were searched using the 
keywords ‘‘yoga’’ and ‘‘systematic review’’ for published SRs and ‘‘yoga’’ and ‘‘randomized 
controlled trials’’ for recent RCTs (see online Supplementary Table S1 for search 
strategies). 
 
Study selection and inclusion process 
Records were pooled from the various databases. Titles and abstracts of SRs that appeared to 
meet the inclusion criteria were retrieved for further evaluation. Systematic reviews were 
defined as articles that included an explicit and repeatable literature search method and had 
explicit and repeatable inclusion and exclusion criteria for studies. RCTs included in the SRs 
were then retrieved. The process was repeated for the supplementary search of RCTs. For 
inclusion in our SR, the studies had to be published in English in a peer-reviewed journal, be 
conducted in adults (18+ years) who were either healthy, at risk, or with a history of CVD 
or metabolic syndrome and no other major comorbidities, test an asana- (or posture-) based 
intervention, and report relevant outcomes. We focused only on SRs that included at least 
 
one randomized controlled trial with yoga therapy as a trial arm. No restrictions were placed 
on style of yoga practiced, frequency, or duration. Articles were excluded if we were unable 
to isolate the effect of yoga (i.e. yoga was part of a multimodal intervention whose non-yoga 
components were given to the active intervention group but not to the control group), 
outcomes reported only psychosocial risk factors or psychological outcomes like stress and 
anxiety, and the population treated focused on other conditions or comorbidities (e.g. 
women with breast cancer, populations with renal disease). Two investigators (PC and RG) 
independently selected studies for inclusion; disagreements were resolved by discussion. 
 
Outcomes 
The outcomes of interest were changes in the levels of modifiable risk factors for CVD and 
metabolic syndrome. Particularly, we were interested in measures of body composition, 
blood pressure, lipid panel, glycemic control, heart rate, and smoking status. Primary 
outcomes include body mass index (BMI), systolic blood pressure (SBP), low-density 
lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Other 
outcomes – body weight, diastolic blood pressure (DBP), total cholesterol (TC), 
triglycerides (TG), fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), heart 
rate, and smoking status – were considered secondary outcomes. Outcomes were kept in 
their natural units.  
 
Data extraction and quality assessment  
From each eligible study we extracted the characteristics, of the participants, intervention 
description (type, length of session, frequency), control group description, duration of 
follow-up, number of patients randomized at baseline and number at follow-up, and effect 
measures (pre- and post-mean and standard deviations in intervention and control arms, 
mean change scores and standard deviations if reported). Data from the longest follow-up 
was extracted. Data extraction was performed by one investigator (PC) and checked for 
accuracy and completeness by a second reviewer (RG). Any discrepancies were resolved by 
discussion. RCTs were appraised using the Cochrane Collaboration’s Risk of Bias (ROB) 
tool, a commonly used tool to assess risk of bias.23 Trial quality was evaluated by using 
categories of high, low, or unclear risk in regards to randomization method, allocation 
concealment, blinding of study personnel and outcomes assessment, attrition, and reporting 
methods. Two reviewers (PC and RG) independently evaluated RCT quality and resolved 
any discrepancies by discussion. 
 
Statistical analysis 
Change scores, mean differences (MDs) between treatment arms, and sample sizes reported 
were on an intention-to-treat basis. MDs were calculated by subtracting the change score in 
the control group from the change score in the yoga group. Where MDs and standard 
deviations were not reported, standard deviations were calculated using a conservative 
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published. We sought to comprehensively review recent RCT evidence of the effectiveness 
of yoga on these risk factors and provide a pooled quantitative measure. 
 
Objectives 
Our objectives were (a) to identify and systematically evaluate the evidence on the 
effectiveness of yoga for modifying risk factors for CVD and metabolic syndrome in adult 
populations using published systematic reviews, (b) to update the evidence by conducting a 
systematic review of recent RCTs and (c) to estimate a summary measure of effectiveness by 
conducting a meta-analysis of the evidence of yoga’s effectiveness versus no-exercise and 
exercise controls. 
 
Methods 
Data sources and search terms 
The protocol for this review has been published on the PROSPERO website 
(http://www.crd.york.ac.uk/PROSPERO) with the registration number 
CRD42013006375. An amendment was added to the protocol including an exercise control 
group and published in an online revision note. Articles in this review were identified by 
accessing the following biomedical electronic databases with the assistance of a medical 
librarian: MEDLINE, CINAHL, Cochrane Central Register of Controlled Trials 
(CENTRAL), Cochrane Database of Systematic Reviews, EMBASE, and PsycINFO. Using 
existing published systematic reviews (SRs) as a starting point for gathering evidence, SRs 
and/or meta-analyses were searched through December 2013. To collect any recent data 
that may have been missed, we supplemented the search by searching for RCTs published in 
the last three years through December 2013. Citations were also retrieved by manually 
searching reference lists of relevant articles. The databases were searched using the 
keywords ‘‘yoga’’ and ‘‘systematic review’’ for published SRs and ‘‘yoga’’ and ‘‘randomized 
controlled trials’’ for recent RCTs (see online Supplementary Table S1 for search 
strategies). 
 
Study selection and inclusion process 
Records were pooled from the various databases. Titles and abstracts of SRs that appeared to 
meet the inclusion criteria were retrieved for further evaluation. Systematic reviews were 
defined as articles that included an explicit and repeatable literature search method and had 
explicit and repeatable inclusion and exclusion criteria for studies. RCTs included in the SRs 
were then retrieved. The process was repeated for the supplementary search of RCTs. For 
inclusion in our SR, the studies had to be published in English in a peer-reviewed journal, be 
conducted in adults (18+ years) who were either healthy, at risk, or with a history of CVD 
or metabolic syndrome and no other major comorbidities, test an asana- (or posture-) based 
intervention, and report relevant outcomes. We focused only on SRs that included at least 
 
one randomized controlled trial with yoga therapy as a trial arm. No restrictions were placed 
on style of yoga practiced, frequency, or duration. Articles were excluded if we were unable 
to isolate the effect of yoga (i.e. yoga was part of a multimodal intervention whose non-yoga 
components were given to the active intervention group but not to the control group), 
outcomes reported only psychosocial risk factors or psychological outcomes like stress and 
anxiety, and the population treated focused on other conditions or comorbidities (e.g. 
women with breast cancer, populations with renal disease). Two investigators (PC and RG) 
independently selected studies for inclusion; disagreements were resolved by discussion. 
 
Outcomes 
The outcomes of interest were changes in the levels of modifiable risk factors for CVD and 
metabolic syndrome. Particularly, we were interested in measures of body composition, 
blood pressure, lipid panel, glycemic control, heart rate, and smoking status. Primary 
outcomes include body mass index (BMI), systolic blood pressure (SBP), low-density 
lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Other 
outcomes – body weight, diastolic blood pressure (DBP), total cholesterol (TC), 
triglycerides (TG), fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), heart 
rate, and smoking status – were considered secondary outcomes. Outcomes were kept in 
their natural units.  
 
Data extraction and quality assessment  
From each eligible study we extracted the characteristics, of the participants, intervention 
description (type, length of session, frequency), control group description, duration of 
follow-up, number of patients randomized at baseline and number at follow-up, and effect 
measures (pre- and post-mean and standard deviations in intervention and control arms, 
mean change scores and standard deviations if reported). Data from the longest follow-up 
was extracted. Data extraction was performed by one investigator (PC) and checked for 
accuracy and completeness by a second reviewer (RG). Any discrepancies were resolved by 
discussion. RCTs were appraised using the Cochrane Collaboration’s Risk of Bias (ROB) 
tool, a commonly used tool to assess risk of bias.23 Trial quality was evaluated by using 
categories of high, low, or unclear risk in regards to randomization method, allocation 
concealment, blinding of study personnel and outcomes assessment, attrition, and reporting 
methods. Two reviewers (PC and RG) independently evaluated RCT quality and resolved 
any discrepancies by discussion. 
 
Statistical analysis 
Change scores, mean differences (MDs) between treatment arms, and sample sizes reported 
were on an intention-to-treat basis. MDs were calculated by subtracting the change score in 
the control group from the change score in the yoga group. Where MDs and standard 
deviations were not reported, standard deviations were calculated using a conservative 
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correlation coefficient of 0.5 for within-patient correlation from baseline to follow-up. MDs 
between groups and 95% confidence intervals (CIs) were calculated for each outcome. The 
magnitude of heterogeneity was evaluated using the I2 statistic testing the null hypothesis that 
all studies are evaluating the same effect.24 I2 values of 25%, 50%, and 75% correspond to 
low, moderate, and high heterogeneity, respectively. Because meta-analysis pools studies 
that are clinically and methodologically diverse, data on MDs from trials were statistically 
pooled using a random effects model.25 We also categorized patients into four subgroups 
based on patient conditions –healthy, with CVD risk factors, with diabetes or metabolic 
syndrome, and diagnosed with coronary artery disease (CAD) – to depict heterogeneity in 
the populations included and their response to treatment. Healthy patients are those free of 
clinical manifestations of any medical or psychiatric illness including clinically significant 
CVD and diabetes mellitus. Those with CVD risk factors included patients with 
hypertension, high cholesterol levels, obesity, and current smokers. Diabetes and metabolic 
syndrome were diagnosed through medical examination or history, and CAD was confirmed 
through angiography. Controls were separated into aerobic exercise (physical training, 
aerobic exercise, cycling, running, brisk walking) and non-aerobic exercise groups. Yoga 
was compared to these two control groups separately to obtain an estimate of its 
effectiveness versus active controls and versus non-active controls (details published in 
protocol amendment). Reference Manager (RevMan) Version 5.2 software from the 
Cochrane Collaboration was used for data analysis.26
Publication bias 
Publication bias was assessed for each of the primary outcomes by visual inspection of funnel 
plots generated using RevMan software. The MDs were plotted on the x-axis and the 
standard errors, a measure of study size, on the y-axis. In the absence of bias, the scatterplot 
should be approximately symmetrical; the more asymmetry, the more bias is present.
Results
Literature search
We identified 643 studies from the SR search and 761 studies from the RCT search for a 
total of 1404 records (Figure 1). After removal of duplicates, a total of 880 titles and
abstracts were screened. A total of 37 RCTs (24 RCTs from 18 SRs and 13 additional RCTs) 
met our criteria for inclusion in the review. Although 37 studies met criteria, five studies did 
not report exact numbers for our primary or secondary outcomes and could not be included 
in the meta-analysis,27–31 leaving 32 studies for statistical analysis.
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Study quality 
Study quality and description of methodology varied amongst the included studies (see Table 
1). Thirteen studies 32–43 provided details on the specific randomization method that was used 
in the RCT and four 31,35,37,38 described treatment assignment. Due to the nature of the 
intervention, all studies had high risk of bias for blinding of participants; however, three 
studies reported blinding of the personnel, indicating that technicians were blinded to 
treatment assignment of individuals.34,44,45 Almost all studies except one34 had unclear risk for 
blinding of outcome assessment. However, there was generally low risk of bias for 
incomplete reporting of outcomes and selective reporting of outcomes. A summary of study 
quality can be seen in online Supplementary Figure S1. 
 
Study characteristics 
Characteristics of the included studies are listed in Table 1. The included studies comprised a 
total of 2768 participants, with about an equal mix of men (47%) and women (53%). RCTs 
included adult participants of all ages with an average age of 50 years. Of these participants, 
1287 (47%) were assigned to receive the yoga intervention and 1461 (53%) assigned to the 
control arm. Altogether 1094 (85%) of yoga participants completed the study while 1301 
(89%) of control participants made it to follow-up. Duration of studies varied, with follow-
up times ranging from 3 weeks to 52 weeks, with a median of 12 weeks. Dividing into 
subgroups, 38% (14/37) of studies were conducted in healthy populations, 22% (8/32) of 
studies in populations with CVD risk factors, 27% (10/32) in populations with diabetes or 
metabolic syndrome, and 13% (5/32) in populations with CAD. Control arms included 
usual care or conventional medical therapy (23%), a form of relaxation (6%), education 
(11%), diet alone (4%), waiting list or no intervention (32%), cognitive-based therapy 
(2%), and exercise (21%). Five two-arm RCTs,41–43,46,47 three three-arm RCTs,27,40,45 and 
one four-arm RCT48 used exercise as one of the comparator strategies. Exercise controls 
consisted of physical training, cycling, running, brisk walking, or resistance training 43. One 
exercise trial27 was excluded from the meta-analysis due to incomplete reporting of effect 
measures. 
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Study quality 
Study quality and description of methodology varied amongst the included studies (see Table 
1). Thirteen studies 32–43 provided details on the specific randomization method that was used 
in the RCT and four 31,35,37,38 described treatment assignment. Due to the nature of the 
intervention, all studies had high risk of bias for blinding of participants; however, three 
studies reported blinding of the personnel, indicating that technicians were blinded to 
treatment assignment of individuals.34,44,45 Almost all studies except one34 had unclear risk for 
blinding of outcome assessment. However, there was generally low risk of bias for 
incomplete reporting of outcomes and selective reporting of outcomes. A summary of study 
quality can be seen in online Supplementary Figure S1. 
 
Study characteristics 
Characteristics of the included studies are listed in Table 1. The included studies comprised a 
total of 2768 participants, with about an equal mix of men (47%) and women (53%). RCTs 
included adult participants of all ages with an average age of 50 years. Of these participants, 
1287 (47%) were assigned to receive the yoga intervention and 1461 (53%) assigned to the 
control arm. Altogether 1094 (85%) of yoga participants completed the study while 1301 
(89%) of control participants made it to follow-up. Duration of studies varied, with follow-
up times ranging from 3 weeks to 52 weeks, with a median of 12 weeks. Dividing into 
subgroups, 38% (14/37) of studies were conducted in healthy populations, 22% (8/32) of 
studies in populations with CVD risk factors, 27% (10/32) in populations with diabetes or 
metabolic syndrome, and 13% (5/32) in populations with CAD. Control arms included 
usual care or conventional medical therapy (23%), a form of relaxation (6%), education 
(11%), diet alone (4%), waiting list or no intervention (32%), cognitive-based therapy 
(2%), and exercise (21%). Five two-arm RCTs,41–43,46,47 three three-arm RCTs,27,40,45 and 
one four-arm RCT48 used exercise as one of the comparator strategies. Exercise controls 
consisted of physical training, cycling, running, brisk walking, or resistance training 43. One 
exercise trial27 was excluded from the meta-analysis due to incomplete reporting of effect 
measures. 
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Risk factor outcomes 
Yoga versus non-exercise controls. Yoga showed significant improvement of risk factors versus 
non-exercise controls for each of the primary outcomes: BMI (0.77 kg/m2 (1.09 to 0.44)), 
SBP (5.21 mmHg (8.01 to 2.42)), LDL–C (12.14 mg/dl (21.80 to 2.48)), and HDL-C 
(3.20 mg/dl (1.86 to 4.54)) (Figure 2). For the secondary outcomes, significant 
improvement was seen in all risk factors except FBG (5.91 mg/dl (16.32 to 4.50)) and 
HbA1c (0.06% Hb (0.43 to 0.31)) (online Supplementary Figure S2). Improvements 
reported in secondary outcomes include reductions of body weight (2.35 kg (4.33 to 0.37)), 
DBP (4.98 mmHg (7.17 to 2.80)), TC (18.48 (29.16 to 7.80), TG (25.89 mg/dl (36.19 to 
15.60)), and heart rate (5.27 beats/min (9.55 to 1.00)) (online Supplementary Figure S2). 
Only one trial was found which evaluated the impact of yoga on smoking status. 32 When 
twice-weekly Vinyasa-style yoga was given in addition to cognitive behavioral therapy (CBT) 
for smoking cessation, smokers in the intervention group had higher odds of seven-day and 
24-hour abstinence compared to a control group receiving CBT and education at the end of 
the eight-week study period (seven-day quit odds ratio (OR) 4.56 (95% CI 1.12 to 18.57), 
24-hour quit OR 4.19 (1.16 to 15.11). These results did not last, however, when abstinence 
was measured at six-month follow-up (seven-day quit OR 1.54 (0.34 to 6.92), 24-hour quit 
OR 1.87 (0.43 to 8.16)). When yoga is used in addition to medication, significant 
improvement was found in body weight,49 BMI,35,36 blood pressure,20,50 lipid levels, 35,38,49,51 
FBG,38,52 HbA1c,38,52 and heart rate36 in patients with type 2 diabetes or CAD. As a substitute 
for medical therapy, results are less definitive. Two RCTs found yoga more effective than 
drug therapy in controlling blood pressure53 and body weight.53,54 In a three-arm trial in 
which yoga was directly compared to a group that received antihypertensive treatment and a 
group receiving no treatment in patients at high risk for CVD, yoga reduced SBP almost 
three times more than the antihypertensive therapy (MD 29.17 mmHg (37.75, 20.59) and 
9.60 mmHg (18.78, 0.42), respectively).53 When yoga is included in addition to continued 
medication in CAD patients, an additional benefit, although smaller, is still observed.35,36 
Among CAD patients, yoga is less effective as a substitute for medication such as statins and 
lipid-lowering drugs in lowering LDL-C;55 however, as an adjunct treatment to medication, 
yoga provides an additional statistically significant benefit.35,49
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Risk factor outcomes 
Yoga versus non-exercise controls. Yoga showed significant improvement of risk factors versus 
non-exercise controls for each of the primary outcomes: BMI (0.77 kg/m2 (1.09 to 0.44)), 
SBP (5.21 mmHg (8.01 to 2.42)), LDL–C (12.14 mg/dl (21.80 to 2.48)), and HDL-C 
(3.20 mg/dl (1.86 to 4.54)) (Figure 2). For the secondary outcomes, significant 
improvement was seen in all risk factors except FBG (5.91 mg/dl (16.32 to 4.50)) and 
HbA1c (0.06% Hb (0.43 to 0.31)) (online Supplementary Figure S2). Improvements 
reported in secondary outcomes include reductions of body weight (2.35 kg (4.33 to 0.37)), 
DBP (4.98 mmHg (7.17 to 2.80)), TC (18.48 (29.16 to 7.80), TG (25.89 mg/dl (36.19 to 
15.60)), and heart rate (5.27 beats/min (9.55 to 1.00)) (online Supplementary Figure S2). 
Only one trial was found which evaluated the impact of yoga on smoking status. 32 When 
twice-weekly Vinyasa-style yoga was given in addition to cognitive behavioral therapy (CBT) 
for smoking cessation, smokers in the intervention group had higher odds of seven-day and 
24-hour abstinence compared to a control group receiving CBT and education at the end of 
the eight-week study period (seven-day quit odds ratio (OR) 4.56 (95% CI 1.12 to 18.57), 
24-hour quit OR 4.19 (1.16 to 15.11). These results did not last, however, when abstinence 
was measured at six-month follow-up (seven-day quit OR 1.54 (0.34 to 6.92), 24-hour quit 
OR 1.87 (0.43 to 8.16)). When yoga is used in addition to medication, significant 
improvement was found in body weight,49 BMI,35,36 blood pressure,20,50 lipid levels, 35,38,49,51 
FBG,38,52 HbA1c,38,52 and heart rate36 in patients with type 2 diabetes or CAD. As a substitute 
for medical therapy, results are less definitive. Two RCTs found yoga more effective than 
drug therapy in controlling blood pressure53 and body weight.53,54 In a three-arm trial in 
which yoga was directly compared to a group that received antihypertensive treatment and a 
group receiving no treatment in patients at high risk for CVD, yoga reduced SBP almost 
three times more than the antihypertensive therapy (MD 29.17 mmHg (37.75, 20.59) and 
9.60 mmHg (18.78, 0.42), respectively).53 When yoga is included in addition to continued 
medication in CAD patients, an additional benefit, although smaller, is still observed.35,36 
Among CAD patients, yoga is less effective as a substitute for medication such as statins and 
lipid-lowering drugs in lowering LDL-C;55 however, as an adjunct treatment to medication, 
yoga provides an additional statistically significant benefit.35,49
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Yoga versus exercise. Five out of nine trials comparing yoga to exercise were conducted in 
healthy populations27,41,42,46,47,56 and the remaining were conducted in young patient 
populations with hypertension,40,48 an elderly female population with CAD,43 and a 
population with type 2 diabetes mellitus.45 Among the outcomes that were reported by 
more than one study, there was no significant difference in the effectiveness of yoga versus 
aerobic exercise in modifying body weight (0.61 kg (2.70, 1.49)),41,43,47 SBP (0.64 mmHg 
(6.71, 5.43)),40,42,46–48 DBP (0.14 mmHg (5.73, 5.44)),40,42,47,48 and heart rate (1.42 
beats/min (6.11, 3.27))41,42,46,47,56 (Figure 3). In addition, there was also no difference 
comparing the two strategies for BMI,43 LDL-C,45 HDL-C,45 TC,45 TG,45 or FBG.45 
When all studies were pooled together, all trends remained irrespective of controls. MDs in 
risk factor reductions changed only slightly (online Supplementary Table S2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Forest plots of yoga versus physical exercise results for body weight, systolic 
blood pressure, diastolic blood pressure, and heart rate. 
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Yoga versus exercise. Five out of nine trials comparing yoga to exercise were conducted in 
healthy populations27,41,42,46,47,56 and the remaining were conducted in young patient 
populations with hypertension,40,48 an elderly female population with CAD,43 and a 
population with type 2 diabetes mellitus.45 Among the outcomes that were reported by 
more than one study, there was no significant difference in the effectiveness of yoga versus 
aerobic exercise in modifying body weight (0.61 kg (2.70, 1.49)),41,43,47 SBP (0.64 mmHg 
(6.71, 5.43)),40,42,46–48 DBP (0.14 mmHg (5.73, 5.44)),40,42,47,48 and heart rate (1.42 
beats/min (6.11, 3.27))41,42,46,47,56 (Figure 3). In addition, there was also no difference 
comparing the two strategies for BMI,43 LDL-C,45 HDL-C,45 TC,45 TG,45 or FBG.45 
When all studies were pooled together, all trends remained irrespective of controls. MDs in 
risk factor reductions changed only slightly (online Supplementary Table S2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Forest plots of yoga versus physical exercise results for body weight, systolic 
blood pressure, diastolic blood pressure, and heart rate. 
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Publication bias 
Funnel plots assessing publication bias of the primary outcomes are shown in online 
Supplementary Figure S3. As the funnel plots are mostly symmetrical, we do not find 
evidence of strong publication bias. 
 
Discussion 
The review shows that the practice of yoga may be beneficial to managing and improving risk 
factors associated with CVD and metabolic syndrome. This finding, however, should be 
cautiously interpreted as the RCTs included were of limited sample size, heterogeneous, and 
had unclear or high risk of bias on several domains. When trials were pooled, all but two of 
the outcomes examined in this review showed improvement after a yoga intervention when 
compared to non-exercise controls. Compared to traditional aerobic exercise controls, there 
was no significant difference in how exercise or yoga changed risk factors, suggesting similar 
effectiveness of the two forms of physical activity and possibly similar underlying 
mechanisms. The mechanism behind the therapeutic effect of yoga for CVD is still unclear; 
studies have suggested that yoga may modulate autonomic function and beneficially alter 
markers of sympathetic and parasympathetic activity.12–14 Through practicing yoga, the 
effects of stress can be reduced, leading to positive impacts on neuroendocrine status, 
metabolic and cardio-vagal function, and related inflammatory responses.12–14 The similarity 
in effectiveness on risk factors between the two forms of exercise suggest that there could be 
comparable working mechanisms, with some possible physiological aerobic benefits 
occurring with yoga practice, and some stress-reducing, relaxation effect occurring with 
aerobic exercise. This review helps strengthen the evidence base for yoga as a potentially 
effective therapy for cardiovascular and metabolic health. Our results support earlier reviews 
on the positive benefits of yoga on primary and secondary prevention of CVD and metabolic 
syndrome.11,13,18–20,22,50,57 Two systematic reviews that were recently published find that there 
is some evidence for yoga having favorable effects on CVD risk factors.58,59 One review, 
conducted by the Cochrane Collaboration, included 11 trials with its more restrictive 
inclusion criteria and found significant improvement in DBP, TG, and HDL. 59 The second 
review, with broad inclusion criteria and a wider list of outcomes, included 44 trials and 
found that yoga improves SBP, DBP, heart rate, respiratory rate, waist circumference, 
waist/hip ratio, TC, HDL, very low density lipoprotein, HbA1c, and insulin resistance.58 
All studies find that published RCTs on yoga are small, of short duration, and 
heterogeneous, precluding any strong conclusions on the effectiveness of yoga. Yoga may 
provide the same benefits in risk factor reduction as traditional physical activity such as 
cycling or brisk walking, supporting a previous narrative review.22 This finding is significant 
as individuals who cannot or prefer not to perform traditional aerobic exercise might still 
achieve similar benefits in CVD risk reduction. Evidence supports yoga’s accessibility and 
acceptability to patients with lower physical tolerance like those with pre-existing cardiac 
conditions, the elderly, or those with musculoskeletal or joint pain.28 Lastly, in addition to 
 
CVD risk factor improvements, other benefits may result from practicing yoga. For 
example, yoga may provide health-related quality of life improvements such as reductions in 
stress and anxiety and better coping mechanisms distinct from other forms of exercise. Yoga 
may also be practiced in a variety of settings with no special equipment needed, potentially 
increasing the frequency and ease of practice. These benefits may produce greater 
willingness to engage in a form of physical activity and better adherence and sustainability, 
ultimately facilitating greater long-term individual- and population-level CVD and metabolic 
risk reductions. 
 
Limitations 
There are potential limitations of this review. First, we included only English language 
articles and articles published in peer-reviewed journals. Second, several outcomes are 
related to cardiovascular and metabolic health; we focused on the major risk factors and 
surrogate markers for these conditions, as they are predictive of CVD risk4 and concrete 
outcomes such as cardiac death and myocardial infarction were not reported in the RCTs. As 
with all RCTs, findings are applicable to the patient population in which the study was 
conducted and wide generalizations should be avoided. There was a great deal of 
heterogeneity across included studies. Because part of the appeal and feasibility of yoga is the 
customizability of the practice to individual practitioners, a wide variety of yoga 
interventions, frequencies and lengths of practice and follow-up were included. To deal with 
some of this variation, we used random effects in the meta-analysis and divided patient 
populations into subgroups. Although I2 values did drop within subgroups compared to 
overall, heterogeneity was still present. As more studies are undertaken and published, 
further division by yoga tradition, duration of follow-up, and other factors can be 
performed. Lastly, study quality and assessment could be improved. Many studies had small 
sample sizes and did not fully report all methods and outcomes, leading to high or unclear 
ratings in the risk of bias on several domains. On a related note, although the Cochrane Risk 
of Bias tool is widely used and applicable, the definitions and structure of the rating system 
can lead to inaccurate estimation of study quality. For example, blinding of participants is 
not possible in RCTs, automatically leading to a high bias rating in the ‘performance bias’ 
domain, which assesses blinding of participants and personnel. Study quality could thus be 
underestimated in many cases. Nevertheless, more complete reporting of methodology and 
outcomes by authors can help enhance the usefulness and rigor of the trials.  
 
Future research directions 
Despite the growing evidence on the health implications of yoga, the physiological 
mechanisms behind the observed clinical effects of yoga on cardiovascular risk remains 
unclear. Inquiries into the minimum effective dose of yoga and the dose-response 
relationship can help elucidate yoga’s potential as a medical therapy. Research is also still 
lacking on the costs and economic implications; more research can be done comparing the 
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Publication bias 
Funnel plots assessing publication bias of the primary outcomes are shown in online 
Supplementary Figure S3. As the funnel plots are mostly symmetrical, we do not find 
evidence of strong publication bias. 
 
Discussion 
The review shows that the practice of yoga may be beneficial to managing and improving risk 
factors associated with CVD and metabolic syndrome. This finding, however, should be 
cautiously interpreted as the RCTs included were of limited sample size, heterogeneous, and 
had unclear or high risk of bias on several domains. When trials were pooled, all but two of 
the outcomes examined in this review showed improvement after a yoga intervention when 
compared to non-exercise controls. Compared to traditional aerobic exercise controls, there 
was no significant difference in how exercise or yoga changed risk factors, suggesting similar 
effectiveness of the two forms of physical activity and possibly similar underlying 
mechanisms. The mechanism behind the therapeutic effect of yoga for CVD is still unclear; 
studies have suggested that yoga may modulate autonomic function and beneficially alter 
markers of sympathetic and parasympathetic activity.12–14 Through practicing yoga, the 
effects of stress can be reduced, leading to positive impacts on neuroendocrine status, 
metabolic and cardio-vagal function, and related inflammatory responses.12–14 The similarity 
in effectiveness on risk factors between the two forms of exercise suggest that there could be 
comparable working mechanisms, with some possible physiological aerobic benefits 
occurring with yoga practice, and some stress-reducing, relaxation effect occurring with 
aerobic exercise. This review helps strengthen the evidence base for yoga as a potentially 
effective therapy for cardiovascular and metabolic health. Our results support earlier reviews 
on the positive benefits of yoga on primary and secondary prevention of CVD and metabolic 
syndrome.11,13,18–20,22,50,57 Two systematic reviews that were recently published find that there 
is some evidence for yoga having favorable effects on CVD risk factors.58,59 One review, 
conducted by the Cochrane Collaboration, included 11 trials with its more restrictive 
inclusion criteria and found significant improvement in DBP, TG, and HDL. 59 The second 
review, with broad inclusion criteria and a wider list of outcomes, included 44 trials and 
found that yoga improves SBP, DBP, heart rate, respiratory rate, waist circumference, 
waist/hip ratio, TC, HDL, very low density lipoprotein, HbA1c, and insulin resistance.58 
All studies find that published RCTs on yoga are small, of short duration, and 
heterogeneous, precluding any strong conclusions on the effectiveness of yoga. Yoga may 
provide the same benefits in risk factor reduction as traditional physical activity such as 
cycling or brisk walking, supporting a previous narrative review.22 This finding is significant 
as individuals who cannot or prefer not to perform traditional aerobic exercise might still 
achieve similar benefits in CVD risk reduction. Evidence supports yoga’s accessibility and 
acceptability to patients with lower physical tolerance like those with pre-existing cardiac 
conditions, the elderly, or those with musculoskeletal or joint pain.28 Lastly, in addition to 
 
CVD risk factor improvements, other benefits may result from practicing yoga. For 
example, yoga may provide health-related quality of life improvements such as reductions in 
stress and anxiety and better coping mechanisms distinct from other forms of exercise. Yoga 
may also be practiced in a variety of settings with no special equipment needed, potentially 
increasing the frequency and ease of practice. These benefits may produce greater 
willingness to engage in a form of physical activity and better adherence and sustainability, 
ultimately facilitating greater long-term individual- and population-level CVD and metabolic 
risk reductions. 
 
Limitations 
There are potential limitations of this review. First, we included only English language 
articles and articles published in peer-reviewed journals. Second, several outcomes are 
related to cardiovascular and metabolic health; we focused on the major risk factors and 
surrogate markers for these conditions, as they are predictive of CVD risk4 and concrete 
outcomes such as cardiac death and myocardial infarction were not reported in the RCTs. As 
with all RCTs, findings are applicable to the patient population in which the study was 
conducted and wide generalizations should be avoided. There was a great deal of 
heterogeneity across included studies. Because part of the appeal and feasibility of yoga is the 
customizability of the practice to individual practitioners, a wide variety of yoga 
interventions, frequencies and lengths of practice and follow-up were included. To deal with 
some of this variation, we used random effects in the meta-analysis and divided patient 
populations into subgroups. Although I2 values did drop within subgroups compared to 
overall, heterogeneity was still present. As more studies are undertaken and published, 
further division by yoga tradition, duration of follow-up, and other factors can be 
performed. Lastly, study quality and assessment could be improved. Many studies had small 
sample sizes and did not fully report all methods and outcomes, leading to high or unclear 
ratings in the risk of bias on several domains. On a related note, although the Cochrane Risk 
of Bias tool is widely used and applicable, the definitions and structure of the rating system 
can lead to inaccurate estimation of study quality. For example, blinding of participants is 
not possible in RCTs, automatically leading to a high bias rating in the ‘performance bias’ 
domain, which assesses blinding of participants and personnel. Study quality could thus be 
underestimated in many cases. Nevertheless, more complete reporting of methodology and 
outcomes by authors can help enhance the usefulness and rigor of the trials.  
 
Future research directions 
Despite the growing evidence on the health implications of yoga, the physiological 
mechanisms behind the observed clinical effects of yoga on cardiovascular risk remains 
unclear. Inquiries into the minimum effective dose of yoga and the dose-response 
relationship can help elucidate yoga’s potential as a medical therapy. Research is also still 
lacking on the costs and economic implications; more research can be done comparing the 
Processed on: 27-10-2016
504961-L-bw-Gotink
Chapter 6128
 
relative costs and benefits of yoga versus traditional methods like exercise or medication. 
Yoga has the potential to be a cost-effective treatment and prevention strategy given its low 
cost, lack of expensive equipment or technology, potential greater adherence, health-related 
quality of life improvements, and possible accessibility to larger segments of the population.  
 
Conclusion 
Our review finds emerging evidence to support a role for yoga in improving common 
modifiable risk factors of CVD and metabolic syndrome. Whereas previous reviews have 
looked at a single or a few risk factors, our review updates the existing literature and 
encompasses numerous CVD and metabolic risk factors that can be used to calculate overall 
CVD risk. We believe that these findings have important implications for the acceptance of 
yoga as an effective therapeutic intervention. Given the growing popularity of yoga in the US 
and around the world, there is a need for larger randomized controlled studies that meet 
explicit, high quality methodological standards to ascertain the effects of yoga. This review 
demonstrates the potential of yoga to have an impact on concrete, physiological outcomes 
that represent some of the greatest health burdens today. 
 
 
 
References 
1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics–2014 update: A report from 
the American Heart Association. Circulation 2014; 129: e28–e292. 
2. World Health Organization. Global status report on non-communicable diseases 2010. Geneva: World 
Health Organization, 2011. 
3. National Heart, Lung, and Blood Institute. What is metabolic syndrome, 
http://www.nhlbi.nih.gov/health/healthtopics/topics/ms/ (2011, accessed 7 March 2014). 
4. D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary 
care: The Framingham heart study. Circulation 2008; 117: 743–753. 
5. World Health Organization. Global recommendations for physical activity for health, 
http://whqlibdoc.who.int/publications/2010/9789241599979_eng.pdf (2010, accessed 7 
March 2014). 
6. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC Guideline on lifestyle management to reduce 
cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task 
Force on Practice Guidelines. Circulation 2014; 63: 2960–2984. 
7. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/ AHA Guideline on the treatment of blood 
cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of 
Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2013. 
8. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in 
clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and 
Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2012; 33: 
1635–1701. 
9. Younge JO, Gotink RA, Baena CP, et al. Mind-body practices for patients with cardiac disease: A 
systematic review and meta-analysis. Eur J Prev Cardiol. Epub 2014.  
10. Cramer H, Lauche R, Haller H, et al. A systematic review of yoga for heart disease. Eur J Prev 
Cardiol. Epub 2014. 
11. Jayasinghe SR. Yoga in cardiac health (a review). Eur J  Cardiovasc Prev Rehabil 2004; 11: 369–375. 
12. Cusumano JA and Robinson SE. The short-term psychophysiological effects of Hatha yoga and 
progressive relaxation on female Japanese students. Appl Psychol 1993; 42: 77–90. 
13. Innes KE, Bourguignon C and Taylor AG. Risk indices associated with the insulin resistance syndrome, 
cardiovascular disease, and possible protection with yoga: A systematic review. J Am Board Fam Pract 
2005; 18: 491–519. 
14. Innes KE and Vincent HK. The influence of yoga-based programs on risk profiles in adults with type 2 
diabetes mellitus: A systematic review. Evid Based Complement Alternat Med 2007; 4: 469–486. 
15. Barnes PM, Bloom B and Nahim RL. Complementary and alternative medicine use among adults and 
children: United States, 2007. National health statistics reports; no 12. Hyattsville, MD: National 
Center for Health Statistics, 2008. 
16. Saper RB, Eisenberg DM, Davis RB, et al. Prevalence and patterns of adult yoga use in the United 
States: Results of a national survey. Altern Ther Health Med 2004; 10: 44–49. 
17. Lau HLK, Yeung JS, Chau F, et al. Yoga for secondary prevention of coronary heart disease. Cochrane 
Database Syst Rev 2012; 12: CD009506. 
18. Bussing A, Michalsen A, Khalsa SB, et al. Effects of yoga on mental and physical health: a short 
summary of reviews. Evid Based Complement Alternat Med 2012; 13: 2–10. 
19. Hagins M, States R, Selfe T, et al. Effectiveness of yoga for hypertension: Systematic review and meta-
analysis. Evid Based Complement Alternat Med 2013. 
20. Raub JA. Psychophysiologic effects of Hatha Yoga on musculoskeletal and cardiopulmonary function: A 
literature review. J Altern Complement Med 2002; 8: 797–812. 
21. Hutchinson SC. Yoga therapy for coronary heart disease: A systematic review. Focus Altern 
Complement Ther 2003; 8: 144. 
22. Ross AT. The health benefits of yoga and exercise: A review of comparison studies. J Altern 
Complement Med 2010; 16: 3–12. 
23. Higgins JPT, ALterman DG and Sterne JAC (eds). Assessing risk of bias in included studies. In: 
Huggins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 
5.1.0 updated March 2011. The Cochrane Collaborations, 2011. 
24. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 
327: 557–560. 
25. DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188. 
Processed on: 27-10-2016
504961-L-bw-Gotink
6
Yoga in cardiovascular disease: a systematic review 129
 
relative costs and benefits of yoga versus traditional methods like exercise or medication. 
Yoga has the potential to be a cost-effective treatment and prevention strategy given its low 
cost, lack of expensive equipment or technology, potential greater adherence, health-related 
quality of life improvements, and possible accessibility to larger segments of the population.  
 
Conclusion 
Our review finds emerging evidence to support a role for yoga in improving common 
modifiable risk factors of CVD and metabolic syndrome. Whereas previous reviews have 
looked at a single or a few risk factors, our review updates the existing literature and 
encompasses numerous CVD and metabolic risk factors that can be used to calculate overall 
CVD risk. We believe that these findings have important implications for the acceptance of 
yoga as an effective therapeutic intervention. Given the growing popularity of yoga in the US 
and around the world, there is a need for larger randomized controlled studies that meet 
explicit, high quality methodological standards to ascertain the effects of yoga. This review 
demonstrates the potential of yoga to have an impact on concrete, physiological outcomes 
that represent some of the greatest health burdens today. 
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Abstract 
 
Background. Evidence is accumulating that mindfulness training has favorable effects on 
psychological outcomes, but studies on physiological outcomes are limited. Patients with 
heart disease have a high incidence of physiological and psychological problems and may 
benefit from mindfulness training.  Our aim was to determine the beneficial physiological 
and psychological effects of online mindfulness training in patients with heart disease.  
Methods. The study was a pragmatic randomized controlled single-blind trial. Between 
June 2012 and April 2014 we randomized 324 patients (mean age 43.2 years, 53.7% male) 
with heart disease in a 2:1 ratio (n=215 versus n=109) to a 12-week online mindfulness 
training in addition to usual care (UC) compared to UC alone. The primary outcome was 
exercise capacity measured with the 6 minute walk test (6MWT). Secondary outcomes were 
other physiological parameters (heart rate, blood pressure, respiratory rate, and NT-
proBNP), subjective health status (SF-36), perceived stress (PSS), psychological well-being 
(HADS), social support (PSSS12) and a composite endpoint (all-cause mortality, heart 
failure, symptomatic arrhythmia, cardiac surgery, and percutaneous cardiac intervention). 
Linear mixed models were used to evaluate differences between groups on the repeated 
outcome measures. 
Results. Compared to UC, mindfulness showed a borderline significant improved 6MWT 
(effect size, meters: 13.2, 95%CI: -0.02; 26.4, p=0.050). There was also a significant lower 
heart rate in favor of the mindfulness group (effect size, beats per minute: -2.8, 95%CI: -
5.4;-0.2, p=0.033). No significant differences were seen on other outcomes.  
Conclusions. Mindfulness training showed positive effects on the physiological parameters 
exercise capacity and heart rate and it might therefore be a useful adjunct to current clinical 
therapy in patients with heart disease. 
 
 
  
 
Introduction 
In recent decades, cardiovascular disease (CVD) has become the foremost cause of health 
burden worldwide.1 Especially the group of adults with congenital heart disease has increased 
over the last decades. While cardiovascular disease cause significant stress,2 chronic stressors 
such as anxiety and depression are themselves independent risk factors for cardiovascular 
morbidity and mortality.3,4 Chronic stress can negatively affect not only quality of life, but 
also physiological parameters such as respiration rate, heart rate, blood pressure, 
inflammatory markers and brain activity.5  
As heart rate is associated with long-term survival, patients are recommended to try 
reducing heart rate in the management and prevention of CVD.6 Often medication, such as 
betablockers, is prescribed for this goal. Stress reduction in itself may also have a beneficial 
effect on heart rate and physical fitness. While the best approach to stress management is 
unclear, increased attention is now being paid to lifestyle interventions such as mindfulness 
therapy.7,8 Mindfulness is described as the capacity to live with open and non-judgmental 
awareness towards all experiences within the present moment.9,10 Several core features, such 
as meditation, yoga, and cognitive assignments, can increase the ability to accept nega tive 
experience or emotions.11 Mindfulness therapy has been found to positively affect 
psychological outcomes in patients with chronic pain, obesity, hypertension, depression, 
anxiety and cardiovascular disease.12-16  
We hypothesized that, besides these psychological effects, mindfulness therapy may 
influence heart rate, breathing patterns and blood pressure through a favorable effect on the 
autonomic nervous system and therefore may positively affect exercise capacity and thus 
long-term outcome17. In a randomized controlled trial (RCT), we therefore investigated the 
effectiveness of online mindfulness training on exercise capacity in patients with heart 
disease.  
 
Methods 
Study design 
The current study is a single blinded, pragmatic RCT performed at the outpatient cardiology 
clinic of the Erasmus MC, Rotterdam, The Netherlands. Ethical approval was obtained from 
the Medical Ethics Committee (METC) of the Erasmus Medical Center and the study 
complied with the Declaration of Helsinki (see supporting information). The study was 
registered at the Dutch trial register, 3453, http://www.trialregister.nl. Patients received 
written information about the study at home, 2-4 weeks prior to their scheduled visit to the 
cardiologist at the outpatient clinic. Full disclosure was given about the nature of the 
intervention. The current study reports the results of 3 month follow-up, which ended in 
July 2014, whereas the 12-month follow-up is still ongoing. 
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outcome measures. 
Results. Compared to UC, mindfulness showed a borderline significant improved 6MWT 
(effect size, meters: 13.2, 95%CI: -0.02; 26.4, p=0.050). There was also a significant lower 
heart rate in favor of the mindfulness group (effect size, beats per minute: -2.8, 95%CI: -
5.4;-0.2, p=0.033). No significant differences were seen on other outcomes.  
Conclusions. Mindfulness training showed positive effects on the physiological parameters 
exercise capacity and heart rate and it might therefore be a useful adjunct to current clinical 
therapy in patients with heart disease. 
 
 
  
 
Introduction 
In recent decades, cardiovascular disease (CVD) has become the foremost cause of health 
burden worldwide.1 Especially the group of adults with congenital heart disease has increased 
over the last decades. While cardiovascular disease cause significant stress,2 chronic stressors 
such as anxiety and depression are themselves independent risk factors for cardiovascular 
morbidity and mortality.3,4 Chronic stress can negatively affect not only quality of life, but 
also physiological parameters such as respiration rate, heart rate, blood pressure, 
inflammatory markers and brain activity.5  
As heart rate is associated with long-term survival, patients are recommended to try 
reducing heart rate in the management and prevention of CVD.6 Often medication, such as 
betablockers, is prescribed for this goal. Stress reduction in itself may also have a beneficial 
effect on heart rate and physical fitness. While the best approach to stress management is 
unclear, increased attention is now being paid to lifestyle interventions such as mindfulness 
therapy.7,8 Mindfulness is described as the capacity to live with open and non-judgmental 
awareness towards all experiences within the present moment.9,10 Several core features, such 
as meditation, yoga, and cognitive assignments, can increase the ability to accept nega tive 
experience or emotions.11 Mindfulness therapy has been found to positively affect 
psychological outcomes in patients with chronic pain, obesity, hypertension, depression, 
anxiety and cardiovascular disease.12-16  
We hypothesized that, besides these psychological effects, mindfulness therapy may 
influence heart rate, breathing patterns and blood pressure through a favorable effect on the 
autonomic nervous system and therefore may positively affect exercise capacity and thus 
long-term outcome17. In a randomized controlled trial (RCT), we therefore investigated the 
effectiveness of online mindfulness training on exercise capacity in patients with heart 
disease.  
 
Methods 
Study design 
The current study is a single blinded, pragmatic RCT performed at the outpatient cardiology 
clinic of the Erasmus MC, Rotterdam, The Netherlands. Ethical approval was obtained from 
the Medical Ethics Committee (METC) of the Erasmus Medical Center and the study 
complied with the Declaration of Helsinki (see supporting information). The study was 
registered at the Dutch trial register, 3453, http://www.trialregister.nl. Patients received 
written information about the study at home, 2-4 weeks prior to their scheduled visit to the 
cardiologist at the outpatient clinic. Full disclosure was given about the nature of the 
intervention. The current study reports the results of 3 month follow-up, which ended in 
July 2014, whereas the 12-month follow-up is still ongoing. 
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Participants 
Adult patients, between 18 and 65 years of age, with diagnosed heart disease (ischemic, 
valvular, congenital heart disease, or cardiomyopathy) were eligible for inclusion between 
June 2012 and April 2014. Patients were excluded based on the following criteria: (1) 
planned operation or percutaneous intervention within the upcoming year; (2) inability or 
unwillingness to give informed consent; (3) inability to understand Dutch, inability to read 
or write Dutch; (4) no internet access, email, or cell phone; (5) patients who did not fill out 
the baseline questionnaires or did not show up for the scheduled baseline tests. All 
participants provided written informed consent. 
 
Intervention 
The active intervention was mindfulness training which consisted of a 12-week structured 
standardized online program. The training was offered in addition to usual care (UC) as 
provided by the treating cardiologist.  All patients received a book about mindfulness by a 
renowned author to support the 12-week training 18. The training was designed to be self-
directed and to be easily accessible and engaging to a wide audience by keeping practice 
sessions and lessons short. The program teaches different meditations, self-reflection, and 
yoga. Furthermore, it includes practical assignments and suggestions for mindfulness in day-
to-day life. The use of breath as a reminder for present moment awareness is emphasized in 
all meditations. The program was divided into four components (see supporting 
information). During the course participants also received biweekly reminders by e-mail and 
standardized text messages. Adherence to the intervention was monitored by whether the 
questions of the online program were completed.  For privacy reasons, the content of the 
answers remained undisclosed. Both the program and the book were provided free of charge 
to participating patients. 
 
Control  
The control group received UC by their treating cardiologist. Treatment and frequency 
differs between patients, but general components are regular outpatient visits, lifestyle 
advice regarding nutrition, smoking, exercise, stress reduction, medication and other 
procedures if indicated. We chose for a pragmatic study design without a placebo online 
training in order to measure effectiveness rather than efficacy. This choice is justified by the 
likelihood of a partial placebo effect that is part-and-parcel of the training as it would be 
implemented in future practice. 
 
Randomization 
After a patient’s eligibility was established by one of the study investigators, written 
informed consent was obtained and baseline measurements were performed. Subsequently, 
patients were randomized according to a 2:1 ratio via dedicated computer software 
(ALEA®) with a block size of 12 to receive the online Mindfulness training or UC.19 The 
 
investigator entered the patients into the computer software, but did not receive the result 
of the allocation. The result of the randomization procedure was sent to an independent 
employee (medical secretary) of the outpatient clinic, who was not involved in establishing 
eligibility, outcome assessment, or data analyses. Subsequently, this employee contacted the 
participant with the result and provided instructions on how to access the web-based 
training.  
 
Blinding 
Due to the nature of the intervention, blinding of patients was not feasible. The intervention 
started as soon as patients logged on to the mindfulness training website. The outcome 
assessors (investigators) were unaware of patients’ treatment allocation. Therefore, the 
design of this study can be considered as a single-blinded randomized controlled trial in 
which the investigators remained blinded throughout the duration of the study. Additionally, 
patients were instructed not to say anything about their treatment allocation,  neither to 
study investigators nor to their cardiologist.  
 
Outcome measures 
Outcomes were measured in all patients pre- (T0) and post-intervention (12 weeks, T1). 
We were interested in evaluating the physical effects of mindfulness and thus chose as 
primary outcome measure the 6MWT, which is an overall measure of exercise tolerance, 
has reproducible results, and has shown to be an independent predictor of long term 
outcome.20-22 The 6MWT was performed in a 20-meter-long corridor at the outpatient 
clinic.23 The corridor had well-indicated ‘start’ and ‘finish’ marks with colored pawns.  
 
Secondary outcome measures were:  
Physical parameters: weight, blood pressure, respiratory rate and heart rate. BMI was 
calculated by weight in kilograms divided by height in meters squared. Blood pressure was 
measured using an automated non-invasive monitor (Mindray Datascope Duo) after the 
participant had rested for 5 minutes in the sitting position. This monitor also reports the 
heart rate. Respiratory rate was measured in rest within a set amount of 30 seconds. 
Blood sampling laboratory tests: N-terminal pro-brain natriuretic peptide (NT-proBNP, Elecsys 
system, Roche Diagnostics, Basel, Switzerland: normal values ≤ 14pmol/L) and creatinin 
were measured from peripheral venous blood samples.  
Subjective health status: The Short-Form Health survey 36 (SF-36) was used to evaluate 
subjective health status. For each of the 8 subdomains a transformed score is generated, 
ranging from 0 to 100,24 with a higher score indicating better health.25 The subdomains were 
used to construct the mental component summary (MCS) measure, which consists of the 
subdomains vitality, social functioning, role-emotional functioning and mental health, and 
the physical component summary (PCS) measure, which consists of the subdomains physical 
functioning, role physical functioning, bodily pain and general health.26 
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or write Dutch; (4) no internet access, email, or cell phone; (5) patients who did not fill out 
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participants provided written informed consent. 
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The active intervention was mindfulness training which consisted of a 12-week structured 
standardized online program. The training was offered in addition to usual care (UC) as 
provided by the treating cardiologist.  All patients received a book about mindfulness by a 
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directed and to be easily accessible and engaging to a wide audience by keeping practice 
sessions and lessons short. The program teaches different meditations, self-reflection, and 
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standardized text messages. Adherence to the intervention was monitored by whether the 
questions of the online program were completed.  For privacy reasons, the content of the 
answers remained undisclosed. Both the program and the book were provided free of charge 
to participating patients. 
 
Control  
The control group received UC by their treating cardiologist. Treatment and frequency 
differs between patients, but general components are regular outpatient visits, lifestyle 
advice regarding nutrition, smoking, exercise, stress reduction, medication and other 
procedures if indicated. We chose for a pragmatic study design without a placebo online 
training in order to measure effectiveness rather than efficacy. This choice is justified by the 
likelihood of a partial placebo effect that is part-and-parcel of the training as it would be 
implemented in future practice. 
 
Randomization 
After a patient’s eligibility was established by one of the study investigators, written 
informed consent was obtained and baseline measurements were performed. Subsequently, 
patients were randomized according to a 2:1 ratio via dedicated computer software 
(ALEA®) with a block size of 12 to receive the online Mindfulness training or UC.19 The 
 
investigator entered the patients into the computer software, but did not receive the result 
of the allocation. The result of the randomization procedure was sent to an independent 
employee (medical secretary) of the outpatient clinic, who was not involved in establishing 
eligibility, outcome assessment, or data analyses. Subsequently, this employee contacted the 
participant with the result and provided instructions on how to access the web-based 
training.  
 
Blinding 
Due to the nature of the intervention, blinding of patients was not feasible. The intervention 
started as soon as patients logged on to the mindfulness training website. The outcome 
assessors (investigators) were unaware of patients’ treatment allocation. Therefore, the 
design of this study can be considered as a single-blinded randomized controlled trial in 
which the investigators remained blinded throughout the duration of the study. Additionally, 
patients were instructed not to say anything about their treatment allocation,  neither to 
study investigators nor to their cardiologist.  
 
Outcome measures 
Outcomes were measured in all patients pre- (T0) and post-intervention (12 weeks, T1). 
We were interested in evaluating the physical effects of mindfulness and thus chose as 
primary outcome measure the 6MWT, which is an overall measure of exercise tolerance, 
has reproducible results, and has shown to be an independent predictor of long term 
outcome.20-22 The 6MWT was performed in a 20-meter-long corridor at the outpatient 
clinic.23 The corridor had well-indicated ‘start’ and ‘finish’ marks with colored pawns.  
 
Secondary outcome measures were:  
Physical parameters: weight, blood pressure, respiratory rate and heart rate. BMI was 
calculated by weight in kilograms divided by height in meters squared. Blood pressure was 
measured using an automated non-invasive monitor (Mindray Datascope Duo) after the 
participant had rested for 5 minutes in the sitting position. This monitor also reports the 
heart rate. Respiratory rate was measured in rest within a set amount of 30 seconds. 
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A Visual Analogue Scale (VAS) was used to assess subjective perceived QoL (“Indicate on the 
line above where you would situate yourself in terms of your overall quality of life’’, ranging 
from 0 to 100, with a higher score indicating better QoL.27 
Psychological well-being: To assess symptoms of anxiety and depression, the Hospital Anxiety 
and Depression scale was used. The questionnaire contains 14 items on depression and 
anxiety with a higher score on the 3 point Likert scale indicating a greater level of emotional 
distress.28 
Stress: The Dutch version of the Perceived Stress Scale (PSS) was used to evaluate perceived 
stress. The scale consists of fourteen 5-point Likert scales, with a higher score indicating a 
higher level of stress (0=never, 4=very often). A total perceived stress score is made by 
summing all individual ite.29  
Social support: To evaluate perceived social support, the Dutch version of the Perceived 
Social Support Scale 12 Blumenthal (PSSS12) was used. The PSSS12 has 12 items with a 7-
point Likert scale addressing the degree of perceived social support with a higher score 
indicating a greater feeling of support (1=very strongly disagree, 7= very strongly agree).30 
For the purpose of this study we used the total score. 
Adverse events: Adverse events were defined as all-cause mortality, heart failure, symptomatic 
arrhythmia, cardiac surgery, and percutaneous cardiac intervention. Arrhythmias were 
defined as symptomatic if antiarrhythmic medication was prescribed, cardioversion or 
ablation had been applied, or a pacemaker or intracardiac defibrillator (ICD) was implanted. 
Heart failure was defined as an event when either medication or hospitalization was 
necessary.  
 
Other study parameters 
In order to document baseline risk levels, traditional cardiovascular risk factors and 
demographics were determined: age, sex, length, weight, smoking, type of heart disease, 
and employment status. Additionally participation in other mindfulness-based exercises and 
the use of other complementary care was monitored with a questionnaire (type, frequency, 
and intensity).  
 
Quality control and audit 
The digitalization of the paper case record forms (CRFs) in the database was independently 
performed by 2 persons (JY and MW).  After digitalization, an error rate of <0.5% was 
observed between JY and MW. An independent audit was performed and the study was 
found to comply with Good Clinical Practice and Scientific Integrity standards.  
  
Sample size justification 
To demonstrate an improvement of 5% in the intervention group vs 1% in the control group 
on the 6MWT, this study required 99 patients in the control group and 198 in the active 
intervention group (SD10%, alpha=0.05, power=0.90, ratio experimental to controls=2). 
 
Even if only 50% of patients in the experimental group adhered to the training, this would 
give us a power of 0.80 in the as-treated analysis. To account for non-adherence and loss to 
follow-up our aim was to randomize at least 300 patients. This number of patients is 
sufficient to demonstrate a smaller difference (5% in the intervention group vs 2% in the 
control group) in a repeated measurements analysis with a power of 75% (2 follow-up 
measurements, correlation between follow up measurements=0.70, correlation between 
baseline & follow-up=0.50).  
 
Statistical analysis 
Descriptive analyses were performed to describe the baseline characteristics of demographic 
and clinical variables stratified by treatment group.  Changes in outcomes at 12 weeks 
compared with baseline (intragroup effect) and differences between treatment groups 
(difference in delta’s, intergroup effect) on physiological and psychological outcomes were 
calculated. To simultaneously account for the correlation between the multiple 
measurements of each patient and dropout, a repeated measurements analysis was 
performed using a multivariate linear regression mixed model to determine intergroup 
effects. In the mean structure of the mixed model we included the time effect, the 
intervention effect and their interaction, while a fully unstructured variance-covariance 
matrix was assumed for the error terms. Due to randomization only p-values for the 
interaction effect are reported. 
An intention-to-treat (ITT) analysis was performed to address whether offering a 
mindfulness training was effective compared to UC. An as-treated (AT) analysis was 
performed to address whether the mindfulness training was beneficial if actually performed. 
In the AT analysis, patients were considered adherent if they completed 50% or more of the 
exercises. Patients allocated to the UC group who sought mindfulness training on their own 
were excluded from the AT analysis. For both ITT and AT, Cohen’s D was calculated to 
enable comparison of effect sizes. This calculation was performed based on the results of the 
mixed model. A p-value less than 0.05 was considered to be indicative of statistical 
significance. All data were analyzed with IBM SPSS Statistics version 21.0 (IBM Corp., 
Somers, NY).  
 
Results 
Patient recruitment and characteristics 
A flowchart of the patients’ recruitment is shown in Figure 1. Patients’ baseline 
characteristics (Table 1) demonstrated no significant differences between the intervention 
and control group which confirmed a successful randomization, also on important 
characteristics such as: age (p=0.98) and, gender (p=0.28).  In total, 5 patients did not 
complete any assignment of the mindfulness training whereas 115 patients completed at least 
50% of the assignments (as-treated analysis) with a mean 53% (SD 34%). 
 
Processed on: 27-10-2016
504961-L-bw-Gotink
7
Online mindfulness in heart disease: 3 month results 139
 
A Visual Analogue Scale (VAS) was used to assess subjective perceived QoL (“Indicate on the 
line above where you would situate yourself in terms of your overall quality of life’’, ranging 
from 0 to 100, with a higher score indicating better QoL.27 
Psychological well-being: To assess symptoms of anxiety and depression, the Hospital Anxiety 
and Depression scale was used. The questionnaire contains 14 items on depression and 
anxiety with a higher score on the 3 point Likert scale indicating a greater level of emotional 
distress.28 
Stress: The Dutch version of the Perceived Stress Scale (PSS) was used to evaluate perceived 
stress. The scale consists of fourteen 5-point Likert scales, with a higher score indicating a 
higher level of stress (0=never, 4=very often). A total perceived stress score is made by 
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point Likert scale addressing the degree of perceived social support with a higher score 
indicating a greater feeling of support (1=very strongly disagree, 7= very strongly agree).30 
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defined as symptomatic if antiarrhythmic medication was prescribed, cardioversion or 
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and employment status. Additionally participation in other mindfulness-based exercises and 
the use of other complementary care was monitored with a questionnaire (type, frequency, 
and intensity).  
 
Quality control and audit 
The digitalization of the paper case record forms (CRFs) in the database was independently 
performed by 2 persons (JY and MW).  After digitalization, an error rate of <0.5% was 
observed between JY and MW. An independent audit was performed and the study was 
found to comply with Good Clinical Practice and Scientific Integrity standards.  
  
Sample size justification 
To demonstrate an improvement of 5% in the intervention group vs 1% in the control group 
on the 6MWT, this study required 99 patients in the control group and 198 in the active 
intervention group (SD10%, alpha=0.05, power=0.90, ratio experimental to controls=2). 
 
Even if only 50% of patients in the experimental group adhered to the training, this would 
give us a power of 0.80 in the as-treated analysis. To account for non-adherence and loss to 
follow-up our aim was to randomize at least 300 patients. This number of patients is 
sufficient to demonstrate a smaller difference (5% in the intervention group vs 2% in the 
control group) in a repeated measurements analysis with a power of 75% (2 follow-up 
measurements, correlation between follow up measurements=0.70, correlation between 
baseline & follow-up=0.50).  
 
Statistical analysis 
Descriptive analyses were performed to describe the baseline characteristics of demographic 
and clinical variables stratified by treatment group.  Changes in outcomes at 12 weeks 
compared with baseline (intragroup effect) and differences between treatment groups 
(difference in delta’s, intergroup effect) on physiological and psychological outcomes were 
calculated. To simultaneously account for the correlation between the multiple 
measurements of each patient and dropout, a repeated measurements analysis was 
performed using a multivariate linear regression mixed model to determine intergroup 
effects. In the mean structure of the mixed model we included the time effect, the 
intervention effect and their interaction, while a fully unstructured variance-covariance 
matrix was assumed for the error terms. Due to randomization only p-values for the 
interaction effect are reported. 
An intention-to-treat (ITT) analysis was performed to address whether offering a 
mindfulness training was effective compared to UC. An as-treated (AT) analysis was 
performed to address whether the mindfulness training was beneficial if actually performed. 
In the AT analysis, patients were considered adherent if they completed 50% or more of the 
exercises. Patients allocated to the UC group who sought mindfulness training on their own 
were excluded from the AT analysis. For both ITT and AT, Cohen’s D was calculated to 
enable comparison of effect sizes. This calculation was performed based on the results of the 
mixed model. A p-value less than 0.05 was considered to be indicative of statistical 
significance. All data were analyzed with IBM SPSS Statistics version 21.0 (IBM Corp., 
Somers, NY).  
 
Results 
Patient recruitment and characteristics 
A flowchart of the patients’ recruitment is shown in Figure 1. Patients’ baseline 
characteristics (Table 1) demonstrated no significant differences between the intervention 
and control group which confirmed a successful randomization, also on important 
characteristics such as: age (p=0.98) and, gender (p=0.28).  In total, 5 patients did not 
complete any assignment of the mindfulness training whereas 115 patients completed at least 
50% of the assignments (as-treated analysis) with a mean 53% (SD 34%). 
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Figure 1. Flowchart of mindfulness training and control group  
 
 
 
 
1044 assessed for eligibility 
720 excluded 
   46 meeting exclusion criteria 
   398 declined to participate 
   276 other reasons 
324 randomized 
109 allocated to control 215 allocated to intervention 
Drop-outs 
   8 loss of contact 
   23 discontinued study 
   16 personal circumstances 
Drop-outs 
   8 loss of contact 
   6 discontinued study  
   4 personal circumstances 
91 included in intention-to-treat analysis 
18 excluded (drop-outs) 
 
85 included in as-treated analysis 
6 excluded (did not complete 50% of 
assignments) 
 
168 included in intention-to-treat analysis 
47 excluded (drop-outs) 
 
115 included in as-treated analysis 
53 excluded (did not complete 50% of 
assignments) 
Analysis 
12-week follow up 
Allocation 
 
Table 1. Baseline characteristics of study participants 
 
Mindfulness 
Group 
N=215 
Control 
Group 
N=109 
Demographics 
     Age (years), mean (SD) 43.2 (14.1) 43.2 (13.7) 
   Female (%) 44.2 50.5 
   Employed (%) 68.7 67.9 
Physiological parameters 
 
   Heart rate (beats/min), mean (SD) 68 (12) 69 (11) 
   Systolic blood pressure (mm Hg), mean (SD) 128 (16) 125 (15) 
   Diastolic blood pressure (mm Hg), mean (SD) 78 (11) 80 (10) 
   Resting respiratory rate (breaths/min), median 
(IQR) 15 (2) 15 (3) 
   Body mass index (kg/m²), mean (SD)  25.9 (4.6) 25.7 (4.7) 
   Obesity* (%) 16.7 15.6 
Psychological parameters 
 
   PCS, mean (SD) 46.6 (9.6) 45.3 (10.3) 
   MCS, mean (SD) 50.2 (10.6) 50.8 (9.6) 
   HADS Anxiety, mean (SD) 8.2 (3.6) 9.0 (3.4) 
   HADS Depression, mean (SD) 3.8 (2.9) 3.8 (2.9) 
   VAS, mean (SD) 75.0 (13.2) 72.7 (13.2) 
   PSS, mean (SD) 22.4 (7.8) 22.0 (7.5) 
   PSSS12, mean (SD) 69.5 (11.6) 71.5 (12.3) 
Exercise tolerance 
  
6 minute walk test distance (meters), mean (SD) 537.5 (77.0) 539.3 (67.3) 
Laboratory works   
   NT-proBNP, median (IQR), pmol/L 16.7 (28.5) 18.3 (33.9) 
   Creatinine, median (IQR), μmol/L 79.0 (21.0) 77.0 (21.0) 
Cardiac history, type of heart disease, (%) 
    Congenital heart disease 41.9 42.2 
    Cardiomyopathy 39.5 29.4 
    Valvular heart disease 18.6 28.4 
Other comorbidity, (%)  
     Diabetes Mellitus** 3.2 3.7 
Number of interventions in life***, mean (SD) 1.4 (1.4) 1.4 (1.2) 
Time since first intervention (years), mean (SD) 19.1 (14.0) 15.9 (11.7) 
ICD (%) 5.9 4.3 
PM (%)  9.3 5.2 
Current medication (%) 70.2 72.5 
       Beta-blocker 43.2 36.7 
       Statin 18.6 13.8 
       Aspirin 16.3 14.7 
       Ace-inhibitor 23.3 22.0 
       Angiotensin II antagonist 8.8 11.9 
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Group 
N=109 
Demographics 
     Age (years), mean (SD) 43.2 (14.1) 43.2 (13.7) 
   Female (%) 44.2 50.5 
   Employed (%) 68.7 67.9 
Physiological parameters 
 
   Heart rate (beats/min), mean (SD) 68 (12) 69 (11) 
   Systolic blood pressure (mm Hg), mean (SD) 128 (16) 125 (15) 
   Diastolic blood pressure (mm Hg), mean (SD) 78 (11) 80 (10) 
   Resting respiratory rate (breaths/min), median 
(IQR) 15 (2) 15 (3) 
   Body mass index (kg/m²), mean (SD)  25.9 (4.6) 25.7 (4.7) 
   Obesity* (%) 16.7 15.6 
Psychological parameters 
 
   PCS, mean (SD) 46.6 (9.6) 45.3 (10.3) 
   MCS, mean (SD) 50.2 (10.6) 50.8 (9.6) 
   HADS Anxiety, mean (SD) 8.2 (3.6) 9.0 (3.4) 
   HADS Depression, mean (SD) 3.8 (2.9) 3.8 (2.9) 
   VAS, mean (SD) 75.0 (13.2) 72.7 (13.2) 
   PSS, mean (SD) 22.4 (7.8) 22.0 (7.5) 
   PSSS12, mean (SD) 69.5 (11.6) 71.5 (12.3) 
Exercise tolerance 
  
6 minute walk test distance (meters), mean (SD) 537.5 (77.0) 539.3 (67.3) 
Laboratory works   
   NT-proBNP, median (IQR), pmol/L 16.7 (28.5) 18.3 (33.9) 
   Creatinine, median (IQR), μmol/L 79.0 (21.0) 77.0 (21.0) 
Cardiac history, type of heart disease, (%) 
    Congenital heart disease 41.9 42.2 
    Cardiomyopathy 39.5 29.4 
    Valvular heart disease 18.6 28.4 
Other comorbidity, (%)  
     Diabetes Mellitus** 3.2 3.7 
Number of interventions in life***, mean (SD) 1.4 (1.4) 1.4 (1.2) 
Time since first intervention (years), mean (SD) 19.1 (14.0) 15.9 (11.7) 
ICD (%) 5.9 4.3 
PM (%)  9.3 5.2 
Current medication (%) 70.2 72.5 
       Beta-blocker 43.2 36.7 
       Statin 18.6 13.8 
       Aspirin 16.3 14.7 
       Ace-inhibitor 23.3 22.0 
       Angiotensin II antagonist 8.8 11.9 
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       Calcium channel blocker 9.8 6.4 
       Nitroglycerin 2.3 0.0 
       Cardiac glycoside 2.3 2.8 
       Diuretic 16.8 19.3 
       Anticoagulant 24.6 33.9 
       Antidepressant 5.1 2.8 
       Tranquilizer 1.9 1.8 
       Other 43.3 57.8 
Intoxication, (%)   
       Current smoking 14.4 18.3 
       Current alcohol use 62.1 55.0 
       Current drugs use 3.3 2.8 
Prior use of complementary therapies****, (%) 14.4 12.8 
* Obesity was defined when the BMI was ≥30 kg/m2  
** Diabetes was defined when a patient reported use of anti -diabetes medication 
*** Include both surgical and percutaneous interventions 
**** Contains yoga, meditation, mindfulness, tai chi, Qigong and acupuncture 
SD, standard deviation; PCS, physical component summary measure; MCS, mental component 
summary measure; VAS, visual analogue scale; HADS, hospital anxiety and depression scale; PSS, 
perceived stress score; PSSS12, perceived social support; NT-proBNP, N-terminal pro-Brain 
Natriuretic Peptide; IQR, interquartile range; ICD, implantable cardioverter-defibrillator; PM, 
pacemaker. 
 
Safety/side effects 
No major side effects were reported during the follow-up period. In 7 patients (5 
mindfulness (2.3%), 2 control (1.8%)) at baseline and 13 patients (8 mindfulness (4.8%), 5 
control (5.5%)) at follow-up, fatigue, dizziness, shortness of breath, or pain due to pre-
existing conditions were described while performing the 6MWT. 
 
Outcome analysis 
At 12 weeks, the mindfulness group showed a notable improvement on their mean 6MWT, 
which was borderline significantly different compared with UC (p = 0.050) (Table 2). The 
intergroup comparison showed that heart rate was significantly lower in the mindfulness 
group (p = 0.033) (Table 2). Mean systolic and mean diastolic blood pressure decreased in 
the mindfulness and UC group, but no significant differences were found in the intergroup 
comparison (Table 2).  
 
  
 
Table 2. Changes in outcomes at 12 weeks compared with baseline (intragroup effect) and 
differences between treatment groups (difference in delta’s, intergroup effect) on 
physiological and psychological outcomes. Intention-to-treat analyses. 
Physiological 
outcomes 
Treatment 
group 
∆ 12-week vs 
baseline 
(intragroup)a 
(mean, SD) 
Effect estimate 
(intergroup)b 
(95%CI) p-value 
6MWT, meters Mindfulness 10.42 (49.0) 13.2 (-0.02 to 26.4) 0.050 
 Control -4.0 (55.6)   
Heart rate, 
beats/minute 
Mindfulness -2 (10.9) -2.8 (-5.4 to -0.2) 0.033 
Control 0.5 (9.0)   
SBP, mmHg Mindfulness 4.2 (15.4) -2.2 (-6.1 to1.7) 0.268 
 Control -1.9 (15.5)   
DBP, mmHg Mindfulness -1.9 (8.9) 1.6 (-0.8 to 4.0) 0.186 
 Control -3.4 (10.1)   
Respiratory rate, 
breath/minute 
Mindfulness -0.5 (3.6) -0.02 (-0.04 to 0.01) 0.189 
Control -0.1 (4.0)   
NT-proBNP, 
pmol/L 
Mindfulness 0.3 (9.7) -0.04 (-0.1 to 0.04) 0.333 
Control 0.0 (11.1)   
SF-36 PCS Mindfulness 0.5 (6.3) -0.4 (-2.0 to 1.3) 0.668 
 Control 0.7 (6.7)   
SF-36 MCS Mindfulness 0.2 (7.4) 0.7 (-1.4 to 2.8) 0.489 
 Control 1.2 (8.8)   
VAS Mindfulness 0.4 (10.4) -0.4 (-3.0 to 2.1) 0.745 
 Control 0.7 (9.3)   
HADS anxiety Mindfulness -0.5 (3.2) 0.6 (-0.2 to 1.4) 0.145 
 Control -0.9 (3.0)   
HADS depression Mindfulness -0.5 (2.9) -0.4 (-1.1 to 0.2) 0.203 
 Control 0.0 (2.3)   
PSS Mindfulness -2.4 (6.3) -1.0 (-2.7 to 0.6) 0.226 
 Control -0.9 (6.8)   
PSSS12 Mindfulness 0.6 (7.4) 0.4 (-1.6 to 2.4) 0.685 
 Control 0.1 (8.0)   
SD standard deviation; SE standard error; 6MWT six minute walk test; SBP systolic blood pressure; 
DBP diastolic blood pressure; NT-proBNP N-terminal pro-brain natriuretic peptide; SF-36 short form 
health survey; PCS physical scale; MCS mental scale; VAS visual analogue scale; HADS hospital anxiety 
depression scale; PSS perceived stress score; PSSS12 percieved social support 
a delta value was calculated for those who attended the 12-week follow-up 
b linear mixed model analyses for repeated measurements for differences between treatment groups 
(time x intervention effect). 
 
Analyses showed no significant differences between the groups on the PCS and MCS of the 
SF-36 (Table 2). At 12 weeks, anxiety levels were lower than baseline scores in both the 
mindfulness and the UC group, but no significant differences were found in the intergroup 
comparison (Table 2). Depressive symptoms decreased at 12 weeks, but did not significantly 
differ between the groups. Neither perceived stress scores nor perceived social support were 
statistically significant different in the intergroup comparison (Table 2). No significant 
differences were found on adverse events. 
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perceived stress score; PSSS12, perceived social support; NT-proBNP, N-terminal pro-Brain 
Natriuretic Peptide; IQR, interquartile range; ICD, implantable cardioverter-defibrillator; PM, 
pacemaker. 
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No major side effects were reported during the follow-up period. In 7 patients (5 
mindfulness (2.3%), 2 control (1.8%)) at baseline and 13 patients (8 mindfulness (4.8%), 5 
control (5.5%)) at follow-up, fatigue, dizziness, shortness of breath, or pain due to pre-
existing conditions were described while performing the 6MWT. 
 
Outcome analysis 
At 12 weeks, the mindfulness group showed a notable improvement on their mean 6MWT, 
which was borderline significantly different compared with UC (p = 0.050) (Table 2). The 
intergroup comparison showed that heart rate was significantly lower in the mindfulness 
group (p = 0.033) (Table 2). Mean systolic and mean diastolic blood pressure decreased in 
the mindfulness and UC group, but no significant differences were found in the intergroup 
comparison (Table 2).  
 
  
 
Table 2. Changes in outcomes at 12 weeks compared with baseline (intragroup effect) and 
differences between treatment groups (difference in delta’s, intergroup effect) on 
physiological and psychological outcomes. Intention-to-treat analyses. 
Physiological 
outcomes 
Treatment 
group 
∆ 12-week vs 
baseline 
(intragroup)a 
(mean, SD) 
Effect estimate 
(intergroup)b 
(95%CI) p-value 
6MWT, meters Mindfulness 10.42 (49.0) 13.2 (-0.02 to 26.4) 0.050 
 Control -4.0 (55.6)   
Heart rate, 
beats/minute 
Mindfulness -2 (10.9) -2.8 (-5.4 to -0.2) 0.033 
Control 0.5 (9.0)   
SBP, mmHg Mindfulness 4.2 (15.4) -2.2 (-6.1 to1.7) 0.268 
 Control -1.9 (15.5)   
DBP, mmHg Mindfulness -1.9 (8.9) 1.6 (-0.8 to 4.0) 0.186 
 Control -3.4 (10.1)   
Respiratory rate, 
breath/minute 
Mindfulness -0.5 (3.6) -0.02 (-0.04 to 0.01) 0.189 
Control -0.1 (4.0)   
NT-proBNP, 
pmol/L 
Mindfulness 0.3 (9.7) -0.04 (-0.1 to 0.04) 0.333 
Control 0.0 (11.1)   
SF-36 PCS Mindfulness 0.5 (6.3) -0.4 (-2.0 to 1.3) 0.668 
 Control 0.7 (6.7)   
SF-36 MCS Mindfulness 0.2 (7.4) 0.7 (-1.4 to 2.8) 0.489 
 Control 1.2 (8.8)   
VAS Mindfulness 0.4 (10.4) -0.4 (-3.0 to 2.1) 0.745 
 Control 0.7 (9.3)   
HADS anxiety Mindfulness -0.5 (3.2) 0.6 (-0.2 to 1.4) 0.145 
 Control -0.9 (3.0)   
HADS depression Mindfulness -0.5 (2.9) -0.4 (-1.1 to 0.2) 0.203 
 Control 0.0 (2.3)   
PSS Mindfulness -2.4 (6.3) -1.0 (-2.7 to 0.6) 0.226 
 Control -0.9 (6.8)   
PSSS12 Mindfulness 0.6 (7.4) 0.4 (-1.6 to 2.4) 0.685 
 Control 0.1 (8.0)   
SD standard deviation; SE standard error; 6MWT six minute walk test; SBP systolic blood pressure; 
DBP diastolic blood pressure; NT-proBNP N-terminal pro-brain natriuretic peptide; SF-36 short form 
health survey; PCS physical scale; MCS mental scale; VAS visual analogue scale; HADS hospital anxiety 
depression scale; PSS perceived stress score; PSSS12 percieved social support 
a delta value was calculated for those who attended the 12-week follow-up 
b linear mixed model analyses for repeated measurements for differences between treatment groups 
(time x intervention effect). 
 
Analyses showed no significant differences between the groups on the PCS and MCS of the 
SF-36 (Table 2). At 12 weeks, anxiety levels were lower than baseline scores in both the 
mindfulness and the UC group, but no significant differences were found in the intergroup 
comparison (Table 2). Depressive symptoms decreased at 12 weeks, but did not significantly 
differ between the groups. Neither perceived stress scores nor perceived social support were 
statistically significant different in the intergroup comparison (Table 2). No significant 
differences were found on adverse events. 
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The results of the physiological outcomes are summarized in Figure 2, the results of the 
psychological outcomes are summarized in Figure 3.  
 
Figure 2. Forest plot of physiological outcomes. All values on the left of the Y-axis indicate a 
difference in favour of the mindfulness group. 6MWT, six-minute walk test; IC, confidence 
interval, NT-proBNP, N-terminal pro-brain natriuretic peptide; * Log-transformed scores. 
 
Figure 3. Forest plot of psychological outcomes. 
All values on the left of the Y-axis indicate a difference in favour of the mindfulness group.  
 
The results of AT-analyses were comparable with the ITT analyses (Table 3). 
Table 3. Changes in outcomes at 12 weeks compared with baseline (intragroup effect) and 
differences between treatment groups (intergroup effect) on physiological and psychological 
outcomes, as-treated analyses. 
Physiological 
outcomes 
Treatment 
group 
∆ 12-week vs 
baseline 
(intragroup)a 
(mean, SD) 
Effect estimate 
(intergroup)b 
(95%CI) p-value 
6MWT, meters Mindfulness 9.4 (35.9) 10.6 (-1.7 to 23.0) 0.091 
 Control -1.9 (51.7)   
Heart rate, 
beats/minute 
Mindfulness -3.1 (11.7) -3.4 (-6.3 to 0.4) 0.027 
Control 0.5 (9.2)   
SBP, mmHg Mindfulness 5.2 (14.5) -3.8 (-8.0 to 0.3) 0.072 
 Control -1.5 (15.5)   
DBP, mmHg Mindfulness -2.3 (8.9) 0.8 (-1.8 to 3.5) 0.524 
 Control -3.4 (10.1)   
Respiratory rate, 
breath/minute 
Mindfulness -0.7 (3.5) -0.7 (-1.8 to 0.3) 0.173 
Control -0.1 (4.1)   
NT-proBNP, 
pmol/L 
Mindfulness 1.0 (28.7) -0.04 (-0.2 to 0.1) 0.540 
Control 4.7 (21.7)   
SF-36 PCS Mindfulness 0.7 (6.4) 0.1 (-1.7 to 2.0) 0.893 
 Control 0.4 (6.8)   
SF-36 MCS Mindfulness -0.1 (7.5) 1.2 (-1.1 to 3.5) 0.302 
 Control 1.5 (8.9)   
VAS Mindfulness 0.4 (10.4) -0.2 (-3.0 to 2.6) 0.878 
 Control 0.7 (9.3)   
HADS anxiety Mindfulness -0.5 (3.2) 0.5 (-0.4 to 1.4) 0.267 
 Control -0.9 (3.0)   
HADS depression Mindfulness -0.5 (2.9) -0.4 (-1.2 to 0.3) 0.267 
 Control 0.0 (2.3)   
PSS Mindfulness -2.4 (6.3) -1.1 (-3.0 to 0.8) 0.244 
 Control -0.9 (6.8)   
PSSS12 Mindfulness 0.6 (7.4) 0.5 (-1.7 to 2.6) 0.670 
 Control 0.1 (8.0)   
SD standard deviation; SE standard error; 6MWT six minute walk test; SBP systolic blood pressure; 
DBP diastolic blood pressure; NT-proBNP N-terminal pro-brain natriuretic peptide; SF-36 short form 
health survey; PCS physical scale; MCS mental scale; VAS visual analogue scale; HADS hospital anxiety 
depression scale; PSS perceived stress score; PSSS12 percieved social support 
a delta value was calculated for those who attended the 12-week follow-up 
b linear mixed model analyses for repeated measurements for differences between treatment groups 
(time x intervention effect). 
 
Cohen’s D 
 
In order to compare different outcome measures, Cohen’s D effect sizes were calculated. In 
the intention-to-treat analyses (Figure 4 and 5), heart rate and depression showed, small, but 
significant improvement (D=0.20, 95%CI 0.04 to 0.36 and d=0.17, 95%CI 0.01 to 0.33 
respectively). In the As-Treated analysis, exercise capacity, heart rate, systolic blood 
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The results of the physiological outcomes are summarized in Figure 2, the results of the 
psychological outcomes are summarized in Figure 3.  
 
Figure 2. Forest plot of physiological outcomes. All values on the left of the Y-axis indicate a 
difference in favour of the mindfulness group. 6MWT, six-minute walk test; IC, confidence 
interval, NT-proBNP, N-terminal pro-brain natriuretic peptide; * Log-transformed scores. 
 
Figure 3. Forest plot of psychological outcomes. 
All values on the left of the Y-axis indicate a difference in favour of the mindfulness group.  
 
The results of AT-analyses were comparable with the ITT analyses (Table 3). 
Table 3. Changes in outcomes at 12 weeks compared with baseline (intragroup effect) and 
differences between treatment groups (intergroup effect) on physiological and psychological 
outcomes, as-treated analyses. 
Physiological 
outcomes 
Treatment 
group 
∆ 12-week vs 
baseline 
(intragroup)a 
(mean, SD) 
Effect estimate 
(intergroup)b 
(95%CI) p-value 
6MWT, meters Mindfulness 9.4 (35.9) 10.6 (-1.7 to 23.0) 0.091 
 Control -1.9 (51.7)   
Heart rate, 
beats/minute 
Mindfulness -3.1 (11.7) -3.4 (-6.3 to 0.4) 0.027 
Control 0.5 (9.2)   
SBP, mmHg Mindfulness 5.2 (14.5) -3.8 (-8.0 to 0.3) 0.072 
 Control -1.5 (15.5)   
DBP, mmHg Mindfulness -2.3 (8.9) 0.8 (-1.8 to 3.5) 0.524 
 Control -3.4 (10.1)   
Respiratory rate, 
breath/minute 
Mindfulness -0.7 (3.5) -0.7 (-1.8 to 0.3) 0.173 
Control -0.1 (4.1)   
NT-proBNP, 
pmol/L 
Mindfulness 1.0 (28.7) -0.04 (-0.2 to 0.1) 0.540 
Control 4.7 (21.7)   
SF-36 PCS Mindfulness 0.7 (6.4) 0.1 (-1.7 to 2.0) 0.893 
 Control 0.4 (6.8)   
SF-36 MCS Mindfulness -0.1 (7.5) 1.2 (-1.1 to 3.5) 0.302 
 Control 1.5 (8.9)   
VAS Mindfulness 0.4 (10.4) -0.2 (-3.0 to 2.6) 0.878 
 Control 0.7 (9.3)   
HADS anxiety Mindfulness -0.5 (3.2) 0.5 (-0.4 to 1.4) 0.267 
 Control -0.9 (3.0)   
HADS depression Mindfulness -0.5 (2.9) -0.4 (-1.2 to 0.3) 0.267 
 Control 0.0 (2.3)   
PSS Mindfulness -2.4 (6.3) -1.1 (-3.0 to 0.8) 0.244 
 Control -0.9 (6.8)   
PSSS12 Mindfulness 0.6 (7.4) 0.5 (-1.7 to 2.6) 0.670 
 Control 0.1 (8.0)   
SD standard deviation; SE standard error; 6MWT six minute walk test; SBP systolic blood pressure; 
DBP diastolic blood pressure; NT-proBNP N-terminal pro-brain natriuretic peptide; SF-36 short form 
health survey; PCS physical scale; MCS mental scale; VAS visual analogue scale; HADS hospital anxiety 
depression scale; PSS perceived stress score; PSSS12 percieved social support 
a delta value was calculated for those who attended the 12-week follow-up 
b linear mixed model analyses for repeated measurements for differences between treatment groups 
(time x intervention effect). 
 
Cohen’s D 
 
In order to compare different outcome measures, Cohen’s D effect sizes were calculated. In 
the intention-to-treat analyses (Figure 4 and 5), heart rate and depression showed, small, but 
significant improvement (D=0.20, 95%CI 0.04 to 0.36 and d=0.17, 95%CI 0.01 to 0.33 
respectively). In the As-Treated analysis, exercise capacity, heart rate, systolic blood 
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pressure and stress improved significantly, with small effect sizes ranging from D=0.19 to 
D=0.21 (Figure 6 and 7).  
 
Figure 4. Forest plot showing the Intention-to-Treat Cohen’s D results of the effectiveness 
of the mindfulness intervention compared to usual care on the physiological outcomes. The 
width of the line indicates the 95%CI. All values lower than 0 indicate a significant 
difference in favour of the mindfulness group.  
 
Figure 5.  Forest plot showing the Intention-to-Treat Cohen’s D results of the effectiveness 
of the mindfulness intervention compared to usual care on the psychological outcomes. The 
width of the line indicates the 95%CI. All values lower than 0 indicate a significant 
difference in favour of the mindfulness group.  
 
Figure 6.  Forest plot showing the As-Treated Cohen’s D results of the effectiveness of the 
mindfulness intervention compared to usual care on the physiological outcomes. The width 
of the line indicates the 95%CI. All values lower than 0 indicate a significant difference in 
favour of the mindfulness group.  
 
 
Figure 7.  Forest plot showing the As-Treated Cohen’s D results of the effectiveness of the 
mindfulness intervention compared to usual care on the psychological outcomes. The width 
of the line indicates the 95%CI. All values lower than 0 indicate a significant difference in 
favour of the mindfulness group.  
 
Discussion 
To our knowledge, this is the first randomized trial to evaluate the effectiveness of 
mindfulness training in patients with heart disease. By taking physiological parameters as its 
main outcome parameter, it is also an innovative study. On the primary endpoint – exercise 
capacity – we found a borderline significant but clinically small effect in favor of 
mindfulness. Heart rate also decreased significantly more with mindfulness training. 
Remarkably, no significant improvements were found on subjective outcome measures, 
although anxiety and depressive symptoms did decrease. 
 
Limited exercise capacity is an important predictor for outcome for cardiac disease, and 
several studies have reported an association with survival.17,31-33 Since a decrease in physical 
performance is also an important predictor of adverse outcomes in patients with congenital 
heart disease, improving physical performance may be an important target of treatment. In 
recent years, cardiac rehabilitation programs, many of them conducted in patients with post -
myocardial infarction, have had good results on total and cardiovascular mortality.34,35 Our 
results indicate that mindfulness training could be part of future treatment modalities 
intended to improve physical performance in heart disease patients. It remains to be shown 
whether this will also affect long-term outcome. Several epidemiological studies in patients 
with hypertension, acute coronary syndromes36, stable coronary heart disease37 and heart 
failure38 have shown that resting heart rate is a risk factor for cardiovascular and all-cause 
mortality. These epidemiological results suggest that the beneficial effect of mindfulness on 
heart rate demonstrated in our study is clinically meaningful. 
 
To date, very few studies have evaluated mindfulness training in patients with cardiac 
disease. A pilot study that offered a brief mindfulness-based stress-reduction program to 
patients with, or at risk of, coronary artery disease16 showed significant but moderate 
reductions on two psychological outcomes, depression (Cohen’s d=0.54) and perceived 
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pressure and stress improved significantly, with small effect sizes ranging from D=0.19 to 
D=0.21 (Figure 6 and 7).  
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Figure 7.  Forest plot showing the As-Treated Cohen’s D results of the effectiveness of the 
mindfulness intervention compared to usual care on the psychological outcomes. The width 
of the line indicates the 95%CI. All values lower than 0 indicate a significant difference in 
favour of the mindfulness group.  
 
Discussion 
To our knowledge, this is the first randomized trial to evaluate the effectiveness of 
mindfulness training in patients with heart disease. By taking physiological parameters as its 
main outcome parameter, it is also an innovative study. On the primary endpoint – exercise 
capacity – we found a borderline significant but clinically small effect in favor of 
mindfulness. Heart rate also decreased significantly more with mindfulness training. 
Remarkably, no significant improvements were found on subjective outcome measures, 
although anxiety and depressive symptoms did decrease. 
 
Limited exercise capacity is an important predictor for outcome for cardiac disease, and 
several studies have reported an association with survival.17,31-33 Since a decrease in physical 
performance is also an important predictor of adverse outcomes in patients with congenital 
heart disease, improving physical performance may be an important target of treatment. In 
recent years, cardiac rehabilitation programs, many of them conducted in patients with post -
myocardial infarction, have had good results on total and cardiovascular mortality.34,35 Our 
results indicate that mindfulness training could be part of future treatment modalities 
intended to improve physical performance in heart disease patients. It remains to be shown 
whether this will also affect long-term outcome. Several epidemiological studies in patients 
with hypertension, acute coronary syndromes36, stable coronary heart disease37 and heart 
failure38 have shown that resting heart rate is a risk factor for cardiovascular and all-cause 
mortality. These epidemiological results suggest that the beneficial effect of mindfulness on 
heart rate demonstrated in our study is clinically meaningful. 
 
To date, very few studies have evaluated mindfulness training in patients with cardiac 
disease. A pilot study that offered a brief mindfulness-based stress-reduction program to 
patients with, or at risk of, coronary artery disease16 showed significant but moderate 
reductions on two psychological outcomes, depression (Cohen’s d=0.54) and perceived 
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stress (d=0.68). Unlike in our study, the participants were not randomized and the 
intervention was fairly short (4-weeks). Two reports of the same study population showed 
that mindfulness-based stress-reduction mainly improved anxiety, emotional control and 
coping, rather than resting-stress hormones or physical functioning.39,40 Recently, a brief 
group-MBSR intervention in patients undergoing a percutaneous coronary intervention 
showed favorable effects on quality of life.41 Additionally, anxiety, depression, and stress 
appeared to be influenced positively but only in the younger age group (<60 years).41 Lastly, 
an individual MBSR training in patients with coronary heart disease showed significant 
reductions in anxiety, depression, perceived stress and the physiological parameters BP and 
BMI.42 However, this study had limited power and was only performed in males. In contrast 
to previous reports, in our study psychological outcomes did not significantly improve by 
mindfulness training. Whereas in previous studies patients were often selected on the basis 
of reduced psychological well-being, in our study they were not. In fact, baseline 
psychological scores were similar to scores in the general population 43-47 implying that 
improvement was hardly possible (a ceiling effect). Also, our training was online without 
any personal contact, which probably resulted in smaller effects.  There is increased interest 
in the effect of acceptance and commitment therapy, which has similarities with mindfulness 
training, focusing on the relationship between persons’ own thoughts and feelings that could 
potentially have a positive effect on several modifiable CVD risk factors.48 
Similar to the ceiling effect for psychological outcomes, we observed a floor effect for blood 
pressure, as our patients had regular blood pressure monitoring and (extra) medication was 
given when necessary. Previous studies, some of which showed potential benefits on blood 
pressure, investigated populations whose blood pressures at baseline were higher than 
average.7,49 
 
Accumulating evidence suggests that mind and body do indeed show an interaction and that 
physiological changes are underlain by several neuro-humoral mechanisms. For example, in 
an extensive study of a framework in mind-body medicine, Benson and colleagues focused 
on the relaxation response as a core component in autonomic function and physical 
changes.50,51 It has been shown that, through emotions and thoughts, the autonomic nervous 
system is key in the brain-heart connection.52 By working through the autonomic nervous 
system, mind-body practices can also benefit endothelial, neuroendocrine and immune 
function.53-55 However, the mechanism between the mind and body is not merely 
unidirectional: several levels of the neuro-axis have been found to contribute to the “top-
down and bottom-up mechanisms” in mind-body practices.56  
 
To date, web-based mindfulness training studies have been limited to small studies on stress 
reduction. A study by Gluck et al.57 reported a trend towards lower levels of stress. Two 
other studies on online mindfulness training showed not only that it was feasible to conduct 
online mindfulness training, but also that it was effective in reducing stress.58,59 It is 
 
important to emphasize that their study populations consisted of mainly females recruited 
from the healthy general population, and in one, no randomization was performed.     
 
Limitations of the current study must be addressed. Our own study used neither a placebo 
nor a waiting list for the control group. We considered the placebo effect of the online 
training to be inherent to the active intervention: we evaluated the training and the control 
as they would be implemented in real-world practice and measured effectiveness rather than 
efficacy. We acknowledge that by doing so our study is pragmatic rather than explanatory. 
Our inclusion of the placebo effect as part of the mindfulness intervention compared with 
UC without placebo in the control group is further justified by the fact that no competing 
therapy exists. Every placebo online training similar to the intervention we could think of 
would likely have an unwanted beneficial effect in the control group.   
Another limitation is that only 80.6% (n=261) of the patients returned for follow-up. 
Reasons for trial discontinuation were not reported due to recommendations from the local 
ethics committee. A possible explanation for the follow-up rate is the fact that the 
intervention was not offered in a group-based setting. The impact of online training may be 
lower than that of personal or group training. While this would mean that the results of 
mindfulness therapy may therefore be even stronger in other settings, the easy accessibility 
of online training may have allowed better generalizability of the results, as patients could do 
the training in their own environment and fit it into a busy schedule. Although we 
monitored participants’ training activity, detailed adherence was difficult to assess and 
control for. Furthermore, ethical considerations prevented us from blinding patients to the 
nature of the intervention during the informed consent procedure and patients’ expectation 
of the interventions was not addressed. The control group was therefore aware that the 
online mindfulness training was available and that they were not receiving it. This could have 
led to selective follow-up but we found no significant difference between the groups at 
follow-up with regard to demographic and clinical variables. A placebo lifestyle intervention 
in the control group could underestimate the effectiveness of the active intervention 
compared to what can be expected in real-world practice. Thus, rather than comparing to a 
unrealistic placebo intervention, we considered the placebo effect as part-and-parcel of the 
procedure. In addition, we did not assess maintenance of blinding, but the inability to blind 
patients could have potentially led to unblinding of the investigators (outcome assessors), 
even though extensive precautions were made to limit this bias. 
 
Conclusions 
Online mindfulness training is feasible in patients with heart disease and shows a small 
positive effect on exercise capacity and heart rate. The current study found no significant 
effect on psychological outcomes.   
Processed on: 27-10-2016
504961-L-bw-Gotink
7
Online mindfulness in heart disease: 3 month results 149
 
stress (d=0.68). Unlike in our study, the participants were not randomized and the 
intervention was fairly short (4-weeks). Two reports of the same study population showed 
that mindfulness-based stress-reduction mainly improved anxiety, emotional control and 
coping, rather than resting-stress hormones or physical functioning.39,40 Recently, a brief 
group-MBSR intervention in patients undergoing a percutaneous coronary intervention 
showed favorable effects on quality of life.41 Additionally, anxiety, depression, and stress 
appeared to be influenced positively but only in the younger age group (<60 years).41 Lastly, 
an individual MBSR training in patients with coronary heart disease showed significant 
reductions in anxiety, depression, perceived stress and the physiological parameters BP and 
BMI.42 However, this study had limited power and was only performed in males. In contrast 
to previous reports, in our study psychological outcomes did not significantly improve by 
mindfulness training. Whereas in previous studies patients were often selected on the basis 
of reduced psychological well-being, in our study they were not. In fact, baseline 
psychological scores were similar to scores in the general population 43-47 implying that 
improvement was hardly possible (a ceiling effect). Also, our training was online without 
any personal contact, which probably resulted in smaller effects.  There is increased interest 
in the effect of acceptance and commitment therapy, which has similarities with mindfulness 
training, focusing on the relationship between persons’ own thoughts and feelings that could 
potentially have a positive effect on several modifiable CVD risk factors.48 
Similar to the ceiling effect for psychological outcomes, we observed a floor effect for blood 
pressure, as our patients had regular blood pressure monitoring and (extra) medication was 
given when necessary. Previous studies, some of which showed potential benefits on blood 
pressure, investigated populations whose blood pressures at baseline were higher than 
average.7,49 
 
Accumulating evidence suggests that mind and body do indeed show an interaction and that 
physiological changes are underlain by several neuro-humoral mechanisms. For example, in 
an extensive study of a framework in mind-body medicine, Benson and colleagues focused 
on the relaxation response as a core component in autonomic function and physical 
changes.50,51 It has been shown that, through emotions and thoughts, the autonomic nervous 
system is key in the brain-heart connection.52 By working through the autonomic nervous 
system, mind-body practices can also benefit endothelial, neuroendocrine and immune 
function.53-55 However, the mechanism between the mind and body is not merely 
unidirectional: several levels of the neuro-axis have been found to contribute to the “top-
down and bottom-up mechanisms” in mind-body practices.56  
 
To date, web-based mindfulness training studies have been limited to small studies on stress 
reduction. A study by Gluck et al.57 reported a trend towards lower levels of stress. Two 
other studies on online mindfulness training showed not only that it was feasible to conduct 
online mindfulness training, but also that it was effective in reducing stress.58,59 It is 
 
important to emphasize that their study populations consisted of mainly females recruited 
from the healthy general population, and in one, no randomization was performed.     
 
Limitations of the current study must be addressed. Our own study used neither a placebo 
nor a waiting list for the control group. We considered the placebo effect of the online 
training to be inherent to the active intervention: we evaluated the training and the control 
as they would be implemented in real-world practice and measured effectiveness rather than 
efficacy. We acknowledge that by doing so our study is pragmatic rather than explanatory. 
Our inclusion of the placebo effect as part of the mindfulness intervention compared with 
UC without placebo in the control group is further justified by the fact that no competing 
therapy exists. Every placebo online training similar to the intervention we could think of 
would likely have an unwanted beneficial effect in the control group.   
Another limitation is that only 80.6% (n=261) of the patients returned for follow-up. 
Reasons for trial discontinuation were not reported due to recommendations from the local 
ethics committee. A possible explanation for the follow-up rate is the fact that the 
intervention was not offered in a group-based setting. The impact of online training may be 
lower than that of personal or group training. While this would mean that the results of 
mindfulness therapy may therefore be even stronger in other settings, the easy accessibility 
of online training may have allowed better generalizability of the results, as patients could do 
the training in their own environment and fit it into a busy schedule. Although we 
monitored participants’ training activity, detailed adherence was difficult to assess and 
control for. Furthermore, ethical considerations prevented us from blinding patients to the 
nature of the intervention during the informed consent procedure and patients’ expectation 
of the interventions was not addressed. The control group was therefore aware that the 
online mindfulness training was available and that they were not receiving it. This could have 
led to selective follow-up but we found no significant difference between the groups at 
follow-up with regard to demographic and clinical variables. A placebo lifestyle intervention 
in the control group could underestimate the effectiveness of the active intervention 
compared to what can be expected in real-world practice. Thus, rather than comparing to a 
unrealistic placebo intervention, we considered the placebo effect as part-and-parcel of the 
procedure. In addition, we did not assess maintenance of blinding, but the inability to blind 
patients could have potentially led to unblinding of the investigators (outcome assessors), 
even though extensive precautions were made to limit this bias. 
 
Conclusions 
Online mindfulness training is feasible in patients with heart disease and shows a small 
positive effect on exercise capacity and heart rate. The current study found no significant 
effect on psychological outcomes.   
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Abstract 
 
Objective: There is increasing evidence that mindfulness can reduce stress, and thereby 
affect other psychological and physiological outcomes as well. In patients with heart disease, 
we evaluated the effect of an online modified mindfulness based stress reduction tra ining at 
12-month follow-up.  
Methods: 324 patients (mean age 43.2 years, 53.7% male) were randomized in a 2:1 ratio 
to additional 3-month online mindfulness training or to usual care (UC) alone. The primary 
outcome was exercise capacity measured with the 6 minute walk test (6MWT). Secondary 
outcomes were blood pressure, heart rate, respiratory rate, NT-proBNP, cortisol levels 
(scalp hair sample), mental and physical functioning (SF-36), anxiety and depression 
(HADS), perceived stress (PSS), and social support (PSSS12). Differences between groups 
on the repeated outcome measures were analyzed with linear mixed models.  
Results: At 12-months follow-up, participants showed a beneficial but not significant effect 
on exercise capacity (6MWT: 17.9 meters, p=0.055) compared to UC. Cohen’s D showed 
small but significant improvement on the 6MWT (d=0.22, 95%CI 0.05 to 0.39), systolic 
blood pressure (d=0.19, 95%CI 0.03 to 0.36), mental functioning (d=0.22, 95%CI 0.05 to 
0.38) and depressive symptomatology (d=0.18, 95%CI 0.02 to 0.35). All other outcome 
measures did not change statistically significant. In the as-treated analysis, systolic blood 
pressure decreased significantly with 5.5 mmHg (p=0.045; d=0.23 (95%CI 0.05-0.41)). 
Conclusion: Online mindfulness training shows favorable albeit small long-term effects on 
exercise capacity, systolic blood pressure, mental functioning, and depressive 
symptomatology in patients with heart disease and might therefore be a beneficial addition to 
current clinical care.  
 
Introduction 
In recent decades, Mindfulness-Based Stress Reduction (MBSR) has grown to be a well-
known adjunct intervention in Western healthcare with reproducible significant 
psychological improvements in multiple patient populations regarding depressive 
symptomatology, anxiety, stress, and quality of life 1. Mindfulness is described as ‘the 
capacity to observe with open and non-judgmental awareness towards all experiences within 
the present moment’ 2. Techniques taught as part of the eight-week MBSR training, mainly 
meditation, yoga and cognitive reappraisal, teach participants to be more present in the here 
and now and to be more aware of bodily sensations and internal psychological processes, 
which can increase the ability to recognize stress symptoms at an early stage. Stress from the 
mindfulness perspective refers to the tension that arises when we have negative experiences 
that we do not want 3: MBSR teaches acceptance of negative emotions or thoughts as passing 
experiences and thereby reducing the stress associated with them 4. People with chronic 
conditions are prone to having negative thoughts and feelings they do not want (depression 
and anxiety comorbidity is high 5, 6) and MBSR has been found to positively affect 
psychological outcomes in patients with chronic pain, obesity, hypertension, depression, 
anxiety and cardiovascular disease 7-11. Over one million people in the Netherlands suffer 
from cardiovascular disease, and each year 100.000 get diagnosed. Healthcare costs are eight 
billion euro; 9.2% of total healthcare costs 12. Cardiovascular disease is affected by stress: 
high perceived stress is associated with a risk ratio of 1.27 for incident coronary heart disease 
13, presence of psychosocial stressors is associated with increased risk of acute myocardial 
infarction 14 and it negatively affects heart rate, blood pressure and inflammatory factors 15. 
Low and variable heart rate and low blood pressure are associated with long-term survival 
and according to the ESC Guidelines cardiovascular patients are recommended to reduce 
stress in order to favorably affect these risk factors 16. Often preventive medical therapy is 
prescribed, but this may have side-effects and be costly. In previous studies on cardiovascular 
patients, MBSR was found to improve heart rate, breathing patterns and blood pressure 17, 18. 
These factors have been related to exercise capacity: lower blood pressure and heart rate are 
directly related to exercise capacity 19-21 and a walking distance of <300 meters on the six 
minute walking test is a prognostic marker of subsequent cardiac death in patients with mild 
to moderate congestive heart failure 22. The aim of this study was to investigate the long-
term effects of an online mindfulness training on exercise capacity in patients with heart 
disease in a randomized controlled trial. In 3-month post-intervention follow-up, 
participants had a higher mean distance on the 6-minute walk test, however this was small 
and not statistically significant (13.4 metres, p=0.050) 23. The rationale of this study is that 
in reducing stress, mindfulness therapy might influence heart rate, breathing patterns and 
blood pressure. These physiological effects may in turn improve exercise capacity and thus 
long-term outcome in cardiovascular patients 24. 
 
Processed on: 27-10-2016
504961-L-bw-Gotink
8
Online mindfulness in heart disease: 12 month results 155
 
Abstract 
 
Objective: There is increasing evidence that mindfulness can reduce stress, and thereby 
affect other psychological and physiological outcomes as well. In patients with heart disease, 
we evaluated the effect of an online modified mindfulness based stress reduction tra ining at 
12-month follow-up.  
Methods: 324 patients (mean age 43.2 years, 53.7% male) were randomized in a 2:1 ratio 
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(scalp hair sample), mental and physical functioning (SF-36), anxiety and depression 
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small but significant improvement on the 6MWT (d=0.22, 95%CI 0.05 to 0.39), systolic 
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Introduction 
In recent decades, Mindfulness-Based Stress Reduction (MBSR) has grown to be a well-
known adjunct intervention in Western healthcare with reproducible significant 
psychological improvements in multiple patient populations regarding depressive 
symptomatology, anxiety, stress, and quality of life 1. Mindfulness is described as ‘the 
capacity to observe with open and non-judgmental awareness towards all experiences within 
the present moment’ 2. Techniques taught as part of the eight-week MBSR training, mainly 
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and now and to be more aware of bodily sensations and internal psychological processes, 
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mindfulness perspective refers to the tension that arises when we have negative experiences 
that we do not want 3: MBSR teaches acceptance of negative emotions or thoughts as passing 
experiences and thereby reducing the stress associated with them 4. People with chronic 
conditions are prone to having negative thoughts and feelings they do not want (depression 
and anxiety comorbidity is high 5, 6) and MBSR has been found to positively affect 
psychological outcomes in patients with chronic pain, obesity, hypertension, depression, 
anxiety and cardiovascular disease 7-11. Over one million people in the Netherlands suffer 
from cardiovascular disease, and each year 100.000 get diagnosed. Healthcare costs are eight 
billion euro; 9.2% of total healthcare costs 12. Cardiovascular disease is affected by stress: 
high perceived stress is associated with a risk ratio of 1.27 for incident coronary heart disease 
13, presence of psychosocial stressors is associated with increased risk of acute myocardial 
infarction 14 and it negatively affects heart rate, blood pressure and inflammatory factors 15. 
Low and variable heart rate and low blood pressure are associated with long-term survival 
and according to the ESC Guidelines cardiovascular patients are recommended to reduce 
stress in order to favorably affect these risk factors 16. Often preventive medical therapy is 
prescribed, but this may have side-effects and be costly. In previous studies on cardiovascular 
patients, MBSR was found to improve heart rate, breathing patterns and blood pressure 17, 18. 
These factors have been related to exercise capacity: lower blood pressure and heart rate are 
directly related to exercise capacity 19-21 and a walking distance of <300 meters on the six 
minute walking test is a prognostic marker of subsequent cardiac death in patients with mild 
to moderate congestive heart failure 22. The aim of this study was to investigate the long-
term effects of an online mindfulness training on exercise capacity in patients with heart 
disease in a randomized controlled trial. In 3-month post-intervention follow-up, 
participants had a higher mean distance on the 6-minute walk test, however this was small 
and not statistically significant (13.4 metres, p=0.050) 23. The rationale of this study is that 
in reducing stress, mindfulness therapy might influence heart rate, breathing patterns and 
blood pressure. These physiological effects may in turn improve exercise capacity and thus 
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Methods 
Study design 
The current study reports the results of the 12-month follow-up of a single blinded, 
pragmatic RCT performed at the outpatient cardiology clinic of the Erasmus MC, 
Rotterdam, the Netherlands. Detailed description of design and methodology, and 3-month 
results have been reported elsewhere 23. Ethical approval was obtained from the Medical 
Ethics Committee of the Erasmus Medical Center and the study complies with the 
Declaration of Helsinki. The study was registered with the Dutch trial registry, NTR3453, 
http://www.trialregister.nl. 
 
Participants 
Adult patients, between 18 and 65 years of age, with existing diagnosed heart disease 
(ischemic, valvular, congenital heart disease, or cardiomyopathy) were approached between 
June 2012 and April 2014 during their scheduled yearly visit at the outpatient clinic. Patients 
were excluded when there was: (1) a planned operation or percutaneous intervention within 
the upcoming year; (2) inability to understand, read, or write Dutch; (3) no internet access, 
email, or cell phone. After written informed consent was obtained and baseline 
measurements were performed, patients were randomized according to a 2:1 ratio to the 
intervention or control group via dedicated computer software (ALEA®) with a block size 
of 12 25. The result of the randomization was sent to an employee not involved in outcome 
assessment, who contacted the participants about their allocation, to ensure outcome 
assessors were blinded. 
 
Intervention 
The mindfulness training consisted of a 12-week structured online program (see Appendix 
Table 1), which was offered in addition to usual care (UC) as provided by the treating 
cardiologist. Participants also received a book about mindfulness by a renowned author to 
support the 12-week training 26. The intervention started as soon as patients logged in on the 
mindfulness training website, to which they gained access the day of the inclusion. Online 
delivery of the training was chosen for pragmatic reasons: the training was designed to be 
self-directed, easily accessible and engaging to a wide audience by keeping practice sessions 
and lessons short, usually ten to fifteen minutes per exercise. The program teaches different 
meditations, self-reflection, and yoga exercises. Furthermore, it includes practical 
assignments and suggestions for mindfulness in daily life. The use of the breath as a reminder 
for present moment awareness is emphasized in all meditations. During the course 
participants also received biweekly reminders by e-mail and standardized text messages. 
After the 12-week online intervention, these reminders continued until the 12 month 
follow-up. Adherence was monitored by whether the questions of the online program were 
completed, without disclosing the content of the answers. The control group received UC 
 
by their treating cardiologist. We considered any partial placebo effect an integral part of the 
active intervention as it would be when implemented in day-to-day practice. 
 
Outcome measures 
Please see for details the publication on short-term outcomes 23. Outcomes were measured 
in all patients at baseline, post-intervention (3 months), and 9 months after the intervention 
was completed (12 months). Blinding of patients was not possible due to the nature of the 
intervention, but the outcome assessors were unaware of patients’ treatment allocation, and  
patients were instructed not to disclose their treatment allocation to the study investigators 
nor to their cardiologist.  
To measure exercise capacity, the 6 Minute Walking Test (6MWT) was chosen as primary 
outcome measure, performed in a quiet corridor of the outpatient clinic 27. Patients were 
instructed to walk the greatest distance they could in 6 minutes. Secondary outcome 
measures were physical parameters (blood pressure, respiratory rate, and heart rate), blood 
sampling laboratory test (N-terminal pro-brain natriuretic peptide (NT-proBNP) measured 
from peripheral venous blood samples), and hair cortisol as a biomarker of stress using 
ELISA as previously described28. Details on lab procedures can be found in Younge et al. 21. 
To assess psychological functioning, we measured quality of life (using the Short-Form 
Health survey 36 29 and a Visual Analogue Scale ranging from 0 to 100 30), anxiety and 
depression (Hospital Anxiety and Depression scale 31), perceived stress (Perceived Stress 
Scale 32) and social support (Perceived Social Support Scale (PSSS12)33). The use of other 
complementary care was monitored with a questionnaire (type, frequency, and intensity).  
 
Quality control and statistical analyses 
An independent audit was performed and the study was found to comply with Good Clinical 
Practice and Scientific Integrity standards. To demonstrate an improvement of 5% in the 
intervention group vs 1% in the control group on the 6MWT, this study required at least 99 
patients in the control group and 198 in the intervention group (SD10%, alpha=0.05, 
power=0.90, ratio experimental to controls=2). A detailed sample size calculation can be 
found in Younge, 2015 23. 
Changes in outcomes at 12 months were compared with baseline and between treatment 
groups. An intention-to-treat (ITT) analysis was performed to address whether offering a 
mindfulness training was effective compared to UC. An as-treated (AT) analysis was 
performed to address whether the mindfulness training was beneficial if actually performed. 
In the AT analysis, patients were considered adherent if they completed 50% or more of the 
exercises. Patients allocated to the UC group who sought mindfulness training on their own 
initiative were excluded from the AT analysis.  
Linear mixed models were used to determine intergroup effects and to simultaneously 
account for the correlation between the repeated measurements of each patient and for 
dropouts. Time effect and its interaction with treatment were included as a categorical 
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variable, while the covariance matrix was assumed unstructured. The F-test was used to test 
treatment effect. In order to compare effect sizes, Cohen’s d was calculated based on the 
linear mixed model results. Finally, we performed log linear regression analyses to see 
which participants were most likely to adhere to the training, and if adherent, what 
characteristics predicted the most benefit from the training. P<0.05 was considered to be 
indicative of statistical significance. All data were analyzed with SPSS version 21.0 34. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of mindfulness intervention group and control group 
  
 
Results 
 
Patient characteristics 
Figure 1 displays the flowchart of the patients’ recruitment and follow-up. A total of 324 
patients were included and successfully randomized over the two treatment arms. Of the 
initial study population, 245 participants returned for long-term follow-up (75.6%), and 
224 participants were present at all three measurement moments.  
Table 1 shows participants’ baseline characteristics. No significant differences were found 
between the groups at follow-up with regard to demographic and clinical variables, and this 
percentage of follow-up still gives us sufficient power and the assumptions of our statistical 
tests were met. No major side effects were reported during the follow-up period. 
 
Table 1. Baseline characteristics of study participants 
 Mindfulness 
Group 
N=215 
Control 
Group 
N=109 
Demographics   
   Age (years), mean (SD) 43.2 (14.1) 43.2 (13.7) 
   Female (%) 44.2 50.5 
   Employed (%) 68.7 67.9 
   Body mass index (kg/m²), mean (SD)  25.9 (4.6) 25.7 (4.7) 
   
Cardiac history   
  Type of heart disease, (%)   
 Congenital heart disease 41.9 42.2 
 Cardiomyopathy 39.5 29.4 
 Valvular heart disease 18.6 28.4 
Number of interventions* mean (SD) 1.4 (1.4) 1.4 (1.2) 
Time since first intervention (years) mean (SD) 19.1 (14.0) 15.9 (11.7) 
Implantable cardioverter-defibrillator (%) 5.9 4.3 
Pacemaker (%) 9.3 5.2 
   
Intoxication, (%)   
 Current smoking 14.4 18.3 
 Current alcohol use 62.1 55.0 
 Current drugs use 3.3 2.8 
   
Prior use of complementary therapies** (%) 14.4 12.8 
* Includes both surgical and percutaneous interventions 
** Includes yoga, meditation, mindfulness, Tai Chi, Qigong and acupuncture 
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Outcome analysis 
In the ITT analyses, the mindfulness group showed an improvement of 17.9 meters on their 
mean 6MWT at 12 months compared to UC, which was not statistically significant 
(p=0.055) (Table 2). Heart rate, systolic and diastolic blood pressure, and hair cortisol level 
decreased over time, but not significantly different from UC. NT-proBNP did not change 
significantly. Analyses on psychological outcomes showed no significant differences between 
the groups Anxiety, depression and stress levels decreased stronger in the mindfulness group 
than in UC, but not statistically significantly. In the AT analyses, 205 participants (63.3%) 
were adherent to their allocated group: in the intervention group 49.8% (N=107) 
completed at least 50% of the training, and in the control group 89.9% (N=98) performed 
no mind-body practice. Systolic blood pressure decreased significantly with 5.5 mmHg (p = 
0.045) compared to UC. The other outcomes were similar to the ITT analysis.  
 
 
Figure 4. Plot showing Linear Mixed Models results: the mean distance walked in meters 
by the Intervention group (red) and the Control group (blue) at each of the three 
measurement moments.  
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Standardized Effect Size 
Cohen’s D calculation of outcome measures resulted in small but significant differences on 
the 6MWT (d=0.22, 95%CI 0.05 to 0.39), systolic blood pressure (d=0.19, 95%CI 0.03 to 
0.36), mental functioning (d=0.22, 95%CI 0.05 to 0.38) and depression (d=0.18, 95%CI 
0.02 to 0.35) compared to UC. All other outcomes showed no significant differences 
(Figure 2). Similar though smaller effects were found in the as-treated analyses (Figure 3). 
 
Effect of compliance 
Regression modelling of adherence showed that women (β=0.86, p=0.045), and with a 
higher diastolic blood pressure (β=0.04 mmHg, p=0.031) are more often compliant (Table 
3). However, when compliant to the online training, men (β=-23.1, p=0.015) with a lower 
BMI (β=-2.1 kg/m, p=0.048) improve more on the 6MWT (Table 4). Also having higher 
stress levels (PSS β=2.6, p=0.007) and experiencing little mental hindrances (MCS β=1.7, 
p=0.011) are associated with a better effect of the training on the 6MWT. 
 
Table 3. Regression model of training adherence (N=215) 
 β  SE Standard. B p-value 
Intercept -5.34 1.6  0.001 
Gender 0.86 0.43 0.13 0.045 
Age 0.03 0.02 0.16 0.084 
Diastolic Blood Pressure 0.04 0.02 0.15 0.031 
Effect of variables on LN(adherence%/1-adherence%), range -5 to 5.  
 
Table 4. Regression model of improvement on 6MWT when adherent (N=107). 
 β  SE Standard. B p-value 
Intercept -71.0 48.9  0.151 
Gender -23.1 9.3 -0.28 0.015 
BMI -2.1 1.0 -0.23 0.048 
Perceived stress 2.6 0.9 2.77 0.007 
Mental QoL 1.7 0.6 0.46 0.011 
Effect of variables on Delta6MWT. 
 
 
  
 
Discussion 
To our knowledge, this is the first randomized trial to evaluate the long-term effectiveness 
of an online mindfulness training on physical fitness in patients with heart disease. Our 
rationale was that by improving stress-related cardiovascular risk factors, mindfulness could 
improve physical functioning in these patients. On the primary endpoint we found that the 
original improvement of 13.4 meters (p=0.050) measured directly after the online training 
was extended to 17.9 meters (p=0.055) in favor of the mindfulness group (Figure 4). 
Although this implies potential long-term improvement on participants’ exercise capacity, 
the demonstrated effect was small. In patients with chronic lung disease, clinically 
meaningful differences on the 6MWT of 35-54 meters have been reported 35, 36.  
 
As our sample size was sufficient and the randomization procedure succeeded, our lack of 
convincing results could be because in our aim to construct a pragmatic and easy-accessible 
training, the working components of the MBSR protocol were cut too short. The online 
training was low in intensity and our hypothesis concerned an indirect effect of a 
psychological intervention on physical fitness. Regarding the level of statistical significance, a 
slight increase in intensity could improve results. A full MBSR RCT in 30 male coronary 
heart patients found significant improvements in anxiety, depression and systolic blood 
pressure 37, although their baseline levels were higher than ours. In our study, psychological 
improvements were not found, which could be because these patients’ baseline psychological 
scores were similar to scores in the general population 38-42. The possible improvement on 
stress, anxiety and depression symptoms was thereby diminished by a ceiling effect. 
Similarly, our participants’ blood pressure was monitored regularly by the outpatient clinic 
and medication was given if necessary, resulting in fairly normal baseline values and little 
room for improvement. Other studies showing effects on either psychological symptoms or 
on blood pressure, investigated populations whose values at baseline were higher than 
average 17, 43. Three other studies on web-based mindfulness training showed that it is 
feasible to conduct online mindfulness training, and also that it was effective in reducing 
stress 44 45, 46. Due to limited power for sub-group analyses, we have to be careful drawing 
firm conclusions, but results indicate that although older women with a higher diastolic 
blood pressure are generally more compliant to this type of intervention, they appear to 
benefit less. Possibly this could be taken into account as well in intensifying the future online 
program. 
 
Using Cohen’s D, four outcomes came out statistically significant, where the initial mixed 
model results did not, due to the different distributions that these analyses use: mixed 
models is based on a T-distribution, whereas Cohen’s D uses a Z-distribution. Using 
different calculation methods for Cohen’s D 47-50 resulted in similar findings. This shows how 
choice of statistical method can make a difference in conclusions, especially when p-values 
are close to the significance level. While 17.9 meters with a d=0.22 is a  small effect, it still 
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Standardized Effect Size 
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gives an indication of potential long-term health benefit for patients with heart disease by 
using mindfulness.  
 
There are several limitations to take into account. Our control group received neither a 
placebo nor a waiting list period. A placebo effect of the online training was in our view part 
of the active intervention as it would be when implemented in real-world practice. By doing 
so this study is pragmatic rather than explanatory implying that we evaluated effectiveness 
rather than efficacy. Second, the training was expected to have less effect than MBSR due to 
its lower intensity, but it also lacked other aspects: there was no social interaction nor any 
form of feedback. As there was no social control, it was completely left to participants 
whether they practiced or not. This can lead to less motivation and lower adherence than a 
training with teacher and other group members. The current online training may therefore 
have been too ‘light’ and too far withdrawn from the origina l MBSR. While this would mean 
that MBSR may have stronger effects, the accessibility of online training possibly allows 
better generalizability of the results, as patients can do the training in their own environment 
and fit it into their schedule. A middle way would therefore be ideal: an easily accessible 
online training, but with more content and feedback from a trainer. Third, although we 
monitored participants’ online activity, it was difficult to assess detailed adherence. 
Additionally, the control group was aware that they were not receiving the online 
mindfulness training. Finally, we did not measure mindfulness skills, so we cannot confirm 
that changes are correlated with improvement of mindfulness skills. Although the only 
difference between the randomized groups was the online training, it would add 
confirmation if future studies also include this outcome. 
 
Conclusions 
Online mindfulness training shows promising long-term effects on exercise capacity in 
patients with heart disease, but further research is necessary.  
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Appendix Table 1. Content of the standardized 8-week MBSR protocol compared to the online 
training ‘Mindfulness for a healthier heart’. 
Week MBSR Online training 
1 Automatic pilot Do you really feel alive 
 - Introduction to mindfulness 
- Raisin exercise 
- 40 minutes Bodyscan 
- Working of the breath 
- Automatic pilot 
- Introduction film Edel Maex 
- Likert-scale ‘really living’ 
- Exercise focused attention, 
watch your computer  
- 15 minutes Bodyscan 
- Observing pictures 
- What deserves more 
attention in your life? 
Home-
work 
- Daily 40 min Bodyscan 
- Daily mindful eating 
- 3x a day aware breathing 
- Daily journal keeping 
- Puzzle 
- Weekly 15 min Bodyscan  
2 Supporting factors Hear what people say, avoid 
the automatic pilot  
 - 40 min Bodyscan 
- 8 supporting factors 
- Plan your practices 
- Pain, disease and attention 
- Thoughts, feelings and bodily 
sensations 
- Adjust questioning and 
listening behavior  
- Short film on living separated 
from your surroundings 
- List of daily activities 
performed on automatic pilot 
Home-
work 
- Daily 40 min Bodyscan 
- Daily 10 min. Sitting meditation 
- Daily routine-activity 
- Calendar of pleasant events 
- 3x per day 3-minutes breathing space 
- Execute 3 automatic activities 
with mindfulness 
3 Bodily experiences Learn to meditate 
 - 25 min sitting meditation 
- 45 min Yoga 
- Boundaries of the body 
- Movement with health issues 
- Short film Edel Maex  
- 15 min sitting meditation 
- Planning sitting meditation 
- Remember what deserves 
more attention? 
Home-
work 
- Daily Bodyscan or Yoga (40 min) 
- Daily 15 min attention training 
- Calendar of unpleasant events  
- Noticing the automatic pilot  
- Daily 15 min sitting 
meditation 
4 Stress Dealing with stress 
 - 40 min sitting meditation 
- 25 min Yoga 
- Stress reaction and symptoms 
- Reaction on unpleasant events  
- Resistance or avoidance 
- Short film stress reaction  
- 3-minute breathing space 
- Description of current day 
 
- Stress aware responding 
- 3-minute breathing space 
Home-
work 
- Daily Bodyscan or Yoga (40 min) 
- Daily 20 min sitting meditation 
- Calendar of stressful events  
- 3x per day 3-minute breathing space 
 
5 Habits and change Learn to stop aware 
 - 40 min sitting meditation 
- Habits and patterns 
- Our self-healing abilities 
- Change begins with awareness 
- 10 min walking meditation 
- Inventory stopping with current 
activity 
- Short film with quotes 
- Short film about death  
Home-
work 
- Daily sitting meditation or Yoga (40 
min) 
- 3x per day 3-minute breathing 
space  
- Calendar of stressful conversations  
- Daily activity with awareness 
- 3x per day 20 minutes stopping 
current activity; with awareness 
6 Thoughts and senses  You are not your thoughts  
 - 40 min sitting meditation 
- Approach without judgment 
- Experience the senses 
- 20 min walking meditation 
- Thoughts are not facts, you are 
not your thoughts  
- Difficult memories 
- Being compassionate  
Home-
work 
- Daily 40 min sitting meditation, Yoga 
or Bodyscan 
- Integrating mindfulness in 
conversations  
- Noticing sensory experiences 
- Noticing the automatic pilot 
 
7 Feelings The art of living consciously  
 - 40 min sitting meditation 
- Present in the place you are 
- The 4 quadrants 
- The continuüm of anger 
- Intention to give more love to 
… 
- Attention to 
seasons/environment  
Home-
work 
- Daily meditation without CD 
- Noticing sensory experiences 
- Evaluation of the training 
 
8 And now onwards… Mindfulness for the rest of 
your life 
 - 40 min sitting meditation 
- Planning meditation after training 
- Living with attention 
- Formulating goals: 
o 3 short term 
o 3 long term 
- Likert-scale feeling of being 
really alive 
- Evaluation of what you have 
learned 
- Short film of laughing people 
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 - 40 min sitting meditation 
- Planning meditation after training 
- Living with attention 
- Formulating goals: 
o 3 short term 
o 3 long term 
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Follow-up online training ‘Mindfulness for a healthier heart’ 
Phase 2  
Four 
weeks 
continuing 
training 
Week 9 Staying Mindful  
 6-minute meditation practice  
Planning mindfulness  
Week 10 Rewrite your personal book of laws 
 What rules do you impose on yourself? 
Which rules do you really have to adhere to?  
What do you allow yourself to do? 
Week 11 Mindful eating 
 Short film about eating in between daily chores 
Assignment eating breakfast, lunch and dinner mindfully 
Note your experiences 
Week 12 Yoga for your heart 
 Yoga 30 minutes (film) 
Likert-scale experiences 
Planning Yoga into your schedule 
Phase 3 
Reminders 
every two 
weeks  
Week 14 Rediscover your body 
 Go back to week 1  
3 websites with more meditation information  
Week 16 Really listening 
 Go back to week 2 
Week 18 Stopping consciously 
 Go back to week 5, 4 websites with group training information  
Week 20 Learning to meditate again 
 Go back to week 3, 8 book titles about mindfulness 
Week 22 Planning Meditation 
 Go back to week 3, 3 CD tips with guided meditations 
Week 24 Feeling alive 
 5 likert scales 
Phase 4  
Monthly 
reminders 
 
Week 28 How do you deal with stress now? 
 Reflection on stressful situations and reactions, what would be a 
mindful reaction? 
Week 32 Dealing with difficult thoughts 
 Reminder: when ruminating, consider facts 
Week 37 Remember what you wanted to give more love? 
 3 things you can do with love 
Week 42 A beautiful quote 
 Reflection on Kabat-Zinn’s quote ‘human beings vs human 
doings’ 
Week 46 Extra attention 
 Choose an activity to do more aware this week 
Week 51 The feeling that you are alive 
 5 Likert scales 
Apps to continue practice 
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Abstract 
 
The aim of this study was to explore the feasibility and effectiveness of mindful walking in 
nature as a possible means to maintain mindfulness skills after a Mindfulness Based Cognitive 
Therapy (MBCT) or Mindfulness Based Stress Reduction (MBSR) course. Mindful walking 
alongside the river Rhine took place for 1, 3, 6 or 10 days, with a control period of a similar 
number of days, one week before the mindful walking period. In 29 mindfulness 
participants, Experience Sampling Method (ESM) was performed during the control and 
mindful walking period. Smartphones offered items on positive and negative affect and state 
mindfulness at random times during the day. Furthermore, self-report questionnaires were 
administered before and after the control and mindful walking period, assessing depression, 
anxiety, stress, brooding, and mindfulness skills. ESM data showed that walking resulted in a 
significant improvement of both mindfulness and positive affect, and that state mindfulness 
and positive affect prospectively enhanced each other in an upward spiral. The opposite 
pattern was observed with state mindfulness and negative affect, where increased state 
mindfulness predicted less negative affect. Exploratory questionnaire data indicated 
corresponding results, though not-significant due to the small sample size. This is the first 
time that ESM was used to assess interactions between state mindfulness and momentary 
affect during a mindfulness intervention of several consecutive days, showing an upward 
spiral effect. Mindful walking in nature may be an effective way to maintain mindfulness 
practice and further improve psychological functioning. 
  
 
Introduction 
The psychological effects of the eight weeks Mindfulness Based Stress Reduction (MBSR) and 
Mindfulness Based Cognitive Therapy (MBCT) are getting increased attention in scientific 
research, with mindfulness techniques being recommended as valuable strategies to relate to 
negative thoughts and emotions. Mindfulness training aims to make participants more aware 
of their automatic reactions on a behavioral, emotional and cognitive level, by encouraging 
them to engage in daily meditation practices. Non-judgmental observing of emotions or 
thoughts present in the here and now enables participant to react in a calm and ‘wise’ 
manner in stressful situations 1. Mindfulness has been shown to lead to improvements in 
depression, anxiety, stress and quality of life in a variety of clinical populations as well as 
healthy participants 2.  
Although studies directly examining the necessity of ongoing practice are lacking, 
mindfulness participants are recommended to maintain mindfulness practice in order to 
maximize and sustain benefits. As many find it difficult to do this on their own, many 
mindfulness centers offer reunion meetings or silent days. Attendees have reported to 
experience these as a booster reminding them of their mindfulness practices and as a 
sanctuary where these practices are further nurtured 3. So, it might be valuable to offer other 
easily accessible means to former participants of MBCT or MBSR courses to help 
maintaining their mindfulness practice.  
One possibility that is available to many people is mindful walking. During the MBCT and 
MBSR training, participants are asked to pay attention to their senses (i.e. sight, hearing, 
smelling, tasting, bodily sensations), emotions, thoughts, and automatic behavioral patterns. 
They are encouraged to experiment with letting go of automatic behaviors (i.e. high 
demands, hurrying) and with approaching difficult emotions or situations (i.e. annoyance, 
sadness). During the training, participants get introduced to mindful walking, which has 
been described as ‘meditation in motion’. Mindful walking uses the everyday activity of 
walking as a mindfulness practice to become more aware of bodily sensations. The physical 
sensation of walking enables people to feel more ‘grounded’ in the present moment 4. When 
people’s minds are occupied or stressed, paying attention to their physical movements can 
be an easy way to become more mindful.  
Walking does not require expensive gear or tools, and it can usually be integrated into a 
person’s schedule without too many difficulties. Mindfulness and walking share similar 
experiences. Both require paying attention to bodily sensations and other sensory input like 
sights, sounds or smells. In addition to the intrinsic link between mindfulness and walking, 
physical exercise in itself has a positive influence on psychological functioning and can reduce 
depressive symptoms 5-7. A recent meta-analysis in the UK shows that outdoor walking can 
lead to lower blood pressure, resting heart rate, body fat, body mass index, total cholesterol 
and depression, and increased VO2max and physical functioning 8. Other studies on 
environment and mental health have shown the benefits of walking in nature 9-12. In 
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Abstract 
 
The aim of this study was to explore the feasibility and effectiveness of mindful walking in 
nature as a possible means to maintain mindfulness skills after a Mindfulness Based Cognitive 
Therapy (MBCT) or Mindfulness Based Stress Reduction (MBSR) course. Mindful walking 
alongside the river Rhine took place for 1, 3, 6 or 10 days, with a control period of a similar 
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participants, Experience Sampling Method (ESM) was performed during the control and 
mindful walking period. Smartphones offered items on positive and negative affect and state 
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mindfulness predicted less negative affect. Exploratory questionnaire data indicated 
corresponding results, though not-significant due to the small sample size. This is the first 
time that ESM was used to assess interactions between state mindfulness and momentary 
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practice and further improve psychological functioning. 
  
 
Introduction 
The psychological effects of the eight weeks Mindfulness Based Stress Reduction (MBSR) and 
Mindfulness Based Cognitive Therapy (MBCT) are getting increased attention in scientific 
research, with mindfulness techniques being recommended as valuable strategies to relate to 
negative thoughts and emotions. Mindfulness training aims to make participants more aware 
of their automatic reactions on a behavioral, emotional and cognitive level, by encouraging 
them to engage in daily meditation practices. Non-judgmental observing of emotions or 
thoughts present in the here and now enables participant to react in a calm and ‘wise’ 
manner in stressful situations 1. Mindfulness has been shown to lead to improvements in 
depression, anxiety, stress and quality of life in a variety of clinical populations as well as 
healthy participants 2.  
Although studies directly examining the necessity of ongoing practice are lacking, 
mindfulness participants are recommended to maintain mindfulness practice in order to 
maximize and sustain benefits. As many find it difficult to do this on their own, many 
mindfulness centers offer reunion meetings or silent days. Attendees have reported to 
experience these as a booster reminding them of their mindfulness practices and as a 
sanctuary where these practices are further nurtured 3. So, it might be valuable to offer other 
easily accessible means to former participants of MBCT or MBSR courses to help 
maintaining their mindfulness practice.  
One possibility that is available to many people is mindful walking. During the MBCT and 
MBSR training, participants are asked to pay attention to their senses (i.e. sight, hearing, 
smelling, tasting, bodily sensations), emotions, thoughts, and automatic behavioral patterns. 
They are encouraged to experiment with letting go of automatic behaviors (i.e. high 
demands, hurrying) and with approaching difficult emotions or situations (i.e. annoyance, 
sadness). During the training, participants get introduced to mindful walking, which has 
been described as ‘meditation in motion’. Mindful walking uses the everyday activity of 
walking as a mindfulness practice to become more aware of bodily sensations. The physical 
sensation of walking enables people to feel more ‘grounded’ in the present moment 4. When 
people’s minds are occupied or stressed, paying attention to their physical movements can 
be an easy way to become more mindful.  
Walking does not require expensive gear or tools, and it can usually be integrated into a 
person’s schedule without too many difficulties. Mindfulness and walking share similar 
experiences. Both require paying attention to bodily sensations and other sensory input like 
sights, sounds or smells. In addition to the intrinsic link between mindfulness and walking, 
physical exercise in itself has a positive influence on psychological functioning and can reduce 
depressive symptoms 5-7. A recent meta-analysis in the UK shows that outdoor walking can 
lead to lower blood pressure, resting heart rate, body fat, body mass index, total cholesterol 
and depression, and increased VO2max and physical functioning 8. Other studies on 
environment and mental health have shown the benefits of walking in nature 9-12. In 
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summary, mindful walking in nature could contribute to keeping up both mindfulness 
practice as well as a healthy lifestyle, thereby reducing stress-related symptoms and diseases.  
Little is known about how exactly mindful walking may affect mindfulness and psychological 
functioning. One method to measure relationships between mental states in a detailed way is 
Experience Sampling Method (ESM). ESM enables repeated in-the-moment assessments of 
experiential states to measure detailed fluctuations in participants 13,14, thereby minimizing 
retrospective bias and enhancing reliability and ecological validity 13. Earlier ESM studies 
found that mindfulness stimulates upward spirals of positive affect and positive cognition 15, 
and that induced mindfulness enhanced valence and calmness, where induced rumination 
reduced these states 16. Furthermore, Snippe (2015) investigated daily affect changes during 
an MBSR training, and reported that changes in mindfulness preceded changes in affect 17. 
The current study is the first to investigate the relationship between state mindfulness and 
momentary affect with ESM during a multi-day mindful walking intervention.  
This pilot study aims to explore the feasibility and effectiveness of mindful walking as a way 
to maintain mindfulness skills in people who previously participated in either an MBCT or 
MBSR course. Using ESM data, we tested whether mindful walking has beneficial effects on 
momentary positive and negative affect, allowance of thoughts and emotions, and state 
mindfulness and compared to a control period. With time-lagged analyses, we also 
investigated temporal relations between state mindfulness (at time t-1) and momentary 
positive and negative affect (at time t), and vice versa. Finally, we tested whether walking 
more days leads to added benefits, compared to the first day of walking. On an exploratory 
base, we used questionnaires to see whether ESM results corresponded with changes in self-
reported depression, anxiety, stress, brooding, and mindfulness skills. 
 
Methods 
Participants 
All adult participants who had previously completed either an MBSR or an MBCT course at 
the Radboudumc Centre for Mindfulness in Nijmegen, the Netherlands, were eligible to 
participate in the study. There were no restrictions in terms of age, current psychopathology 
or duration since completion of the mindfulness course. Of the 49 people attending the 
organized information meeting, 32 chose to participate in the study. Three participants were 
excluded from analyses due to acquired brain damage associated with cognitive impairments, 
which raised uncertainty about whether they could properly complete the assessments. The 
remaining 29 participants were on average 54.3 years old (SD 9.0) and 69% were female 
(see Table 1). Six persons had participated in an MBSR course (general population) and 23 in 
an MBCT course (mainly patients with recurrent depressive disorder). Participation in these 
courses took place 2.7 years (SD 1.5) before the study. Many of the participants regularly 
attended reunion meetings at the Radboudumc Centre for Mindfulness. Ten people (34.5%) 
participated in the one-day walking retreat, 14 (48.3%) in the three days walking retreat and 
five (17.2%) walked for six or more days. 
 
Table 1. Characteristics of study participants. 
Participants (N=29) 1 day  
N=10 (34%) 
3 days  
N=14 (48%) 
6 or more days  
N=5 (17%) 
Age (SD) 55.1 (7.5) 52.5 (9.1) 57.9 (12.5) 
Female 9 (90%) 10 (71%) 1 (20%) 
Education 
  Lower education 
   
3 (30%) 4 (29%) 1 (20%) 
  Higher education 7 (70%) 10 (71%) 4 (80%) 
Living situation    
  Alone 2 (20%) 6 (43%) 2 (40%) 
  Partner 2 (20%) 3 (21%) 2 (40%) 
  Partner and children 6 (60%) 5 (36%) 1 (20%) 
History of depression 5 (50%) 14 (100%) 4 (80%) 
 
 
Procedure 
By means of the center’s website, a Facebook group, and on reunion days at the center, 
adult participants of previous training groups were invited to an informal meeting at which 
they were informed about both the mindful walking period itself and the associated self-
report measures and experience sampling. After the meeting, people gave their definitive 
consent to participate. For participants of the one and three days walking periods, all costs 
were reimbursed. Participants of the six or more days walking periods received €50 per day 
as a compensation for their accommodation costs. Participants were provided with 
smartphones to complete the experience sampling for ten quasi-random times a day both 
during the mindful walking period and control period (five times a day for those walking six 
or more days). In addition, participants were asked to complete self-report questionnaires 
before and after both the mindful walking period, and the control period of similar duration 
exactly one week before. As participants were no (longer) patients of the Radboud 
University Medical Center and the intervention and assessments were not considered to 
represent any risk to the participants, the medical ethics committee of the hospital waived 
the need to apply for formal ethical permission (CMO registration no. 2014/250).  
The walking route took place alongside the river Rhine, from where it enters the 
Netherlands to where it joins the North Sea, reaching a total length of 240 km. The route 
was mostly unpaved, and participants were instructed to keep the river on their right and to 
overcome obstacles they might come across, such as fences and detours, in their own way. 
They received a map with a rough description of the route and available accommodation 
addresses.  
People were offered three different possibilities to participate in the mindful walking: either 
as a one-day walking retreat in a group, accompanied by a mindfulness teacher; or a three-
day walking retreat in a group, accompanied by two mindfulness teachers; or a solitary 
walking retreat of six days or more, with the possibility of daily contact with a mindfulness 
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summary, mindful walking in nature could contribute to keeping up both mindfulness 
practice as well as a healthy lifestyle, thereby reducing stress-related symptoms and diseases.  
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Methods 
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participated in the one-day walking retreat, 14 (48.3%) in the three days walking retreat and 
five (17.2%) walked for six or more days. 
 
Table 1. Characteristics of study participants. 
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  Alone 2 (20%) 6 (43%) 2 (40%) 
  Partner 2 (20%) 3 (21%) 2 (40%) 
  Partner and children 6 (60%) 5 (36%) 1 (20%) 
History of depression 5 (50%) 14 (100%) 4 (80%) 
 
 
Procedure 
By means of the center’s website, a Facebook group, and on reunion days at the center, 
adult participants of previous training groups were invited to an informal meeting at which 
they were informed about both the mindful walking period itself and the associated self-
report measures and experience sampling. After the meeting, people gave their definitive 
consent to participate. For participants of the one and three days walking periods, all costs 
were reimbursed. Participants of the six or more days walking periods received €50 per day 
as a compensation for their accommodation costs. Participants were provided with 
smartphones to complete the experience sampling for ten quasi-random times a day both 
during the mindful walking period and control period (five times a day for those walking six 
or more days). In addition, participants were asked to complete self-report questionnaires 
before and after both the mindful walking period, and the control period of similar duration 
exactly one week before. As participants were no (longer) patients of the Radboud 
University Medical Center and the intervention and assessments were not considered to 
represent any risk to the participants, the medical ethics committee of the hospital waived 
the need to apply for formal ethical permission (CMO registration no. 2014/250).  
The walking route took place alongside the river Rhine, from where it enters the 
Netherlands to where it joins the North Sea, reaching a total length of 240 km. The route 
was mostly unpaved, and participants were instructed to keep the river on their right and to 
overcome obstacles they might come across, such as fences and detours, in their own way. 
They received a map with a rough description of the route and available accommodation 
addresses.  
People were offered three different possibilities to participate in the mindful walking: either 
as a one-day walking retreat in a group, accompanied by a mindfulness teacher; or a three-
day walking retreat in a group, accompanied by two mindfulness teachers; or a solitary 
walking retreat of six days or more, with the possibility of daily contact with a mindfulness 
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teacher by telephone, text or email. Participants were instructed to walk the route silently 
except for times conversation was necessary for practical purposes (i.e. arrival at 
accommodation). They were reminded to pay attention to their senses (i.e. sight, hearing, 
smelling, tasting, bodily sensations), emotions, thoughts and automatic behavioral patterns. 
They were encouraged to experiment with letting go of automatic behaviors (i.e. high 
demands, hurrying) and with approaching difficult emotions or situations (i.e. annoyance, 
sadness). They were also encouraged to choose wisely between walking alongside the river, 
the grass bank or the surfaced road on the dyke. For the one-day walking retreat, there was a 
15-minute sitting meditation at the start of the day, at lunchtime, and at the end of the day. 
For the three-day walking retreat, participants were offered standing yoga exercises for 30 
minutes before breakfast, a sitting meditation of 30 minutes followed by a plenary enquiry in 
the evening and the possibility of individual interviews with one of the mindfulness teachers. 
The participants walking for six or more days walked on their own and hence only received 
the general walking meditation instructions. They were, however, encouraged to spend at 
least half an hour every day to write about their experiences and process in a personal diary. 
They also had the possibility of individual interviews at the end of the day to discuss their 
process with a mindfulness teacher.  
 
The control period was of similar duration as the mindful walking period the participant had 
opted for and took place exactly one week before the intervention period, i.e. when the 
mindful walking period was from Friday to Sunday, the control period was from Friday to 
Sunday as well. The participants received no particular instructions about what to do during 
the control period. 
 
Measures 
The assessments consisted of both electronic brief questions using the Experience Sampling 
Method (ESM) at quasi-random times during the control and intervention periods, and self-
report questionnaires before and after the control and mindful walking periods.  
To closely monitor the course of participants’ experiential state, we collected ESM data 
using smartphones that quasi-randomly gave a signal several times a day between 9 AM and 4 
PM to cover the period of mindful walking, with a maximum time in between of 90 
minutes. For the one and three-day walking periods samples were taken 10 times a day, for 
the six and more day retreats five times a day. After each signal, participants answered 18 
Likert scale items each ranging from 0 (not at all) to 7 (very much). All items are listed in 
Table 2. The first nine items comprised different moods 18 with five items measuring 
positive affect (content, cheerful, relaxed, energetic, and calm) and four negative affect (sad, 
irritated, insecure, tense). The selection of affect items was based on previous experience 
sampling studies in this area of research 19,20. Cronbach’s alpha of the positive affect items 
was .92 and of negative affect items .89. The items on affect were followed by four items 
measuring suppressing or allowing negative thoughts and emotions. These items were 
 
combined into one outcome ‘allowing’, indicating the ability to allow negative thoughts and 
emotions, and not suppress them. Cronbach’s alpha of these four items was .79. Finally, 
participants answered the items with the highest factor loadings on four of the five subscales 
of the Five Facet Mindfulness Questionnaire (FFMQ) 21, namely Observing, Acting with 
awareness, Non-judgment and Non-reacting. An item on self-compassion was added instead 
of an item for Describing, which has not been found influential in previous research 22. The 
Cronbach’s alpha of these five items was .80.  
All items not filled in within 15 minutes after the signal were excluded from analysis, as 
reports completed after this interval are considered less reliable and less ecologically valid 23. 
Experience sampling data (control or intervention period) with fewer than 33% valid 
reports were also excluded from the analysis.  
 
The Dutch version of the Depression Anxiety Stress (DASS-21) questionnaire was used to 
measure depression, anxiety and stress. The three subscales each consist of seven items 
scored on a Likert scale ranging from 0 (never) to 3 (very often). The DASS-21 has good 
validity and reliability in a non-clinical sample 24, Cronbach’s alpha in this sample was 0.90. 
The brooding subscale of the 22-item Ruminative Response Scale (RRS) 25 was used to assess 
rumination. This scale consists of five items scored on a Likert scale ranging from 0 (never) 
to 3 (very often). Cronbach’s alpha of this subscale was 0.84.  
As the pre and post assessments were so close together, particularly during the one-day 
walking retreat, we selected a measure assessing mindfulness as a state rather than a trait, 
i.e. the subscales Decentering and Curiosity of the Toronto Mindfulness Scale 26. These two 
subscales are significantly and positively correlated with absorption and awareness of one’s 
surroundings. Curiosity is also significantly correlated with awareness of internal states 
(thoughts and feelings). The 13 items are scored on a 5-point Likert scale ranging from 0 
(not at all) to 4 (very much so). Their Cronbach’s alpha was 0.81. 
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Likert scale items each ranging from 0 (not at all) to 7 (very much). All items are listed in 
Table 2. The first nine items comprised different moods 18 with five items measuring 
positive affect (content, cheerful, relaxed, energetic, and calm) and four negative affect (sad, 
irritated, insecure, tense). The selection of affect items was based on previous experience 
sampling studies in this area of research 19,20. Cronbach’s alpha of the positive affect items 
was .92 and of negative affect items .89. The items on affect were followed by four items 
measuring suppressing or allowing negative thoughts and emotions. These items were 
 
combined into one outcome ‘allowing’, indicating the ability to allow negative thoughts and 
emotions, and not suppress them. Cronbach’s alpha of these four items was .79. Finally, 
participants answered the items with the highest factor loadings on four of the five subscales 
of the Five Facet Mindfulness Questionnaire (FFMQ) 21, namely Observing, Acting with 
awareness, Non-judgment and Non-reacting. An item on self-compassion was added instead 
of an item for Describing, which has not been found influential in previous research 22. The 
Cronbach’s alpha of these five items was .80.  
All items not filled in within 15 minutes after the signal were excluded from analysis, as 
reports completed after this interval are considered less reliable and less ecologically valid 23. 
Experience sampling data (control or intervention period) with fewer than 33% valid 
reports were also excluded from the analysis.  
 
The Dutch version of the Depression Anxiety Stress (DASS-21) questionnaire was used to 
measure depression, anxiety and stress. The three subscales each consist of seven items 
scored on a Likert scale ranging from 0 (never) to 3 (very often). The DASS-21 has good 
validity and reliability in a non-clinical sample 24, Cronbach’s alpha in this sample was 0.90. 
The brooding subscale of the 22-item Ruminative Response Scale (RRS) 25 was used to assess 
rumination. This scale consists of five items scored on a Likert scale ranging from 0 (never) 
to 3 (very often). Cronbach’s alpha of this subscale was 0.84.  
As the pre and post assessments were so close together, particularly during the one-day 
walking retreat, we selected a measure assessing mindfulness as a state rather than a trait, 
i.e. the subscales Decentering and Curiosity of the Toronto Mindfulness Scale 26. These two 
subscales are significantly and positively correlated with absorption and awareness of one’s 
surroundings. Curiosity is also significantly correlated with awareness of internal states 
(thoughts and feelings). The 13 items are scored on a 5-point Likert scale ranging from 0 
(not at all) to 4 (very much so). Their Cronbach’s alpha was 0.81. 
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Table 2. ESM items and Cronbach’s alpha. 
Outcome Item  Cronbach’s 
alpha 
Positive affect Right now, how cheerful are you? .92  
 Right now, how content are you? 
 Right now, how energetic are you? 
 Right now, how calm are you? 
 Right now, how relaxed are you? 
Negative affect Right now, how sad are you? .89 
 Right now, how insecure are you? 
 Right now, how irritated are you? 
 Right now, how tense are you? 
Allowing My thoughts will not leave me alone .79 
 I try to ignore my thoughts  
 My feelings carry me away  
 I try to suppress my feelings  
Mindfulness I pay attention to sensations, such as the wind in 
my hair or sun on my face 
.80 
 I perceive my feelings and emotions without having 
to react to them. 
 
 When I have distressing thoughts or images, I just 
notice them and let them go. 
 
 I find it difficult to stay focused on what’s 
happening in the present. 
 
 I am friendly and kind to myself   
All Likert scale items ranged from 1 (not at all) to 7 (very much). Cronbach’s alpha’s are based on 
between subject analyses. 
 
Data Analysis 
All analyses were performed in SPSS 22.0 27. The approach used for the ESM data  was the 
following: ESM data have a hierarchical structure. Thus, multiple observations (level 1) are 
clustered within participants (level 2). Mixed effect multilevel analyses with random (i.e., 
participant-specific) intercepts were used in order to take the variability associated with each 
level of nesting into account 28.  On top of the random intercept, all time-lagged analyses 
used auto-correlated covariance structures with a random slope. 
In the questionnaire data, 6.9% of values were missing, and these were imputed based on 
multiple imputation regression with 10 iterations. ANCOVA analyses describe the levels of 
dependent variables depression, anxiety, stress, brooding, mindfulness decentering, and 
mindfulness curiosity at each time point adjusted for gender, clinical indication, and number 
of days walked. This way the effect of the intervention could be observed more accurately, 
as gender, clinical indication and number of days walked may influence the outcome. In 
order to compare the different outcome measures, Cohen’s d for within subject 
measurements 29 was calculated by comparing the mean delta of the pre-measurement with 
 
the mean delta of the post-measurements (based on the ANCOVA results). In other words: 
Cohen’s d indicates whether the change during the walking period was larger than during the 
control period.  
 
Results 
In addition to the three cognitively impaired participants, data from two more participants 
were excluded from the ESM analysis because the proportion of valid assessments was less 
than 33%. The baseline assessment of one participant was excluded from the analyses due to 
procedural problems during data collection; the data of the intervention period were still 
used.  
The results of the regression analyses are presented in Table 3. Compared to the control 
period, the mindful walking periods resulted in a significant increase of positive affect 
(β=0.91, p<0.001) and state mindfulness (β=0.98, p<0.001), and a reduction of negative 
affect (β=-0.71, p<0.001). Allowing thoughts and emotions showed only a trend of effect 
(β=0.43, p=0.067). Positive affect and mindfulness were highly correlated (r=0.75, 
p<0.001), and there was a negative correlation between negative affect and mindfulness (r= 
-0.66, p<0.001). State mindfulness in the previous moment appeared to predict positive 
affect in the next, even after controlling for affect at the previous moment (β=0.18, 
p<0.001). Similarly, positive affect at the previous moment appeared to predict mindfulness 
in the next, even after controlling for mindfulness at the previous moment (β=0.21, 
p<0.001). Negative affect showed an opposite relationship: after controlling for the 
previous level, state mindfulness predicted a reduction of negative affect in the next moment 
(β=-0.14, p<0.001) and negative affect predicted a reduction of mindfulness in the next 
moment (β=-0.19, p<0.001). 
Mindfulness on the previous day did not predict positive affect on the next day, even after 
controlling for positive affect on the previous day (β=.23, p=.192), nor did mindfulness on 
the previous day predict a reduction of negative affect on the next day (β=-0.11, p=0.411). 
Positive affect on the previous day did however significantly predict the level of mindfulness 
on the next day when controlling for the level of mindfulness on the day before (=-0.36, 
p=0.027), and negative affect on the previous day predicted a reduction of mindfulness the 
next day (β=0.41, p=.002). Both state mindfulness and positive affect appeared to 
significantly improve with the number of days walked (β=0.14, p<0.001 and β=0.12, 
p=0.011, respectively), but negative affect did not (β=-0.04, p=0.286).  
 
 
Processed on: 27-10-2016
504961-L-bw-Gotink
9
Mindful walking using Experience Sampling Method 187
 
Table 2. ESM items and Cronbach’s alpha. 
Outcome Item  Cronbach’s 
alpha 
Positive affect Right now, how cheerful are you? .92  
 Right now, how content are you? 
 Right now, how energetic are you? 
 Right now, how calm are you? 
 Right now, how relaxed are you? 
Negative affect Right now, how sad are you? .89 
 Right now, how insecure are you? 
 Right now, how irritated are you? 
 Right now, how tense are you? 
Allowing My thoughts will not leave me alone .79 
 I try to ignore my thoughts  
 My feelings carry me away  
 I try to suppress my feelings  
Mindfulness I pay attention to sensations, such as the wind in 
my hair or sun on my face 
.80 
 I perceive my feelings and emotions without having 
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the mean delta of the post-measurements (based on the ANCOVA results). In other words: 
Cohen’s d indicates whether the change during the walking period was larger than during the 
control period.  
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In addition to the three cognitively impaired participants, data from two more participants 
were excluded from the ESM analysis because the proportion of valid assessments was less 
than 33%. The baseline assessment of one participant was excluded from the analyses due to 
procedural problems during data collection; the data of the intervention period were still 
used.  
The results of the regression analyses are presented in Table 3. Compared to the control 
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affect in the next, even after controlling for affect at the previous moment (β=0.18, 
p<0.001). Similarly, positive affect at the previous moment appeared to predict mindfulness 
in the next, even after controlling for mindfulness at the previous moment (β=0.21, 
p<0.001). Negative affect showed an opposite relationship: after controlling for the 
previous level, state mindfulness predicted a reduction of negative affect in the next moment 
(β=-0.14, p<0.001) and negative affect predicted a reduction of mindfulness in the next 
moment (β=-0.19, p<0.001). 
Mindfulness on the previous day did not predict positive affect on the next day, even after 
controlling for positive affect on the previous day (β=.23, p=.192), nor did mindfulness on 
the previous day predict a reduction of negative affect on the next day (β=-0.11, p=0.411). 
Positive affect on the previous day did however significantly predict the level of mindfulness 
on the next day when controlling for the level of mindfulness on the day before (=-0.36, 
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Because the questionnaire data are underpowered, we present Cohen’s d to give an 
indication of the effect size, rather than focusing on statistical significance. During the 
control period (between measurement 1 and 2), there were no consistent or large changes 
from pre to post (Table 4). Depression, anxiety, stress, brooding, and mindfulness all 
improved moderately (Cohen’s d ranged from 0.27 for depression to 0.53 for brooding) 
from pre to post during the intervention period (between measurement 3 and 4), but not 
statistically significant compared to the control period.  
 
Table 4. Questionnaire data: ANCOVA repeated measures analysis, Delta within control 
period and intervention period, and Standardized Effect size (Cohen’s d) 
 Time Mean (95%CI) Δ Cohen’s d (95% CI) 
Depression 
 
1 6.7 (5.3-8.2) -0.6 0.27 (-0.26 to 0.79) 
2 6.1 (4.6-7.5)   
3 5.7 (4.2-7.1) -1.8  
 4 3.9 (2.5-5.4)   
Anxiety 
 
1 5.1 (4.2-6.1) 0.0 0.45 (-0.08 to 0.98) 
2 5.1 (4.1-6.0)   
 3 4.6 (3.6-5.5) -1.7  
 4 2.9 (2.0-3.8)   
Stress 1 9.9 (8.6-11.2) -0.5 0.49 (-0.05 to 1.02) 
 2 9.4 (8.1-10.7)   
 3 9.3 (8.0-10.6) -3.0  
 4 6.3 (5.0-7.6)   
Brooding 1 6.4 (5.3-7.5) +0.3 0.53 (-0.006 to 1.06) 
 2 6.7 (5.6-7.8)   
 3 6.3 (5.3-7.4) -1.7  
 4 4.6 (3.4-5.6)   
Mindfulness 
Decentering 
1 12.6 (11.2-14.0) -0.5 0.53 (-0.005 to 1.06) 
2 12.1 (10.7-13.6)   
 3 13.2 (11.8-14.6) +2.2  
 4 15.4 (14.0-16.8)   
Mindfulness 
Curiosity 
1 14.8 (13.2-16.4) -0.1 0.20 (-0.32 to 0.73) 
2 14.7 (13.1-16.4)   
 3 16.0 (14.3-17.6) +0.9  
 4 16.9 (15.2-18.5)   
N=29. Time 1 (pre) and 2 (post) represent the control period. The intervention took place between 
Time 3 (pre) and Time 4 (post). Analyses are adjusted for sex, number of days walked, and 
MBSR/MBCT. 
95% CI: 95% Confidence Interval. A positive Cohen’s d indicates a stronger improvement on the 
outcome measure during the intervention than during the control period.  
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 4 4.6 (3.4-5.6)   
Mindfulness 
Decentering 
1 12.6 (11.2-14.0) -0.5 0.53 (-0.005 to 1.06) 
2 12.1 (10.7-13.6)   
 3 13.2 (11.8-14.6) +2.2  
 4 15.4 (14.0-16.8)   
Mindfulness 
Curiosity 
1 14.8 (13.2-16.4) -0.1 0.20 (-0.32 to 0.73) 
2 14.7 (13.1-16.4)   
 3 16.0 (14.3-17.6) +0.9  
 4 16.9 (15.2-18.5)   
N=29. Time 1 (pre) and 2 (post) represent the control period. The intervention took place between 
Time 3 (pre) and Time 4 (post). Analyses are adjusted for sex, number of days walked, and 
MBSR/MBCT. 
95% CI: 95% Confidence Interval. A positive Cohen’s d indicates a stronger improvement on the 
outcome measure during the intervention than during the control period.  
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Discussion 
This pilot study explored the feasibility and effectiveness of mindful walking as a way of 
maintaining practice after having participating in an MBCT or MBSR course, using standard 
questionnaires as well as experience sampling. The ESM data shows that mindful walking 
resulted in significant improvements of both mood and mindfulness skills. Moreover, the 
ESM data provided more detailed insight in how the moment-to-moment changes in mood 
and mindfulness affect each other during the mindful walking period: an earlier randomized 
controlled trial showed that MBCT increases positive affect as well as individual’s 
susceptibility to rewarding situations in daily life 30. The current data corroborate and extend 
this finding by showing that state mindfulness and positive affect, measured during a 
mindfulness intervention which covered a period of consecutive days, appear to stimulate 
each other. Increased state mindfulness predicted a more positive affect in the next moment 
and less negative affect, which in turn predicted a higher state mindfulness, thereby creating 
an upward spiral from one moment to the next. The moment-to-moment ESM data have 
enough power to monitor this relationship. The less well powered day-to-day data show a 
different trend, in the sense that positive affect seemed to predict less mindfulness and 
negative affect more. It could be that over such a period, having a good day slackens 
mindfulness practice on the next, where having more negative feelings increases practice the 
next day.  
 
Our findings are in accordance with previous research showing that changes in mindfulness 
precede changes in affect 17. Garland and colleagues compared interactions between positive 
affect and cognitions before and after MBCT and found that MBCT appeared to enhance 
upward spirals between positive affect and cognition 15. While Garland and Snippe 
investigated the influence of mindfulness training on mood, we investigated the moment-to 
moment temporal relationships between mindfulness and mood. Our method of analysis 
adheres to state of the art principles in multilevel time-series modeling, which has also been 
used in previous high-impact publications 17,20,31. Regarding the (underpowered) self-report 
questionnaires, the results were in line with the ESM outcomes: mindful walking can reduce 
depression, anxiety, stress and brooding, and increase mindfulness skills, although these 
changes did not reach statistical significance, compared to a control period of similar length. 
 
Although the current study offers promising results, there are several limitations that have to 
be taken into account. First, this is a small sample of self-referred participants. Chances are 
that there is a selection bias of people who benefitted from the mindfulness training or 
believe in the effect of walking in nature, and thus were more motivated to participate in this 
study. As the study population was limited to people who previously participated in MBCT 
of MBSR, it is not sure what the effectiveness of the mindful walking would have been in 
people who do not have that experience. Our choice of restricting the study population to 
graduates of the mindfulness courses was influenced by the fact that we anticipated that 
 
being in silence for prolonged periods of time would not be easy for people who are naïve to 
meditation. We also anticipated it would not have been easy for them to pay non-judgmental 
attention to bodily sensations, emotions and thoughts, to become aware of automatic 
patterns and start experimenting with alternative ways of dealing with situations without any 
further guidance. However, as the mean time since completion of the MBCT or MBSR 
course was several years for most participants, it remains unsure whether the effectiveness of 
the mindful walking was due to consolidating prior practice or rather due to being offered 
something new. Many of the participants, though, had been maintaining their mindfulness 
skills by attending the reunion meetings of the Radboudumc Centre for Mindfulness.  
 
With regard to the small sample size, the questionnaire results have been more affected than 
the ESM data due to the number of repeated measurements per person. In addition, 
although pragmatic, using subscales of validated questionnaires may reduce validity and 
reliability of our questionnaire measurements 32. Also, while most participants previously 
participated in an MBCT group for their recurrent depression, no formal psychiatric 
assessment has been done before inclusion of participants, so apart from demographic 
information unfortunately no further information about current psychopathology is 
available.  
Although the study included a control period, it did not include a control group. 
Consequently, it remains unclear if similar effects would be evident with any other activity 
in a group or in nature. Furthermore, the intervention varied in length and in presence of a 
group leader. As the intervention consisted of a combination of mindfulness practice and 
physical exercise, it also remains unclear to what extent either of these is helpful. Possibly, 
monitoring of physical exercise in addition to mood and mindfulness skills in a next study 
might enable us to further disentangle this process. Finally, the study did not include a 
follow-up period, preventing conclusions about the consolidation of the treatment effects.  
 
The results of this study should be regarded as preliminary. Replication in a properly 
powered randomized controlled trial, including a control group and a follow-up period, is 
necessary. The ESM data however, give us a glimpse of a possible working mechanism 
between mindfulness and enhanced well-being, through upward spiral effects between state 
mindfulness and improved mood from one moment to the next.   
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Abstract 
 
Mindfulness is an important skill for patients with Borderline Personality Disorder (BPD). 
Mindfulness Based Emotion Regulation Training (MB-ERT) specifically addresses the 
development of mindfulness and self-compassion in this population, characterized by 
emotion regulation problems. This exploratory study investigates the applicability and 
clinical relevance of MB-ERT as an autonomous module.   
Ten BPD patients in inpatient psychotherapeutic treatment in Centrum 
Persoonlijkheidsstoornissen Jelgersma in Oegstgeest, the Netherlands, received MB-ERT 
between February and June 2013. Mindfulness skills, rumination and borderline symptoms 
were measured and the training was evaluated by participants. 
Despite the limitations of this study, the results indicate a safe applicability of MB-ERT in 
BPD patients and significant improvements in mindfulness skills, rumination and borderline 
symptoms. 
  
 
Introduction 
BPD and emotion regulation 
Borderline Personality Disorder (BPD) is characterized by impulsiveness, deficient emotion 
regulation and a pattern of instability in self-image and interpersonal relationships 1. The easy 
emotional disruption forms the foundation for the BPD characteristic patterns in cognitive 
and behavioral instability 2-4. The behavior of BPD patients includes suicide attempts, auto 
mutilation, substance abuse, physical aggression, eating disorders and other forms of 
destructive behavior for both the patient and the environment 1,5. BPD patients have a strong 
tendency to avoid unpleasant thoughts, emotions or bodily sensations. Situations that can 
evoke these experiences are also avoided 6,7. (Self) destructive behavior can be regarded as an 
inadequate method to temporarily avoid the (emotional) suffering. 
The Trimbos Institute estimates that in the Netherlands around 100.000 patients live with 
BPD: less than 1% of the population 8. Compared to other patients with psychological 
disorders, BPD patients rely heavily on mental health care 9,10. The direct and indirect costs 
of BPD patients for the Dutch society are calculated to be two billion euro per year. 
Although almost 25% of this amount is spent on health care, the largest part is caused by the 
inability to work and job absence 11. Furthermore, there is high axis-1 comorbidity in BPD12, 
13. Treatment modules for depression, anxiety and trauma related disorders, eating disorders 
and addiction could therefore also have value in the treatment of BPD. 
 
DBT and mindfulness 
Dialectical Behavioral Therapy (DBT) is the most investigated treatment for BPD 12, 14. The 
Multidisciplinary Guideline for Personality Disorders 15 states that “DBT is an effective 
treatment for the reduction of acute hospitalization and symptoms (…) and for improving 
social functioning in patients with Borderline Personality Disorder.” According to DBT bio-
social theory, the ongoing emotional disruption is caused by mutual influence of innate 
vulnerability and invalidation from the environment. This disruption is further increased by 
the self-invalidation following the combination of these two factors 14. DBT teaches four 
clusters of skills, aimed at five areas in which BPD patients experience disruption. These 
areas are: emotions, interpersonal relations, self-image, cognitions and behavior. The four 
skill clusters are mindfulness, interpersonal effectiveness, emotion regulation and stress 
tolerance 14.  
Mindfulness in DBT is defined as the ability to focus all attention on that what arises in this 
moment, without judgment. The goal of mindfulness in DBT is becoming one with or 
engrossed in an experience or a task, which is called ‘participation’ 14, 16. Who participates, 
will act intuitively. In mindfulness, Linehan distinguishes three ‘what’-skills: observing, 
describing and participating; and three ‘how’-skills: without judgment, one task at a time, 
and acting effectively. She experimented with offering formal sitting meditation to BPD 
patients, in which they had to focus their attention on their breath for half an hour. This was 
no success: participants reported a large increase in tension and limited behavioral control 17. 
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DBT and mindfulness 
Dialectical Behavioral Therapy (DBT) is the most investigated treatment for BPD 12, 14. The 
Multidisciplinary Guideline for Personality Disorders 15 states that “DBT is an effective 
treatment for the reduction of acute hospitalization and symptoms (…) and for improving 
social functioning in patients with Borderline Personality Disorder.” According to DBT bio-
social theory, the ongoing emotional disruption is caused by mutual influence of innate 
vulnerability and invalidation from the environment. This disruption is further increased by 
the self-invalidation following the combination of these two factors 14. DBT teaches four 
clusters of skills, aimed at five areas in which BPD patients experience disruption. These 
areas are: emotions, interpersonal relations, self-image, cognitions and behavior. The four 
skill clusters are mindfulness, interpersonal effectiveness, emotion regulation and stress 
tolerance 14.  
Mindfulness in DBT is defined as the ability to focus all attention on that what arises in this 
moment, without judgment. The goal of mindfulness in DBT is becoming one with or 
engrossed in an experience or a task, which is called ‘participation’ 14, 16. Who participates, 
will act intuitively. In mindfulness, Linehan distinguishes three ‘what’-skills: observing, 
describing and participating; and three ‘how’-skills: without judgment, one task at a time, 
and acting effectively. She experimented with offering formal sitting meditation to BPD 
patients, in which they had to focus their attention on their breath for half an hour. This was 
no success: participants reported a large increase in tension and limited behavioral control 17. 
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Linehan concluded that patients benefit more from short and practical exercises aimed at 
participation. Another important concept in DBT is validation: the therapist actively 
expresses to the patient that her thoughts, feelings and behavior are understandable and 
meaningful in the context of her current situation 16. Mindfulness and validation are grouped 
under acceptance-increasing strategies. They are combined with cognitive behavioral 
therapy’s change-increasing strategies and together they form the dialectical approach of 
DBT. During treatment patients gain necessary, sometimes life-saving, control over their 
impulses and over the following (self)destructive behavior. It is also important that patients 
learn to validate their own behavior and emotions, and to do what is possible to change their 
invalidating environment into a validating one. 
The three skill clusters of DBT mentioned earlier are based on mindfulness skills. Especially 
the emotion regulation skills and the stress tolerance skills build on mindfulness. To be able 
to regulate emotions, the patient will have to be aware of her experience in the ‘here and 
now’. Standing still, observing and describing without judgment of what is happening in this 
moment are important, but often painful challenges. Opening up to inner experiences like 
thoughts, emotions and bodily sensations are a form of exposure and can reduce anxiety and 
avoiding behavior on the long term. Linehan describes three goals of training in emotion 
regulation skills: understanding experienced emotions, reducing emotional vulnerability –
for instance by taking good care of yourself and increasing positive emotions-, and reducing 
emotional suffering by focusing attention on the emotion present in this moment. This 
shows a lot of similarities to Mindfulness Based Cognitive Therapy (MBCT). 
Until now very little research has been done on the effectiveness of mindfulness as a single 
element of DBT. Regular ambulatory treatment usually takes a year and is costly in that. The 
search for an effective and efficient treatment of BPD asks for detailed research on the 
working elements of DBT. Mindfulness could be an important factor in the treatment.  
 
MBCT and self-compassion. 
Mindfulness Based Cognitive Therapy is based on Mindfulness Based Stress Reduction 
(MBSR), developed in 1982 by Jon Kabat-Zinn 18. MBCT comprises attention training 
combined with cognitive behavioral therapy elements, such as recognizing dysfunctional 
conceptions and attitudes, and changing them. In developing MBCT, Segal, Williams, and 
Teasdale concluded that ‘decentering’ is an important element in the training: patients learn 
to take an attentive, benevolent attitude towards every inner experience. They learn about 
the passing nature of their thoughts, emotions and bodily sensations, and develop a different 
relationship with their experiences (‘you are not your thoughts, you have them’). 
Participants learn to discover and to break automatic reaction patterns19. In MBCT, patients 
diagnosed with recurrent depression are offered experience focused exercises and psycho-
education during eight weekly sessions of approximately two hours.  Homework exercises in 
between the weekly sessions are an essential part of the training. Multiple meta-analyses 
show the effectiveness of MBCT in patients with three or more recurrent depressive 
 
episodes 20-22. Many of the MBCT interventions can be found in Linehan’s validating 
strategies 14, and there are many adapted mindfulness-based programs and interventions 
described for Axis-1 disorders, like compulsive disorder 23, eating disorder 24, and autism 
spectrum disorder 25. In recent years, therapists acquainted with mindfulness show a 
growing interest in self-compassion 26-28. Compassion is ‘the ability to feel involved in pain 
or suffering in both ourselves as in others. It is accompanied by the desire to alleviate this 
suffering and the willingness to take responsibility in that 29. Developing self-compassion can 
be salutary for BPD patients, as they are inclined to invalidate themselves. Furthermore, 
self-compassion seems effective in reducing experiential avoidance 30.  
 
MB-ERT 
Research shows that after DBT treatment, mindfulness skills together with the ability to 
endure crises are most applied by BPD patients 31, up to 44% of all DBT skills 32. In a pilot 
study, 40 borderline patients received mindfulness training in addition to standard 
treatment. Compared to 19 control patients, the intervention group showed increased 
attention and impulse control 33. The number of minutes participants practiced showed a 
positive relationship with self-reported emotion regulation and clinical (depressive) 
symptoms. An adjusted MBCT treatment in BPD patients showed decreased experiential 
avoidance, anxiety, and somatoform dissociation 34.  
However, MBCT was not always fitting for BPD patients: exercises were experienced as 
overflowing, and the idea rose to develop a mindfulness training for this specific patient 
group. Mindfulness Based Emotion Regulation Training (MB-ERT) is based on the MBCT 
protocol, the mindfulness and emotion regulation skills of DBT and contains self-compassion 
exercises. The training comprises 13 weekly sessions of 75 minutes and is preferably given 
by two therapists (Table 1). Similarly to MBSR and MBCT, in MB-ERT the body forms the 
starting point. Patients learn to focus attention on bodily sensations in general, or in specific 
places like the breath. They are invited to stop experiential avoidance by using small steps 
and short exercises. Just like in MBCT, they learn to distinguish experiences as cognitions, 
feelings and bodily sensations, the so-called ‘triangle of attention’.   
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Table 1. MB-ERT training 
Week Theme Subjects 
1 The automatic pilot Biosocial theory 
The ‘why’ of the training 
Connection to emotion regulation 
2 Awareness without 
judgment 
Importance of awareness without judgment* 
Awareness practices* 
Triangle of attention* 
Fundamental attitude* 
3 The body – here 
and now 
Body as point of departure* 
Attention and aversion 
The ‘here and now’-stone 
Walking with awareness (audio)* 
4 From the outside to 
inside  
Bodyscan (audio)* 
Awareness of the breath (audio)* 
5 Compassion 
towards yourself 
and others 
The importance of (self)compassion 
Self-compassion in between (audio) 
Developing kindness for yourself (audio) 
6 Perceiving and 
labeling positive 
emotions  
Positive emotion* 
Logbook pleasant events* 
Nice little moment 
7 Perceiving and 
labeling negative 
emotions  
Negative emotion* 
Labeling emotions (audio)* 
Breathing space (audio)* 
Logbook unpleasant events* 
8 Staying with Pain x resistance = suffering* 
Intense emotions x resistance = submerging emotions 
Fighting, fleeing and drowning* 
Mountain meditation (audio)* 
Sitting with difficulties (audio)* 
9 Making conscious 
choices 
Action plan to create space for wise decisions* 
Softening, soothing, and allowing (audio) 
10 Thoughts are not 
facts 
Automatic thoughts* 
Content of thoughts* 
Thoughts are not facts (audio)* 
11 Dealing with 
destructive 
thoughts 
Destructive thoughts x resistance = increased 
tendency for destructive behavior 
Action plan in case of destructive thoughts 
12 Awareness in 
contact 
Action plan meeting* 
Passive, assertive and aggressive behavior* 
13 Taking care of 
yourself  
Energy givers – energy takers* 
Eight helping factors* 
Five ways for self-compassion 
Getting into action* 
Relaxing (audio)* 
* Corresponding to MBCT and MBSR protocol 
 
Contrary to MBSR and MBCT, in MB-ERT the development of self-compassion has an 
explicit place. Second, in MB-ERT focusing attention on positive experiences is emphasized 
by acknowledging ‘a beautiful little moment’ every week.  
In the Centre Personality disorders Jelgersma (CPJ) in Oegstgeest, the Netherlands, there 
were two treatment programs available for BPD patients: Mentalisation Based Therapy 
(MBT) and DBT. Short-term clinical DBT was offered to severe BPD patients, in whom 
suicidality and auto-mutilation were profound. To explore whether mindfulness can 
improve emotion regulation, this department decided to start offering MB-ERT on 
experimental basis. Patients received mindfulness additional to the mindfulness in DBT. 
During 13 weeks, MB-ERT was offered for 75 minutes by one therapist, in groups of 5-9 
patients. From January 2012, the program was improved along the way by experiences and 
critical feedback of 32 patients. In September 2013 the protocol was published in a book: 
‘Stilstaan in de storm, mindfulness bij heftige emoties’ 35. Audio exercises can be 
downloaded from the publisher’s website.  
 
The pilot study 
The goal of this pilot study was to explore the applicability and effectiveness of the MB-ERT 
protocol as an independent module. From February to June 2013 MB-ERT was offered on 
the clinical MBT department. Contrary to DBT, on this department mindfulness is not a 
taught skill.  
 
Outcome measures 
Mindfulness 
The Kentucky Inventory of Mindfulness Skills-Extended (KIMS-E) 37 contains 46 items 
measuring five aspects of mindfulness: observing, describing, acting consciously, accepting 
without judgment and not reacting to inner experiences. These five subscales can be 
combined in a total score. The 46 items are 5-point Likert scales (‘never to seldomly true’ to 
‘very often or always true’). The KIMS-E contains the original KIMS 37, and the seven items 
of the Five Factor Mindfulness Questionnaire (FFMQ) subscale ‘not reacting on inner 
experiences’ 38. Validity and reliability of the original KIMS are good 37, the internal 
consistency of the Dutch KIMS-E is between 0.78-0.88 39.  
 
Brooding 
The Penn State Worry Questionnaire (PSWQ) measures brooding and has strong internal 
consistency and good test-retest reliability 40. The questionnaire contains items on the 
amount, intensity and disability to control brooding. The PSWQ consists of 16 items, of 
which 11 items are phrased positive and five items negative. The items are 5-point Likert 
scales, ranging from ‘Not at all typical of me’ (1) to ‘Very typical of me’ (5).  
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Borderline Personality Symptoms 
The Borderline Personality Disorder Severity Index (BPDSI-IV) is a questionnaire containing 
47 items using 5-point Likert scales (‘not at all’ to ‘very much so’)41. The BPDSI-IV 
measures BPD symptoms based on the DSM IV 42 in the preceding month, and has a very 
good internal consistency and validity 41, 46.  
 
Patient Evaluation 
An evaluation form with open questions was composed, based on the MBCT/MBSR 
evaluation form. The form contained items on the appreciation of the training, possible 
difficulties participants experienced, the effect of the training, the expectations of 
participants, the execution of home exercises, the rating of the workbook and audio 
exercises, and feedback on the therapist’s approach.  
 
Procedure 
Two weeks before the start of the additional mindfulness training, patients were informed 
verbally and in writing, and had the opportunity to ask questions. The staff was informed in a 
work meeting. There was no financial compensation for participation. The questionnaires 
were taken anonymously, and distributed and collected by the team psychologist before and 
within two weeks after the training.  
 
Analysis 
Baseline and follow-up measurements of the KIMS-E, PSWQ and BPDSI-IV were analyzed 
using a paired samples T-test. Furthermore, we analyzed per patient whether chances in 
outcome were clinically significant and reliably, using the Jacobson en Truax (1991) formula 
45. An effect is clinically signifianc when a patient’s score shifts from one belonging to a 
clinical population, to one belonging to a non-clinical population after the intervention. The 
cut-off is based on the means of functional and dysfunctional populations. For the KIMS-E 
cut-off we used the results of 215 students 37 and 101 patients with Post Traumatic Stress 
Disorder39. Of the subscale Not reacting to inner experiences there was no mean score 
available, so no cut-off could be calculated here 36 (Table 2). For the PSWQ we used the 
mean score of a ‘normal’ population 43 and of 22 patients with Generalized Anxiety Disorder 
44. On the BPDSI-IV a score of 100 or higher indicates BPD, and a score of 67 is the cut-off 
for recovery 41.  
Using the Reliable Change Index (RCI) 8, 45 we calculated whether the difference between 
pre- and post-measurement is reliable 37, 40, 43, 46. 
 
 
  
 
Results 
Patient Characteristics 
Within the study period, fifteen patients were treated on the MBT department, divided in 
two groups of seven and eight patients. The maximum treatment duration on this 
department is nine months. MB-ERT was offered weekly in these two groups by one 
therapist. Although five patients refused to fill in the questionnaires, they participated in the 
training (5.4 meetings). These five were women with a mean age of 24.8 years (range 19 – 
38 years). Four were diagnosed with BPD, one with Paranoid Personality Disorder. All of 
them had one or more Axis-1 disorders (mean 1.6), were not married and unemployed.  
The ten patients participating both measurements (eight women and two men, see Table 2), 
were present at least eight of the 13 sessions (mean 10.1). Their mean age was 35.5 years 
(range: 19 – 51 years). 
One participant was diagnosed with Personality disorder Not Otherwise Specified; the other 
nine had BPD as main diagnosis (seven had two or more personality disorders). All ten 
participants were diagnosed with one or more Axis-1 disorders (mean 1.6). All had Axis-IV 
issues: especially problems in the primary surroundings and problems with work. All were 
unemployed and were on welfare based on illness or not being able to work. Six had no 
partner (one was divorced); four were living with their partner.  
 
Table 2. Patient demografics  
 Participants 
(N=10) 
Female  80% 
Age (year, SD) 35.5 (11.6) 
Number of sessions attended  10.1 (1.9) 
BPD diagnosed 90% 
Axis-1 disorder 1.6 (range 1-3) 
Unemployed  100% 
Single 60% 
 
Questionnaires 
Table 3 shows the mean scores on both measurements. Before MB-ERT all mindfulness 
subscale scores were similar to those of a clinical population. The mean PSWQ score 
(brooding) was between scores of a normal population 43 and those of a clinical population 
with anxiety disorders 44. The mean BPDSI-IV score of 116 was above the score indicating 
BPD 41. 
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Table 3. Questionnaire scores 
 Cut-
off 
score 
Baseline 
(SD) 
Follow-
up (SD) 
Statistical 
significance 
Clinical 
significance 
Mindfulness      
Observing 37.4 32.3 (6.4) 38.8 (6.9) p < .001 - 
Describing 25.9 21.5 (6.2) 27.3 (7.3) p = .003 N=4 
Acting with 
awareness  
27.3 28.8 (6.3) 29.4 (7.2) p < .001 - 
Acceptating 27.5 22.1 (9.7) 25.5 (9.5) p = .06  N=1 
Not-responding  16.2 (4.4) 20.3 (3.7) p = .01 - 
Total score 136.5 120.8 
(23.2) 
141.3 
(27.7) 
p < .001 N=2 
      
Brooding 53.7 59.7 (9.7) 54.5 (12.0) p = .005 N=2 
      
Borderline 
Symptoms 
67 116 (26.2) 93.8 (26.7) p = .015 - 
 
After the training 
On a group level mindfulness skills increased significantly (range 8-35). Whether this is 
clinically significant cannot be calculated, as the baseline score is already above the cut-off. In 
two patients the increase was clinically significant, and in three patients the change on the 
KIMS-E Total was reliable according to the RCI. Subscale Observing showed a significant 
mean increase. In one patient the change was reliable, but not clinically significant as the 
value was above the cut-off (37.4). Subscale Describing also showed a significant mean 
increase. In four patients this increase was both reliable and clinically significant. Scores on 
subscale Conscious acting increased significantly too, though none of the changes were 
clinically significant nor reliable. On the subscale Accepting the mean increase was not 
statistically significant (p = 0.6), but in one patient the increase was both reliable and 
clinically significant. The mean score on subscale Non-reacting increased significantly, but 
clinical significance and reliability could not be assessed due to missing test data.  
 
The mean brooding score decreased significantly (PSWQ -5.5; range 2-12). Baseline scores 
of three patients were below the cut-off; in all three the decrease was reliable and in two 
patients the decrease was clinically significant.  
 
On a group level Borderline symptoms decreased significantly (BPDSI-IV -22.2, range 6-
68). None of the patients showed a clinically significant decrease of BPD (below the cut-off 
of 67). In two patients the decrease was reliable according to the RCI. 
 
All participants reported on the evaluation form that they noticed an improved ability to 
regulate their emotions. Five participants expressed the wish that MB-ERT would become a 
standard addition to MBT treatment. Participants appreciated the protocol and its 
 
applicability, the workbook, and the audio-exercises. The biggest change 9 out of 10 
participants noticed was that they applied attention more aware in their daily lives. Three 
participants mentioned difficulty with the amount of theory and the speed of the training. 
We should note that half of the participants did not practice at home. The therapist was 
prized for her clarity and patience, but was also experienced as too directive. Two 
participants did not rate the training, the other eight gave the training an 8.5 out of ten. 
 
Some statements of participants: 
‘I have learned to pause for reflection and I am more aware of small positive moments’ 
‘I succeed more often in stopping myself. I notice that I get caught up less often in a negative spiral’ 
‘The training is very much written on Borderline (PD), so that the theory is recognizable and the 
exercises endure. Finally I succeed in bringing myself to a stop regularly and accessing my emotions. This 
provides space for choosing with awareness how to react, instead of using my negative automatic pilot.’  
 
Discussion 
In recent decades, evidence has grown on the effectiveness of mindfulness in treatment of 
psychological disorders. In looking for applicability in BPD, the first therapy that comes to 
mind is DBT, a mindfulness-based therapy in itself. In this protocol, however, mindfulness is 
intertwined with other skills, which makes studying the effect of mindfulness itself becomes 
difficult. It could even be the most effective element in DBT. The aim of this pilot study was 
to gain clinical experience with MB-ERT as an independent module and assessing the 
applicability in a clinical setting for BPD patients.  
It seems that the MB-ERT protocol can be applied safely in this setting: no patients have 
deteriorated. The number of non-completers (33%; five out of fifteen) is comparable to 
other BPD studies, with drop-outs ranging from 15% 47 to 51% 34, 41, 46.  
 
On a group level we found the expected changes. Mindfulness skills increased, and brooding 
and BPD symptomatology decreased. The qualitative evaluations were positive. On 
individual level the changes were clinically significant and/or reliable only in a (small) 
minority of participants. Assessing reliability with the Reliable Change Index takes the 
standard error of the delta between two measurements into account. The test corrects for 
coincidental results, which can be larger in individuals than in groups. Downside of this 
method is that due to this correction, only very big changes can be labeled ‘reliable’, often 
bigger than occurs in patients (especially patients with severe and long-term problems like 
BPD). In the assessment of clinical significance, the cut-off value is based on a value in 
between scores of the ‘normal’ population and those of a dysfunctional population.  In a 
number of participants, the baseline measurement showed scores already below or above 
(dependent of the questionnaire) the cut-off score. In these patients, clinical significance was 
already unachievable. Furthermore, wellknown criticism on this technique states that for 
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Table 3. Questionnaire scores 
 Cut-
off 
score 
Baseline 
(SD) 
Follow-
up (SD) 
Statistical 
significance 
Clinical 
significance 
Mindfulness      
Observing 37.4 32.3 (6.4) 38.8 (6.9) p < .001 - 
Describing 25.9 21.5 (6.2) 27.3 (7.3) p = .003 N=4 
Acting with 
awareness  
27.3 28.8 (6.3) 29.4 (7.2) p < .001 - 
Acceptating 27.5 22.1 (9.7) 25.5 (9.5) p = .06  N=1 
Not-responding  16.2 (4.4) 20.3 (3.7) p = .01 - 
Total score 136.5 120.8 
(23.2) 
141.3 
(27.7) 
p < .001 N=2 
      
Brooding 53.7 59.7 (9.7) 54.5 (12.0) p = .005 N=2 
      
Borderline 
Symptoms 
67 116 (26.2) 93.8 (26.7) p = .015 - 
 
After the training 
On a group level mindfulness skills increased significantly (range 8-35). Whether this is 
clinically significant cannot be calculated, as the baseline score is already above the cut-off. In 
two patients the increase was clinically significant, and in three patients the change on the 
KIMS-E Total was reliable according to the RCI. Subscale Observing showed a significant 
mean increase. In one patient the change was reliable, but not clinically significant as the 
value was above the cut-off (37.4). Subscale Describing also showed a significant mean 
increase. In four patients this increase was both reliable and clinically significant. Scores on 
subscale Conscious acting increased significantly too, though none of the changes were 
clinically significant nor reliable. On the subscale Accepting the mean increase was not 
statistically significant (p = 0.6), but in one patient the increase was both reliable and 
clinically significant. The mean score on subscale Non-reacting increased significantly, but 
clinical significance and reliability could not be assessed due to missing test data.  
 
The mean brooding score decreased significantly (PSWQ -5.5; range 2-12). Baseline scores 
of three patients were below the cut-off; in all three the decrease was reliable and in two 
patients the decrease was clinically significant.  
 
On a group level Borderline symptoms decreased significantly (BPDSI-IV -22.2, range 6-
68). None of the patients showed a clinically significant decrease of BPD (below the cut-off 
of 67). In two patients the decrease was reliable according to the RCI. 
 
All participants reported on the evaluation form that they noticed an improved ability to 
regulate their emotions. Five participants expressed the wish that MB-ERT would become a 
standard addition to MBT treatment. Participants appreciated the protocol and its 
 
applicability, the workbook, and the audio-exercises. The biggest change 9 out of 10 
participants noticed was that they applied attention more aware in their daily lives. Three 
participants mentioned difficulty with the amount of theory and the speed of the training. 
We should note that half of the participants did not practice at home. The therapist was 
prized for her clarity and patience, but was also experienced as too directive. Two 
participants did not rate the training, the other eight gave the training an 8.5 out of ten. 
 
Some statements of participants: 
‘I have learned to pause for reflection and I am more aware of small positive moments’ 
‘I succeed more often in stopping myself. I notice that I get caught up less often in a negative spiral’ 
‘The training is very much written on Borderline (PD), so that the theory is recognizable and the 
exercises endure. Finally I succeed in bringing myself to a stop regularly and accessing my emotions. This 
provides space for choosing with awareness how to react, instead of using my negative automatic pilot.’  
 
Discussion 
In recent decades, evidence has grown on the effectiveness of mindfulness in treatment of 
psychological disorders. In looking for applicability in BPD, the first therapy that comes to 
mind is DBT, a mindfulness-based therapy in itself. In this protocol, however, mindfulness is 
intertwined with other skills, which makes studying the effect of mindfulness itself becomes 
difficult. It could even be the most effective element in DBT. The aim of this pilot study was 
to gain clinical experience with MB-ERT as an independent module and assessing the 
applicability in a clinical setting for BPD patients.  
It seems that the MB-ERT protocol can be applied safely in this setting: no patients have 
deteriorated. The number of non-completers (33%; five out of fifteen) is comparable to 
other BPD studies, with drop-outs ranging from 15% 47 to 51% 34, 41, 46.  
 
On a group level we found the expected changes. Mindfulness skills increased, and brooding 
and BPD symptomatology decreased. The qualitative evaluations were positive. On 
individual level the changes were clinically significant and/or reliable only in a (small) 
minority of participants. Assessing reliability with the Reliable Change Index takes the 
standard error of the delta between two measurements into account. The test corrects for 
coincidental results, which can be larger in individuals than in groups. Downside of this 
method is that due to this correction, only very big changes can be labeled ‘reliable’, often 
bigger than occurs in patients (especially patients with severe and long-term problems like 
BPD). In the assessment of clinical significance, the cut-off value is based on a value in 
between scores of the ‘normal’ population and those of a dysfunctional population.  In a 
number of participants, the baseline measurement showed scores already below or above 
(dependent of the questionnaire) the cut-off score. In these patients, clinical significance was 
already unachievable. Furthermore, wellknown criticism on this technique states that for 
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some populations (autism, schizophrenia), recovery is not possible 48. One could imagine 
that this might also apply in (therapy resistant) BPD patients.  
 
Previous attempts of Soler e.a. (2012) and Sachse e.a. (2010) to offer mindfulness training 
to BPD patients showed that patients who did not improve in mindfulness skills after MBCT, 
had underwent much more therapy than fellow participants that did improve. This indicates 
that therapy resistance could interfere with the possible benefit of the treatment.  They also 
found a dose-effect relation between the number of attended sessions and the decrease of 
experiential avoidance, anxiety and dissociation 34. This is in line with a relationship between 
improved emotion regulation skills and a decrease of depressive symptoms, and the number 
of minutes participants practiced formal mindfulness skills 33. This might indicate that more 
sessions, like in MB-ERT, are needed to induce change in this chronic population.  
 
Without a control group we cannot determine whether the changes are attributable to MB-
ERT. Randomization is not easy in this population, as commitment is a condition for this 
training. N=1 studies with repeated measurements, so-called case series, can be executed in 
clinical practice and could be a valuable alternative for single-group studies, and maybe even 
randomized studies 49. Another limitation is that next to the MB-ERT training, participants 
received regular MBT therapy. This also obscures to which elements of the treatment 
improvements can be attributed. The high scores at baseline and the fact that they 
participated in a clinical psychotherapeutic treatment (often after earlier ambulatory or part-
time treatment was insufficient), indicates the severity of pathology. Furthermore, the 
conclusions of this pilot study are limited by the small number of participants.  
 
The goal of the pilot study was to explore the applicability and effectiveness of the MB-ERT 
protocol. The results are positive: patients and therapists regard MB-ERT as a valuable 
addition to current options. As this study is limited by design, it is important that future 
studies use more elaborate methods to sustain current preliminary findings.  
  
 
References 
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5 2014. 
Available from: http://dsm.psychiatryonline.org/book.aspx?bookid=556. 
2. Crowell SE, Beauchaine TP, Linehan MM. A biosocial developmental model of borderline personality: 
Elaborating and extending Linehan's theory. Psychol Bull. 2009;135(3):495-510. 
3. Livesley J. Toward a genetically-informed model of borderline personality disorder. Journal of 
Personality Disorders. 2008;22(1). 
4. Reisch T, Ebner-Priemer UW, Tschacher W, Bohus M, Linehan MM. Sequences of emotions in 
patients with borderline personality disorder. Acta Psychiatr Scand. 2008;118(1):42-8. 
5. Tragesser SL, Solhan M, Brown WC, Tomko RL, Bagge C, Trull TJ. Longitudinal associ ations in 
borderline personality disorder features: Diagnostic Interview for Borderlines-Revised (DIB-R) scores 
over time. J Pers Disord. 2010;24(3):377-91. 
6. Bijttebier P, Vertommen H. Coping strategies in relation to personality disorders. . Personality and 
Individual Differences. 1999;26:847-56. 
7. Yen S, Zlotnick C, Costello E. Affect regulation in women with borderline personality disorder traits. J 
Nerv Ment Dis. 2002;190(10):693-6. 
8. Zahra DHC. The reliable change index: why isn't it more popular in academic psychology? . PsyPag 
Quarterly. 2010;76(14-19). 
9. Bender DS, Dolan RT, Skodol AE, Sanislow CA, Dyck IR, McGlashan TH, et al. Treatment utilization 
by patients with personality disorders. Am J Psychiatry. 2001;158(2):295-302. 
10. Comtois KA, Russo J, Snowden M, Srebnik D, Ries R, Roy-Byrne P. Factors associated with high use 
of public mental health services by persons with borderline personality disorder. Psychiatr Serv. 
2003;54(8):1149-54. 
11. Van Asselt ADI, Dirksen CD, Arntz A, Severens JL. The cost of borderline personality disorder: 
societal cost of illness in BPD-patients. submitted. 
12. Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet. 
2004;364(9432):453-61. 
13. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with 
borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 
2004;161(11):2108-14. 
14. Linehan MM. Cognitive-behavioral treatment of borderline personality disorder. New York: The 
Guilford Press; 1993. 
15. Trimbos Instituut. Multidisciplinaire richtlijn persoonlijkheidsstoornissen. In: GGZ LSMRid, editor. 
Utrecht: Trimbos-instituut; 2008. 
16. Meijer S., Van den Bosch W. Vademecum Dialectische Gedragstherapie, blijven zoeken naar balans. 
Amsterdam: Pearson; 2011. 
17. Welch SS, Rizvi S, Dimidjian S. Mindfulness in dialectical behavior therapy (DBT) for borderline 
personality disorder.  Mindfulness-based treatment approaches. Amsterdam: Elsevier; 2006. p. 117-39. 
18. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the 
practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp 
Psychiatry. 1982;4(1):33-47. 
19. Segal ZV, Williams M, Teasdale JD. Mindfulness-based cognitive therapy for depression: A new 
approach to preventing relapse. New York: The Guilford Press; 2002. 
20. Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration 
of differential relapse prevention effects. J Consult Clin Psychol. 2004;72(1):31-40. 
21. Piet J, Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in 
recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev. 
2011;31(6):1032-40. 
22. Fjorback LO, Arendt M, Ornbol E, Fink P, Walach H. Mindfulness-based stress reduction and 
mindfulness-based cognitive therapy: a systematic review of randomized controlled trials. Acta 
Psychiatr Scand. 2011;124(2):102-19. 
23. Didonna F. Clinical Handbook of Mindfulness New York: Springer; 2009. 
24. Wolever RQ, Best JL. Mindfulness-Based Approaches to Eating Disorders.  Clinical Handbook of 
Mindfulness New York: Springer; 2009. p. 259-87. 
25. Spek A. Mindfulness bij volwassenen met autisme – Een wegwijzer voor hulpverleners en mensen met 
ASS. Amsterdam: Hogrefe; 2010. 
Processed on: 27-10-2016
504961-L-bw-Gotink
10
Mindfulness for Borderline Personality Disorder 209
 
some populations (autism, schizophrenia), recovery is not possible 48. One could imagine 
that this might also apply in (therapy resistant) BPD patients.  
 
Previous attempts of Soler e.a. (2012) and Sachse e.a. (2010) to offer mindfulness training 
to BPD patients showed that patients who did not improve in mindfulness skills after MBCT, 
had underwent much more therapy than fellow participants that did improve. This indicates 
that therapy resistance could interfere with the possible benefit of the treatment.  They also 
found a dose-effect relation between the number of attended sessions and the decrease of 
experiential avoidance, anxiety and dissociation 34. This is in line with a relationship between 
improved emotion regulation skills and a decrease of depressive symptoms, and the number 
of minutes participants practiced formal mindfulness skills 33. This might indicate that more 
sessions, like in MB-ERT, are needed to induce change in this chronic population.  
 
Without a control group we cannot determine whether the changes are attributable to MB-
ERT. Randomization is not easy in this population, as commitment is a condition for this 
training. N=1 studies with repeated measurements, so-called case series, can be executed in 
clinical practice and could be a valuable alternative for single-group studies, and maybe even 
randomized studies 49. Another limitation is that next to the MB-ERT training, participants 
received regular MBT therapy. This also obscures to which elements of the treatment 
improvements can be attributed. The high scores at baseline and the fact that they 
participated in a clinical psychotherapeutic treatment (often after earlier ambulatory or part-
time treatment was insufficient), indicates the severity of pathology. Furthermore, the 
conclusions of this pilot study are limited by the small number of participants.  
 
The goal of the pilot study was to explore the applicability and effectiveness of the MB-ERT 
protocol. The results are positive: patients and therapists regard MB-ERT as a valuable 
addition to current options. As this study is limited by design, it is important that future 
studies use more elaborate methods to sustain current preliminary findings.  
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Abstract  
 
In psychotherapy research, double blind trials are deemed nearly impossible, as participants 
play such an active role in the intervention. In this article, we discuss the possibility of 
implementing double blind trials in psychotherapy research. We discuss essential 
components of psychotherapy, several methods used in literature, and the implications of 
their results. The Zelen design seems a feasible solution to meet the methodological issue of 
double blinding in psychotherapeutic intervention trials, as participants are unaware of the 
other treatment arm, would still have free choice in participation to the study, and would 
not be harmed by the randomization procedure. We therefore propose this model to be 
considered more often as an alternative in future psychotherapeutic research. 
  
 
Introduction 
In methodology, there are different study designs for different purposes, and each design has 
certain guidelines of how trustworthy its outcome can be interpreted as being correct, and 
when risk of bias may be present. Most of the time, a double-blind experiment is regarded 
to have a higher standard of scientific rigor than a single-blind or non-blind experiment. 
Double blinding in trials refers to the unawareness of group allocation of participants in both 
outcome assessors, intervention administrators, and participants themselves. If succeeded, 
during the trial none of these parties know which intervention is being received by wh ich 
participant. This is most relevant when it is possible that conscious or unconscious 
interference on the part of researchers, participants, or both, can affect the outcome (i.e. 
information bias). In psychotherapy research, however, double blind trials are deemed 
nearly impossible, as participants play such an active role in the intervention.  
For years, surgical research also claimed that double blind studies were impossible1. It was 
considered unethical to give a control group a sham incision without the prospect of a 
therapeutic benefit (which violates the principle of “do no harm”). Furthermore, surgeons 
expressed concerns that delaying a certain surgical procedure until after well-defined trials 
could harm patients. These arguments could also apply to psychotherapy research: keeping 
patients from treatment or offering them fake treatment could be considered unethical. 
However, ethically one can also question this rejection of procedure. How many patients 
underwent unnecessary surgical procedures and suffered adverse effects that might have 
been avoided had proper clinical trials been done beforehand? The general public can be 
protected from a treatment protocol that is ineffective, unanticipated adverse effects can be 
discovered before large numbers of patients are exposed, and post hoc analyses provide new 
insights for designing protocols that might have a better chance of success. In this 
argumentation the greater good of the population’s health outweighs participants’ needs. 
Recently, by giving participants in the placebo control group a sham operation, keeping the 
administrating surgeons outside of the investigating group and keeping the outcome assessors 
blind, this claim of impossibility proved untrue. A meta-analysis on placebo controlled trials 
of surgical procedures concluded they are a powerful, feasible way of showing efficacy with 
small risk of adverse effects. Furthermore, in half of 53 studies results provided evidence 
against continued use of the investigated surgical procedures 2. Inclusion rates of placebo-
controlled surgery studies show one in twelve participants consent, with oral explanation by 
the surgeon (69%) and contribution to research (90%) being the most important reasons to 
participate 3.  
However, the main difficulty double blinding faces in psychotherapy trials is not fear of 
harm, but the active role patients play in the intervention. In this article, we discuss the 
possibility of implementing double blind trials in psychotherapy research. First, it is 
important to understand what is meant by psychotherapy. According to Orlinsky, 
psychotherapy contains the following aspects: a formal aspect (the therapeutic contract), 
technical aspect (the therapeutic interventions), interpersonal aspect (the therapeutic 
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relationship), intrapersonal aspect (client’s characteristics), clinical aspect (impact of 
sessions) and temporal aspect (sequence of events during treatment) 4. Psychotherapy is 
defined as: “the informed and intentional application of clinical methods and interpersonal 
stances derived from established psychological principles for the purpose of assisting people 
to modify their behaviours, cognitions, emotions, and/or other personal characteristics in 
directions that the participants deem desirable.”5, 6. Second, it is important to separate the 
question whether blinding is possible from the question how we can measure whether 
psychotherapy is effective: one is the means to the other. The first is a technical problem, 
which if solved can serve clinical research with implications for practice. Once blinding is 
achieved, one can experiment more accurately with comparing therapies, components of 
therapy, therapists and patients. 
 
Terminology 
Placebo 
Literally meaning ‘I will please’ in Latin, a placebo effect influences the outcome of interest, 
and thereby obscures the pure effect of the intervention investigated. For instance, 
compared to baseline performance, participants taking a pill every day may improve over 
time even when the pill itself does nothing. This effect is then embedded in the overall 
measurement of real medication, enlarging the outcome attributed to the substance itself. 
To measure purely the effect of the intervention itself, investigators therefore often use a 
placebo intervention in the control group. A placebo intervention has been defined as ‘a 
substitute for a treatment or intervention, which has no known activity that would be 
expected to affect the outcome’ 7, 8. Blinding of participants applies specifically to the 
perception of the participant. When offering a placebo to keep participants blinded, it 
therefore has to have the exact same characteristics as the intervention in order to raise the 
same expectations, except for not having the working component of interest. The easiest 
example can be found in medication trials. The placebo pill should have the same colour, 
shape, taste, weight, intake instructions, and packaging, so that there is no information from 
which the participant can deduct his or her allocation, and the effect of solely taking a pill on 
a daily basis has been neutralized.  
When comparing psychotherapy to pharmacological treatment however, patients 
randomized to psychotherapy know to which condition they have been allocated9, 10. This 
may result in expectations affecting both treatment arms, inflating or deflating the effect 
sizes of psychotherapy11. In studies with wait lists or care-as-usual control conditions, 
information bias can be introduced. As an illustration of this problem, a recent meta-analysis 
on randomized trials comparing psychotherapy to pharmacotherapy found that single-blind 
studies (studies using no pill placebo) showed significant effect on depression in favour of 
pharmacotherapy over psychotherapy (Hedges g=0.13, 0.03 to 0.23), where double-blind 
studies (where pill placebo was implemented) did not show significant differences between 
groups (g=0.07, -0.07 to 0.21) 12. 
 
Blinding 
Where blinding of outcome assessors creates a problem less often, blinding of intervention 
administrators is in some cases more difficult. Handing out a blinded box of pills is a 
different procedure than, for instance, performing surgery or psychotherapy. As opposed to 
using an external vessel like medication, these professionals themselves are a vital part of the 
treatment: they have to know what they do with whom. Surgeons can be blinded to who is 
lying on their table, to a certain extent, and during some operations but not all. Likewise, it 
has long been convention that blinding in psychotherapeutic interventions is not possible 13, 
14. After all, psychotherapy does not use pills that can be fabricated to look alike, but 
depends on communication, contact, interaction between patient and therapist. Where pills 
have characteristics that can be copied in detail, communication is very fluent and variable. 
The intervention administrator in psychotherapy has to have knowledge of what he is doing 
and why, and blinding him can cause serious damage to the therapeutic relationship, and thus 
to the patient. Furthermore, genuineness is an important factor in the therapeutic 
relationship 15, 16: when a therapist does not believe in the treatment he is giving, the patient 
will often somehow notice. The patient, however, has a smaller role in choosing therapeutic 
interventions, and could therefore technically be blinded to which therapy he is receiving. As 
long as outcome assessor and patient are unaware of treatment allocation, double blinding 
may be considered achieved. 
 
In this article we propose a method to blind participants in psychotherapeutic intervention 
studies. To clarify our method, we will use the example of randomizing patients with 
recurrent depression to either Cognitive Behavioural Therapy (CBT), or Mindfulness Based 
Cognitive Therapy (MBCT). 
 
Method 1: Pre-randomization 
One way of keeping participants unaware of allocation (intervention or control), is if they do 
not know what the other group is receiving. A Zelen design 17 could provide that 
unawareness: after first randomising participants to a treatment arm and then asking them 
whether they would want to participate in a study on this particular intervention, patients 
would not be given information about the other treatment (Figure 1). Therefore, it is harder 
for them to distinguish whether they are receiving the intervention of interest or the control 
intervention. Second, a frustrebo response is eliminated: patients consenting because they 
wish to receive mindfulness but end up disappointed in the other treatment arm (and 
thereby interfering with treatment effect) will not occur. Another way of keeping the 
treatment options obscured is not naming the exact intervention, but calling it an 
investigation on ‘two psychotherapy treatments for recurrent depression’, treatment A and 
treatment B. 
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Figure 1. Zelen design. 
 
When comparing an additional intervention with care as usual, the participants randomized 
to the control group would be asked whether they would consent to observational research 
and partake at several measurement moments. This could also lower the threshold of 
partaking in research. 
Some ethical concerns on the Zelen design have been raised: by first randomizing and then 
asking permission of the patient, the investigator crosses privacy rules protecting the patient. 
On the other hand, the patient will notice nothing of the randomization process, and can still 
decide freely to join or decline partaking in the study. The only thing different from a 
standard randomization procedure is that he will not know about the other intervention 
group. Second, not specifying the treatment but obscuring the name is withholding 
important information from the study participant. However, expected side-effects, 
duration, frequency of contact and possibly the goal of the treatment can still be mentioned.  
 
Method 2: Language 
When not using a Zelen design and participants are aware of the other treatment arm, all 
treatment arms should offer a similar intervention: if CBT is to be compared to 
antidepressants, the CBT group should receive placebo pills, and the medication group some 
kind of weekly meetings. The placebo group session should only offer the structure and 
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social interaction, without the actual exercises given by the group therapist. As mentioned 
above, blinding applies to the senses concerned, and the primary sense in psychotherapy is 
social perception. This is such a delicate sense that our means to fake and withhold 
information in such a way that both treatment arms keep their credibility seem inadequate. 
Using language to conceal the comparison between an intervention and a wait list control 
group in a randomized setting is therefore nearly impossible. 
When comparing two psychotherapeutic interventions, one way to conceal allocation is to 
resolve the different vocabularies of different psychological protocols but offer the actual 
exercises unaltered. Rather than calling it a meditation exercise, which most likely would 
lead the participants to the conclusion they participate in a mindfulness treatment arm, one 
could refer to the exercise as ‘internal exposure practice’ or ‘concentration training’. Using 
similar terminology in the CBT group, a lay participant would probably not be able to 
distinguish what name ‘treatment A’ carries outside of the study setting. Therefore, the 
effect can be attributed to the content of the exercises themselves rather than a person’s 
attitude towards a certain treatment allocation.  
One could also try to keep all common factors the same (group size, contact hours, therapist 
attention) and vary the techniques implemented. Treatment A would be a group therapy 
conducting only the challenging thoughts intervention of CBT, Treatment B would perform 
just the observing of thoughts (open monitoring) of MBCT. To examine full therapy 
protocols, one would need many treatment arms, and as the differences between 
interventions are small, a very large population. 
 
Method 3: Computer based therapy 
Another option is to rule out the psychotherapist as intervention administrator, and to offer 
the intervention techniques by computer or audio tape. Although in this way the effect of 
solely the exercises can be tested without the social, empathic aspect of therapy, the same 
difficulties apply in blinding of the patient. If the participant is to be unaware of treatment 
allocation, language has to be equalised. Furthermore, these exercises would fit less well to 
personal needs of the patient, as a therapist might vary in pace, timing or emphasis 
depending on the patient’s needs. A recent systematic review of computerized CBT for 
anxiety and depression identified 16 studies on e-health programmes (including 11 RCTs), 
showing some evidence that computer based cognitive therapy is as effective as therapist-led 
cognitive behaviour for the treatment of depression/anxiety and phobia/panic 18. Another 
meta-analysis showed a medium effect size of Hedges g = 0.63 (two trials, N=58) in favour 
of face-to-face therapies (no confidence intervals given) 19. When comparing computer 
treatments with wait-list or treatment as usual, they found an effect size of g=0.34 (no 
confidence intervals given) in favour of computerised treatments in three studies (N=155).  
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Effects vs side effects 
Like in any other field of medicine, uniqueness of psychiatric patients plays a vital role in 
choice of treatment. Personality, background, childhood, social environment and personal 
wishes make a fitting choice of content and course of psychotherapy essential. Therefore, no 
treatment will work for all patients.  
Studies often make use of instruction manuals, and monitor whether or not the therapist 
follows that protocol. However, use of treatment manuals suggests that each manual 
contains strategies that are unique and essential to the treatment, while in practice all of 
these therapies consist of multiple interventions. Studies often do not show which treatment 
exercises are important and which ones are not, or even more importantly, which ones may 
even be counterproductive. This effectiveness of exercises is highly dependent on personal 
features: some will appeal to one and not with another. Also, delivery of techniques is often 
more important than the techniques themselves. Techniques can be performed skilfully, or 
in an abrasive, authoritarian, or uninterested way. Research suggests that the skill of the 
therapist can be more important for good results than individual exercises 20. 
If we expect exercises to be effective, one must assume that side-effects can also occur. 
Psychological research is often assumed ‘safe’ and low-risk for participants, but there 
certainly are risks involved, sometimes only noticeable on the long term 21. Psychologically 
vulnerable people can be much affected by the attitude of the therapist, certain exposure 
exercises, or the feeling of failure for instance when the therapy takes longer than expected. 
Sometimes one particular remark can give a patient a great insight, but just as well 
sometimes one remark is enough to cause tremendous stress without the therapist intending 
to do so.      
 
Discussion 
Blinding patients from a psychotherapeutic intervention is more difficult than from pills, but 
not necessarily impossible. This article offers three options by which participants can remain 
unaware of their allocation: the Zelen design, language synchronization, and computer based 
therapy. If combined, double blinding can almost certainly be obtained. If due to ethical 
reasoning the Zelen design is undesirable, applying the two therapy administration 
adjustment strategies could still obtain a certain level of participant blinding. Adjusting 
vocabulary can be a lot of work, and our example is just an example as group dynamics can 
change the direct application of certain techniques. This framework therefore has to be 
adjusted depending on which psychotherapeutic protocol is being investigated in which 
population. Furthermore, computer based therapy could lack in flexibility and empathy 
where a human psychotherapist would not. Therefore, the Zelen design seems to be the 
most suitable option to keep participants blind to their allocation in psychotherapeutic 
intervention trials. Participants would still have free choice in participation to the study, and 
would not be harmed by the randomization procedure. It would, however, lose its 
advantages if patients were in contact with each other 22. Previous studies using the Zelen 
 
design report that it may be preferable in drug addiction trials for reducing drop-out 23 and 
can increase internal validity 24. A review on 58 Zelen trials 25 reports that the most common 
reason for this method was to avoid the introduction of bias and that few had explicitly used 
the design to enhance participant recruitment. Most trials (n=41) did experience some 
crossover from one group to the other although this was usually within acceptable limits.  
The use of blinding serves the research question ‘does this therapy really work, or do 
expectations, placebo effect, attention, therapeutic relationship, and a certain structure 
explain the effect?’ One has to realize, though, expectations will always be present in human 
patients. Furthermore, in our view, attention, the therapeutic relationship and structure are 
a vital part of psychotherapy, as we address persons rather than enzymes or cells. These 
aspects of the intervention serve the delivery of techniques and exercises in such a way that 
should certain exercises prove helpful on their own, these components should still be part of 
the intervention.  
 
Also, one can argue that a (partial) placebo effect is not a bad thing. If a patient improves 
because he feels supported and seen by the therapist, they can then build a strategy by which 
the patient can provide himself with that support. One could go even further and say that 
perhaps in psychotherapy there is no such thing as a placebo effect: all variables in the 
therapeutic relationship are psychological and all are active, having some direct or specific 
effects on the patient 26.  
There is also the difference between effectiveness versus efficacy. Effectiveness refers to the 
extent to which an intervention achieves its intended effect in the usual clinical setting, 
whereas efficacy refers to the extent to which an intervention has the ability to bring about 
its intended effect under ideal circumstances, such as in a randomized clinical trial 27. 
Therefore, as participants are unaware of the other treatment arm, implementing a Zelen 
design could result in outcomes closer to reality, showing effectiveness of the intervention 
rather than efficacy. 
 
Conclusion 
The Zelen design seems a feasible solution to meet the methodological issue of double 
blinding in psychotherapeutic intervention trials.  
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Summary and general discussion 
In this thesis, our aim was to gain insight in whether offering mindfulness training to patients 
with different chronic diseases can reduce psychological distress and improve quality of life. 
Additionally, we tried to elucidate which brain structures are involved in the MBSR training, 
to improve our knowledge on a neuronal working mechanism of this eight-week protocol. 
Next to the link between mindfulness and the brain, was the effect of mindfulness training in 
heart patients. Lastly, a perspective on future applications of mindfulness is offered, and how 
we could improve research on psychotherapeutic interventions. In this chapter we report 
and discuss the main findings of our studies, and we close with concluding remarks and 
suggestions for future research on the link between mind and body. 
 
Main findings 
Overview of Mindfulness in different patient populations  
As so many trials have been conducted since 1982 1, and in turn so many systematic reviews 
have been performed to summarize the trials, in Chapter 2 we systematically reviewed 
systematic reviews of RCTs assessing MBSR and MBCT, summarizing the effects per patient 
category. This overview of MBSR and MBCT shows that both patients with medical 
conditions and those with psychological disorders benefit from these training protocols. 
Patients with cancer, chronic pain, cardiovascular disease, mental disorders, and healthy 
participants show significant improvements in depression, anxiety, stress and quality of life. 
This says little about the ‘how’ these outcomes improve, but the observed results  can help 
trigger awareness in physicians to take mindfulness into account in weighing supportive 
treatment options. In prevention, mindfulness can be valuable in teaching a coping style that 
prevents long-term stress and other psychopathological symptoms that might otherwise 
develop into clinical conditions. Since MBSR and MBCT consist of not just meditation, but 
also psycho-education and yoga exercises, it is difficult to pinpoint which aspect contributes 
most to the observed improvements. In our meta-analysis, chronic as opposed to acute 
conditions seemed to respond better to the training as acceptance and reflection may be 
more applicable to chronic symptoms than to acute symptoms. In acute settings, the focus 
often still lies on changing the undesired situation, making acceptance untimely. Publication 
bias is always a risk in reviewing current literature, as we have not assessed this we have no 
estimation of how many studies we miss. The 115 unique RCTs included, however, show 
that MBSR and MBCT have value in offering a new way of coping with daily struggles.  
 
Mindfulness and neuroimaging 
In chapter 3 we wanted to know more about the neuronal changes that accompany using 
this coping method, so that we might begin to understand how these trainings affect 
psychological functioning. We reviewed studies that looked at functional and structural 
differences in the brain after MBSR, MBCT, and aspects of the protocols. We hypothesized 
 
that the distilled techniques of MBSR and MBCT would have similar effects on brain 
structures known from neuroimaging studies on traditional meditation. Earlier meta-
analyses on traditional meditation identified increased activation in the prefrontal cortex, the 
insula, cingulate cortex and hippocampus 2-5. Although MBSR and MBCT are only eight 
weeks and cannot be expected to have the same structural effect as years of meditation,  
activation and connectivity change could give an indication of structural effects on the long 
term. The 30 neuroimaging studies on MBSR and aspects of the protocol reported similar 
effects on prefrontal cortex, insula, cingulate cortex and hippocampus. At the same time, 
the amygdala seemed to have a larger effect in MBSR participants. It showed less activity, 
increased connectivity with the prefrontal cortex and earlier deactivation after emotional 
stimuli. The amygdala is known for its central role in the fight-flight response 6, and might 
therefore be affected by learning to cope differently with stress using mindfulness. It seems 
that the prefrontal cortex, the hippocampus and the amygdala form a network that reflects 
the acquired emotion regulation by MBSR on a neuronal map. The prefrontal cortex is more 
able to down-regulate the amygdala response, taking previous experiences (hippocampus) 
into account in conscious decision making. This is in line with neuroimaging results of other 
emotion-regulation strategies, as Tang and collegues argue7, alongside with higher awareness 
of present-moment experiences. One of the explanations of the fact that the amygdala shows 
more effect in MBSR participants than in long-term meditators could be that there might be 
more room for improvement. Monks might not experience many stressful events in their 
monastery, and if they do, their long experience may enable them to cope mindfully better. 
It seems likely that Western participants, however, experience more stress in daily life, 
whether this is in proportion to the actual threat or not. Their amygdala probably shows a 
higher baseline activity than long-term meditators 8. The down-regulation of the amygdala 
and the increased activation of prefrontal cortex and hippocampus underline the stress-
reducing effect by using MBSR. However, a strong limitation of this review is the variety in 
methodology included: of the MBSR studies five were RCTs, but they used different imaging 
techniques. More RCTs are needed to confirm our hypothesis.  
 
Chapter 4 takes the observations made in the systematic review to a subcohort of the 
Rotterdam Study, a large population-based cohort in the Ommoord region of Rotterdam. A 
total of 3,742 participants were interviewed on whether they practiced any form of 
meditation, yoga, or other methods ‘to find stillness in themselves’. Furthermore, they 
underwent an MRI brain scan. Our hypothesis was that participants practicing meditation or 
yoga for more than one hour per week, report less stress and show different amygdala and 
hippocampal volumes than non-practitioners. A number of 588 participants (15.7%) 
reported practicing meditation and/or yoga, similar to other studies (18.9%)9. After 
adjustment for covariables that could also explain structural differences, we found that the 
practitioners actually reported more stress and depressive symptoms, but had a smaller right 
amygdala and left hippocampus volumes than the control group. This was remarkable, as 
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more stress and depressive symptoms are associated with larger amygdala volume. At the 
same time, 90% of practitioners did report that their method helped them cope with stress. 
This might be placebo effect (knowing they do something relieves stress but the practice 
itself has no effect), or it could indicate confounding by indication. As people experience 
more stress, it is more likely that they seek methods that are known to reduce stress. That 
way, meditation and yoga practice could be perceived as a biomarker of stress. 
 
Acknowledging the limitations of cross-sectional research, we looked at a subsample that 
underwent a scan five years earlier as well. In total 2,397 participants were included, of 
whom 9.8% practiced meditation and/or yoga for five years or longer. Over time, 
practitioners showed a stronger decrease of right amygdala volume than the control group, 
whereas the left hippocampus did not show significant differences in volume reduction. The 
latter is in line with the MBSR-studies, where hippocampal volume even increased. The 
initial smaller hippocampus could have been due to atrophy. Depression showed no 
difference in increase between the two groups, further underlining the possibility of 
confounding by indication. Although practitioners report more experienced stress, their 
brains show no compatible increased stress-structure. In other words, their higher stress 
scores might also be explained by them being more aware of their stress levels rather than 
their having higher stress levels per se.  
 
Even though we used longitudinal data, there are still limitations to take into account. First, 
although depression and anxiety were measured with validated questionnaires, stress was 
assessed with a one-item rating scale, and at only one time point, which can increase the risk 
of information bias due to inaccuracy or variability. To fully understand the relationship 
between the amygdala and stress over time, more information is needed on for instance 
experience sampling of stress or cortisol values. Second, there might be selection bias as this 
is an elderly population which is generally healthy and motivated to join research, but who 
may not be as actively involved in meditation and yoga practices as younger people. They 
might also show a different structural response than younger participants due to decreased 
brain plasticity. In addition, there is also a risk of information bias since the amount of 
practice was assessed retrospectively.  
Finally, this study took a broad approach to the intervention of interest. Practice involved 
meditation, yoga and breathing exercises, which in turn can comprise different styles and is 
broader than MBSR and MBCT. This makes accurate research harder and the 
recommendations following the results less valid.  
Although none of these brain structures can be seen separately from another and the brain 
only functions as a whole, the connectivity between prefrontal cortex, hippocampus and 
amygdala could elucidate a working mechanism underlying the psychological changes 
measured earlier.  
 
 
Mindfulness in cardiovascular disease 
In Chapter 5 we reviewed the current evidence of the effect of meditation in cardiovascular 
patients. In this systematic review and meta-analysis, we included not only MBSR, but also 
other meditation-based interventions like Zen, Vipassana and relaxation, with studies from 
various countries. Our meta-analysis showed that systolic and diastolic blood pressure 
improved, as did depressive symptoms, anxiety and quality of life. However, the 
standardized effect size was often moderate and studies were generally low in quality with a 
small sample size. Furthermore, in the pooled analyses all these different interventions 
(some of which were not meditation) were combined, inducing bias. Meditation practice 
shows encouraging results in patients with cardiac disease, but firmer research is necessary. 
Not all meditation practices are the same, just like not all cardiac patients can be compared. 
More knowledge of the working mechanism could help to decide which meditation 
technique to apply in which patient.  
 
Chapter 6 is a systematic review and meta-analysis on yoga in cardiovascular patients. 
Results showed that in patients with heart disease yoga improved body mass index, systolic 
and diastolic blood pressure, cholesterol, triglycerides, and heart rate. There is promising 
evidence of yoga on improving cardio-metabolic health, although findings are limited by 
small trial sample sizes, heterogeneity, and moderate quality of RCTs. 
Both meditation and yoga being part of the MBSR protocol, the findings of these two 
chapters support the effectiveness of MBSR in these patients. The included studies however, 
often had small sample sizes, so we designed a large RCT of high methodological quality to 
measure the effect of mindfulness in cardiovascular patients.  
 
In Chapter 7 we aimed to investigate the effectiveness of a 12-week online mindfulness 
training in a randomized controlled trial in patients with diagnosed structural heart disease, 
at the time under surveillance at the outpatient clinic of the Erasmus Medical Center, 
Rotterdam, the Netherlands. 324 patients with structural heart disease were included. The 
hypothesis was that by reducing stress, mindfulness can reduce cardiovascular risk in 
lowering blood pressure and improving heart rate and respiratory rate. These improvements 
in cardiovascular patients have been found in our meta-analyses on meditation and yoga, and 
in a meta-analysis on MBSR included in our meta-review as well 10. As these outcomes are 
related to exercise capacity, we wanted to see whether mindfulness could affect exercise 
capacity as measured by a six-minute walking test. We chose an online delivery of the 
training which was adapted to patient specific symptoms but less intensive than the standard 
MBSR program in order to be a realistic possible additive to standard treatment. After 12 
weeks, the intervention group had better exercise tolerance and a lower heart rate, although 
this was borderline significant.  
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measure the effect of mindfulness in cardiovascular patients.  
 
In Chapter 7 we aimed to investigate the effectiveness of a 12-week online mindfulness 
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related to exercise capacity, we wanted to see whether mindfulness could affect exercise 
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weeks, the intervention group had better exercise tolerance and a lower heart rate, although 
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To see how the participants developed after the online mindfulness training, Chapter 8 
reports the one-year follow-up results of this RCT. Our primary outcome, exercise 
tolerance, further improved compared to the control group. Where the intervention group 
walked 13.4 meters further than the control group right after the intervention, at 12 months 
they walked 17.9 meters further. However, the difference between groups was still 
borderline significant. All other physiological and psychological outcome measures did not 
improve significantly. Post-intervention 261 patients (80.5%) returned for follow-up 
measurement, where at 12 months 245 patients (75.6%) came back for follow-up 
measurements. Although we monitored participants’ training activity, we only have a rough 
estimation of adherence. The expected non-adherence of 50% found in the intervention 
group was anticipated adequately in the 2:1 randomization structure.  
 
To be able to compare the effect size of different outcome measures, we calculated the 
Cohen’s D standardized mean difference, which is based on a different distribution than the 
Linear Mixed Model uses. Using this method, the improvement on the 6MWT was 
significant, as were systolic blood pressure and depression symptoms. This again shows how 
choice of statistical method affects the interpretation of results. Whichever way the balance 
falls, one can question whether the improvement of walking 17.9 meters further is clinically 
meaningful: in severe COPD patients a clinical improvement was determined at 35 meters 
11. However, these patients might have more room for improvement as they walked 360 
meters at baseline, where our patients walked 540 meters and healthy participants walk 655 
meters 12. Additionally, we studied which characteristics of participants were indicative of 
treatment outcome: although women were generally more adherent, stressed men with a 
lower BMI and less psychological struggling seemed to benefit most from the program 
regarding the 6MWT. This could indicate that physicians can keep this adjunct treatment 
option in mind when seeing men, or that it might be beneficial to adjust the training to be 
more effective for women as well. For this a qualitative interview on the experiences of 
participants could be conducted in order to improve the content and delivery of the training.  
 
Our results do not correspond with those of the RCTs included in our reviews: stress, 
anxiety and quality of life did not improve. This could be partially explained by a ceiling 
effect, as the psychological baseline scores of the included patients were similar to 
population norms. The other part of lack of effect could be sought in the intervention itself. 
The low intensity of exercises of our 12-week program was part of the pragmatic and easy-
accessible approach, but it could have cut out the effective components of the original 
protocol. Intensifying the program could lead to more profound improvements as seen in 
MBSR. Intrinsic motivation is key to the effect size in these kinds of interventions, as active 
participation is required 13. The high percentage of non-adherence could be improved by 
giving some type of online feedback by a trainer. When participants can ask questions or 
express frustrations they are more likely to commit than when the information is one-way. 
 
Online training is less intense than face-to-face contact, which may influence participation 
and compliance, and is therefore expected to have a smaller effect. Furthermore, when 
getting frustrated during an online training, it is easy for a participant to drop out. Drop-out 
rates in online programs are often twice as high compared to group trainings with weekly 
meetings 14-16. In a group training the trainer could take the frustration of the participant as 
an object of mindfulness and as a metaphor for other frustrations in life. This opportunity is 
missed in our online training and could prove a beneficial addition in future application. Also 
in decreasing the intensity of the MBSR protocol, we altered an evidence-based format into 
an unfamiliar intervention. As we did not measure mindfulness, we do not know whether 
the changes found are related to an increased ability to be mindful. Furthermore, we were 
not able to blind patients to the nature of the intervention during the informed consent 
procedure. The control group therefore knew that the online mindfulness training was 
available and that they were not receiving it. This could have led to selective follow-up, 
although we found no significant difference between the groups at follow-up with regard to 
demographic and clinical variables. Nevertheless, these changes in physical functioning give 
an indication of the possibilities of an online adjunct intervention to support cardiovascular 
patients.  
 
Future applications of mindfulness training 
To continue in the exercise realm, in Chapter 9 we studied whether walking in nature can 
sustain the long term effects of mindfulness training. By using Experience Sampling, we 
were able to study the moment-by-moment changes in mood, mindfulness and coping 
behavior. This revealed a positive relationship between mindfulness and positive mood, 
which stimulate each other in an upward spiral. Though this pilot study has methodological 
limitations which could have affected the questionnaire data, the ESM data are less affected 
by the small sample size and the lack of a control group 17. Using this method for the first 
time during evoked mindfulness state, we could get a glimpse of the subtle psychological 
changes during mindful walking in nature. Although not significantly in this small, non-
clinical population, mindfulness did increase and stress, depression, anxiety, and brooding 
all decreased. Whether the changes were mostly affected by mindfulness or by being 
outdoor remains unclear, but walking in nature and mindfulness can mutually affect each 
other and form an easy accessible method for people to maintain their mindfulness practice.  
 
Chapter 10 describes a pilot study performed among Borderline Personality disorder 
patients. As earlier research showed that the meditation exercises in the regular protocol are 
too long and evoke too many fierce emotions in this population, this pilot implemented 
shorter meditations and focused on emotion regulation. Within Dialectical Behavior 
Treatment, mindfulness represents more of a distraction method away from the emotion 
(‘keep your attention on the task at hand’ Linehan 199318) than a de-identification and letting 
go. Compassion is also an important concept taught in MB-ERT, as this population is very 
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express frustrations they are more likely to commit than when the information is one-way. 
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an object of mindfulness and as a metaphor for other frustrations in life. This opportunity is 
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in decreasing the intensity of the MBSR protocol, we altered an evidence-based format into 
an unfamiliar intervention. As we did not measure mindfulness, we do not know whether 
the changes found are related to an increased ability to be mindful. Furthermore, we were 
not able to blind patients to the nature of the intervention during the informed consent 
procedure. The control group therefore knew that the online mindfulness training was 
available and that they were not receiving it. This could have led to selective follow-up, 
although we found no significant difference between the groups at follow-up with regard to 
demographic and clinical variables. Nevertheless, these changes in physical functioning give 
an indication of the possibilities of an online adjunct intervention to support cardiovascular 
patients.  
 
Future applications of mindfulness training 
To continue in the exercise realm, in Chapter 9 we studied whether walking in nature can 
sustain the long term effects of mindfulness training. By using Experience Sampling, we 
were able to study the moment-by-moment changes in mood, mindfulness and coping 
behavior. This revealed a positive relationship between mindfulness and positive mood, 
which stimulate each other in an upward spiral. Though this pilot study has methodological 
limitations which could have affected the questionnaire data, the ESM data are less affected 
by the small sample size and the lack of a control group 17. Using this method for the first 
time during evoked mindfulness state, we could get a glimpse of the subtle psychological 
changes during mindful walking in nature. Although not significantly in this small, non-
clinical population, mindfulness did increase and stress, depression, anxiety, and brooding 
all decreased. Whether the changes were mostly affected by mindfulness or by being 
outdoor remains unclear, but walking in nature and mindfulness can mutually affect each 
other and form an easy accessible method for people to maintain their mindfulness practice.  
 
Chapter 10 describes a pilot study performed among Borderline Personality disorder 
patients. As earlier research showed that the meditation exercises in the regular protocol are 
too long and evoke too many fierce emotions in this population, this pilot implemented 
shorter meditations and focused on emotion regulation. Within Dialectical Behavior 
Treatment, mindfulness represents more of a distraction method away from the emotion 
(‘keep your attention on the task at hand’ Linehan 199318) than a de-identification and letting 
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sensitive to (self) judgment 18. The pilot study showed that this adapted 13-week protocol is 
feasible in borderline patients, and that it could be effective in reducing symptoms, both 
statistically and clinically relevant. It is however limited due to lack of a control group, a 
small sample size and the fact that all participants also received MBT. A methodologically 
stronger study is under development to test these preliminary results.  
 
Chapter 11 is a methodological study that takes a broader scope to psychotherapeutic 
research. As it is nearly impossible to blind patients to a psychotherapeutic intervention, 
strategies are discussed that could enable research that resolves the problem of participants’ 
expectations towards the allocated treatment arm. As these type of interventions address 
different senses than for instance medication studies, blinding requires a more extensive 
strategy than merely copying a pill. Also, it is discussed whether these expectations are really 
a problem, as these will always be present in the clinical situation and psychotherapeutic 
interventions can adapt to them, even work with them, unlike medication.   
 
Clinical implications  
With our studies we have shown that there is evidence for the beneficial effects of MBSR and 
MBCT in supportive care of chronic conditions. Psychological functioning improves, which 
can be related to alterations in brain activity, connectivity, and structure. Online delivery 
showed borderline significant effects on exercise capacity which insinuates intensifying our 
training could attain real benefits. The studies show that the core techniques of MBSR can be 
adjusted to many different patient categories. Mindful awareness of bodily sensations, of 
negative thoughts, or of disruptive emotions like in Borderline personality disorder, all lead 
to patient-specific improvements when adjusted to patient-specific symptoms. We have 
touched on multiple methods to indicate the effect of mindfulness: from meta-analysis 
techniques using the Cohen’s D standardized effect size, to regression analysis estimates on 
the relation between psychological and physical outcomes, to detailed experience sampling 
method, to calculating clinical significance over statistical significance. All these approaches 
form a rich diversity in which we tried to elucidate the effects of MBSR and derivatives of 
the protocol from multiple perspectives. Not only physical versus psychological, not only 
brain, heart and mind, but also statistically versus clinically relevant. Because in the end all 
statistics, all methodology and all hypothesizing are aimed to better understand and possibly 
improve the outer world. The real world, where there are people, not participants. Lives, 
not scores on a questionnaire or reading instrument. The true art of research is to build the 
bridge between science and practice, so the numbers and p-values have actual meaning.  
 
 
 
 
 
It seems the techniques and experiences encompassed in the eight-week mindfulness training 
can help patients cope with daily life struggles, and that the experiential and cognitive 
teachings have an effect on physical parameters. Brain activation, connectivity, and thereby 
structures are affected by learning new response patterns. In heart patients, a mild dose of 
the training almost affected physical fitness. The connection between a mental training and 
physical outcomes shows that there is much more to learn about ways to improve patients’ 
health, and thereby how to organize healthcare.  
 
By teaching individuals to recognize automatic patterns and early signs of stress, it increases 
the ability to self-reflect and to make conscious decisions. Mindfulness teaches de-
identification (‘I have sad thoughts, but as I can observe them, I am not the thoughts’). 
Accepting thoughts as passing entities instead of identifying with or suppressing them also 
relieves a tension between you and your experience. It is okay that this feeling is here, it will 
come, pass, come again and pass again. Compassion is also an important instrument as we 
tend to judge ourselves for our flaws, which can obstruct acceptance of the situation and in 
some cases makes this worse.  
As these aspects are not easy to master, participants are recommended to apply patience 
with themselves, and not strive for perfection. As different derivatives of the initial MBSR 
program quickly arose to fit different patient populations, like we did in the online training 
and MB-ERT, Carmody & Baer (2009) studied how long the program should be in order to 
still be effective20. They report that although the eight-week program was designed to be 
long enough for participants to grasp the principles of self-regulation through mindfulness 
and develop skill and autonomy in their own practice, adaptations of MBSR that include less 
class time than the traditional format may be worthwhile for populations for whom 
reduction of psychological distress is an important goal (such as the shorter exercises in MB-
ERT for Borderline Personality Disorder patients) and for whom a lesser time commitment 
may be an important determinant of their ability to participate. MBSR, however, still has the 
most empirical support for its efficacy, and may be the format of choice for many 
applications. One study showed that more knowledge of the intervention in 140 medical 
students was strongly associated with an increased willingness to administer or recommend 
it 21. As the protocol seems to have beneficial applications in the additional care of many 
patient categories, it is important to increase knowledge about this program in medical 
professionals and integrate psychological and physical health care more. 
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Future research  
As addressed in Chapter 11, studies on psychotherapeutic interventions such as MBSR and 
MBCT can lead to more bias than in intervention studies where blinding of participants is 
easier. Psychological research therefore seems to have a set-back. Furthermore, group-based 
therapy trials should be wary of assuming independent observations:  participants may 
influence each other and thus create dependencies between observations 22. One or two very 
depressed or unmotivated participants could aggravate outcomes of the rest of the group, 
and, one or two very motivated participants could facilitate progress in their entire group. 
Williams & Russel (2008) recommend that in designing group-based therapy trials (MBCT 
training in particular) intragroup correlation should be taken into account, as should its 
variance inflation and, thus, the necessary sample size 23. Furthermore, Bergomi (2013) 
raised several issues regarding self-report measures of mindfulness 24. Limitations include 
ambiguous interpretations of some items of these scales, a lack of consensus on which aspects 
of mindfulness should be included in a scale, and the kind of relationships existing between 
them. Given the increasing application of mindfulness in research and in health-related 
fields, the assessment of mindfulness could use a more solid theoretical and methodological 
basis. The development of one golden standard that carries the consensus of the developers 
of the existing questionnaires would greatly help mindfulness research.  
 
Future research could focus on the exact link between the mind and the body, so often seen 
as separate entities. Where does the upward spiral between mindfulness and positive affect 
touch the amygdala? Where does less depression touch on walking further? In my opinion, 
there is no cut-off where mind ceases and body begins. We are one, a whole. We have the 
awareness capacity to observe both mental and bodily sensations, identifying with only one 
of them neglects a vital part of your being.  
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Future research  
As addressed in Chapter 11, studies on psychotherapeutic interventions such as MBSR and 
MBCT can lead to more bias than in intervention studies where blinding of participants is 
easier. Psychological research therefore seems to have a set-back. Furthermore, group-based 
therapy trials should be wary of assuming independent observations:  participants may 
influence each other and thus create dependencies between observations 22. One or two very 
depressed or unmotivated participants could aggravate outcomes of the rest of the group, 
and, one or two very motivated participants could facilitate progress in their entire group. 
Williams & Russel (2008) recommend that in designing group-based therapy trials (MBCT 
training in particular) intragroup correlation should be taken into account, as should its 
variance inflation and, thus, the necessary sample size 23. Furthermore, Bergomi (2013) 
raised several issues regarding self-report measures of mindfulness 24. Limitations include 
ambiguous interpretations of some items of these scales, a lack of consensus on which aspects 
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them. Given the increasing application of mindfulness in research and in health-related 
fields, the assessment of mindfulness could use a more solid theoretical and methodological 
basis. The development of one golden standard that carries the consensus of the developers 
of the existing questionnaires would greatly help mindfulness research.  
 
Future research could focus on the exact link between the mind and the body, so often seen 
as separate entities. Where does the upward spiral between mindfulness and positive affect 
touch the amygdala? Where does less depression touch on walking further? In my opinion, 
there is no cut-off where mind ceases and body begins. We are one, a whole. We have the 
awareness capacity to observe both mental and bodily sensations, identifying with only one 
of them neglects a vital part of your being.  
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Samenvatting en Algemene Discussie 
Ons doel in deze thesis was om te onderzoeken of het aanbieden van Mindfulness Based 
Stress Reduction (MBSR) en Mindfulness Based Cognitive Therapy (MBCT) bij chronische 
patiënten psychologisch lijden kan verminderen. Vervolgens probeerden we erachter te 
komen welke breinstructuren betrokken zijn bij hetgeen geleerd wordt in MBSR, om onze 
kennis van het neuronale werkingsmechanisme van dit achtweken protocol te vergroten. 
Volgend op de verbinding tussen mindfulness en het brein onderzochten we het effect van 
mindfulness training bij hartpatiënten. We sluiten af met een toekomstperspectief op 
toepassingen van mindfulness, en hoe we onderzoek naar psychotherapeutische interventies 
zouden kunnen verbeteren. In dit hoofdstuk bespreken we de hoofdbevindingen van de 
studies en besluiten we met concluderende opmerkingen en suggesties voor toekomstig 
onderzoek betreffende de verbinding tussen psyche en lichaam.  
 
Belangrijkste bevindingen 
Overzicht van Mindfulness in verschillende patiëntpopulaties  
Aangezien zoveel studies zijn uitgevoerd sinds 1982 1, en daaropvolgend zoveel 
systematische reviews zijn uitgevoerd om de studies samen te vatten, hebben wij in 
Hoofdstuk 2 een systematische review van systematische reviews van gerandomiseerde 
gecontroleerde interventiestudies van MBSR en MBCT uitgevoerd, om per 
patiëntencategorie de resultaten samen te kunnen vatten. Dit overzicht laat zien dat zowel 
patiënten met medische aandoeningen als degenen met psychologische stoornissen baat 
hebben van deze trainingen. Patiënten met kanker, chronische pijn, hart-en-vaatziekten, 
psychische stoornissen en gezonde deelnemers rapporteerden significante verbeteringen wat 
betreft symptomen van depressie, angst, stress en kwaliteit van leven. Het zegt nog weinig 
over hoe deze uitkomstmaten verbeteren, maar de geobserveerde resultaten kunnen artsen 
aansporen mindfulness te overwegen als ondersteunende behandeloptie. In de preventieve 
zorg kan mindfulness waardevol zijn door een coping methode aan te leren die op de lange 
termijn stress en andere psychopathologische symptomen kan voorkomen die anders zouden 
kunnen ontwikkelen tot stoornissen. Omdat MBSR en MBCT niet alleen uit meditatie 
bestaat maar ook psycho-educatie en yoga-oefeningen bevat, is het moeilijk om aan te wijzen 
welk aspect het meeste bijdraagt aan de geobserveerde verbeteringen. In onze meta-analyse 
leken mensen met chronische condities beter te reageren op de training dan mensen met 
acute aandoeningen, waarbij acceptatie en reflectie mogelijk te vroeg gevraagd zijn. In acute 
situaties ligt de focus immers nog vaak op het veranderen van de ongewenste toestand. 
Publicatiebias is altijd een risico bij het reviewen van bestaande literatuur; aangezien we dit 
niet hebben gemeten hebben we geen schatting van hoeveel studies we missen. De 115 
unieke RCTs laten echter zien dat MBSR en MBCT waardevol zijn door een nieuwe manier 
van coping met dagelijkse problemen aan te leren.  
 
 
Mindfulness en neuroimaging 
In Hoofdstuk 3 wilden we meer weten over de neuronale veranderingen die met het leren 
gebruiken van deze coping methode gepaard gaan, zodat we mogelijk beginnen te begrijpen 
hoe deze training het psychologisch functioneren beïnvloedt. We bestudeerden studies die 
het effect van MBSR, MBCT en componenten van de training op hersenactiviteit en -
structuur. Onze hypothese was dat de gedestilleerde technieken van MBSR en MBCT 
vergelijkbare hersengebieden zouden aanspreken als gebieden die bekend zijn uit traditionele 
meditatie onderzoeken. Eerdere meta-analyses lieten namelijk verhoogde activatie van de 
prefrontale cortex, de insula, cingulate cortex en de hippocampus zien 2-5. Hoewel MBSR en 
MBCT maar acht weken beslaan en daarom niet verwacht kan worden dat het dezelfde 
structurele verandering kan bewerkstelligen als jarenlange beoefening van meditatie, zouden 
verandering in activatie en connectiviteit van gebieden een indicatie kunnen geven van 
structurele veranderingen op de lange termijn. De 30 gevonden neuro-imaging studies 
rapporteerden vergelijkbare effecten van MBSR op de prefrontale cortex, insula, cingulate 
cortex en hippocampus. Tegelijkertijd leek de amygdala juist een groter effect te vertonen in 
MBSR deelnemers: minder activiteit, verbeterde connectiviteit met de prefrontale cortex en 
eerdere de-activatie na blootstelling aan emotionele stimuli.  
 
De amygdala is bekend van zijn rol in de fight-flight respons 6, en zou daarom beïnvloed 
kunnen worden door anders te leren omgaan met stress. Het lijkt dat de prefrontale cortex, 
de hippocampus en de amygdala een netwerk vormen dat de verworven emotieregulatie 
door MBSR in kaart brengt. De prefrontale cortex is beter in staat de amygdalarespons te 
temperen, door eerdere ervaringen (hippocampus) mee te nemen in het maken van bewuste 
beslissingen. Dit is in lijn met hersenscanresultaten van andere emotieregulatie strategieën, 
zoals Tang en collega’s aanvoeren7, samen met een vergroot bewustzijn van ervaringen in 
het hier en nu. Dat de amygdala meer effect laat zien in MBSR-deelnemers dan in jarenlange 
beoefenaars van traditionele meditatiestijlen, zou verklaard kunnen worden door een grotere 
ruimte voor verbetering. Hiervoor zou gekeken moeten worden naar het stressniveau van 
monniken versus Westerse mensen, en hun baseline amygdala activiteit. Monniken ervaren 
wellicht minder stressvolle gebeurtenissen in een klooster, en als ze dan toch plaatsvinden 
kunnen ze er door hun lange ervaring mogelijk gemakkelijker mindful mee omgaan. Het is 
waarschijnlijk dat Westerse deelnemers meer dagelijkse stress ervaren, of dit nu 
proportioneel is of niet. Het zou daardoor kunnen dat hun amygdala hogere baseline 
activiteit vertoont dan lange termijn beoefenaars 8. De afremming van de amygdala en de 
toegenomen activiteit van de prefrontale cortex en hippocampus onderstrepen het stress-
reducerende effect van MBSR. Een grote beperking van deze review is echter de variatie in 
methodologie gebruikt door de geïncludeerde studies: van de studies naar MBSR waren er 
vijf RCTs, maar deze gebruikten verschillende hersenscantechnieken. Er zijn meer RCTs 
nodig om onze hypothese te bevestigen. 
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Hoofdstuk 4 toetst de gevonden resultaten van hoofdstuk 3 in een sub-cohort van de 
Rotterdam Study, een groot bevolkingscohort in de regio Ommoord, Rotterdam. 3742 
deelnemers werden geïnterviewd over hun beoefening van meditatie, yoga, of andere 
methoden ‘om stilte in henzelf te vinden’. Ook ondergingen ze een MRI hersenscan. Onze 
hypothese was dat deelnemers die meer dan een uur meditatie of yoga beoefenden minder 
stress zouden rapporteren en andere amygdala en hippocampus volumes zouden laten zien 
dan niet-beoefenaars. 588 deelnemers (15.7%) gaven aan meditatie en/of yoga te 
beoefenen, vergelijkbaar met ander bevolkingsonderzoek (18.9%) 9. Rekening houdend met 
andere factoren die ook verschillen in hersenstructuur zouden kunnen verklaren, vonden we 
dat beoefenaars meer stress en depressieve symptomen rapporteren dan de controlegroep, 
maar een kleinere rechteramygdala en linker hippocampus hadden. Dit was opvallend, 
aangezien meer stress en depressieve symptomen juist geassocieerd zijn met een groter 
amygdalavolume. Dit zou placebo-effect kunnen zijn (weten dat ze iets doen vermindert 
stress, niet de beoefening zelf), of het wijst op confounding by indication. Omdat mensen 
meer stress ervaren, is het waarschijnlijker dat ze op zoek gaan naar methoden waarvan 
bekend is dat ze stress verminderen. Op deze manier zou meditatie en yoga beoefening 
gezien kunnen worden als een zogenaamde ‘marker’ van stress. 
 
Gezien de beperkingen van cross-sectioneel onderzoek hebben we ook gekeken naar een 
subgroep die vijf jaar daarvoor ook een MRI scan had. 2397 deelnemers werden 
geïncludeerd, waarvan 9.8% minstens vijf jaar meditatie of yoga beoefende. Gedurende die 
periode lieten beoefenaars een sterkere afname van rechter amygdalavolume zien dan de 
controlegroep, waar de linker hippocampus echter geen significante verschillen in 
volumeafname liet zien. Dit laatste is weer in lijn met MBSR-studies, waarbij de 
hippocampus zelfs toenam in volume. De initieel gevonden kleinere hippocampus zou dus 
ook atrofie kunnen zijn. De mate van toename van depressie verschilde niet tussen de twee 
groepen, hetgeen confounding by indication onderschrijft. Hoewel beoefenaars dus meer 
ervaren stress rapporteren, tonen hun hersenscans geen overeenkomstige toename van 
stress-structuur. Met andere woorden, hun hogere stress-scores zouden ook verklaard 
kunnen worden doordat ze zich beter bewust zijn van hun stressniveau.  
 
Hoewel we longitudinale data hebben gebruikt, zijn er nog steeds beperkingen die aangestipt 
moeten worden. Ten eerste, hoewel angst en depressie met gevalideerde vragenlijsten 
werden gemeten, werd stressniveau met een enkele schaal vastgesteld op een enkel 
meetmoment. Dit kan het risico op informatiebias vergroten door onnauwkeurigheid of 
variabiliteit. Om de relatie tussen de amygdala en de ontwikkeling van stress beter te 
begrijpen is meer informatie over nodig, bijvoorbeeld door experience sampling of door 
cortisolwaarden mee te nemen. Ten tweede bestaat er risico op selectiebias, aangezien de 
studiepopulatie uit oudere mensen bestaat die over het algemeen gezond zijn en gemotiveerd 
zijn om deel te nemen aan onderzoek, maar wie tegelijkertijd misschien niet zo actief zijn op 
 
het gebied van yoga en meditatie als jongeren. Ook zouden ze een andere neuronale reactie 
kunnen vertonen dan jongere deelnemers, door verminderde hersenplasticiteit. Bovendien is 
er risico op informatiebias doordat de mate van oefenen retrospectief gevraagd werd. 
Tenslotte nam deze studie een ruime benadering van de interventie: meditatie, yoga en 
ademhalingsoefeningen zijn verschillende activiteiten, die bovendien intern nog kunnen 
variëren door verschillende stijlen en dus breder zijn dan MBSR of MBCT. Dit maakt het 
onderzoek minder nauwkeurig en het advies wat eruit volgt minder valide.  
Hoewel geen van deze hersenstructuren als afgezonderd van elkaar kan worden gezien en het 
brein als geheel functioneert, zou de verbinding tussen prefrontale cortex, hippocampus en 
amygdala een werkingsmechanisme kunnen illustreren dat onder de reeds aangetoonde 
psychologische verbeteringen ligt. 
 
Mindfulness in hart- en vaatziekten 
In Hoofdstuk 5 hebben we de huidige literatuur over het effect van meditatie in 
cardiovasculaire patiënten bestudeerd. In deze systematische review en meta-analyse hebben 
we niet alleen MBSR, maar ook andere meditatie-interventies zoals Zen, Vipassana en 
ontspanningsoefeningen geïncludeerd. Onze meta-analyse liet zien dat systolische en 
diastolische bloeddruk verbeterden, alsook depressieve symptomen, angst en kwaliteit van 
leven. Wanneer gestandaardiseerd was dit effect echter vaak klein, en de studies waren van 
magere kwaliteit. In de gepoolde analyses waren deze verschillende interventies (waarvan 
sommigen ook geen meditatie bevatten) bovendien gecombineerd, wat bias introduceert. 
Het beoefenen van meditatie laat veelbelovende resultaten zijn bij cardiovasculaire 
patiënten, maar zorgvuldiger onderzoek is nodig. Niet alle meditatievormen zijn hetzelfde, 
net zoals niet alle cardiovasculaire patiënten hetzelfde zijn. Meer kennis van het 
werkingsmechanisme kan helpen bij de beslissing welke meditatietechniek het beste 
toegepast kan worden door welke patiënt.  
 
Hoofdstuk 6 is een systematische review en meta-analyse van yoga bij cardiovasculaire 
patiënten. De resultaten tonen dat yoga bij deze patiënten BMI, systolische en diastolische 
bloeddruk, cholesterol, triglyceriden, en de hartslagfrequentie verbetert. Er is dus 
veelbelovend bewijs dat yoga cardio-metabolische gezondheid kan bevorderen, hoewel de 
resultaten beperkt zijn door kleine onderzoeksgroepen, heterogeniteit en matige RCT 
kwaliteit. 
 
Meditatie en yoga vormen belangrijke onderdelen van het MBSR protocol, en de 
bevindingen van deze twee hoofdstukken wijzen op de effectiviteit van MBSR bij deze 
patiënten. De studies waarop dit gebaseerd is bevatten echter vaak kleine 
onderzoekspopulaties, dus daarom hebben we een grote RCT van hoge methodologische 
kwaliteit opgezet om het effect van mindfulness in cardiovasculaire patiënten te meten.  
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In Hoofdstuk 7 onderzochten we de effectiviteit van een 12-weken online mindfulness 
training in een gerandomiseerde gecontroleerde studie bij patiënten met gediagnostiseerde 
structurele hartafwijkingen, op dat moment onder ambulante zorg van het Erasmus MC. 324 
patiënten werden geïncludeerd. De hypothese was dat mindfulness door het verminderen 
van stress het cardiovasculaire risico kan verlagen door bloeddruk, hartslagfrequentie en 
ademhalingsfrequentie te verbeteren. Deze verbeteringen zijn eerder gevonden in onze 
reviews over meditatie en yoga, en in een meta-analyse die in Hoofdstuk 1 is geïncludeerd 
10. Omdat deze uitkomstmaten effect hebben op fysieke conditie, hebben we als primaire 
uitkomstmaat een zes-minuten looptest afgenomen. Een online training was gekozen vanuit 
praktisch oogpunt: zo konden de deelnemers de oefeningen thuis uitvoeren en gemakkelijk 
inpassen in hun agenda. De training was aangepast naar patiëntspecifieke symptomem, maar 
minder intensief dan de MBSR training. Zo zou de training als realistische mogelijke 
toevoeging aan de huidige standaardbehandeling overwogen kunnen worden. Na 12 weken 
liet de interventiegroep een betere fysieke conditie en een lagere hartslag zien, hoewel dit op 
het randje niet significant was.  
 
Om te zien hoe de deelnemers presteerden op de lange termijn, rapporteert Hoofdstuk 8 
de 12-maanden follow-up van deze studie. De fysieke conditie van de interventiegroep bleek 
nog verder te verbeteren ten opzichte van de controlegroep: waar de interventiegroep direct 
na de online training 13.4 meter verder liep dan de controlegroep, liep deze groep op 12 
maanden 17.9 meter verder. Het verschil tussen de groepen was echter nog steeds net niet 
statistisch significant. Alle andere fysiologische en psychologische uitkomstmaten 
verbeterden ook niet significant. Na de interventie kwamen 261 patiënten terug (80.5%) 
terug voor de follow-up meting, en op 12 maanden 245 patiënten (75.6%). Hoewel 
trainingsactiviteit werd bijgehouden, hebben we alleen een ruwe schatting van mate van 
adherentie. Op de verwachte non-adherentie van 50% die werd gevonden was daarom 
adequaat geanticipeerd door 2:1 te randomiseren.  
 
Om de effecten op verschillende uitkomstmaten met elkaar te kunnen vergelijken, hebben 
we de Cohen’s D ‘standardized mean difference’ berekend, welke gebruik maakt van een 
andere verdeling dan de Linear Mixed Model methode. Volgens deze berekenmethode was 
de verbetering op de 6MWT wel significant, alsmede systolische bloeddruk en depressie 
symptomen. Dit toont opnieuw aan dat keuze van statistische methode de interpretatie van 
resultaten kan beïnvloeden, zeker als de resultaten zich op het randje van significantie 
bevinden. Welke kant de balans ook uitslaat, je kunt je afvragen hoe relevant een afstand van 
17.9 meters is: in ernstig COPD patiënten is een klinisch relevante verbetering van 35 meter 
vastgesteld 11. Deze patiënten hebben echter mogelijk meer ruimte voor verbetering, 
aangezien ze 360 meter op baseline liepen, waar onze patiënten 540 meter liepen, en 
gezonde deelnemers zelfs 655 meter 12. We hebben ook bestudeerd of er deelnemers waren 
die meer baat hadden van de training dan anderen: hoewel vrouwen gemiddeld meer 
 
adherent waren, hadden licht gestreste mannen met een lagere BMI meer effect op de 
6MWT. Dit zou kunnen betekenen dat artsen online mindfulness in het achterhoofd kunnen 
houden als aanvullende leefstijlinterventie bij deze groep mannen; of dat de training 
aangepast zou kunnen worden zodat deze beter aansluit bij vrouwen. Hiervoor zou 
kwalitatief onderzoek naar de ervaringen van deelnemers uitgevoerd kunnen worden om de 
inhoud en methode van de training te optimaliseren.  
 
Onze resultaten komen niet overeen met die van de RCTs in onze reviews: stress, angst en 
kwaliteit van leven verbeterden niet. Dit kan gedeeltelijk verklaard worden door een 
zogenaamd plafond-effect: het psychologisch functioneren op de meting vóór de studie was 
niet anders dan populatiegemiddelden, waardoor hier ook weinig verbeterruimte aanwezig 
was. Het andere gedeelte kan in de interventie zelf gezocht worden: hoewel de lage 
intensiteit van het 12-weken programma onderdeel was van een pragmatische en 
toegankelijke benadering, kan het zijn dat we de werkzame elementen van het originele 
protocol te ver hebben ingekort. Het intensiveren van de online training zou kunnen leiden 
tot duidelijkere effecten zoals gezien bij MBSR. Intrinsieke motivatie is essentieel voor de 
mate van effect bij dit type interventies, daar actieve eigen bijdrage vereist is 13. Het hoge 
percentage non-adherence zou verbeterd kunnen worden door een vorm van feedback door 
een trainer toe te voegen. Wanneer deelnemers vragen kunnen stellen of frustraties kunnen 
uiten, blijven ze wellicht langer gemotiveerd dan wanneer de informatieoverdracht 
eenrichtingsverkeer is. Online training is minder intensief dan face-to-face groepstraining, 
hetgeen mate van participatie kan beïnvloeden en een kleiner effect zou kunnen 
teweegbrengen. Wanneer tijdens een online training frustratie opkomt, is het immers 
gemakkelijker om te stoppen. Uitval bij online programma’s is vaak tweemaal zo hoog als bij 
groepstrainingen met wekelijkse bijeenkomsten 14-16. Bij een groepstraining kan de trainer de 
frustratie van een deelnemer nemen als object van mindfulness en als een metafoor voor 
andere frustraties in het leven. Deze kans wordt gemist in onze online training en zou een 
goede toevoeging kunnen zijn. Met het verlagen van de intensiteit van het oorspronkelijke 
MBSR protocol hebben we een evidence-based methode veranderd in een onbekende 
interventie. Omdat we mindfulness niet gemeten hebben weten we bovendien niet of de 
veranderingen die we gevonden hebben, samenhangen met een verbeterde vaardigheid om 
mindful te zijn. Daarnaast konden we de deelnemers niet blinderen voor de interventie 
tijdens informed consent procedure. De controlegroep wist daardoor dat de online 
mindfulness training beschikbaar was en dat zij die niet ontvingen. Dit zou geleid kunnen 
hebben tot een selectieve follow-up, hoewel we geen significante verschillen tussen de 
groepen op de nameting hebben gevonden wat betreft demografische en klinische 
uitkomstmaten. Al met al wijzen de gevonden resultaten erop dat een online mindfulness 
training de standaardbehandeling van cardiovasculaire patiënten zou kunnen ondersteunen.  
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Toekomstige toepassingen van mindfulness training 
We blijven nog even bij het onderwerp lichaamsbeweging, want in Hoofdstuk 9 
bestudeerden we of wandelen in de natuur de lange termijn effecten van mindfulness 
training kan onderhouden. Door gebruik te maken van Experience Sampling konden we van 
moment tot moment veranderingen in stemming, mindfulness en coping gedrag nauwgezet 
bestuderen. Dit onthulde een positieve relatie tussen mindfulness en positieve stemming, 
waarbij deze elkaar stimuleren in een opwaartse spiraal. Hoewel deze pilotstudie 
verschillende methodologische beperkingen had die de data van de vragenlijsten kan 
beïnvloeden, heeft de ESM data minder last van de kleine studiepopulatie en het ontbreken 
van een controlegroep 17. Dit is de eerste keer dat deze methode is gebruikt tijdens een staat 
van mindfulness (in plaats van voor en na MBSR), en hierdoor konden we een glimp 
opvangen van de subtiele psychologische veranderingen tijdens mindful wandelen in de 
natuur. Hoewel het in deze kleine, niet klinische populatie niet statistisch significant was, 
namen over de tijd mindfulnessvaardigheden toe en namen stress, depressie, angst, en 
piekeren af. Het blijft onduidelijk of deze verschillen toe te wijden zijn aan mindfulness of 
aan het buiten wandelen, maar het lijkt alsof wandelen in de natuur en mindfulness elkaar 
kunnen beïnvloeden en een gemakkelijk toegankelijke methode voor mensen vormen om 
hun mindfulnessoefening te onderhouden.  
 
Hoofdstuk 10 beschrijft een pilot studie bij Borderline persoonlijkheidsstoornis patiënten. 
Omdat eerdere studies aantoonden dat de meditatieoefeningen in het standaardprotocol te 
lang zijn voor deze patiënten en teveel heftige emoties oproepen, maakte deze pilot gebruik 
van kortere oefeningen en werd er gefocust op emotieregulatie. Binnen Dialectische 
gedragstherapie staat mindfulness voor een focus weg van de emotie (‘houd je aandacht bij 
de taak omhanden’, Linehan 1993 18) en minder rondom de-identificatie en het loslaten van 
de emotie. Compassie is ook een belangrijk concept van MB-ERT, omdat deze populatie erg 
gevoelig is voor (zelf)veroordeling 19. De pilot studie liet zien dat dit aangepaste 13-weken 
protocol uitvoerbaar is bij borderline patiënten, en dat het zowel klinisch als statistisch 
gezien symptomatologie kan verbeteren. De studie wordt echter beperkt door het 
ontbreken van een controlegroep, het hebben van een kleine onderzoekspopulatie en het feit 
dat alle deelnemers ook MBT ontvingen. Een methodologisch sterkere studie wordt 
momenteel voorbereid om deze voorlopige resultaten verder te onderzoeken.  
Hoofdstuk 11 is een methodologisch artikel dat een breder perspectief neemt op 
onderzoek naar psychotherapie. Omdat het vrijwel onmogelijk is patiënten te blinderen voor 
een psychotherapeutische interventie, stelt dit artikel methoden voor om onderzoekers in 
staat te stellen met de invloed van verwachtingen van deelnemers om te gaan. Omdat 
psychotherapeutische interventies andere zintuigen aanspreken dan bijvoorbeeld 
medicatiestudies, vraagt het blinderen van deelnemers een uitgebreidere strategie dan het 
kopiëren van een pil. Het pre-randomisatie ontwerp van Zelen lijkt een waardevol 
alternatief op de traditionele gerandomiseerde studies. Er wordt ook ingegaan op de vraag of 
 
deze verwachtingen van deelnemers daadwerkelijk een probleem zijn, daar ze altijd 
aanwezig zullen zijn in de klinische werkelijkheid. Bovendien kunnen psychotherapeutische 
interventies daar soepel op aangepast worden, en er zelfs mee werken, in tegenstelling tot 
medicatie.  
 
Implicaties voor de praktijk 
Met onze studies hebben we laten zien dat er bewijs is voor de gunstige effecten van MBSR 
en MBCT in de ondersteunende zorg van chronische aandoeningen. Het psychologische 
functioneren verbetert, hetgeen verbonden kan worden aan veranderingen in 
hersenactiviteit, verbindingen en structuur. Onze online training resulteerde in een 
randsignificant effect op fysieke conditie, wat impliceert dat het intensiveren van de training 
(door meer oefeningen, langere oefeningen, of het invoegen van persoonlijk contact) deze 
patiënten echt kan helpen. De studies die gedaan zijn, laten zien dat de kerneigenschappen 
van MBSR naar verschillende patiëntencategorieën aangepast kunnen worden. Mindful 
bewustzijn van lichamelijke sensaties, van negatieve gedachten, of van heftige emoties zoals 
in Borderline persoonlijkheidsstoornis, leiden tot patiënt-specifieke vooruitgang wanneer 
aangepast naar patiënt-specifieke symptomen.  
We hebben van verschillende methoden gebruik gemaakt om het effect van mindfulness in 
kaart te brengen: van vragenlijst tot MRI-scan, van meta-analyse technieken met de Cohen’s 
D gestandaardiseerde effectmaat, tot regressieanalyse van de relatie tussen psychologische en 
fysieke uitkomstmaten, tot de gedetailleerde Experience Sampling methode, tot het 
berekenen van klinische significantie ten opzichte van statistische significantie. Al deze 
benaderingen vormen een diversiteit van perspectieven waarin we de effecten van MBSR en 
afleidingen daarvan probeerden te belichten. Niet alleen lichamelijk versus psychologisch, 
niet alleen brein, hart en geest, maar ook statistisch versus klinisch relevant. Want 
uiteindelijk zijn alle statistieken, alle methodologie en alle hypotheses bedoeld om de 
buitenwereld beter te begrijpen en mogelijk te verbeteren. De echte wereld, waar mensen 
zijn, niet deelnemers. Levens, niet scores op een vragenlijst of instrument. De kunst van 
onderzoek is een brug tussen wetenschap en praktijk te bouwen, zodat de getallen en p-
waarden betekenis krijgen.  
Het lijkt erop dat de technieken en ervaringen binnen de acht-weken mindfulness training 
patiënten kunnen helpen leren omgaan met dagelijkse problemen, en dat de experiëntiele en 
cognitieve technieken een effect hebben op fysieke parameters. Hersenactiviteit, 
connectiviteit, en daarmee hersenstructuren worden beïnvloed door het leren van nieuwe 
reactiepatronen. Bij hartpatiënten heeft een lage dosis van online mindfulness bijna fysieke 
conditie verbeterd. Deze verbinding tussen een mentale training en lichamelijke 
uitkomstmaten laat zien dat er nog veel te leren valt over hoe we de gezondheid van 
patienten kunnen verbeteren, en daarmee ook hoe we de gezondheidszorg kunnen 
organiseren.  
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Door mensen te leren hun automatische reactiepatronen en vroege signalen van stress te 
herkennen, kan mindfulness het vermogen tot zelfreflectie en het bewust keuzes maken 
vergroten. Mindfulness leert de-identificatie (‘ik heb droevige gedachten, maar aangezien ik 
ze kan observeren, ben ik ze niet’). Het accepteren van gedachten als voorbijgaande 
ervaringen, in plaats van je ermee te identificeren of ze te onderdrukken, lost ook een 
spanning op tussen jou en je ervaring. Onderdrukking werkt alleen op de korte termijn, 
waar het toelaten van ervaringen om er te zijn en ze te erkennen ontspanning kan bieden. 
Het is oké dat dit gevoel er is, het zal opkomen, voorbijgaan, weer opkomen en weer 
voorbijgaan. Compassie is ook een belangrijk element aangezien we de neiging hebben 
onszelf te veroordelen voor onze beperkingen, wat deze in sommige gevallen zelfs erger 
maakt.  
Aangezien deze aspecten niet gemakkelijk aan te leren zijn, wordt deelnemers aangeraden 
geduldig te zijn en niet perfectie na te streven. Na de ontwikkeling van MBSR zijn in korte 
tijd verschillende afgeleide programma’s ontwikkeld voor andere patiëntenpopulaties, zoals 
wij ook de online training en MB-ERT hebben gebaseerd op de originele MBSR. Carmody & 
Baer (2009) hebben bestudeerd hoe lang de training moet zijn om nog steeds effectief te zijn 
20. Ze rapporteren dat hoewel het 8-weken programma ontworpen is om deelnemers 
voldoende tijd te geven de principes van zelfregulatie door mindfulness te begrijpen en door 
eigen oefening vaardigheid en autonomie te ontwikkelen, aanpassingen van MBSR die 
minder groepstijd bevatten dan het traditionele format waardevol kunnen zijn voor 
populaties waarvoor het reduceren van psychologische stress een belangrijk doel is (zoals de 
kortere oefeningen in MB-ERT voor Borderline Persoonlijkheidsstoornis patiënten) en 
waarvoor minder tijdsbesteding een belangrijke factor is voor de mogelijkheid om deel te 
nemen. MBSR heeft echter nog steeds de meest empirische ondersteuning voor effectiviteit, 
en zou in vele gevallen de voorkeur hebben. Een andere studie liet zien dat mate van kennis 
van de mindfulness training sterk geassocieerd was met de bereidheid MBSR toe te passen of 
aan te raden 21. Aangezien de training gunstige effecten lijkt te hebben wanneer toegevoegd 
aan de standaardzorg bij veel patiëntencategorieën, is het belangrijk om de kennis over dit 
programma bij medische professionals te vergroten en psychologische en lichamelijke zorg 
meer te integreren.  
  
 
Toekomstig Onderzoek 
Zoals gezien in Hoofdstuk 11 kan in studies naar psychotherapeutische interventies zoals 
MBSR en MBCT meer ruis optreden dan in studies waar de blindering van deelnemers 
gemakkelijker is. Psychologisch onderzoek lijkt daardoor een achterstand te hebben. 
Bovendien zouden studies met groepstherapie behoedzaam moeten omgaan met de aanname 
onafhankelijke metingen te doen: deelnemers kunnen elkaar beïnvloeden 21. Enkele zeer 
depressieve of ongemotiveerde deelnemers kunnen de uitkomsten van de rest van de groep 
naar beneden trekken, en enkele zeer gemotiveerde kunnen het groepsproces juist 
versnellen. Williams & Russel (2008) raden aan dat in het ontwerpen van groepstherapie 
studies (met name de MBCT-training) rekening wordt gehouden met intragroep correlaties, 
evenals variantie inflatie en dus de nodige groepsgrootte 23. Verder heeft Bergomi (2013) 
aandacht gevraagd voor de zelfrapportage van mindfulness als meetmethode 24. Er zijn 
verschillende vragenlijsten, maar er is geen consensus over welke elementen van 
mindfulness bij welke schaal zouden moeten horen, en meerdere vragen kunnen op 
verschillende manieren worden geïnterpreteerd. Gezien het groeiende gebruik van 
mindfulness in onderzoek en in gezondheidgerelateerde velden is een steviger theoretisch 
onderbouwde en methodologische basis gewenst voor het meten van mindfulness. De 
ontwikkeling van één vragenlijst die de consensus van de makers van de andere draagt zou 
het onderzoek naar mindfulness zeer helpen.  
 
Onderzoek in de toekomst zou zich kunnen richten op de exacte verbinding tussen lichaam 
en geest, zo vaak bezien als afgescheiden entiteiten. Hoe beïnvloedt de opwaartse spiraal 
tussen mindfulness en positief affect de amygdala? Waar raakt minder depressie op verder 
lopen? Naar mijn mening is er geen grens waar de geest eindigt en het lichaam begint. We 
zijn een geheel. We hebben het bewustzijn om zowel mentale als lichamelijke sensaties te 
kunnen observeren; het identificeren met slechts een ervan verzaakt een essentieel deel van 
ons wezen. 
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De afgelopen drie jaar is er een wereld voor me opengegaan: waar ik altijd de praktijk in 
wilde en nooit over promoveren had nagedacht, kwam ik erachter dat ik het heerlijk vind 
om wetenschappelijk onderzoek te doen. Alle mensen die ik met dit werk heb leren kennen 
maakten dat ik me alleen maar meer op mijn plek voelde. Tijdens mijn werk verhuisde mijn 
focus van de epidemiologie naar de cardiologie, naar de radiologie en uiteindelijk ben ik bij 
de medische psychologie uitgekomen. De drie jaar zijn voorbij gevlogen, en voordat ik mijn 
promotie goed en wel had afgerond kon ik al op een andere plek met onderzoek beginnen, 
ditmaal dichter bij de praktijk. Ik dank u zeer voor het lezen van dit proefschrift en hoop dat 
wat ik de afgelopen jaren geleerd heb u ook van toegevoegde waarde kan zijn. Dit resultaat 
had er niet kunnen zijn zonder de invloed van vele bijzondere mensen! 
 
Mijn eerste promotor, Prof.dr. MGM Hunink, beste Myriam, 
Ik ben je ontzettend dankbaar voor de kans die je me gegeven hebt om mezelf te ontplooien 
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onze gemeenschappelijke interesses breidden het professionele vaak uit met het gezellige. Ik 
vond het heel plezierig om voor/met je te werken en ik hoop dat we in de toekomst nog 
vaker kunnen brainstormen, aan het bureau of op de mat!  
 
Mijn tweede promotor, Prof.dr. AEM Speckens, beste Anne, 
Je scherpe blik wist altijd precies uit te lichten waar ik meer uitleg moest geven of meer 
argumenten moest aanvoeren. Je ervaring in het publiceren over mindfulness heeft me 
geholpen om concreet te blijven en de rode draad goed voor ogen te houden. Je passie voor 
onderzoek naar mindfulness en je strijd voor erkenning van zorgverzekeraars zijn 
inspirerend; dank dat je mijn tweede promotor wilde zijn! 
 
Leden van de leescommissie: Prof.dr. Tiemeier, Prof.dr. Roos-Hesselink, dr. Nyklicek. 
Beste Henning, dank voor je scherpe geest en energie. Je gedrevenheid om onderzoek altijd 
zo zuiver en gedegen mogelijk uit te voeren heeft mij geinspireerd verder te gaan in dit vak 
en niet tevreden te zijn met de gemakkelijke weg. Vergeef me dat ik zo vaak om je moest 
lachen, ik vond onze gesprekken altijd zeer plezierig! Beste Jolien, dank voor je hulp en je 
vriendelijke woorden iedere keer dat ik op de cardiologiepoli rondliep in een doktersjas die 
niet van mij was. Ik waardeer je optimisme en wil om verder te kijken dan de bestaande 
structuren. Beste dr. Nyklicek, hartelijk dank voor uw bereidheid deel te nemen aan de 
leescommissie en het kritisch beoordelen van dit proefschrift. Ik hoop dat we elkaar in de 
toekomst nog vaker zullen spreken over onderzoek in de psychologie. 
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